1/2008
‫התשס"ח‬/'‫ז‬
‫רשומות‬
ISRAEL STATE RECORDS
‫י"ג באדר ב' התשס"ח‬
March 20, 2008
‫יומן הפטנטים והמדגמים‬
PATENTS AND DESIGNS JOURNAL
PATENTS
Applications filed
Applications accepted
Patents granted
Patents renewed
Patents not in force
Patents renewed for 20 years
Extension orders
Notices
Changes in particulars entered
in register
Corrigenda
Country codes
Indices of applications accepted
DESIGNS
Designs registered
Designs renewed
Designs void
1
‫עמוד‬
Page
1
199
417
418
420
421
422
424
‫פטנטים‬
426
428
i
‫בקשות שהוגשו‬
‫בקשות שקובלו‬
‫פטנטים שניתנו‬
‫פטנטים שחודשו‬
‫פטנטים שתוקפם פקעו‬
‫פטנטים שחודשו לעשרים שנה‬
‫צווי הארכה‬
‫הודעות‬
‫שינויים בפרטים רשומים‬
‫בפנקס‬
‫תיקוני טעויות‬
‫קודים למדינות‬
‫מפתחות לבקשות שקובלו‬
430
441
442
‫מדגמים‬
‫מדגמים שנרשמו‬
‫מדגמים שחודשו‬
‫מדגמים שבוטלו‬
425
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ידיעות כלליות‬
:‫ וכו' בענייני פטנטים ומדגמים יש לשלוח אל‬,‫ מסמכים‬,‫מכתבים‬
‫ ירושלים‬,4 ‫ רח' הסדנא‬,‫רשם הפטנטים והמדגמים‬
‫ ירושלים והיא פתוחה לציבור בימי חול‬,‫ תלפיות‬,4 ‫לשכת הפטנטים נמצאת ברח' הסדנא‬
.12:30 -‫ ו‬8:30 ‫שאינם ערבי שבת או מועד בין השעות‬
‫ שקלים בעד כל‬2.50 ‫לשכת הפטנטים מספקת תצלומים של פירוטים ושרטוטים במחיר של‬
.‫עמוד או חלק ממנו‬
'‫אגרות ללשכת הפטנטים מתקבלות אך ורק על ידי תשלום לחשבון הלשכה בבנק הדואר מס‬
‫ יש להציג קבלת בנק הדואר ללשכה יחד עם הבקשה לפעולה שעבורה האגרה‬. 0-24145-2
.‫שולמה‬
GENERAL INFORMATION
Letters, documents, etc. concerning Patents and Designs should be addressed to:
The Commissioner of Patents and Designs, 4 Hasadnah St., Jerusalem
The Patent Office is located at 4 Hasadnah St., Talpiot, Jerusalem and is open to the public on
weekdays, except on Fridays or on the eves of holydays, from 08:30 to 12:30 hrs.
The Patent Office supplies photocopies of specifications and drawings at the rate of NIS 2.50
per page or part thereof.
Fees to the Patent Office can be accepted only by payment to the Postal Bank Account of the
Office, No. 0-24145-2. The receipt of the Postal Bank must be presented to the office together
with the application for the action for which the fee has been paid.
Copyright by the State of Israel. No
Extracts may be published except with the
permission of the Patent Office.
‫זכות היוצרים בתקצירים אלה שמורה‬
‫ אין להעתיק מת‬,‫למדינת ישראל‬
‫קצירים‬
.‫אלה אלא ברשות לשכת הפטנטים‬
Price per single issue (incl. VAT) : NIS 96.
.₪ 96 ).‫מ‬.‫ע‬.‫ לכל חוברת בודדת (כולל מ‬:‫מחיר‬
Annual subscription (incl. VAT):
NIS 1,152.
Available at the Distribution Service of
Government Publications, 29 B-Street,
Hakirya, Tel-Aviv.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
.₪ 1,152 ).‫מ‬.‫ע‬.‫דמי חתימה לשנה (כולל מ‬
:‫אפשר להשיג אצל‬
'‫ רחוב ב‬,‫שרות ההפצה של פרסומי הממשלה‬
.‫אביב‬-‫ תל‬,‫ הקריה‬,29 '‫מס‬
2
NOTICE UNDER SECTION 16 OF THE
PATENTS LAW, 5727-1967
In the following there are listed new
Applications complying with the
Provisions of rule 32(a) of the Patent
Regulations, 5728-1968
Particulars of the applications are
given in the following order:
Number and date of application
And the first four symbols of the
International Classification
Title of invention
(as proposed by applicant)
Applicant
Priority right: Convention country –
Number and date of
Foreign application
3
‫ לחוק הפטנטים‬16 ‫הודעה לפי סעיף‬
1967 - ‫תשכ"ז‬
‫להלן רשימת בקשות חדשות‬
‫הממלאות אחר הדרישות שנקבעו‬
,‫(א) לתקנות הפטנטים‬32 ‫בתקנה‬
:1968–‫תשכ"ח‬
‫פרטי הבקשות מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה – ותאריך הגשתה‬
‫וארבעה הסמנים הראשונים של‬
‫הסיווג הבינלאומי‬
‫שם האמצאה (כפי שהוצע ע"י‬
)‫המבקש‬
‫המבקש‬
– ‫ מדינת האיגוד‬:‫דין קדימה‬
‫תאריך ומספר‬
‫בקשת החוץ‬
International Application Number
‫מספר בקשה בינלאומית‬
International Publication Number
‫מס' פרסום בינלאומי‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
01/07/2005
174526
SURFACE-COATED CUTTING TOOL
WITH COATED FILM HAVING
STRENGTH DISTRIBUTION OF
COMPRESSIVE STRESS
SUMITOMO ELECTRIC INDUSTRIES,
LTD.
2004JP
08/07/2004
202191
2004-218602 27/07/2004
JP
2004-222085 29/07/2004
JP
2004-238580 18/08/2004
JP
PCT/JP/2005/012205
WO/2006/006429
13/10/2004
174859
MINE COUNTER MEASURE SYSTEM
RAYTHEON COMPANY
US
10/685242
14/10/2003
PCT/US/2004/033980
WO/2005/099362
05/11/2004
175453
USE OF GLUCOSIDASE INHIBITORS
FOR THERAPY OF MUCOVISIDOSIS
UNIVERSITE DE POITIERS
FR
0313134
07/11/2003
PCT/FR/2004/002858
WO/2005/046672
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
B23B
‫כלי לחיתוך מצופה משטח עם משטח‬
‫עטוי שכבה דקה בעלת יכולת פיזור של‬
‫לחץ דוחס‬
B64D
‫מערכת נגד למוקשים‬
C07D
‫שימוש במעכבי גלוקוסידאז לטיפול‬
‫במוקוביסידוסיס‬
4
01/12/2004
175689
ENOXAPARIN FOR THE TREATMENT
OF CANCER
AVENTIS PHARMA S.A.
EP
03293028.1 04/12/2003
PCT/EP/2004/014807
WO/2005/053713
21/01/2005
176722
METHOD OF PRODUCING SALTS OF
DINITRAMIDIC ACID
FORSVARETS MATERIELVERK
SE
0400117-8
21/01/2004
PCT/SE/2005/000060
WO/2005/070823
17/01/2005
176776
APPARATUS AND METHOD FOR
CONSTRUCTING A MULTI-CHANNEL
OUTPUT SIGNAL OR FOR
GENERATING A DOWNMIX SIGNAL
FRAUNHOFER-GESELLSCHAFT ZUR
FORDERUNG DER ANGEWANDTEN
FORSCHUNG E.V.
US
10/762100
20/01/2004
PCT/EP/2005/000408
WO/2005/069274
5
A61K
‫אנוקסאפארין לטיפול הסרטן‬
C01B
‫שיטות לייצור מלחים של חומצה‬
‫דיניטראמידית‬
G10L
‫התקן ושיטה לבניית אות פלט רב–ערוצי‬
‫או ליצירת אות בתדירות נמוכה‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
26/01/2005
176897
A PROCEDURE FOR THE
DETERMINATION OF
FRAGMENTATION OF DNA IN
ANIMAL SPERM
UNIVERSIDAD AUTONOMA DE
MADRID
ES
200400163
26/01/2004
PCT/IB/2005/000187
WO/2006/079864
28/01/2005
‫ בזרע בעלי חיים‬DNA ‫הליך למניעת קיטוע‬
176922
C07D
‫תכשירים ושיטות לשימוש בפרוקיאנידים‬
A ‫מסוג‬
COMPOSITIONS AND METHODS OF
USE OF A-TYPE PROCYANIDINS
MARS, INCORPORATED
US
60/539689
PCT/US/2005/003406
WO/2005/072726
C12Q
28/01/2004
14/03/2005
176945
ABSORBENT PRODUCTS WITH A
LINKED ENZYME TREATMENT
KIMBERLY-CLARK WORLDWIDE,
INC.
US
10/837133
30/04/2004
PCT/US/2005/008537
WO/2005/110503
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61L
‫מוצרים סופגים המטופלים עם אנזים‬
‫מקושר‬
6
27/01/2005
177060
GASTROINTESTINAL
PROLIFERATIVE FACTOR AND USES
THEREOF
NUVELO, INC.
US
60/539605
27/01/2004
60/619241
15/10/2004
US
PCT/US/2005/002996
WO/2005/072419
18/02/2005
‫פקטור פרוליפרטיבי של הקיבה והמעיים‬
‫והשימושים בו‬
177067
IMPROVED THERAPY USING A
COMBINATION OF RALOXIFENE
AND ALENDRONATE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/545975
19/02/2004
PCT/US/2005/005267
WO/2005/079811
27/01/2005
7
A61K
‫טיפול משופרת המשלבת שימוש‬
‫ברלוקספין עם אלנדרונאט‬
‫טבע תעשיות פרמצבטיות בע"מ‬
177111
OLIGORIBONUCLEOTIDES AND
METHODS OF USE THEREOF FOR
TREATMENT OF FIBROTIC
CONDITIONS AND OTHER DISEASES
QUARK PHARMACEUTICALS, INC.
US
60/540687
30/01/2004
60/641522
04/01/2005
US
PCT/IL/2005/000102
WO/2005/072057
C07D
A61K
‫אוליגונוקלאוטידים ושיטות לשימוש בהם‬
‫לטיפול במצבים פיברוטיים ובמחלות‬
‫אחרות‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
26/01/2005
177118
USE OF A GINGO COMPLEXES FOR
THE ENHANCEMENT OF COGNITIVE
FUNCTIONS AND THE ALLEVIATION
OF MENTAL FATIGUE
INDENA S.P.A.
EP
04001937.4 29/01/2004
PCT/EP/2005/000738
WO/2005/074956
27/01/2004
GINKGO ‫שימוש בקומפלקסים של‬
‫להגברת פונקציות קוגניטיביות והקלה‬
‫בתשישות מנטלית‬
177119
MYOCARDIAL PERFUSION IMAGING
USING ADENOSINE RECEPTOR
AGONISTS
CV THERAPEUTICS, INC.
C12N
A61K
‫הדמיית פרפוזיה של שריר הלב באמצעות‬
‫שימוש באגוניסטים של קולטן אדנוסין‬
PCT/US/2004/002304
WO/2005/082379
28/01/2005
177143
COMPOSITIONS, METHODS AND
USES FOR A NOVEL FAMILY OF
PEPTIDES
THE TEXAS A&M UNIVERSITY
SYSTEM
US
60/540569
30/01/2004
PCT/US/2005/003343
WO/2005/074626
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07K
‫ שיטות ושימושים למשפחה‬,‫תכשירים‬
‫חדשה של פפטידים‬
8
04/02/2005
177179
METHODS OF REFOLDING
MAMMALIAM
GLYCOSYLTRANSFERASES
NEOSE TECHNOLOGIES, INC.
US
60/542210
04/02/2004
60/599406
06/08/2004
US
60/627406
12/11/2004
US
PCT/US/2005/003856
WO/2005/089102
09/02/2005
31/01/2005
‫שיטות לקיפול מחדש של‬
‫גליקוסילטרנספראזים של יונקים‬
177239
MONOCLONAL ANTIBODY BASED
BIOMARKER DISCOVERY AND
DEVELOPMENT PLATFORM
NORTHEASTERN UNIVERSITY
US
60/543004
09/02/2004
PCT/US/2005/004484
WO/2005/077106
177247
177323
A DIGITAL PRINTING APPARATUS
KORNIT DIGITAL LTD.
US
10/776163
12/02/2004
162231
30/05/2004
IL
PCT/IL/2005/000166
WO/2005/076730
9
C12N
‫המצאה של סמן ביולוגי המבוסס על נוגדן‬
‫חי–שבטי ותשתית התפתחות‬
TECHNIQUES FOR PREDICTION AND
MONITORING OF RESPIRATIONMANIFESTED CLINICAL EPISODES
LANGE DANIEL
US
60/541779
05/02/2004
PCT/IL/2005/000113
WO/2005/074361
10/02/2005
A61K
G01N
‫שיטות לחיזוי וניתור של ארועים קליניים‬
‫המתבטאים בנשימה‬
‫לאנג דניאל‬
C07D
‫מכונת דפוס דיגיטאלי‬
‫קורנית דיגיטל בע"מ‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
16/03/2005
177424
GALENIC FORMULATIONS OF
ORGANIC COMPOUNDS
NOVARTIS AG
US
60/553878
17/03/2004
PCT/EP/2005/002798
WO/2005/089729
03/03/2005
‫תכשירים גלניים של תרכובות אורגניות‬
177467
MEDIA FOR CLOSTRIDIUM
BACTERIUM AND PROCESSES FOR
OBTAINING A CLOSTRIDIAL TOXIN
ALLERGAN, INC.
US
11/072050
03/03/2005
11/072673
03/03/2005
US
PCT/US/2005/007014
WO/2006/096164
03/03/2005
17/02/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07K
‫מערכת נקי ממוצר מן החי ותהליך לטהר‬
‫רעלן בוטולינם‬
177473
DISACCHARIDE MOLECULES AND
DERIVATIVES THEREOF AND
METHODS OF USING SAME
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
60/544305
17/02/2004
PCT/IL/2005/000197
WO/2005/076743
A61K
‫מדיה לחיידקי קלוסטרידיום ותהליכים‬
‫לקבל רעלן קלוסטרידיאלי‬
177468
ANIMAL PRODUCT FREE SYSTEM
AND PROCESS FOR PURIFYING A
BOTULINUM TOXIN
ALLERGAN, INC.
US
11/072050
03/03/2005
11/072673
03/03/2005
US
PCT/US/2005/007013
WO/2006/096163
E01B
C07K
‫ ושימושים‬,‫חומרים דיסכרידיים ונגזרותיהם‬
‫בהם‬
‫ידע חברה למחקר ופיתוח בע"מ‬
10
22/02/2005
177489
SYSTEMS AND METHODS FOR
PARALLEL COMMUNICATION
GEORGIA TECH RESEARCH
CORPORATION
US
60/546034
19/02/2004
11/063284
22/02/2005
US
PCT/US/2005/005509
WO/2005/079534
17/02/2005
177495
METHODS OF ISOLATING AND
IDENTIFYING CELLS USING
SIGNALING PROBES
CHROMOCELL CORPORATION
US
60/546075
18/02/2004
PCT/US/2005/005080
WO/2005/079462
15/02/2005
177588
METHOD OF PREVENTING FIBRIN
CLOTS IN PULMONARY TISSUE
THROUGH THE USE OF
AEROSOLIZED ANTICOAGULANTS
GTC BIOTHERAPEUTICS, INC.
US
60/546236
20/02/2004
11/057522
14/02/2005
US
PCT/US/2005/004604
WO/2005/081816
11
C07H
‫מערכות ושיטות לתקשורת מקבילה‬
C12Q
‫שיטות לבדוד וזיהוי של תאים על ידי‬
‫שימוש בגלאים מאותתים‬
A61K
‫שיטה למניעת קרישי פיברין ברקמות‬
‫ריאה באמצעות ימוש בנוגדי קרישת דם‬
‫בצורת תרסיס‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
16/04/2004
177600
ON-LINE MAKING OF POWDER-FREE
RUBBER GLOVES
ANSELL HEALTHCARE PRODUCTS
LLC
B23B
‫ייצור ממוכן של כפפות גומי נטולות אבקה‬
PCT/US/2004/011799
WO/2005/110749
22/03/2005
177665
C07D
NOVEL PHARMACEUTICAL
COMPOSITIONS COMPRISING
AGONISTS OF THE THYROID
RECEPTOR
KARO BIO AB
GB
0406378.0
22/03/2004
PCT/EP/2005/003030
WO/2005/092316
23/02/2005
‫תכשירי רוקחות חדשים המכילים‬
‫אגוניסטי קולט התירואיד‬
177671
PLURIPOTENT EMBRYONIC-LIKE
STEM CELLS DERIVED FROM
CORNEAL LIMBUS, METHODS OF
ISOLATION AND USES THEREOF
RELIANCE LIFE SCIENCES PVT. LTD.
IN
240/MUM/2004 26/02/2004
60/621476
22/10/2004
US
PCT/IB/2005/000516
WO/2005/084119
23/02/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C12N
‫תאי–גזע פלוריפוטנטים הדומים לתאי‬
,‫עובר הנגזרים מהלימבוס של הקרנית‬
‫ והשימושים בהם‬,‫שיטות לבידודם‬
177672
C12N
12
PLURIPOTENT EMBRYONIC-LIKE
STEM CELLS DERIVED FROM
CORNEAL LIMBUS, METHODS OF
ISOLATION AND USES THEREOF
RELIANCE LIFE SCIENCES PVT. LTD.
IN
240/MUM/2004 26/02/2004
60/621476
22/10/2004
US
PCT/IB/2005/000516
WO/2005/084119
03/03/2005
‫תאי–גזע פלוריפוטנטים הדומים לתאי‬
,‫עובר הנגזרים מהלימבוס של הקרנית‬
‫ והשימושים בהם‬,‫שיטות לבידודם‬
177727
SELF-ENERGIZING ELECTRICAL
CONNECTION
NOVACENTRIX CORP.
US
60/549840
03/03/2004
PCT/US/2005/007338
WO/2005/084396
15/03/2005
11/03/2005
‫חיבור חשמלי בעל הטענה עצמית‬
177969
MAN-PORTABLE COUNTER MORTAR
RADAR SYSTEM
SYRACUSE RESEARCH
CORPORATION
US
60/553262
15/03/2004
PCT/US/2005/008453
WO/2005/089276
13
G01S
‫מערכת מכ"ם הנישאת ע"י האדם לספירת‬
‫מרגמות‬
177996
A METHOD OF EVALUATING
FRESHNESS OF A FISH PRODUCT
WINTERLAB LIMITED
US
60/552778
12/03/2004
60/553059
15/03/2004
US
PCT/US/2005/008371
WO/2005/089254
16/03/2005
H01H
177999
A23L
‫שיטה להערכת טריות מוצרי דגים‬
H01L
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
NON-CONTACT THERMAL
PLATFORMS
COREFLOW SCIENTIFIC SOLUTIONS
LTD.
US
60/553546
17/03/2004
PCT/IL/2005/000299
WO/2005/086588
21/03/2005
‫קורפלוו פתרונות מדעיים בע"מ‬
178035
MONOLITHIC CLOCK GENERATOR
AND TIMING/FREQUENCY
REFERENCE
MOBIOUS MICROSYSTEMS, INC.
US
60/555193
22/03/2004
PCT/US/2005/009429
WO/2005/092044
11/03/2005
‫משטחים טרמיים ללא מגע‬
‫תדירות‬/‫מחולל שעון מונוליתי ויחוס תזמון‬
178043
BLOCK-RAMMING MACHINE
LARRY DON WILLIAMSON
US
10/800170
12/03/2004
PCT/US/2005/007868
WO/2005/089181
18/03/2005
178078
STREPTOCOCCUS AGALACTIAE
VACCINE FOR FISH
THE UNITED STATES OF AMERICA
AS REPRESENTED BY THE
SECRETARY OF AGRICULTURE
US
10/807575
18/03/2004
PCT/US/2005/008972
WO/2005/089447
17/03/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
H03L
178115
B29C
‫מכונה לדחיסת בלוקים‬
A61K
‫חיסון סטרפטוקוקוס אגלאקטיה לדגים‬
A61K
14
TREATMENT OF SEVERE
COMMUNITY-ACQUIRED
PNEUMONIA BY ADMINISTRATION
OF TISSUE FACTOR PATHWAY
INHIBITOR (TFPI)
CHIRON CORPORATION
US
60/554681
17/03/2004
PCT/US/2005/009097
WO/2005/110059
08/11/2004
‫טיפול בדלקת ריאות חמורה באמצעות‬
TFPI ‫מתן של‬
178121
THERAPEUTIC USE OF ANTI-CS1
ANTIBODIES
PDL BIOPHARMA, INC.
US
60/557621
29/03/2004
60/557620
29/03/2004
US
60/557622
29/03/2004
US
10/842011
07/05/2004
US
10/982357
05/11/2004
US
PCT/US/2004/037430
WO/2005/102387
18/03/2005
15/03/2005
15
CS1 ‫שימוש תרפואטי בנוגדני אנטי‬
178129
A METHOD FOR EVALUATING
RELATIVE OXYGEN SATURATION IN
BODY TISSUES
BOARD OF SUPERVISORS OF
LOUISIANA STATE UNIVERSITY
AND AGRICULTURAL AND
MECHANICAL COLLEGE
US
60/554456
19/03/2004
PCT/US/2005/009185
WO/2005/092008
A61K
A61B
‫שיטה לחישוב רווית חמצן יחסית ברקמות‬
‫הגוף‬
178134
H02K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
LINEAR GENERATOR AND SYSTEM
TO CAPTURE ENERGY FROM
IRREGULAR LINEAR MOVEMENT
GEORGIA TECH RESEARCH
CORPORATION
US
60/553219
15/03/2004
PCT/US/2005/008663
WO/2005/089347
01/05/2005
‫מערכת ומחולל לינאריים לקבלת אנרגיה‬
‫מתנועה לינארית לא–סדירה‬
178147
AUTONOMOUS MOLECULAR
COMPUTER DIAGNOSES
MOLECULAR DISEASE MARKERS
AND ADMINISTERS REQUISITE
DRUG IN VITRO
YEDA RESEARCH AND
DEVELOPMENT CO. LTD.
US
60/565536
27/04/2004
PCT/IL/2005/000458
WO/2005/101981
29/03/2005
178165
USE OF PPR DELTA AGONISTS FOR
TREATING DEMYELINATING
DISEASES
AVENTIS PHARMACEUTICALS INC.
US
60/558533
01/04/2004
PCT/US/2005/010371
WO/2005/097098
19/09/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
178173
G01N
‫מחשב ביולוגי עצמאי המאבחן סמנים‬
‫מולקולאריים למחלות ומספק התרופות‬
‫הרצויות במבחנה‬
‫ידע חברה למחקר ופיתוח בע"מ‬
A61K
PPR ‫שימוש של אגוניסטים של דלתא‬
‫לטיפול במחלות דה–מיאליניזציה‬
F03G
16
‫מתקן לניצול אידוי ועיבוי בהפרשי גובה‬
‫לשם יצירת אנרגיה‬
‫אלי סומפולינסקי‬
‫‪A61K‬‬
‫אאאאאאאאאאאאאאאאאאאאאאאאאאאאא‬
‫‪ELI SOMPOLINSKY‬‬
‫‪178302‬‬
‫גורמים המכילים תחליפי סטרואידים‬
‫ושיטות לשימוש בהם‬
‫‪B65G‬‬
‫‪STEROID SPARING AGENTS AND‬‬
‫‪METHODS OF USING SAME‬‬
‫‪ELAN PHARMACEUTICALS, INC.‬‬
‫‪US‬‬
‫‪60/558120‬‬
‫‪01/04/2004‬‬
‫‪PCT/US/2005/010848‬‬
‫‪WO/2005/099776‬‬
‫‪178342‬‬
‫משטחי תמיכה ללא מגע לצורך כוון מרחק‬
‫קורפלו פתרונות מדעיים בע"מ‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫‪30/03/2005‬‬
‫‪13/04/2005‬‬
‫‪NON-CONTACT SUPPORT‬‬
‫‪PLATFORMS FOR DISTANCE‬‬
‫‪ADJUSTMENT‬‬
‫‪CORE-FLOW SCIENTIFIC SOLUTIONS‬‬
‫‪LTD.‬‬
‫‪US‬‬
‫‪60/561904‬‬
‫‪14/04/2005‬‬
‫‪PCT/IL/2005/000390‬‬
‫‪WO/2005/099350‬‬
‫‪17‬‬
29/03/2005
178349
METHOD AND APPARATUS FOR
CONTROLLING AT LEAST ONE
VENTILATION PARAMETER OF AN
ARTIFICIAL VENTILATOR FOR
VENTILATING THE LUNG OF A
PATIENT IN ACCORDANCE WITH A
PLURALITY OF LUNG POSITIONS
KCI LICENSING, INC.
EP
04007580.6 29/03/2004
05005418.8
11/03/2005
EP
PCT/US/2005/010741
WO/2005/094369
08/04/2005
08/04/2005
G06K
‫גילוי סרטן ריאה באמצעות שלוש נקודות‬
‫ איבחון והערכת סכות‬,‫זמן‬
‫ידע חברה למחקר ופיתוח בע"מ‬
178480
METHODS FOR GENERATING
NEURONAL CELLS FROM HUMAN
EMBRYONIC STEM CELLS AND USES
THEREOF
REUBINOFF, BENJAMIN
US
60/561147
09/04/2004
60/650694
07/02/2005
US
PCT/US/2005/011857
WO/2005/118920
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫שיטה והתקן לשליטה על לפחות פרמטר‬
‫ כדי לאוורור‬,‫אוורור אחד במכשיר הנשמה‬
‫ריאה של חולה בהתאם למספר מקומות‬
‫הריאה‬
178472
THREE TIME POINT LUNG CANCER
DETECTION, DIAGNOSIS AND
ASSESSMENT OF PROGNOSIS
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/560898
08/04/2004
PCT/IB/2005/001252
WO/2005/096694
A61B
C12N
‫שיטות להשראת התמיינות תאי גזע‬
‫עובריים לתאים נוירונליים והשימוש בהם‬
18
06/04/2005
178502
COMBINED 2D/3D FACIAL
AUTHENTICATION
RF INTELLIGENT SYSTEMS, INC.
US
60/559804
06/04/2004
PCT/US/2005/011518
WO/2005/096768
27/04/2005
178725
COMPOSITE PATTERNING DEVICES
FOR SOFT LITHOGRAPHY
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
60/565604
27/04/2004
PCT/US/2005/014449
WO/2005/104756
07/05/2005
178953
METHOD FOR PERFORMING
HANDOVER IN BROADBAND
WIRELESS ACCESS SYSTEM
LG ELECTRONICS INC.
US
60/568738
07/05/2004
60/570836
14/05/2004
US
10-200422/09/2004
KR
0076085
10-200411/11/2004
KR
0092156
10-200502/05/2005
KR
0036861
PCT/KR/2005/001342
WO/2005/107377
19
G06K
D/D23 ‫אימות פנים משולב‬
C02F
‫התקנים מרוכבים לעשיית תבניות עבור‬
‫ליתוגרפיה רכה‬
H04Q
‫שיטה לביצוע העברה במערכת גישה‬
‫אלחוטית רחבת–פס‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
17/05/2005
179072
NOVEL USE OF PEPTIDE
COMPOUNDS FOR TREATING
DYSKINESIA
SCHWARZ PHARMA AG
US
60/571932
18/05/2004
04011833.3
18/05/2004
EP
PCT/EP/2005/005355
WO/2005/110390
19/05/2005
179077
CHEMICAL LINKERS AND
CONJUGATES THEREOF
MEDAREX, INC.
US
60/572667
19/05/2004
60/661174
09/03/2005
US
60/669871
08/04/2005
US
PCT/US/2005/017804
WO/2005/112919
16/05/2005
IMPROVED PREBIOTIC
GLYCOLOGIC LIMITED
GB
0410785.0
PCT/GB/2005/001888
WO/2005/111195
179238
A61K
‫שימוש חדש בתרכובות פפטיד לטיפול‬
‫בדיסקינסיה‬
A61K
‫מקשרים כימיים וצמדים איתם‬
C12N
‫טרום ביוטי משופר‬
14/05/2004
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
20
08/06/2005
179528
NOVEL USE OF PEPTIDE
COMPOUNDS FOR TREATING
AMYOTROPHIC LATERAL
SCLEROSIS
SCHWARZ PHARMA AG
EP
04013636.8 09/06/2004
60/578063
09/06/2004
US
PCT/EP/2005/006169
WO/2005/120476
09/06/2005
18/07/2005
HYDRAULIC POWER UNIT FOR A
REFRIGERATION SYSTEM
HYDRACOOL INC.
‫שימוש חדש של תרכובות פפטידיות‬
‫לטיפול בטרשת צד חוט השדרה‬
179540
NOVEL USE OF PEPTIDE
COMPOUNDS FOR TREATING PAIN
IN TRIGEMINAL NEURALGIA
SCHWARZ PHARMA AG
EP
04013635.0 09/06/2004
60/578,062
09/06/2004
US
PCT/EP/2005/006202
WO/2005/120539
A61K
A61K
‫שימוש חדש בתרכובות פפטידיות לטיפול‬
‫בכאב עצב משולש‬
179574
B60H
‫יחידת כוח הידראולית עבור מערכת קירור‬
PCT/US/2005/018300
WO/2007/011324
21
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
01/06/2005
179675
SYSTEM AND METHOD FOR
TRANSDERMAL DELIVERY OF AN
ANTICOAGULANT
ALZA CORPORATION
US
60/576905
03/06/2004
PCT/US/2005/019576
WO/2005/120482
30/05/2005
179694
CRTH2 RECEPTOR LIGANDS FOR
MEDICINAL USES
7TM PHARMA A/S
GB
0412198.4
29/05/2004
0414196.6
24/06/2004
GB
0424018.0
29/10/2004
GB
PCT/EP/2005/005884
WO/2005/115382
14/06/2005
179725
AMINO-HALOGENIMIDAZOPYRIDINE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
NYCOMED GMBH
EP
04102726.9 15/06/2004
PCT/EP/2005/052741
WO/2005/123730
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61P
‫מערכת ושיטה לשחרור טרנסדרמלי של‬
‫חומר נוגד קרישה‬
C07C
‫ לשימושים‬CRTH2 ‫ליגנדים לקולטן‬
‫רפואיים‬
C07D
‫תולדות אמינו–הלוגן–אימידאזופירידין‬
‫ותכשירי רוקחות המכילים אותן‬
22
04/07/2005
179828
C07H
THERAPEUTIC AGENTS FOR THE
TREATMENT OF HMGB1-RELATED
PATHOLOGIES
CREABILIS THERAPEUTICS S.P.A.
US
60/584678
02/07/2004
60/646586
26/01/2005
US
PCT/EP/2005/007198
WO/2006/002971
21/06/2005
‫חומרים ריפויים לטיפול בפתולוגיות‬
HMGB1–‫הקשורות ל‬
179863
D04H
‫אריג לולאתי בלתי ארוג‬
LOOPED NONWOVEN WEB
THE PROCTER & GAMBLE
COMPANY
US
60/581679
21/06/2004
PCT/US/2005/021754
WO/2006/009997
21/06/2005
179874
ANTIBODIES AGAINST WEST NILE
VIRUS AND THERAPEUTIC AND
PROPHYLACTIC USES THEREOF
WASHINGTON UNIVERSITY
US
60/581819
21/06/2004
PCT/US/2005/022251
WO/2005/122741
28/11/2001
‫נוגדנים כנגד וירוס הנילוס המערבי‬
‫ושימושים רפואיים ומניעתיים שלהם‬
179894
SYSTEM AND METHOD FOR ADAPTIVE
BROADCAST RADAR SYSTEM
LOCKHEED MARTIN CORPORATION
US
60/253095
28/11/2000
WO
PCT/US2001/44267 28/11/2001
PCT/US/2001/044267
WO/2002/097467
23
C12Q
G01S
‫מערכת ושיטה למערכת רדאר‬
‫בעלת שידור מסתגל‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
07/06/2005
179920
SYSTEMS AND METHOD FOR
FABRICATING SUBSTRATE
SURFACES FOR SERS AND
APPARATUSES UTILIZING SAME
GRYPHON ANALYTICS, LLC
US
60/577753
07/06/2004
PCT/US/2005/020245
WO/2006/076040
28/11/2001
‫מערכות ושיטה להרכבת שטחי פנים‬
‫ והתקנים המשתמשים‬SERS ‫לסובסטראט‬
‫במערכות אלו‬
180048
SYSTEM AND METHOD FOR
ADAPTIVE BROADCAST RADAR
SYSTEM
LOCKHEED MARTIN CORPORATION
US
60/253095
28/11/2000
PCT/US/2001/044267
WO/2002/097467
20/06/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G01S
‫מערכת ושיטה למערכת רדאר בעלת‬
‫שידור מסתגל‬
180156
METHOD AND APPARATUS FOR
DETERMINING LOCATION OF A
BASE STATION USING A PLURALITY
OF MOBILE STATIONS IN A
WIRELESS MOBILE NETWORK
QUALCOMM INCORPORATED
US
60/580929
18/06/2004
10/971591
21/10/2004
US
PCT/US/2005/022090
WO/2007/027166
C23C
H04Q
‫שיטה ומערכת עבור קביעת מיקום של‬
‫תחנת בסיס בעזרת שימוש בריבוי תחנות‬
‫ניידות ברשת תקשורת אלחוטית‬
24
28/06/2005
180320
CITRUS SUDDEN DEATH
CARGILL INCORPORATED
US
60/583589
29/06/2004
60/600128
10/08/2004
US
PCT/US/2005/022679
WO/2006/004634
20/06/2005
180385
ICE-CONTAINING PRODUCTS
UNILEVER PLC
EP
04254313.2 19/07/2004
PCT/EP/2005/006699
WO/2006/007923
28/12/2006
180416
CURRENT DAMPER FOR THE STUDY
OF CELLS
SENG ENTERPRISES LTD.
US
60/754195
28/12/2005
60/855173
30/10/2006
US
04/07/2005
180422
COMBINATION TREATMENT FOR
NON - HEMATOLOGIC
MALIGNANCIES USING AN ANTIOGF-1R ANTIBODY
PFIZER PRODUCTS, INC.
US
60/588721
16/07/2004
PCT/IB/2005/002096
WO/2006/008639
25
C12N
‫מוות פתאומי של הדרים‬
A23L
‫מוצרים המכילים קרח‬
A61K
‫משכך זרמים כעזר לבחינת תאים‬
A61K
– ‫טיפול משולב למליגנאנסים לא‬
ANTI– ‫המטולוגים על ידי שימוש בנוגדן‬
OGF–1R
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
20/06/2005
180423
COMBINATIONS OF STATINS WITH
BRONCHODILATORS
ASTRAZENECA AB
GB
0415789.7
15/07/2004
PCT/GB/2005/002413
WO/2006/008437
04/07/2005
180425
HAIR GROWTH PROMOTING
AGENTS
WARNER-LAMBERT COMPANY LLC
US
60/588543
16/07/2004
PCT/IB/2005/002150
WO/2006/008641
05/08/2005
180517
NOVEL STATIN PHARMACEUTICAL
COMPOSITIONS AND RELATED
METHODS OF TREATMENT
TRANSFORM PHARMACEUTICALS,
INC.
US
60/599543
06/08/2004
60/623518
29/10/2004
US
60/655982
24/02/2005
US
PCT/US/2005/027815
WO/2006/017698
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61P
‫צירופי סטטינים עם ברונכודילטורים‬
A61P
‫חומרים המקדמים צמיחת שיער‬
A61K
‫הרכבים רוקחיים חדשים של סטטין‬
‫ושיטות קשורות לטיפול‬
26
05/07/2005
180525
PHARMACEUTICAL COMPOSITION
FOR THE TREATMENT OF BONE
FRACTURE
DONG WHA PHARMACEUTICAL IND.
CO. LTD.
10-2004KR
05/07/2004
0052069
PCT/KR/2005/002138
WO/2006/004369
05/07/2005
‫תכשיר רוקחות לטיפול בסדק של עצם‬
180526
COMPOSITION FOR THE
PREVENTION AND TREATMENT OF
ALLERGIC INFLAMMATORY
DISEASE
DONG WHA PHARMACEUTICAL IND.
CO. LTD.
10-2004KR
05/07/2004
0052071
PCT/KR/2005/002139
WO/2006/004370
23/06/2005
A61P
‫תכשיר למנוע ולטפל במחלה דלקתית‬
‫אלרגית‬
180551
USE OF SUBSTITUTED 2-THIO-3,5DICYANO-4-PHENYL-6AMINOPYRIDINES IN THE TREATMENT
OF NAUSEA AND VOMITING
BAYER HEALTHCARE AG
DE
102004032651.7 06/07/2004
PCT/EP/2005/006779
WO/2006/002823
27
A61P
A61P
–4–‫– דיזיאנו‬5 , 3–‫–תיאו‬2–‫שימוש ב‬
‫–אמינופירידינים מותמרים‬6–‫פניל‬
‫לטיפול בבחילה והקאה‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
29/07/2005
180557
COMBINATION OF A SELECTIVE
NORADRENALINE REUPTAKE
INHIBITOR AND A PDEV INHIBITOR
PFIZER INC.
GB
0417777.0
10/08/2004
60/606302
31/08/2004
US
PCT/IB/2005/002457
WO/2006/016262
24/06/2005
‫צירוף של מעכב סלקטיבי של תפיסה‬
PDEV ‫בחזרה של נוראדרנלין עם מעכב‬
180599
CERTAIN AMINOALKYL
GLUCOSAMINIDE PHOSPHATE
COMPOUNDS AND THEIR USE
CORIXA CORPORATION
US
10/888683
08/07/2004
PCT/US/2005/022522
WO/2006/016997
08/07/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
H04N
‫תרכובות אמינואלקיל גלוקוסאמיניד‬
‫פוספט מסוימות ושימוש שלהן‬
180600
COMPOSITIONS AND METHODS OF
USE FOR TREATMENT OF
MAMMALIAN DISEASES
ROBERT SABIN
US
10/888576
09/07/2004
60/598179
02/08/2004
US
60/666135
29/03/2005
US
PCT/US/2005/024272
WO/2006/017179
A61P
A61K
‫תרכובות ושיטות לשימוש בטיפול במחלות‬
‫יונקים‬
28
19/07/2005
180602
‫תכשיר המכיל סטטינים וחומצות שומן‬
3–‫אומגה‬
COMPOSITION CONTAINING STATINS
AND OMEGA-3 FATTY ACIDS
SIGMA-TAU INDUSTRIE
FARMACEUTICHE RIUNITE S.P.A.
IT
RM2004A000395 03/08/2004
PCT/IT/2005/000414
WO/2006/013602
25/07/2005
180604
180657
ARYLIDENES FOR THE TREATMENT
OF ESTROGEN RELATED RECEPTORALPHA MEDIATED DISEASES
JANSSEN PHARMACEUTICA N.V.
US
60/587850
14/07/2004
PCT/US/2005/024703
WO/2006/019741
02/08/2005
29
A61P
‫ארילאינדנים לטיפול במחלות המושפעות‬
‫מרצפטור קשור–אסטרוגן אלפא‬
180678
METHODS FOR IMPROVING
BIOAVAILABILITY OF A RENIN
INHIBITOR
NOVARTIS AG
US
60/598700
03/08/2004
PCT/EP/2005/008369
WO/2006/013094
A61P
‫צירופי אפותילון‬
EPOTHILONE COMBINATIONS
NOVARTIS AG
US
60/591225
26/07/2004
PCT/EP/2005/008076
WO/2006/010585
08/07/2005
A61P
A61P
‫שיטות לשיפור הזמינות הביולוגית של‬
‫מעכב רנין‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
15/07/2005
180709
‫טיפול בגידולים‬
TREATMENT OF TUMOURS
AQ+PLC
GB
0415768.1
15/07/2004
0508411.6
26/04/2005
GB
PCT/GB/2005/002759
WO/2006/008470
19/07/2005
180785
COMPOSITIONS CONTAINING
PARTICULATE CONSTRUCTS FOR
RELEASE OF ACTIVE AGENTS
THE TRUSTEES OF PRINCETON
UNIVERSITY
US
60/589164
19/07/2004
PCT/US/2005/025549
WO/2006/014626
25/07/2005
02/08/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61K
‫שתל עיני המיוצר בתהליך של אקסטרוזיה‬
‫כפולה‬
181120
TRICYCLIC ? -OPIOID
MODULATORS
JANSSEN PHARMACEUTICA N.V.
US
60/599131
05/08/2004
PCT/US/2005/027568
WO/2007/030089
A61K
‫תכשירים המכילים מבנים חלקיקיים‬
‫לשחרור חומרים פעילים‬
180865
OCULAR IMPLANT MADE BY A
DOUBLE EXTRUSION PROCESS
ALLERGAN, INC.
US
10/918597
13/08/2004
PCT/US/2005/026500
WO/2006/036280
A61P
C07D
–‫מודולטורים טריציקליים של דלטא‬
‫אופיאויד‬
30
12/08/2005
181262
AN ULTRA HIGH-THROUGHPUT
OPTI-NANOPORE DNA READOUT
PLATFORM
MELLER, Amit
US
60/601264
13/08/2004
PCT/US/2005/028566
WO/2006/020775
31/08/2005
‫זיהוי מהיר ביותר של דנ"א באמצעים‬
‫אופטיים ונקבוביות בקוטר נאנו‬
181371
METHODS OF REMOVING
PHOTORESIST ON SUBSTRATES
LAM RESEARCH CORPORATION
US
10/934697
07/09/2004
PCT/US/2005/031008
WO/2006/028858
22/08/2005
30/08/2005
31
A61K
‫שימוש בתרכובות פפטיד לטיפול בכאב‬
–‫ כמותרפיה וכאב הנגרם על‬,‫סרטן העצם‬
‫ידי נוקלאוסיד‬
181416
USE OF IL-6 IN VASCULAR
COMPLICATIONS
LABORATOIRES SERONO SA
IL
163856
01/09/2004
PCT/IL/2005/000928
WO/2006/025057
H01L
‫שיטות להסרת חומר ניגוד אור ממצעים‬
181383
USE OF PEPTIDE COMPOUNDS FOR
TREATING BONE CANCER PAIN,
CHEMOTHERAPY-AND
NUCLEOSIDE-INDUCED PAIN
SCHWARZ PHARMA AG
US
60/604810
27/08/2004
04020402.6
27/08/2004
EP
PCT/EP/2005/009067
WO/2006/021412
G06F
A61K
‫ בסיבוכים של כלי דם‬IL–6 ‫שימוש של‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
20/12/2005
181460
ACTIVE POWER FILTER WITH INPUT
VOLTAGE FEEDFORWARD, OUTPUT
LOAD FEEDFORWARD, AND
OUTPUT VOLTAGE
RAYTHEON COMPANY
US
11/053295
07/02/2005
PCT/US/2005/047652
WO/2006/086088
02/09/2005
21/09/2005
A61P
‫נגזרות פוריניל מותמרות בעלות פעילות‬
‫אימונומודולטורית וכמופרוטקטיבית‬
‫ושימושן בנפרד או ביחד עם גליצרידים או‬
‫חומצות שומן בעלות אורך שרשרת בינוני‬
181713
USE OF IL-17F FOR THE TREATMENT
AND/OR PREVENTION OF
NEUROLOGICAL DISEASES
LABORATOIRES SERONO SA
EP
04104573.3 21/09/2004
60/630105
22/11/2004
US
PCT/EP/2005/054719
WO/2006/032673
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫מסנן כוח אקטיבי בעל היזון קדימה של‬
‫ היזון קדימה של חיבור מתקן‬,‫מתח נכנס‬
‫ ומתח יוצא‬,‫יוצא‬
181684
SUBSTITUTED PURINYL
DERIVATIVES WITH
IMMUNOMODULATOR AND
CHEMOPROTECTIVE ACTIVITY AND
USE ALONE OR WITH MEDIUMCHAIN LENGTH FATTY ACIDS OR
GLYCERIDES
PROMETIC BIOSCIENCES INC
US
60/606915
03/09/2004
PCT/CA/2005/001343
WO/2006/024174
G05F
A61K
‫או מניעת‬/‫ לטיפול ו‬F 17 – IL ‫שימוש ב‬
‫מחלות נוירולוגיות‬
32
07/10/2005
181931
METHOD AND APPARATUS FOR
IMPLEMENTING DIRECT ROUTING
UTSTARCOM, INC.
US
10/966018
15/10/2004
PCT/US/2005/036221
WO/2006/044261
28/09/2005
19/04/2007
‫שיטה ומכשור ליישום ניתוב ישיר‬
182280
SINGLE STRANDED
ANTIMICROBIAL
OLIGONUCLEOTIDES AND USES
THEREOF
CYTOGENIX, INC.
US
60/613999
28/09/2004
PCT/US/2005/035263
WO/2006/037127
SILIVIRAX PORTA
ZION YEDID
33
C12N
‫אוליגונוקלאוטידים נוגדי חיידקים מחוברים‬
‫בצורה יחידה ושימושם‬
182699
H04Q
‫התקן להצפנת קול‬
‫גיטה טכנולוגיות בע"מ‬
VOICE ENCRYPTION DEVICE
GITA TECHNOLOGIES LTD.
22/04/2007
H04L
182708
A61K
‫סילבירקס פורטה‬
‫ציון ידיד‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
30/04/2007
182866
PROCESS FOR STABILISING
THIOPHENE DERIVATIVES
H.C. STARCK GMBH & CO. KG
DE
102006020744.0 04/05/2006
06/05/2007
183024
SAFE SELF-DESTRUCTION OF DATA
GITA TECHNOLOGIES LTD.
16/11/2005
183082
PHARMACEUTICAL
MANUFACTURING PROCESS
NORTON HEALTHCARE LTD.
GB
0425266.4
16/11/2004
PCT/US/2005/041524
WO/2006/055632
13/05/2007
TRANSFERRING DIGITAL DATA
NDS LIMITED
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
183151
A61K
‫תהליך ליצוב תולדות תיאופן‬
G06F
‫השמדה עצמית בטוחה של נתונים‬
‫גיטה טכנולוגיות בע"מ‬
A61K
‫תהליך ייצור תרופתי‬
H04L
‫העברת מדיע דיגיטלי‬
34
30/11/2005
183179
WEAPON LAUNCHED
RECONNAISSANCE SYSTEM
O.D.F. OPTRONICS LTD.
IL
165489
01/12/2004
PCT/IL/2005/001278
WO/2006/059326
21/11/2005
183278
ROD-COUPLING ASSEMBLIES
ENSIGN, Michael, D.
US
60/629840
19/11/2004
60/666819
30/03/2005
US
60/672590
18/04/2005
US
60/703622
29/07/2005
US
60/703684
29/07/2005
US
PCT/US/2005/042181
WO/2006/055914
28/11/2005
183468
MULTI-PRIMARY COLOR DISPLAY
GENOA COLOR TECHNOLOGIES
LTD.
US
60/631183
29/11/2004
PCT/IL/2005/001266
WO/2006/056995
13/06/2007
A METHOD AND APPARATUS FOR
BANDWITDTH ALLOCATION IN A
WIRELESS COMMUNICATION
SYSTEM
ALVARION LTD.
35
183904
F42B
‫מערכת סיור הנורית מנשק‬
‫ אופטרוניקס בע"מ‬.‫אפ‬.‫ד‬.‫או‬
A61B
‫מיכל לצימוד מוטות‬
G02B
‫צג בעל צבעי יסוד מרובים‬
‫גנואה טכנולוגיות צבע בע"מ‬
H04N
‫שיטה ומכשיר להקצאת רוחב סרט‬
‫במערכת תקשורת אלחוטית‬
‫אלווריון בע"מ‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
20/12/2005
184014
SYSTEM AND METHOD FOR
FEEDING AND CUTTING MEDIA FOR
CONTINUOUS PRINTING
PETER MICHAEL MUELLER
US
60/637493
20/12/2004
PCT/US/2005/046403
WO/2006/069164
24/06/2007
A METHOD AND APPARATUS FOR
CONNECTING A CELLULAR
TELEPHONE USER TO THE
INTERNET
RDC RAFAEL DEVELOPMENT
CORPORATION LTD.
24/06/2007
A METHOD AND APPARATUS FOR
CONNECTING A CELLULAR
TELEPHONE USER TO THE
INTERNET
RDC RAFAEL DEVELOPMENT
CORPORATION LTD.
26/06/2007
PROCESSING VIDEO CONTENT
NDS LIMITED
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
B41J
‫שיטה ומערכת להזנה וחיתוך של מדיה‬
‫להדפסה רציפה‬
184178
H04Q
‫שיטה ומכשיר לחיבור של משתמש טלפון‬
‫סלולרי לרשת האינטרנט‬
‫אר די סי רפאל חברה לפיתוח בע"מ‬
184179
H04Q
‫שיטה ומכשיר לחיבורו של משתמש טלפון‬
‫סלולרי לרשת האינטרנט‬
‫אר די סי רפאל חברה לפיתוח בע"מ‬
184232
H04N
‫עיבוד תוכן וידאו‬
36
27/06/2007
184255
‫מטען מחסנית נשק‬
‫רן טל‬
FIREARM MAGAZINE LOADER
RAN TAL
27/06/2007
184260
MOBILE TELECOMMUNICATIONS
DEVICE HAVING SIM/ANTENNA
COIL INTERFACE
ON TRACK INNOVATIONS LTD.
28/06/2007
‫און טרק אינובישנס בע"מ‬
184305
G06F
‫ מכשיר ומערכת המיועדים לאפשר‬,‫שיטה‬
‫תקשורת בין משתמשים‬
‫משה פטרבורג‬
184492
WARHEAND WITH EJECTABLE
FRAGMENTS
STATE OF ISRAEL, ATOMIC ENERGY
COMMISSION
IL
109014
17/03/1994
37
H04Q
SIM ‫מכשיר תקשורת נייד בעל ממשק בין‬
‫לסליל אנטנה‬
METHOD, APPARATUS AND SYSTEM
FOR ENABLING COMMUNICATIONS
BETWEEN USERS
YITZHAK PETERBURG
09/07/2007
F41A
F42B
‫ראש קרבי עם חלקיקים הניתנים לפליטה‬
‫רפא"ל רשות לפיתוח אמצעי לחימה בע"מ‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
26/07/2007
184868
MOTION DETECTION SYSTEM AND
METHOD
BAR ILAN UNIVERSITY
05/08/2007
09/08/2007
‫מערכת ושיטה לגלוי תנועה‬
‫אוניברסיטת בר אילן‬
185038
METHOD AND DEVICE FOR
SECURITY IN PUBLIC PLACES
UZI EZRA HAVOSHA
‫עוזי עזרא חבושה‬
185184
G01S
‫שיטה והתקן לגילוי הולכי רגל‬
‫אלתא מערכות בע"מ‬
185186
COMPACT ACTIVE PHASED ARRAY
ANTENNA FOR RADARS
BEAM NETWORKS LTD
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G08B
‫שיטה ומתקן לבטיחות במקומות ציבוריות‬
METHOD AND APPARATUS FOR
DETECTING PEDESTRIANS
ELTA SYSTEMS LTD.
09/08/2007
G01S
H01Q
‫אנטנה קומפקטית לרדאר הנשלטת‬
‫בהזזת פאזה‬
‫בים נטוורקס בע"מ‬
38
06/03/2006
185325
PROCESS FOR THE PRODUCTION OF
CALCIUM COMPOSITIONS IN A
CONTINUOUS FLUID BED
NYCOMED PHARMA AS
DK
PA200500334 04/03/2005
PCT/IB/2006/000474
WO/2006/092727
08/02/2006
‫תהליך לייצור תכשירי סידן בקרקעית‬
‫נוזלית מתמשכת‬
185337
SYSTEM AND METHOD FOR
COMPUTERIZED ORDERING
DOLPHIN SOFTWARE LTD.
US
60/655410
24/02/2005
60/719963
26/09/2005
US
PCT/IL/2006/000154
WO/2006/090360
26/02/2006
39
G06Q
‫מערכת ושיטה לסידור ממוחשב‬
‫דולפין תוכנה בע"מ‬
185338
SYSTEM AND METHOD FOR
COMPUTERIZED ORDERING AMONG
REPLACEABLE OR OTHERWISE
ASSOCIATED PRODUCTS
DOLPHIN SOFTWARE LTD.
US
60/655410
24/02/2005
60/719963
26/09/2005
US
PCT/IL/2006/000253
WO/2006/090391
A61K
G06Q
‫מערכת ושיטה לסידור ממוחשב בין‬
‫תוצרים הניתנים להחלפה או הקשורים זה‬
‫לזה‬
‫דולפין תוכנה בע"מ‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
29/03/2006
185705
PRECIPITATED CALCIUM
CARBONATE PIGMENT, ESPECIALLY
FOR USE IN INKJET PRINTING PAPER
COATINGS
OMYA DEVELOPMENT AG
EP
05075840.8 11/04/2005
PCT/IB/2006/000932
WO/2006/109168
20/09/2007
ARMOR MODULE
RAFAEL ARMAMENT
DEVELOPMENT AUTHORITY LTD.
25/09/2007
‫פיגמנט למשקע של קלציום קרבונאט‬
‫בייחוד לשימוש בהדפסה בהזרקת דיו של‬
‫ציפוי נייר‬
186152
F41H
‫מודול מיגון‬
‫רפא"ל רשות לפיתוח אמצעי לחימה בע"מ‬
186287
H04N
‫החלפה של מפתחות‬
REPLACEMENT OF KEYS
NDS LIMITED
07/02/2006
C09C
186346
A METHOD AND SYSTEM FOR
REPRESENTING FINANIAL
INFORMATION IN A GAMING
ENVIRONMENT
TRADONOMI LTD.
G06Q
‫שיטה ומערכת להצגת מידע פיננסי‬
‫בסביבת משחקים‬
PCT/IL/2006/000149
WO/2007/091234
11/04/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
186374
C07C
40
COMBINED USE OF
PROSTAGLANDIN COMPOUND AND
PROTON PUMP INHIBITOR FOR THE
TREATMENT OF
GASTROINTESTINAL DISORDERS
SUCAMPO AG
US
60/670238
12/04/2005
PCT/JP/2006/308001
WO/2006/109881
07/10/2007
–‫שימוש משולב בתרכובת פרוסטגלנדין ו‬
‫ לטיפול באי סדרים של הקיבה‬PPI
‫והמעיים‬
186397
‫לוח מיגון‬
‫פלסן סאסא בע"מ‬
ARMOR PANEL
PLASAN SASA LTD.
07/10/2007
186398
41
F41H
‫מודול מיגון‬
‫פלסן סאסא בע"מ‬
ARMOR MODULE
PLASAN SASA LTD.
05/04/2006
F41H
186434
A61B
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
MICROWAVE DEVICES FOR
TREATING BIOLOGICAL SAMPLES
AND TISSUE AND METHODS FOR
USING THE SAME
RENEWAVE MEDICAL SYSTEMS SA.
US
60/668059
05/04/2005
60/668073
05/04/2005
US
60/676298
02/05/2005
US
PCT/IB/2006/001521
WO/2006/117682
07/04/2006
‫התקני מיקרוגל לטיפול בדגימות ביולוגיות‬
‫וברקמה ושיטות לשימוש בהם‬
186466
SIDE-PORTED FILAMENT WOUND
PRESSURE VESSELS
BEKAERT PROGRESSIVE
COMPOSITES CORPORATION
US
60/670362
11/04/2005
PCT/US/2006/013482
WO/2006/110754
10/04/2006
186507
METHODS FOR TREATING
INFECTIOUS DISEASE
EXACERBATED ASTHMA
SANOFI-AVENTIS U.S. LLC
US
60/669548
08/04/2005
PCT/US/2006/013193
WO/2006/110607
12/04/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
186532
B23B
‫מיכלי לחץ מליפופי סיבים עם פתח צדדי‬
A61K
‫שיטות לטיפול במחלת אסתמה חריפה‬
‫עם זיהום‬
G06Q
42
METHOD AND SYSTEM FOR AN
ASSESSMENT WITHIN A MULTILEVEL ORGANIZATION
BLACKBOARD, INC.
US
60/670963
12/04/2005
11/363868
27/02/2006
US
11/398240
04/04/2006
US
11/398073
04/04/2006
US
PCT/US/2006/014043
WO/2006/110892
02/05/2006
186549
MANUFACTURING METHOD FOR A
NON-PLANAR CURVED STENT
VERYAN MEDICAL LIMITED
GB
0508859.6
29/04/2005
PCT/GB/2006/001598
WO/2006/117545
11/04/2006
186563
METHOD AND SYSTEM OF PRICING
FINANCIAL INSTRUMENTS
SUPERDERIVATIVES, INC
US
60/669903
11/04/2005
PCT/IL/2006/000459
WO/2006/109306
03/04/2006
186625
MAP-BASED TRAJECTORY
GENERATION
HONEYWELL INTERNATIONAL INC.
US
11/105788
14/04/2005
PCT/US/2006/012137
WO/2006/113104
14/04/2006
43
186626
‫שיטה ומערכת להערכה בתוך אירגון‬
‫מיכפל קומה‬
A61F
‫שיטה ליצור סטנט מעוקל שאינו מישורי‬
G06Q
‫שיטה ומערכת לתמחור כלים פיננסיים‬
G01C
‫ייצור מסלול מבוסס מפה‬
G06Q
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
SYSTEMS AND METHODS
COMBINING SUBSCRIPTION
SERVICES, REWARDS PROGRAMS,
AND SWEEPSTAKES
1-800-JACKPOT, INC.
US
60/671848
15/04/2005
60/677965
05/05/2005
US
60/733986
04/11/2005
US
PCT/US/2006/014007
WO/2006/113401
21/04/2006
186758
COLLUSION RESISTANT
DESYNCHRONIZATION FOR
DIGITAL VIDEO FINGERPRINTING
MICROSOFT CORPORATION
US
11/139176
27/05/2005
PCT/US/2006/015558
WO/2006/130271
05/04/2006
‫מערכות ושיטות המשלבות שירותי‬
‫ והימורים‬,‫ תוכניות תגמול‬,‫תמיכה‬
‫עמידות בפני דה–סינכרוניזציה של רישום‬
‫טביעת אצבעות דיגיטלי בווידאו‬
186779
COMPOSITIONS AND METHODS FOR
PROMOTING HEMOSTASIS AND
OTHER PHYSIOLOGICAL ACTIVITIES
MASSACHUSETTS INSTITUTE OF
TECHNOLOGY
US
60/674612
25/04/2005
60/758827
13/01/2006
US
PCT/US/2006/015850
WO/2006/116524
22/10/2007
186849
TARGET DESIGNATION METHOD
AND MEANS
OMIND LTD
23/10/2007
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G06K
A61K
‫תכשירים ושיטות לעודד עצירת דם‬
‫ופעילויות פיזיולוגיות אחרות‬
G01S
‫שיטה ואמצעים לסימון מטרות‬
‫ישראל פרייר‬
186856
G01S
44
A REMOTE SENSING IMAGERY
SYSTEM AND METHOD
ELTA SYSTEMS LTD.
28/10/2007
‫מערכת ושיטה לחישה מרחוק‬
‫אלתא מערכות בע"מ‬
186966
CASING FOR INSENSITIVE
MUNITIONS AND PROCESS FOR
MAKING SANE
ISRAEL MILITARY INDUSTRIES LTD.
08/05/2006
187176
NON-PNEUMATIC VEHICLE TIRE
NEW TECH TIRE LLC
US
11/123808
06/05/2005
PCT/US/2006/017893
WO/2006/122107
08/11/2007
187252
45
‫מעטפת לתחמושת לא רגישה ותהליך‬
‫לייצורה‬
‫התעשייה הצבאית לישראל בע"מ‬
B60C
‫צמיג לא – פנאומטי לרכב‬
F41H
‫משכך התפוצצות‬
BLAST MITIGATION
CARMEL TACTICAL SOLUTIONS
GROUP, LLC
08/11/2007
F42B
187265
E04H
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫מחסום נגיפה רב–שכבתי‬
‫רן גור‬
A MULTILAYER IMPACT BARRIER
RAN GUR
03/05/2006
187271
METHOD AND INSTALLATION FOR
PYROLISIS OF TIRES
RADKA BORISOVA LJUTZKANOVA
BG
109150
09/05/2005
PCT/BG/2006/000010
WO/2006/119594
17/05/2006
187278
INHALATOR CAPSULES
BOEHRINGER INGELHEIM PHARMA
GMBH & CO. KG
10 2005 022
DE
18/05/2005
862.3
PCT/EP/2006/004684
WO/2006/122790
30/05/2006
187365
PESTICIDAL MIXTURE
BASF AKTIENGESELLSCHAFT
US
60/687111
03/06/2005
PCT/EP/2006/062714
WO/2006/128863
12/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187366
C09C
‫שיטה ומתקן לפירוליזה של צמיגים‬
A61K
‫משאף לכמוסות‬
A01N
‫תערובת קוטלת מזיקים בחקלאות‬
G06F
46
MECHANISM FOR MANAGING
RESOURCE LOCKING IN A MULTITHREADED ENVIRONMENT
CONSENTRY NETWORKS, INC.
US
11/131600
17/05/2005
PCT/US/2006/018643
WO/2006/124730
14/11/2007
–‫מנגנון לניהול משאב נעילה בסביבה רבת‬
‫שרשורים‬
187368
‫כנף בעלת היכנוס זרימה‬
‫וסטל טכנולוגיות בע"מ‬
SCOOP-EFFECT WING
VESTAL LTD.
11/05/2006
187369
SYSTEMS, METHODS AND SERVERS
FOR REPAIR USING EITHER POINTTO-POINT OR POINT-TOMULTIPOINT TRANSMISSION
NOKIA CORPORATION
US
11/132554
19/05/2005
PCT/IB/2006/001240
WO/2006/123212
16/05/2006
47
H04L
‫ שיטות ושרתים לתיקון בעזרת‬,‫מערכות‬
‫העברה נקודה–לנקודה או נקודה–לנקודות‬
‫מרובות‬
187371
PROCESS FOR MODIFYING A SILICONE
RUBBER SURFACE
REHAU AG + CO.
DE
102005023018.0 19/05/2005
102005023017.2
19/05/2005
DE
PCT/EP/2006/004596
WO/2006/122744
17/05/2006
B64C
187372
C23C
‫תהליך עבור התאמת משטח גומי‬
‫מסיליקון‬
A61B
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
PROBE FOR MEASURING THE OXYGEN
CONTENT IN BIOLOGICAL TISSUE AND
A CATHETER COMPRISING A PROBE OF
THIS TYPE
RAUMEDIC AG
DE
102005024578.1 25/05/2005
PCT/EP/2006/004664
WO/2007/033707
18/05/2006
‫מכשיר מדידה עבור מדידת תכולת‬
‫חמצן ברקמה ביולוגית וצנתר המכיל‬
‫מכשיר מדידה מסוג זה‬
187374
ECTOPARASITE ERADICATION METHOD
AND DEVICE
UNIVERSITY OF UTAH RESEARCH
FOUNDATION
US
11/133067
18/05/2005
US
PCT/US2005/017969 19/05/2005
11/286155
23/11/2005
US
PCT/US/2006/019466
WO/2006/125160
18/11/2007
187442
187457
BREATH ACTUATED DRUG
DELIVERY SYSTEM
KOS LIFE SCIENCES, INC
US
11/160493
27/06/2005
PCT/US/2006/018252
WO/2007/001650
19/04/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫שיטה והתקן להשמדת טפילי חוץ‬
F42B
‫מתקן נפץ‬
‫פטר גורוביץ‬
EXPLOSIVE DEVICE
VALIANU CHERNA
09/05/2006
A61N
187458
A61M
‫מערכת למתן תרופה המופעלת על ידי‬
‫נשימה‬
C07C
48
PROCESS FOR PREPARATION OF
SULFAMIDE DERIVATIVES
JANSSEN PHARMACEUTICA N.V.
US
60/683151
20/05/2005
PCT/US/2006/014766
WO/2006/127184
19/05/2006
‫תהליך להכנת נגזרות של סולפאמיד‬
187459
ANTI - MCP-1 ANTIBODIES,
COMPOSITIONS, METHODS AND
USES
CENTOCOR, INC.
US
60/682654
19/05/2005
60/682620
19/05/2005
US
PCT/US/2006/019627
WO/2006/125202
18/05/2006
17/05/2006
49
‫ שיטות‬,‫ הרכבים‬, MCP –1–‫נוגדני אנטי‬
‫ושימושים‬
187460
VERSATILE HIGH LOAD
CONCENTRATE COMPOSITIONS
COMPRISING METAFLUMIZONE FOR
CONTROL OF ECTO- PARASITES
WYETH
US
60/683949
24/05/2005
PCT/US/2006/019284
WO/2006/127399
A61K
A01N
‫הרכבים וורסטיליים מרוכזים בעלי מעמס‬
‫גבוה המכילים מטאפלומיזון לבקרת‬
‫אקטופרזיטים‬
187461
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A METHOD FOR THE TREATMENT
OF POMPE DISEASE USING 1DEOXYNOJIRIMYCIN DERIVATIVES
AMICUS THERAPEUTICS, INC.
US
60/682241
17/05/2005
60/729329
21/10/2005
US
PCT/US/2006/019406
WO/2006/125141
18/05/2006
187462
CACHING INSTRUCTIONS FOR A
MULTIPLE-STATE PROCESSOR
QUALCOMM INCORPORATED
US
11/132748
18/05/2005
PCT/US/2006/019788
WO/2006/125219
19/05/2006
‫שיטה לטיפול בגליקוגנוזיס באמצאות‬
‫–דיאוקסינוג'ירמיצין‬1 ‫שימוש בתולדות‬
‫הוראות הטמנה עבור מעבד מרובה מצבים‬
187463
PROTEASOME INHIBITORS AND
USES THEREOF
JACK ARBISER
US
60/683385
20/05/2005
PCT/US/2006/019591
WO/2006/127525
18/05/2006
09/12/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61K
‫מעכבי פרוטיאוזום ושימושיו‬
187464
HANDLING CACHE MISS IN AN
INSTRUCTION CROSSING A CACHE
LINE BOUNDARY
QUALCOMM INCORPORATED
US
11/132749
18/05/2005
PCT/US/2006/019789
WO/2006/125220
G06F
G06F
‫טיפול בחסר מטמון בהוראה חוצה של קו‬
‫גבול מטמון‬
187467
H01L
50
HIGH CURRENT ELECTRICAL
SWITCH AND METHOD
PERFECT SWITCH, LLC
US
11/135232
23/05/2005
PCT/US/2005/044711
WO/2006/127047
22/05/2006
187468
GRID NETWORK FOR DISTRIBUTION
OF FILES
GRID NETWORKS
US
60/683129
20/05/2005
11/419482
19/05/2006
US
11/419483
19/05/2006
US
11/419484
19/05/2006
US
11/419486
19/05/2006
US
PCT/US/2006/019855
WO/2006/125225
19/05/2006
187469
GELATIN-CONTAINING TOPICAL
COMPOSITION
KILDA BIOLINK AS
GB
0510286.8
19/05/2005
0607174.0
10/04/2006
GB
PCT/GB/2006/001874
WO/2006/123173
29/06/2006
51
187470
‫מתג חשמלי לזרם גבוה ושיטה‬
G06F
‫רשת תקשורת להפצת קבצים‬
A61K
‫תכשיר מקומי המכיל ג'לטין‬
G06F
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
DEVICE FOR QUANTITATIVE
ANALYSIS OF A METABOLITE
PROFILE
BIOCRATES LIFE SCIENCES AG
US
60/694983
30/06/2005
60/694984
30/06/2005
US
PCT/EP/2006/006328
WO/2007/003344
29/06/2006
‫התקן לאנליזה כמותית של פרופיל של‬
‫מתאדוליט‬
187471
QUADRAPHASIC CONTINUOUS
GRADUATED ESTROGEN
CONTRACEPTIVE
WARNER CHILCOTT COMPANY, INC
US
60/695093
29/06/2005
PCT/US/2006/025721
WO/2007/002910
22/05/2006
‫אמצעי ארבע פאזי אסטרוגני המשכי‬
‫והדרגתי למניעת הריון‬
187472
SECURITY DEVICE HAVING A
HOOKING ELEMENT
SENSORMATIC ELECTRONICS
CORPORATION
US
60/683657
23/05/2005
PCT/US/2006/019860
WO/2006/127674
25/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
E05B
‫התקן בטיחות המכיל גוף לכידה‬
187473
A61P
‫שיטות ותכשירים לניהול אי–סדרים‬
‫פסיכוטיים‬
METHODS AND COMPOSITIONS FOR
MANAGING PSYCHOTIC DISORDERS
OREXIGEN THERAPEUTICS, INC.
US
60/686128
31/05/2005
PCT/US/2006/020616
WO/2006/130522
18/05/2006
A61K
187474
B03C
52
METHOD AND DEVICE FOR
MANUFACTURING DISPERSED
MINERAL PRODUCTS
OMYA GMBH
DE
102005023950.1 20/05/2005
PCT/EP/2006/062425
WO/2006/122967
24/05/2006
‫שיטה והתקן ליצור תוצרים מינרליים‬
‫מבודרים‬
187475
‫צורת מתן פומית המכילה מערכת‬
‫הנוגדת שימוש לא נכון‬
ORAL DOSAGE FORM COMPRISING AN
ANTIMISUSE SYSTEM
FLAMEL TECHNOLOGIES
EP
PCT/EP2005/012721 13/06/2005
PCT/EP/2006/062625
WO/2006/134018
24/05/2006
187477
A PROCESS COMPRISING CODON
OPTIMIZATION FOR THE
PRODUCTION OF RECOMBINANT
ACTIVATED HUMAN PROTEIN C FOR
THE TREATMENT OF SEPSIS
AVESTHA GENGRAINE
TECHNOLOGIES PVT. LTD
IN
626/CHE/2005 24/05/2005
PCT/IB/2006/001359
WO/2006/126070
20/11/2007
53
187496
A61K
C12N
‫תהליך הכולל אופטימיזצית קודון לייצור‬
‫ אנושי רקומביננטי מופעל‬C ‫חלבון‬
‫לטיפול באלח דם‬
A61F
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫חיתול חד פעמי אליו מוצמדת שקית‬
‫ייעודית לאיחסונו‬
‫רינת לוק אלחייק‬
DISPOSABLE DIAPER WITH SELF
ATTACHED WASET BAG
RINAT LOOK ELHAIK
20/11/2007
187497
METHOD SYSTEM AND DEVICE FOR
IGNITION OF MOTOR-VEHICLES
UZI EZRA HAVOSHA
US
11/602701
22/11/2006
20/11/2007
187498
USING POLARIZING ADAPTORS IN
LASER BASED OPTICAL SYSTEMS
FOR REFLECTION EFICENCY
IMPROVEMENT
NEZER ZVI
20/11/2007
‫שמעון דבוש‬
G02B
‫נזר צבי‬
187499
187500
DETACHER OF A SECURITY DEVICE
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫שיטה מערכת ומתקן להניעת רכבים‬
‫שילוב מתאמי קיטוב במערכות אופטיות‬
‫מבוססות לייזר לשיפור יעילות ההחזר‬
ACTIVE DEVICE FOR JOINT MOTION
ERAN WERNER
23/05/2006
B60M
A63B
‫מתקן להנעת מפרקים‬
‫ערן ורנר‬
E05B
‫מנתק עבור התקן בטיחות‬
54
SENSORMATIC ELECTRONICS
CORPORATION
US
60/683657
23/05/2005
PCT/US/2006/020293
WO/2006/127925
29/03/2006
187501
BENZOYL-SUBSTITUTED SERINE
AMIDES
BASF AKTIENGESELLSCHAFT
DE
102005024598.6 25/05/2005
PCT/EP/2006/061135
WO/2006/125688
29/03/2006
187502
HETEROAROYL-SUBSTITUTED SERINE
AMIDES
BASF AKTIENGESELLSCHAFT
DE
102005024599.4 25/05/2005
PCT/EP/2006/061128
WO/2006/125687
06/06/2006
187503
STABLE AND SOLUBLE ANTIBODIES
INHIBITING TNF?
ESBATECH AG
US
60/687971
07/06/2005
60/785353
23/03/2006
US
PCT/CH/2006/000300
WO/2006/131013
30/05/2006
55
187504
C07C
‫סרין אמידים מותמרים בבנזואיל‬
C07D
‫סרין אמידים מותמרים בהטרוארואיל‬
C07K
‫? יציבים ומסיסים‬TNF ‫נוגדנים מעכבי‬
A01N
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
COMPOSITION FOR THE
IMPREGNATION OF FIBERS,
FABRICS AND NETTINGS
IMPARTING A PROTECTIVE
ACTIVITY AGAINST PESTS
BASF AKTIENGESELLSCHAFT
US
60/687028
03/06/2005
PCT/EP/2006/062724
WO/2006/128870
20/11/2007
187505
APPARATUS FOR MOVING A
CONTROL SURFACE
EATON CORPORATION
US
11/603360
21/11/2006
18/05/2006
187506
CONTAINER WITH HOLLOW NEEDLE
VIFOR (INTERNATIONAL) AG.
EP
05104386.7 24/05/2005
PCT/EP/2006/062415
WO/2006/125747
26/06/2006
187507
PROPYLENE POLYMERS HAVING
BROAD MOLECULAR WEIGHT
DISTRIBUTION
BASELL POLIOLEFINE ITALIA S.R.L
EP
05106024.2 01/07/2005
60/697488
08/07/2005
US
PCT/EP/2006/063535
WO/2007/003523
18/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187509
‫ בדים‬,‫תכשיר לאימפרגנציה של סיבים‬
‫ורשתות המעניק פעילות הגנתית נגד‬
‫מזיקים‬
B64C
‫התקן להזזת משטח בקרה‬
A61J
‫מיכל עם מחט חלולה‬
C08L
‫פולימרי פרופילן בעלי התפלגות משקל‬
‫מולקולרי רחב‬
C07D
56
‫ ושיטות לשימוש‬RAF ‫תרכובות מעכבות‬
‫בהן‬
RAF INHIBITOR COMPUNDS AND
METHODS OF USE THEREOF
ARRAY BIOPHARMA INC.
US
60/683175
20/05/2005
PCT/US/2006/019280
WO/2006/125101
16/06/2006
187510
PROTEASES FOR PHARMACEUTICAL
USE
SOLVAY PHARMACEUTICALS GMBH
DK
PA200500930 24/06/2005
DK
PA200501643 23/11/2005
PCT/DK/2006/000353
WO/2006/136160
16/06/2006
187511
LIPASES FOR PHARMACEUTICAL USE
SOLVAY PHARMACEUTICALS GMBH
DK
PA200500929 24/06/2005
PCT/DK/2006/000352
WO/2006/136159
09/06/2006
187514
HEADEND MODELING OF DATA
NDS LIMITED
GB
0511774.2
09/06/2005
PCT/GB/2006/002113
WO/2006/131748
20/11/2007
57
187515
A61K
‫פרוטאזות לשימוש רוקחי‬
C12N
‫ליפאז לשימוש רוקחי‬
H04N
‫מידע מונחה בניית מודל‬
G01S
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
BI-DIRECTIONAL OPTICAL
COMMUNICATIONS SYSTEM AND
CORRESPONDING METHOD
OERLIKON SPACE AG
EP
06125318.3 04/12/2006
20/11/2007
‫מערכת לתקשורת אופטית דו–כיוונית‬
‫ושיטה תואמת‬
187517
CELLULAR COMMUNICATION AND
SALES PROMOTION MEDIA
INTEGRATION METHOD
SHIMON BUHBUT
20/11/2007
‫שיטה לשילוב תכני קידום מכירות‬
‫בתקשורת סלולרית‬
‫שמעון בוחבוט‬
187518
APPARATUS FOR DISPENSING
PRESERVATIVE-FREE MEDICINAL
PRODUCTS
OCUPHARMA LTD
20/11/2007
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61C
‫מתקן לחלוקת תכשירים רפואיים נטולי‬
‫חומרים משמרים‬
‫אוקופארמה בע"מ‬
187519
ROTARY ASSEMBLY COMPONENTS
AND METHODS OF FABRICATING
SUCH COMPONENTS
GENERAL ELECTRIC COMPANY
US
11/564064
28/11/2006
27/07/2006
G06Q
F01C
‫רכיבי מכלל סיבובי ושיטות לייצור רכיבים‬
‫כאלה‬
187520
C07K
58
C3a ‫פפטידים הנגזרים מקומפלמנט‬
‫ושימושים שלהם‬
COMPLEMENT C3a DERIVED
PEPTIDES AND USES THEREOF
YEDA RESEARCH AND
DEVELOPMENT CO. LTD
US
60/702627
27/07/2005
60/776668
27/02/2006
US
PCT/IL/2006/000878
WO/2007/013083
17/05/2006
ASSAY DEVICE
RMIT UNIVERSITY
AU
2005902630
PCT/AU/2006/000656
WO/2006/122360
19/06/2006
187521
59
G01N
‫התקן בדיקה‬
20/05/2005
187522
LKKTET AND/OR LKKTNT
COMPOSITIONS AND METHODS FOR
TREATING OR PREVENTING TISSUE
DETERIORATION, INJURY OR
DAMAGE
REGENERX BIOPHARMACEUTICALS,
INC.
US
60/691261
17/06/2005
60/776947
28/02/2006
US
PCT/US/2006/023758
WO/2006/138707
19/05/2005
‫ידע חברה למחקר ופיתוח בע"מ‬
A61K
‫ ושיטות‬LKKTNT ‫או‬/‫ ו‬LKKTET ‫תכשירי‬
‫ פציעה או‬,‫לטיפול או מניעה בהידרדרות‬
‫נזק לרקמה‬
187523
G21K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
FABRICATION METHOD THEREOF,
AND NARROW BAND X-RAY FILTER
AND SYSTEM INCLUDING SAME
MONOCHROMATIC X-RAY FILTER
TECHNOLOGIES
US
11/132305
19/05/2005
PCT/US/2006/019602
WO/2007/005130
26/05/2006
187524
CYCLIC AMINE DERIVATIVES
HAVING A SUBSTITUTED ALKYL
GROUP AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
DAIICHI SANKYO COMPANY,
LIMITED
2005JP
27/05/2005
155009
PCT/JP/2006/310556
WO/2006/126676
24/05/2006
‫ ומסנן‬,‫ שיטת ייצור מכך‬,‫כונן למחזיר–אור‬
‫קרינת איקס צר סרט ומערכת הכוללים‬
‫את הנ"ל‬
‫תולדות אמין ציקלית עם קבוצת אלקיל‬
‫מותמרת ותכשירי רוקחות המכילים אותן‬
187525
METHOD AND APPARATUS FOR
MAKING CRYSTALLINE POLYMERIC
PELLETS AND GRANULES
GALA INDUSTRIES, INC.
US
60/684556
26/05/2005
PCT/US/2006/019899
WO/2006/127698
26/05/2000
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
187526
B29B
‫שיטה והתקן ליצור גלולות וגרגירים‬
‫פולימריים גבישיים‬
A61K
60
PHARMACEUTICAL COMPOSITIONS
CONTAINING AN A? FRAGMENT
NEURALAB LIMITED
US
09/322289
28/05/1999
PCT/US/2000/014810
WO/2000/072880
22/05/2006
?A ‫תכשירי רוקחות המכילים קטע‬
187527
PRISM-TYPE ELECTRICAL CONVERTER
FOR THE GENERATION, TRANSMISSION,
DISTRIBUTION AND SUPPLY OF
ELECTRIC CURRENT, AND PRODUCTION
METHOD THEREOF
MENDOZA CEBALLOS, VICENTE
ARTURO
MX
PA/A/2005/005770 23/05/2005
PCT/MX/2006/000039
WO/2006/126868
02/05/2003
26/05/2006
61
,‫ לייצור‬,‫ממיר חשמלי מסוג פריזמה‬
‫ חלוקה ואספקה של זרם‬,‫העברה‬
‫ ושיטה לייצורו‬,‫חשמלי‬
187528
USE OF PYRIMIDINE COMPOUNDS
IN THE MANUFACTURE OF
MEDICAMENTS
SMITHKLINE BEECHAM
CORPORATION
US
60/379,658
09/05/2002
PCT/US/2003/013627
WO/2003/094839
H01F
C07D
‫שימוש תרכובות פירימידין בייצור תרופות‬
187529
A61M
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
OPTICAL COHERENCE
TOMOGRAPHIC DETECTION OF
CELLS AND COMPOSITIONS
BOARD OF REGENTS, THE
UNIVERSITY OF TEXAS SYSTEM
US
60/685559
27/05/2005
PCT/US/2006/020903
WO/2006/128167
24/05/2006
187530
‫גילוי טומוגרפי עם חיבור אופטי לתאים‬
‫ולתכשירים‬
C07D
‫אקטיבטור לרצפטור המופעל ע"י‬
‫פרוקסיסום‬
)PPAR( ‫פרוליפרטור‬
ACTIVATOR FOR PEROXISOME
PROLIFERATOR-ACTIVATED
RECEPTOR
NIPPON CHEMIPHAR CO., LTD.
2005JP
25/05/2005
152949
PCT/JP/2006/310822
WO/2006/126714
04/05/2006
187531
METHOD AND COMPOSITION FOR
TREATING OSTEOARTHRITIS
DAVID D. WADDELL
US
11/138744
25/05/2005
11/138738
25/05/2005
US
PCT/US/2006/017638
WO/2006/127249
28/04/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187532
A61K
‫שיטה ותכשיר לטיפול בדלקת מפרקים‬
‫ניוונית‬
C07D
62
METHODS OF SYNTHESIZING
SUBSTITUTED 3CYANOQUINOLINES AND
INTERMEDIATES THEREOF
WYETH
US
60/684391
25/05/2005
PCT/US/2006/016215
WO/2006/127207
29/05/2006
‫–ציאנוקווינולינים‬3 ‫שיטות לסינתזה של‬
‫מותמרים ותוצרי ביניים שלהם‬
187533
‫נגזרת פיפרידין חדשה‬
NOVEL PIPERIDINE DERIVATIVE
BANYU PHARMACEUTICAL CO.,
LTD.
2005JP
30/05/2005
157739
2006-115778 19/04/2006
JP
PCT/JP/2006/311155
WO/2006/129826
24/05/2006
187534
THIAZOLE DERIVATIVES, USE
THEREOF AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THEM
LABORATOIRES SERONO SA
EP
05104418.8 24/05/2005
60/686266
01/06/2005
US
PCT/EP/2006/062592
WO/2006/125803
03/03/2006
63
C07D
C07D
‫ השימוש בהן ותכשירי‬,‫תולדות תיאזול‬
‫רוקחות המכילים אותן‬
187535
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
USE OF POLYMER MIXTURES FOR THE
PRODUCTION OF COATED
PHARMACEUTICAL FORMULATIONS
AND PHARMACEUTICAL
FORMULATION WITH MIXED
POLYMERIC COATING
ROHM GMBH & CO. KG
DE
102005024614.1 25/05/2005
PCT/EP/2006/001949
WO/2006/125483
23/06/2006
187536
METHOD FOR PRODUCTION OF
SUBSTITUTED PHENYLMALONATE
ESTERS NOVEL PHENYLMALONATE
ESTERS AND USE THEREOF
BASF AKTIENGESELLSCHAFT
DE
102005030093.6 27/06/2005
PCT/EP/2006/063491
WO/2007/000414
31/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187538
C07C
‫שיטה ליצור אסטרים של פנילמאלונאט‬
‫ אסטרים של פנילמאלונאט‬,‫מותמר‬
‫ושימושיהם‬
187537
METHOD FOR PREFORMING
OXIDATION CATALYSTS
BASF AKTIENGESELLSCHAFT
DE
102005026360.7 07/06/2005
PCT/EP/2006/062787
WO/2006/131480
09/06/2006
‫שימוש בתערובות פולימרים ליצור‬
‫הרכבי רוקחות מצופים והרכבי רוקחות‬
‫עם ציפוי פולימרים מעורבים‬
B01J
‫שיטה לשפעול מקדים של זרזים‬
‫לחמצון‬
C07F
64
PROCESS FOR SYNTHESIS OF
DIALKOXYORGANOBORANES
BASF AKTIENGESELLSCHAFT
US
60/690113
13/06/2005
PCT/EP/2006/063044
WO/2006/134074
25/05/2006
‫תהליך להכנת דיאלקוקסיאורגנו בוראנים‬
187539
TIGECYCLINE AND METHODS OF
PREPARING 9-NITROMINOCYCLINE
WYETH
US
60/685291
27/05/2005
PCT/US/2006/020540
WO/2006/130501
25/05/2006
187540
POLYPEPTIDES AND COMPOSITIONS
COMPRISING SAME AND METHODS
OF USING SAME FOR TREATING
CXCR4 ASSOCIATED MEDICAL
CONDITIONS
RAPPAPORT FAMILY INSTITUTE
FOR RESEARCH IN THE MEDICAL
SCIENCES
US
60/684517
26/05/2005
PCT/IL/2006/000626
WO/2006/126209
21/11/2007
65
187541
C07C
–9 ‫טיגציקלינים ושיטות להכנת‬
‫ניטרומינוציקלין‬
C07K
‫פוליפפטידים ותכשירים המכילים אותם‬
‫ושיטות לשימושם לטיפול במצבים‬
CXCR4–‫רפואיים הקשורים ב‬
‫מכון רפפורט המכון למחקר במדעי‬
‫הרפואה ע"ש משפחת רפפורט‬
G01B
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
SYSTEM AND METHOD FOR
RENDERING A THREEDIMENSIONAL LANDSCAPE AND
DISPLAYING CORRESPONDING
REAL IMAGES OF THE LANDSCAPE
BENTZUR YORAM
21/11/2007
‫שיטה ומערכת להמרה של נוף תלת ממדי‬
‫ולהצגה של תמונות אמיתיות של נוף זה‬
‫צור‬-‫יורם בן‬
187542
SHOWERHEAD WITH TURBOCHARGER
MECHANISM
WEIHU
CN
200720120924.0 19/06/2007
21/05/2006
21/11/2007
CIRCUITRY OF A LOW-POWER
PIEZOELECTRIC DRIVER AND
METHOD THEREOF
AUDIODENT ISRAEL LTD
21/11/2007
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ראש מקלחת עם מנגנון מגדש טורבו‬
187543
PIGMENTED INKS SUITABLE FOR
USE WITH CERAMICS AND A
METHOD OF PRODUCING SAME
JETTABLE LTD.
US
60/594977
24/05/2005
PCT/IL/2006/000599
WO/2006/126189
B05B
C09D
‫דיו פיגמנטי מטאים לשימוש עם קרמיקה‬
‫ושיטה ליצרו‬
‫ג'טאבל בע"מ‬
187544
H01L
‫מעגל של דריבר פיאזואלקטרי בעל הספק‬
‫נמוך ושיטה בשל כך‬
‫אודיודנט ישראל בע"מ‬
187545
A47B
66
A METHOD OF VERIFYING THE
CONTENTS OF BUNDLES OF PAPER
CURRENCY
IOIMAGE LTD.
21/11/2007
67
H01L
,‫ מכשיר ליטוגרפי‬,‫מכשיר ושיטה לפיקוח‬
‫תא עיבוד ליטוגרפי ושיטה ליצור מתקן‬
187547
SLURRY COMPOSITION FOR COLOR
FILTER POLISHING
BASF AKTIENGESELLSCHAFT
TW
94119462
13/06/2005
PCT/IB/2006/001571
WO/2006/134462
12/07/2006
‫איאואימאג' בע"מ‬
187546
INSPECTION METHOD AND
APPARATUS, LITHOGRAPHIC
APPARATUS, LITHOGRAPHIC
PROCESSING CELL AND DEVICE
MANUFACTURING METHOD
ASML NETHERLANDS B.V.
US
11/603257
22/11/2006
12/06/2006
‫שיטה לוידוא התכולה של חבילות של‬
‫שטרות כסף‬
C09G
‫הרכב תרכובות דלילה עבור הברקת מסנן‬
‫צבע‬
187548
G03B
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
MOVIE COPY PROTECTION
NDS LIMITED
US
60/710054
22/08/2005
60/710264
22/08/2005
US
60/710048
22/08/2005
US
PCT/IL/2006/000809
WO/2007/023482
17/04/2006
187549
VIBRATION SYSTEMS AND
METHODS
AEROGEN, INC.
US
60/684720
25/05/2005
PCT/US/2006/014654
WO/2006/127181
09/07/1999
187551
ANTIMICROBIAL CAPURAMYCIN
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
DAIICHI SANKYO COMPANY
LIMITED
JP
10-194285
09/07/1998
10-269445
24/09/1998
JP
PCT/JP/1999/003718
WO/2000/002892
05/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187553
‫הגנה נגד העתקת סרטים‬
E02B
‫מערכות רטט ושיטות‬
C12P
‫תולדות קפוראמיצין אנטימיקרוביות‬
‫ותכשירי רוקחות המכילים אותן‬
A01N
68
METHODS OF TREATING CANCER
AND OTHER CONDITIONS OR
DISEASE STATES USING LFMAU
AND LDT
YALE UNIVERSITY
US
60/688159
07/06/2005
60/741728
02/12/2005
US
PCT/US/2006/021742
WO/2006/133092
23/05/2006
‫שיטות לטיפול בסרטן ומצבים נוספים או‬
–‫ ו‬LFMAU–‫מחלות באמצעות שימוש ב‬
LDT
187554
FLAT CABLE SHIELD GROUND
CONNECTION
3M INNOVATIVE PROPERTIES
COMPANY
EP
05104333.9 23/05/2005
PCT/US/2006/019950
WO/2006/127723
26/05/2006
187555
INCREASE OF STRESS TOLERANCE
BY APPLICATION OF
NEONICOTINOIDS ON PLANTS
ENGINEERED TO BE STRESS
TOLERANT
BAYER CROPSCIENCE AG
EP
05012090.6 04/06/2005
PCT/EP/2006/005072
WO/2006/131222
06/06/2006
69
187556
H01B
‫חיבור הארקה למגן כבל שטוח‬
A01N
‫עלייה בסבילות לעקב על ידי יישום של‬
‫נאוניקוטינואידים על צמחים שהונדסו‬
‫להיות סבילים לעקות‬
A01N
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
SUBSTITUTED ARYLPYRAZOLES AS
PARASITICIDAL AGENTS
PFIZER LIMITED
US
11/153103
15/06/2005
PCT/IB/2006/001579
WO/2006/134466
22/11/2007
‫ארילפיראזולים מותמרים כגורמים קוטלי‬
‫טפילים‬
187557
HIGH FIDELITY TARGET
IDENTIFICATION AND ACQUISITION
THROUGH IMAGE STABILIZATION
AND IMAGE SIZE REGULATION
HONEYWELL INTERNATIONAL INC.
US
11/562563
22/11/2006
22/11/2007
187558
A HANDS-FREE ENFORCING
APPARATUS
MOSHE NAKASH
23/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫זיהוי מטרה עם דיוק גבוה והשגה‬
‫באמצעות ייצוב תמונה והסדרת גודל‬
‫תמונה‬
B60R
‫מכשיר אכיפה לדיבורית‬
‫משה נקש‬
187559
MEDIA RECORDING AND
PLAYBACK
BRITISH SKY BROADCASTING
LIMITED
GB
0510521.8
23/05/2005
PCT/GB/2006/001886
WO/2006/125971
11/10/2001
G06K
187560
H04N
‫הקלטה והשמעה חוזרת של מדיה‬
B62K
70
CONTROL OF A PERSONAL
TRANSPORTER
DEKA PRODUCTS LIMITED
PARTNERSHIP
US
09/687757
13/10/2000
09/687789
13/10/2000
US
09/687557
13/10/2000
US
09/739192
18/12/2000
US
PCT/US/2001/042657
WO/2002/030730
09/05/2006
‫שליטה על מוביל אישי‬
187561
CYCLONIC SEPARATING
APPARATUS
Dyson Technology Limited
GB
0510863.4
27/05/2005
PCT/GB/2006/001673
WO/2006/125945
09/05/2006
25/05/2006
71
‫התקן הפרדה ציקלונית‬
187562
DIRT AND DUST CYCLONIC
SEPARATING APPARATUS
Dyson Technology Limited
GB
0510862.6
27/05/2005
PCT/GB/2006/001678
WO/2006/125946
A47L
A47L
‫התקן להפרדה של לכלוך ואבק באמצעות‬
‫ציקלון‬
187563
C07C
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
INTERMEDIATE IN PRODUCTION OF [2(3,3,5,5TETRAMETHYLCYCLOHEXYL)PHENYL]
PIPERAZINE COMPOUND
EISAI R&D MANAGEMENT CO. LTD.
JP
2005-151697
25/05/2005
JP
PCT/JP2005/023166 16/12/2005
PCT/JP/2006/310450
WO/2006/126635
09/06/2006
187564
PROGRAM GUIDE OPTIMIZATION
SYSTEM
NDS LIMITED
GB
0511774.2
09/06/2005
PCT/GB/2006/002109
WO/2006/131746
26/05/2006
–5,5,3,3(–2[ ‫מתווך בייצור תרכובת‬
‫טטראמתילציקלוהקסיל)פניל]פיפראזין‬
‫מערכת לאופטימזציה של מדריך תוכניות‬
187565
COMPOSITIONS AND METHODS FOR
THE TREATMENT OR PREVENTION
OF CHEMORESISTANT NEOPLASIA
THE JOHNS HOPKINS UNIVERSITY
US
60/684928
26/05/2005
PCT/US/2006/020579
WO/2006/128041
25/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
H04N
187566
A61K
‫הרכבים ושיטות למניעת בניאופלזיה‬
‫עמידה לטיפול כימי ולטיפול בה‬
C11D
72
COPPER PASSIVATING POSTCHEMICAL MECHANICAL
POLISHING CLEANING
COMPOSITION AND METHOD OF
USE
ADVANCED TECHNOLOGY
MATERIALS, INC.
US
60/684812
26/05/2005
60/736036
10/11/2005
US
60/773126
13/02/2006
US
PCT/US/2006/020214
WO/2006/127885
19/05/2006
‫תרכובת כימית שאינה מגיבה לאחר ניקוי‬
‫והברקה מיכניים ושיטה לשימוש‬
187568
CUTTING MACHINE TO CUT ROLLS OR
LOGS OF WEB MATERIAL AND
RELATIVE METHOD
FABIO PERINI S.P.A.
IT
FI2005A000113 27/05/2005
PCT/IT/2006/000376
WO/2006/126229
22/11/2007
187569
MOUNTING SET, SYSTEM AND
METHOD
ISRAEL AEROSPACE INDUSTRIES
LTD.
22/11/2007
73
B26D
‫מכונת חיתוך לחיתוך גלילים או גלילי‬
‫חומר ארג ושיטה בהתאם‬
G09B
‫ מערכת ושיטה‬,‫סט להרכבה‬
‫התעשייה האוירית לישראל בע"מ‬
187570
H01L
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
INSPECTION METHOD AND
APPARATUS, LITHOGRAPHIC
APPARATUS, LITHOGRAPHIC
PROCESSING CELL AND DEVICE
MANUFACTURING METHOD
ASML NETHERLANDS B.V
US
11/606376
30/11/2006
24/05/2006
,‫ מכשיר ליטוגרפי‬,‫מכשיר ושיטה לפיקוח‬
‫תא עיבוד ליטוגרפי ושיטה ליצור מתקן‬
187571
LARYNGEAL MASK AIRWAY
DEVICE
THE LARYNGEAL MASK COMPANY
LIMITED
GB
0510951.7
27/05/2005
PCT/GB/2006/001913
WO/2006/125989
24/05/2006
187572
LARYNGEAL MASK AIRWAY
DEVICE
THE LARYNGEAL MASK COMPANY
LIMITED
GB
0510951.7
27/05/2005
PCT/GB/2006/001915
WO/2006/125990
24/05/2006
187573
LARYNGEAL MASK AIRWAY
DEVICE
THE LARYNGEAL MASK COMPANY
LIMITED
GB
0510951.7
27/05/2005
PCT/GB/2006/001908
WO/2006/125986
23/03/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187574
A61M
‫מכשיר מיסוך דרכי אויר לגרון‬
A61M
‫מכשיר מיסוך דרכי אויר לגרון‬
A61M
‫מכשיר מיסוך דרכי אויר לגרון‬
H01B
74
ELECTRICAL CABLE HAVING A
SURFACE WITH REDUCED
COEFFICIENT OF FRICTION
SOUTHWIRE COMPANY
US
11/135986
24/05/2005
PCT/US/2006/011069
WO/2007/081372
15/06/2006
187575
BENZOFURANYL DERIVATIVES AS
5-HT6-RECEPTOR INHIBITORS
BIOVITRUM AB
SE
0501383-4
17/06/2005
60/706523
09/08/2005
US
PCT/EP/2006/063249
WO/2006/134150
24/05/2006
‫כבל חשמלי בעל משטח עם מקדם חיכוך‬
‫מופחת‬
HT–6 ‫תולדות בנזופורניל כמעכבי רצפטור‬
5
187576
LARYNGEAL MASK AIRWAY
DEVICE AND METHOD OF
MANUFACTURE
THE LARYNGEAL MASK COMPANY
LIMITED
GB
0510951.7
27/05/2005
PCT/GB/2006/001909
WO/2006/125987
08/06/2006
75
C07D
187577
A61M
‫מכשיר מיסוך דרכי אויר לגרון ושיטה‬
‫לייצורו‬
H04Q
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
SYSTEMS AND METHODS FOR
MAKING CHANNEL ASSIGNMENTS
TO REDUCE INTERFERENCE AND
INCREASE CAPACITY OF WIRELESS
NETWORKS
ADAPTIX, INC.
US
11/172604
30/06/2005
PCT/US/2006/022296
WO/2007/005192
22/06/2006
187578
PROCESS FOR PREPARING PURE
AMORPHOUS ROSUVASTATIN
CALCIUM
LEK PHARMACEUTICALS D.D.
SI
P200500187 24/06/2005
PCT/EP/2006/006008
WO/2006/136408
25/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫תהליך להכנת רוסווסטטין סידן טהור חסר‬
‫צורה‬
187579
PRODUCTION OF BIODIESEL FROM
BALANITES AEGYPTIACA
BEN GURION UNIVERSITY OF THE
NEGEV RESEARCH AND
DEVELOPMENT AUTHORITY
US
60/684516
26/05/2005
PCT/IL/2006/000622
WO/2006/126206
14/06/2006
‫מערכות ושיטות לביצוע שיוך ערוצים על‬
‫מנת להקטין אינטרפרנציה ולהגדיל‬
‫קיבולת של רשתות אלחוטיות‬
C10L
BALANITES ( ‫ייצור ביודיזל מזקום מצרי‬
)AEGYPTIACA
187580
‫ הרשות‬,‫גוריון בנגב‬-‫אוניברסיטת בן‬
‫למחקר ופיתוח‬
C07D
76
THROMBIN INHIBITING 2-OXO1,2,5,6-TETRAHYDROPYRIDINE
DERIVATIVES
ASTRAZENECA AB
SE
0501413-9
17/06/2005
PCT/SE/2006/000709
WO/2006/135323
16/06/2006
–6,5,2,1–‫–אוקסו‬2 ‫נגזרות‬
‫טטראהידרופירידין המעכבות תרומבין‬
187581
COMPOUNDS FOR THE TREATMENT
OF MULTI-DRUG RESISTANT
BACTERIAL INFECTIONS
ASTRAZENECA AB
US
60/691340
16/06/2005
PCT/GB/2006/002207
WO/2006/134378
07/12/2006
‫תרכובות לטיפול בזיהומים חיידקיים‬
‫העמידים לתרופות רבות‬
187582
ONE-WAY INJECTOR WITH
CONTINUOUSLY CHARGED SPRING
ENERGY STORE
LTS-LOHMANN THERAPIE-SYSTEME
AG
DE
102005062206.2 24/12/2005
PCT/EP/2006/011747
WO/2007/073839
22/11/2007
187583
AN ELECTRICAL POWER SUPPLY
FOR AN AIRCRAFT
HISPANO-SUIZA
FR
0655072
23/11/2006
77
C07D
A61M
‫מזרק חד–כיווני עם מלאי אנרגיה‬
‫בקפיץ טעון ברציפות‬
B64C
‫אספקת כוח חשמלי לכלי טייס‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
23/05/2006
187584
PEDIATRIC FORMULATION OF
TOPIRAMATE
JANSSEN PHARMACEUTICA N.V.
EP
05104491.5 25/05/2005
60/690391
14/06/2005
US
PCT/EP/2006/062518
WO/2006/125774
02/06/2006
‫פורמולציה של טופירמאט לילדים‬
187586
METHOD FOR PRODUCING
DIHYDROQUINAZOLINES
AICURIS GMBH & CO.KG
DE
102005027517.6 15/06/2005
PCT/EP/2006/005298
WO/2006/133822
21/06/2006
187587
METHODS AND COMPOSITIONS FOR
TARGETING IFNAR2
GENENTECH, INC.
US
60/692786
22/06/2005
PCT/US/2006/023993
WO/2007/002096
26/04/2006
187589
PROVIDING COMMUNITY-BASED
MEDIA ITEM RATINGS TO USERS
MICROSOFT CORPORATION
US
11/156892
20/06/2005
PCT/US/2006/015665
WO/2007/001605
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61K
C07D
‫שיטה ליצור דיהידרוקווינאזולינים‬
C07K
IFNAR2 ‫שיטות ותכשירים להכוונת‬
G06F
‫הספקת מידרוגים של פריט מדיה‬
‫המבוססים על הציבור למשתמשים‬
78
30/05/2006
187590
CONVERSION OF AMORPHA-4,11DIENE TO ARTEMISININ AND
ARTEMISININ PRECURSORS
AMYRIS BIOTECHNOLOGIES, INC.
US
60/685713
27/05/2005
60/775517
21/02/2006
US
11/419975
23/05/2006
US
PCT/US/2006/020806
WO/2006/128126
19/07/2004
16/01/2004
A61K
‫תכשיר רוקחות בצורת מינון מוצקה ושיטה‬
‫לייצורו‬
187592
CAPTURE COMPOUNDS,
COLLECTIONS THEREOF AND
METHODS FOR ANALYZING THE
PROTEOME AND COMPLEX
COMPOSITIONS
HK PHARMACEUTICALS, INC.
US
60/441398
16/01/2003
PCT/US/2004/001037
WO/2004/064972
79
‫– דיאן‬11 ,4–‫המרה של אמורפה‬
‫לארטמיסינין ופרקורסורים של ארטמיסינין‬
187591
PHARMACEUTICAL COMPOSITION
AS SOLID DOSAGE FROM AND
METHOD FOR MANUFACTURING
THEREOF
FERRING B.V.
US
10/626857
25/07/2003
03016945.2
25/07/2003
EP
PCT/EP/2004/051538
WO/2005/011640
C07D
G01N
‫ אוספים שלהן ושיטות‬,‫תרכובות לוכדות‬
‫לבחינת הפרוטיאום והרכבים קומפלקסים‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
13/01/1998
187593
GASTROINTESTINAL DRUG
COMPOSITION
GEORGES SERGE GRIMBERG
FR
97/01410
07/02/1997
26/05/2006
‫תכשיר תרופה לקיבה ולמעיים‬
187594
HUMANIZED ANTI-CD40
ANTIBODIES AND THEIR METHODS
OF USE
SEATTLE GENETICS, INC.
US
60/684853
26/05/2005
PCT/US/2006/020688
WO/2006/128103
18/07/2000
22/11/2007
SYSTEM, MACHINE AND METHOD
FOR EXECUTING OF MONETARY
TRANSACTION USING CREDIT
CARDS AND CHEQUES
JOSEPHSBERG AVNER
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61K
‫ ושיטות‬CD40–‫נוגדנים אנושיים אנטי‬
‫לשימוש בהם‬
187595
ANTITUMOR ANTIBODIES,
PROTEINS, AND USES THEREOF
UNIVERSITY OF MASSACHUSETTS
US
60/145337
23/07/1999
PCT/US/2000/019589
WO/2001/007481
A61K
C07K
‫נוגדנים חלבוניים נוגדי גידול ושימוש בהם‬
187596
G07F
‫ שיטה ומערכת להמרה של‬,‫מכונה‬
‫עסקאות כספיות המתבצעות באמצעות‬
‫כרטיסי אשראי והמחאות‬
‫יוספסברג עמי‬
80
22/11/2007
187597
‫מד גובה לנוזלים‬
‫וירטיו סנס בע"מ‬
FLUID LEVEL INDICATOR
VIRTUE SENSE LTD
25/11/2007
187598
PLAYING CARD SYSTEM FOR
TEACHING GRAMMAR
ADIT ELDAR
25/11/2007
‫עדית אלדר‬
187599
G08B
‫שיטה לאפיון קוד אישי מישתנה והתקנים‬
‫ ישום והכוונה לשיפור‬,‫ תגובה‬,‫לזיהוי‬
‫התאמות פוטנציאליות לצריכה אישית‬
‫ואישיותית של משאבים וזמן‬
187600
AN APPARATUS FOR UNBLOCKING
PLUMBING BLOCKAGE
SHAUL HALIF
81
A63F
‫משחק קלפים ללימוד דקדוק‬
A METHOD FOR CHARACTERIZING
A TECTONIC EVOLVING PERSONAL
CODE AND DEVICES FOR IMPROVED
COMPATIBILITIES OF
PERSONALIZED CONSUMPTIVE USE
OF RESOURCES AND TIME
YAIR TRIBELSKY
25/11/2007
G01F
‫יאיר טריבלסקי‬
A47K
‫מכשיר לשחרור סתימה בצנרת‬
‫שאול חליף‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
25/11/2007
187601
A SOLUBLE CAPSULE FOR
PREPARING A FLAVORD BEVERAGE
AND A DISPENSER THEREOF
SHAUL HALIF
25/11/2007
187602
A PROCESS FOR REDUCING CO2
EMISSIONS FROM COMBUSTION
ENGINES
CLUE AS
26/05/2006
‫קפסולה נמסה להכנת משקה בטעמים‬
‫ודיספנסר מחלק‬
‫שאול חליף‬
F02M
‫ ממנועי‬CO2 ‫שיטה להפחתת פליטת‬
‫בעירה‬
187603
PIPERAZINE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
THE BOARD OF TRUSTEES OF THE
UNIVERSITY OF ILLINOIS
US
60/684807
26/05/2005
60/743878
28/03/2006
US
11/420425
25/05/2006
US
PCT/US/2006/020910
WO/2006/128173
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A47J
C07D
‫תולדות פיפראזין ותכשירי רוקחות‬
‫המכילים אותן‬
82
02/04/2002
187604
PHARMACEUTICAL COMPOSITIONS
CONTAINING AN INTERLEUKIN-6
ANTAGONIST
CHUGAI SEIYAKU KABUSHIKI
KAISHA
2001JP
02/04/2001
103627
2001-109131 06/04/2001
JP
PCT/JP/2002/003312
WO/2002/080969
02/06/2000
24/05/2006
C07C
‫תכשירי רוקחות המכילים תולדות חומצת‬
)‫ – הלופניל‬4( )‫ – טריהלומתילפנוקסי‬3( )–(
‫אציטת‬
187606
METHODS AND COMPOSITIONS FOR
REGULATING BIOFILM
DEVELOPMENT
ENVIRONMENTAL
BIOTECHNOLOGY CRC PTY LIMITED
AU
2005902660 24/05/2005
PCT/AU/2006/000693
WO/2006/125262
83
‫תכשירי רוקחות המכילים אנטגוניסט‬
6–‫לאינטרלוקין‬
187605
PHARMACEUTICAL COMPOSITIONS
CONTAINING (-) (3TRIHALOMETHYLPHENOXY) (4HALOPHENYL)
ACETIC ACID DERIVATIVES
METABOLEX, INCORPORATED
US
09/325997
04/06/1999
PCT/US/2000/015235
WO/2000/074666
A61K
C12N
‫שיטות והרכבים לשם וויסות פיתוח‬
‫ביופילם‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
11/06/2006
187608
PATCH FOR TRANSDERMAL DRUG
DELIVERY
TRANSPHARMA MEDICAL, LTD.
US
60/689763
10/10/2005
PCT/IL/2006/000679
WO/2006/131931
24/05/2006
187609
A METHOD AND APPARATUS FOR
PREDICTING BRANCH
INSTRUCTIONS
QUALCOMM INCORPORATED
US
11/144206
02/06/2005
PCT/US/2006/020440
WO/2006/130466
10/05/2006
187610
SYSTEM AND METHOD FOR
ANALYZING POWER FLOW IN
SEMICONDUCTOR PLASMA
GENERATION SYSTEMS
BIRD TECHNOLOGIES GROUP, INC.
US
60/689769
10/06/2005
PCT/US/2006/018087
WO/2006/135515
20/06/2006
187611
DIFFERENTIATION OF PRIMATE
PLURIPOTENT STEM CELLS TO
CARDIOMYOCYTE-LINEAGE CELLS
GERON CORPORATION
US
60/693141
PCT/US/2006/024060
WO/2007/002136
A61F
‫רטייה למתן טרנסדרמלי של תרופה‬
‫טרנספרמה מדיקל בע"מ‬
G06F
‫שיטה והתקן לחיזוי הוראות ענפיות‬
H01J
‫מערכת ושיטה לניתוח זרימת כוח‬
‫במערכות יצירה מוליכות למחצה של‬
‫פלסמה‬
C12N
‫התמיינות של תאי גזע פרימאטיים‬
‫פלוריפוטנטיים לתאים משורת‬
‫קרדומיוציטים‬
22/06/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
84
30/09/2005
187612
METHODS AND APPARATUS FOR
SELECTIVE WORKLOAD OFFLOADING ACROSS MULTIPLE DATA
CENTERS
IBM CORPORATION
US
11/140429
27/05/2005
PCT/US/2005/035323
WO/2006/130170
20/01/2006
187613
PORTABLE PERSONAL COMPUTING
ENVIRONMENT SERVER
IBM CORPORATION
US
11/154084
16/06/2005
PCT/US/2006/002105
WO/2007/001490
12/05/2006
187615
NATURAL ALUMINOSILICATE
COMPOSITES AND AGGREGATES
SYNTHESIZED IN ALKALINE
ENVIRONMENT AND THEIR
MANUFACTURING PROCESS
OLIVEIRA, ROADOLFO DAFICO
BERNARDES DE
PI 0504155BR
25/05/2005
4
PCT/BR/2006/000097
WO/2006/125287
85
G06F
‫שיטה ומערכת לפריקה סלקטיבית של‬
‫עומס עבודה של מרכזי מידע‬
G06F
‫שרת לסביבת מחשב אישית ניידת‬
C04B
‫סינתזה ותהליכי ייצור של הרכבת‬
‫אלומיניום – סיליקט טבעי בסביבה‬
‫אלקלינית‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
08/06/2005
187616
A61K
POLYINOSINIC ACID– ‫שימוש ב‬
POLYCYTIDYLIC ACID–BASED
‫כחומר מסייע חיסוני‬
POLYINOSINIC ACIDPOLYCYTIDYLIC ACID-BASED
ADJUVANT
NEWBIOMED PIKA PTE LTD.
PCT/CN/2005/000810
WO/2006/131023
19/06/2006
187617
‫או‬/‫ ו‬LKKTET ‫תכשירים המכילים‬
‫ ושיטות‬LKKTNT
LKKTET AND/OR LKKTNT PEPTIDE
COMPOSITIONS AND METHODS
UNIVERSITAET ERLANGENNUERNBERG
US
60/691261
17/06/2005
60/776947
28/02/2006
US
PCT/US/2006/023760
WO/2006/138709
21/05/2006
187618
CXCR4 ANTAGONISTS FOR WOUND
HEALING AND REEPITHELIALIZATION
KYOTO UNIVERSITY
US
60/684160
25/05/2005
PCT/IL/2006/000596
WO/2006/126188
24/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61K
‫ לריפוי פצעים‬CXCR4 ‫אנטגוניסטים של‬
‫ורה–אפיתליאליזציה‬
187620
17?-HSD1 AND STS INHIBITORS
SOLVAY PHARMACEUTICALS GMBH
EP
05104534.2 26/05/2005
PCT/EP/2006/062587
WO/2006/125800
A61K
‫הדסית בע"מ‬
C07J
HSD ?171 –‫ ו‬STS ‫מעכבי‬
86
17/05/2006
187621
METHOD AND SYSTEM FOR
DETERMINATION OF
PHYSIOLOGICAL CONDITIONS AND
EMOTIONAL STATES OF A LIVING
ORGANISM
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
IL
168839
26/05/2005
PCT/IL/2006/000579
WO/2006/126186
24/05/2006
‫שיטה ומערכת וקביעת תנאים פיזיולוגיים‬
‫ומצבים רגשיים של בעלי חיים חי‬
187622
LOCATING DEVICE FOR AN INK-JET
PRINTER
DURST PHOTOTECHNIK DIGITAL
TECHNOLOGY GMBH
AT
A 895/2005 25/05/2005
PCT/AT/2006/000213
WO/2006/125239
12/06/2006
187623
ASPARTYL PROTEASE INHIBITORS
SCHERING CORPORATION
US
60/690326
14/06/2005
PCT/US/2006/022698
WO/2006/138192
25/11/2007
SECURE MESSAGING
POSTALGUARD LTD.
87
A61B
187624
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
B41J
‫מתקן מיקום למדפסת הזרקת דיו‬
C07D
‫מעכבי אספרטיל פרוטאיז‬
G06F
‫דואר אלקטרוני מובטח‬
‫פוסטאלגארד בע"מ‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
02/03/2001
187625
PRODUCTION, FORMING, BONDING,
JOINING AND REPAIR SYSTEM FOR
COMPOSITE AND METAL
COMPONENTS
QUICKSTEP TECHNOLOGIES PTY
LTD.
AU
PQ6041
03/03/2000
05/09/2000
AU
PQ9924
PCT/AU/2001/000224
WO/2001/064387
25/05/2006
26/11/2007
DISEASE TREATMENT VIA
ANTIMICROBIAL PEPTIDES OR
THEIR INHIBITORS
RIPHON PHARMA LTD
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ חיבור‬,‫ הדבקה‬,‫ עיצוב‬,‫מערכת לייצור‬
‫ותיקון עבור רכיבים ממתכת ומחומר‬
‫מרוכב‬
187626
PROCESSES FOR PRODUCTION OF 4(BIPHENYLYL)AZETIDIN-2-ONE
PHOSPHONIC ACIDS
MICROBIA, INC.
US
60/684481
25/05/2005
PCT/US/2006/020226
WO/2006/127893
B23P
C07C
–‫–ביפנילאזטידינ‬4 ‫תהליך להכנת חומצות‬
‫–אונים פוספוניים‬2
187627
A61K
‫טיפול במחלות על ידי פפטידים‬
‫אנטימיקרוביאלים או ע"י עיכובם של אותם‬
‫פפטידים‬
‫ריפאון פארמה בע"מ‬
88
31/05/2006
187628
METHOD OF FORMING DENDRITIC
CELLS FROM EMBRYONIC STEM
CELLS
WISCONSIN ALUMNI RESEARCH
FOUNDATION
US
60/686145
01/06/2005
PCT/US/2006/021054
WO/2006/130651
16/06/2006
15/06/2006
C07J
‫סטרואידים בעלי פרופיל מעורב אנדרוגני‬
‫ופרוגסטוגני‬
187630
TRANSGLUTAMINASE MEDIATED
CONJUGATION OF GROWTH
HORMONE
NOVO NORDISK HEALTH CARE AG
EP
05105256.1 15/06/2005
05109667.5
18/10/2005
EP
PCT/EP/2006/063246
WO/2006/134148
89
‫שיטה ליצירת תאים דנדריטיים מתאי גזע‬
‫עובריים‬
187629
STEROIDS HAVING A MIXED
ANDROGENIC AND
PROGESTAGENIC PROFILE
N.V. ORGANON
EP
05076437.2 17/06/2005
PCT/EP/2006/063282
WO/2006/134167
C12N
A61K
‫הצמדת הורמון גדילה המתווכת ע"י‬
‫טרנסגלוטאמינאז‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
23/05/2006
187631
‫תולדות אמידיות חדשות של פיפרידין‬
‫חומצה קרבוקסילית‬
NOVEL PIPERIDINE CARBOXYLIC ACID
AMIDE DERIVATIVES
ACTELION PHARMACEUTICALS LTD.
EP
PCT/EP05/005732 27/05/2005
IB
PCT/IB06/050134 13/01/2006
PCT/IB/2006/051641
WO/2006/129237
03/07/2006
187632
3-ESTER PRODRUGS OF
ETHYNYLESTRADIOL
WARNER CHILCOTT COMPANY, INC
US
60/698865
12/07/2005
PCT/US/2006/025852
WO/2007/024338
03/07/2006
C07D
C07J
–‫מטרימי תרופות של אתינילאסטראדיאול‬
‫–אסטר‬3
187633
3-ESTER PRODRUGS OF ESTRADIOL
C07J
–3–‫מטרימי תרופות של אסטראדיאול‬
‫אסטר‬
WARNER CHILCOTT COMPANY, INC
US
60/698866
12/07/2005
PCT/US/2006/025853
WO/2007/008474
07/06/2006
187634
AZINONE AND DIAZINONE V3
INHIBITORS FOR DEPRESSION AND
STRESS DISORDERS
PHARMACOPEIA, INC.
US
60/688306
07/06/2005
PCT/US/2006/022025
WO/2006/133242
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫ אזינון ודיאזינון לדיכאון‬V3 ‫מעכבי‬
‫ולהפרעות לחץ‬
90
16/06/2006
187635
AMYLASES FOR PHARMACEUTICAL
USE
SOLVAY PHARMACEUTICALS GMBH
DK
PA200500931 24/06/2005
PCT/DK/2006/000354
WO/2006/136161
23/05/2006
187636
DE-ROTATION SYSTEM FOR
COUNTER-ROTATING COAXIAL
ROTOR HUB SHAFT FAIRING
SIKORSKY AIRCRAFT
CORPORATION
US
60/684694
26/05/2005
60/693592
24/06/2005
US
60/776278
23/02/2006
US
PCT/US/2006/020349
WO/2006/127955
26/11/2007
187637
PROXIMITY TO TARGET DETECTION
SYSTEM AND METHOD
KILOLAMBDA TECHNOLOGIES LTD.
91
A61K
‫תססי עמילן לשימוש רוקחי‬
H04J
‫מערכת מרפה–סיבוב עבור מעטה זירמי‬
‫של טבור רוטור משותף–ציר סובב נגדית‬
G09B
‫מערכת וישטה לגילוי קירבה למטרה‬
‫קילולמבדה טכנולוגיות בע"מ‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
28/04/2006
187638
SPLIT TORQUE GEARBOX FOR
ROTARY WING AIRCRAFT WITH
TRANSLATIONAL THRUST SYSTEM
SIKORSKY AIRCRAFT
CORPORATION
US
11/140762
31/05/2005
PCT/US/2006/016614
WO/2007/086907
05/06/2006
187639
CRYSTALLINE AZITHROMYCIN LMALATE MONOHYDRATE AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
HANMI PHARM. CO., LTD.
10-2005KR
08/06/2005
0048923
PCT/KR/2006/002157
WO/2006/132486
28/11/2005
187640
METHOD FOR PREPARING
CLOPIDOGREL AND
INTERMEDIATES USED THEREIN
HANMI PHARM. CO., LTD.
10-2005KR
23/06/2005
0054303
PCT/KR/2005/004017
WO/2006/137628
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
B64D
‫תיבת הילוכים סיבוב מפציל עבור כנף‬
‫סיבובית של כלי טייס עם מערכת דחף‬
‫הניתנת להתקה‬
C07H
‫ –מלט מונוהידרט גבישי‬L ‫אזיתרומיצין‬
‫ותכשירי רוקחות המכילים אותן‬
C07D
‫שיטה להכנת קלופידוגרל וחומרי ביניים‬
‫לשימוש בה‬
92
02/06/2006
187641
UMBILICAL CORD BLOOD
COMPOSITIONS
STEMCYTE INC.
US
60/687127
02/06/2005
60/733956
03/11/2005
US
PCT/US/2006/021405
WO/2006/130812
16/06/2006
‫תכשירי דם מחבל הטבור‬
187642
METHODS FOR PURIFYING
PROTEINS HAVING Fc REGIONS
WYETH
US
60/691821
17/06/2005
PCT/US/2006/023478
WO/2006/138553
26/11/2007
B65D
‫מיכל מתקפל חסין בפני נזילות בעל צורה‬
‫משולשת‬
‫אלי לויס‬
187644
METHOD AND SYSTEM FOR
DISPLAYING VIA A NETWORK OF
AN INTERACTIVE MOVIE
MENTORWAVE TECHNOLOGIES
LTD.
IL
168903
31/05/2005
PCT/IL/2006/000629
WO/2006/129308
93
C07K
Fc ‫שיטות לטהור חלבונים עם עיזורי‬
187643
TRIANGULAR SHAPED NONLEAKING FOLDABLE CONTAINER
ELI LEVIS
29/05/2006
A01N
H04L
‫שיטה ומערכת להצגה דרך רשת של סרט‬
‫אינטראקטיבי‬
‫מנטורווב טכנולוג'יס בע"מ‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
26/11/2007
187651
A DEVICE FOR DRIVING AWAY
BIRDS
AMOS BESHARI
26/11/2007
‫מתקן להברחת בעלי כנף‬
‫עמוס בשארי‬
187653
INSPECTION METHOD AND
APPARATUS, LITHOGRAPHIC
APPARATUS, LITHOGRAPHIC
PROCESSING CELL AND DEVICE
MANUFACTURING METHOD
ASML NETHERLANDS B.V
US
11/635081
07/12/2006
26/11/2007
187667
187669
FIXED-ORIENTATION LIQUID
DISPENSER
PROFILE-DISPENSING INNOVATION
LLC
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
H01L
,‫ מכשיר ליטוגרפי‬,‫מכשיר ושיטה לפיקוח‬
‫תא עיבוד ליטוגרפי ושיטה ליצור מתקן‬
SYSTEM AND METHOD FOR
NAVIGATING A SURGICAL NEEDLE
TOWARD AN ORGAN OF THE BODY
OF A PATIENT
MEDIGUIDE LTD.
US
60/861118
27/11/2006
27/11/2007
A01M
A61B
‫שיטה ומערכת לניווט של מחט אל איבר‬
‫בגוף של מטופל‬
‫מדיגייד בע"מ‬
B05B
‫ממנן נוזלים בעל כיוון קבוע‬
94
27/11/2007
187670
A METHOD AND DEVICE FOR
JOINING CUPS INTO A BOTTLE
UZI EZRA HAVOSHA
27/11/2007
‫שיטה ומתקן לבקבוק מכוסות‬
‫עוזי עזרא חבושה‬
187671
METHOD AND DEVICE TO COMFORT
BABIES
UZI EZRA HAVOSHA
27/11/2007
187672
CRYO SYSTEM AND METHOD OF
OPERATION
SHPELTER LEV
27/11/2007
SPARE TIRE RETAINER ADAPTOR
MAG-EH LTD.
95
A47J
G08B
‫שיטה ומתקן להרגעת תינוקות‬
‫עוזי עזרא חבושה‬
A61B
‫מערכת קריוגנית ועיקרון פעולתה‬
‫שפלטר לב‬
187681
B62D
‫מתאם לגלגל רזרבי‬
‫עה בע"מ‬-‫מאג‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
27/11/2007
187687
TECHNIQUES FOR MINIMIZING
RADIOFREQUENCY-INDUCED
TISSUE HEATING
BIOSENSE WEBSTER, INC.
US
11/565261
30/11/2006
28/11/2007
187718
IMAGE SPLITTING IN OPTICAL
INSPECTION SYSTEMS
NEGEVTECH, LTD
US
60/861303
28/11/2006
11/944684
26/11/2007
US
28/11/2007
187719
IMAGE SPLITTING IN OPTICAL
INSPECTION SYSTEMS
NEGEVTECH, LTD
US
60/861303
28/11/2006
11/944677
26/11/2007
US
28/11/2007
187720
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫טכניקות לצמצום התחממות רקמה‬
) RF( ‫החשופה לתדרי רדיו‬
H01L
‫פיצול תמונה במערכות בדיקה אופטיות‬
H01L
‫פיצול תמונה במערכות בדיקה אופטיות‬
G06Q
‫טלפון נייד סולרי‬
‫אדידה קלוד‬
PORTABLE TELEPHON SOLAR
HADIDA CLAUDE
28/11/2007
A61B
187721
B23B
96
‫שימת חיתוך‬
‫ישקר בע"מ‬
CUTTING INSERT
ISCAR LTD.
21/06/2006
187741
NOVEL 2-AZETIDINONE
DERIVATIVES AS CHOLESTEROL
ABSORPTION INHIBITORS FOR THE
TREATMENT OF HYPERLIPIDAEMIC
CONDITIONS
ASTRAZENECA AB
SE
0501464-2
22/06/2005
PCT/SE/2006/000766
WO/2006/137797
29/11/2007
‫–אזטידינון חדשות כמעכבי ספיגת‬2 ‫נגזרות‬
‫כולסטרול לטיפול במצבי יתר–שומן בדם‬
187742
CORNER STORAGE DEVICE
VERTICALLY LIFTED
ROIE BAR ZAKAY
01/06/2006
97
A47F
‫מתקן אחסון פינתי נשלף אנכית‬
‫זכאי‬-‫רועי בר‬
187743
TRANSFER OF KINETIC ENERGY TO
AND FROM FLUIDS
ARNOLD SYSTEMS LLC
US
60/685891
01/06/2005
PCT/US/2006/021157
WO/2006/130719
29/11/2007
C07D
F03D
‫העברת אנרגיה קינטית לניגרים ומניגרים‬
187752
D04H
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHOD AND DEVICE FOR
PRODUCING A NONWOVEN
REIFENHAUSER GMBH & CO.
MASCHINENFABRIK
EP
06025192.3 06/12/2006
01/10/1998
‫שיטה ומכשיר ליצור אריג לא סרוג‬
187755
USE OF COMPOSITION FROM PLANT
MATTER ENRICHED IN
PHYTOCHEMICALS, FOR
PREPARATION OF A MEDICAMENT
FOR TREATING VARIOUS
DISORDERS
A61K
‫שימוש בתכשירים ממקור צמחי מועשרים‬
‫ להכנת תרופות לטיפול‬,‫בחומרים צמחיים‬
‫במגוון תופעות‬
ARCHER-DANIELS-MIDLAND
COMPANY
US
60/060549
02/10/1997
162038
28/09/1998
US
14/04/2005
187756
AN INJECTION MOLDING SYSTEM
AND A HOT RUNNER FOR USE
THEREIN, FOR MOLDING METAL
ALLOY
HUSKY INJECTION MOLDING
SYSTEMS LTD.
US
10/846516
17/05/2004
PCT/CA/2005/000556
WO/2005/110704
14/04/2005
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187757
B29C
‫מערכת להזרקה בתבניות ופיית הזרקה‬
‫ להזרקת סגסוגת‬,‫חמה לשימוש בה‬
‫מתכת‬
B29C
98
AN INJECTION MOLDING SYSTEM
AND A HOT RUNNER FOR USE
THEREIN, FOR MOLDING METAL
ALLOY
HUSKY INJECTION MOLDING
SYSTEMS LTD.
US
10/846516
17/05/2004
PCT/CA/2005/000556
WO/2005/110704
25/02/1997
187758
USE OF A PHOTOACTIVE
COMPOUND FOR THE
MANUFACTURE OF A MEDICAMENT
FOR ENHAHCENENT OF VISUAL
ACTIVITY, COMDINED WITH
IRRADIATING THEREAFTER
TARGET OCULAR TISSUE WITH
LIGHT ADSORDEB BY A
PHOTOACTIVE COMPOUND
QLT INC.
US
08/613420
11/03/1996
PCT/CA/1997/000134
WO/1997/033619
29/11/2007
‫מערכת להזרקה בתבניות ופיית הזרקה‬
‫ להזרקת סגסוגת‬,‫חמה לשימוש בה‬
‫מתכת‬
‫שימוש בתרכובת פעילה באור ליצור‬
‫תרופה לשיפור פעילות ראיה בצירוף‬
‫הקרנת הרקמה העינית עם אור הנבלע על‬
‫ידי התרכובת הפעילה באור‬
187760
BEDDUNGS WITH ATTACHMENT
MEANS TO ATTACH DOWN
COMFORTES AND BLANKETS TO
COVER COMFORTERS AND SHEETS
HANA AMSELAM
29/11/2007
99
A61K
187762
A47G
‫מצעים למיטה הכוללים אמצעי לחיבור‬
‫שמיכות ושמיכות פוך לציפות ולסדינים‬
‫חנה אמסלם‬
B05B
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
SPRINKLER WITH MAGNETIC
NUTATING MECHANISM AND
RELATED METHOD
NELSON IRRIGATION
CORPORATION
US
11/606958
01/12/2006
29/11/2007
187774
P-WAVES INDUCED LIQUEFACTION
IN THE WEAKLY CEMENTED SOILS
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
02/06/2006
187778
MULTILAYER TUBE FOR
TRANSPORTING WATER OR GAS
ARKEMA FRANCE
FR
0505603
02/06/2005
0506189
17/06/2005
FR
60/716429
17/10/2005
US
PCT/FR/2006/001292
WO/2006/129029
26/06/2001
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187795
‫ממטרה עם מנגנון מנענע מגנטי ושיטה‬
‫הקשורה לה‬
C12N
‫ בקרקעות‬P–‫ניזול מושרה באמצעות גלי‬
‫מודבקות באופן חלש‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
B32B
‫צינור רב–שכבתי להעברת מים או גז‬
C07C
100
‫תוצרי ביניים של אמידים מותמרים של‬
‫אוקטנואיל‬
INTERMEDIATES OF SUBSTITUTED
OCTANOYL AMIDES
SPEEDEL PHARMA AG
CH
1329/00
05/07/2000
2450/00
15/12/2000
CH
PCT/CH/2001/000399
WO/2002/002508
26/06/2001
187796
‫חומרי ביניים של אמידים מותמרים של‬
‫אוקטנואיל‬
INTERMEDIATES OF SUBSTITUTED
OCTANOYL AMIDES
SPEEDEL PHARMA AG
CH
1329/00
05/07/2000
2450/00
15/12/2000
CH
PCT/CH/2001/000399
WO/2002/002508
29/11/2007
187797
A METHOD OF MEASUREMENT, AN
INSPECTION APPARATUS AND A
LITHOGRAPHIC APPARATUS
ASML NETHERLANDS B.V.
US
11/641124
19/12/2006
29/11/2007
101
H01L
‫ מנגנון לפיקוח ומכשיר‬,‫שיטה למדידה‬
‫ליטוגרפי‬
187798
A SCATTEROMETER, A
LITHOGRAPHIC APPARATUS AND A
FOCUS ANALYSIS METHOD
ASML NETHERLANDS B.V.
US
11/635787
08/12/2006
C07C
H01L
‫ מכשיר ליטוגרפי ושיטה לניתוח‬,‫מד פיזור‬
‫מיקוד‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
31/05/2006
187822
A LOCK KEY AND A METHOD OF ITS
MANUFACTURE
ASSA AB
SE
0501333-9
10/06/2005
PCT/SE/2006/000644
WO/2006/132576
10/02/2006
187823
DENTAL PROSTHESIS AND ITS
MANUFACTURING METHOD
KWON, OH-DAL
10-2005KR
10/06/2005
0049604
10-200505/07/2005
KR
0059983
10-200512/07/2005
KR
0062693
10-200514/12/2005
KR
0122872
10-200606/01/2006
KR
0001540
PCT/KR/2006/000477
WO/2006/132464
08/06/2006
187824
PROCESSES FOR THE PREPARATION
OF PACLITAXEL
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC.
US
60/689425
10/06/2005
60/708929
17/08/2005
US
60/708931
17/08/2005
US
60/724527
07/10/2005
US
60/788943
04/04/2006
US
PCT/US/2006/022214
WO/2006/135656
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G07C
‫מפתח למנעול ושיטה לייצורו‬
A61C
‫תותב דנטלי ושיטת ייצורו‬
C07D
‫תהליכים להכנת פקליטקסל‬
102
01/06/2006
187825
‫ לטיפול בהשמנת‬B–MAO ‫מעכבים של‬
‫יתר‬
MAO-B INHIBITORS USEFUL FOR
TREATING OBESITY
JENRIN DISCOVERY
US
60/686585
02/06/2005
PCT/US/2006/021142
WO/2006/130707
02/06/2006
187826
A SOLID PHARMACEUTICAL
COMPOSITION WITH A FIRST
FRACTION OF A DISPERSION
MEDIUM AND A SECOND FRACTION
OF A MATRIX, THE LATTER BEING AT
LEAST PARTIALLY FIRST EXPOSED
TO GASTROINTESTINAL FLUIDS
EGALET A/S
DK
PA200500813 03/06/2005
PCT/DK/2006/000312
WO/2006/128471
17/07/2006
A61K
‫תכשיר רוקחי מוצק עם פרקציה ראשונה‬
‫של תווך פיזור ופרקציה שנייה של‬
‫מטריצה החשופה באופן חלקי לנוזלי‬
‫קיבה ומעיים‬
187827
IDENTIFICATION OF NOVEL BITTER
TASTE RECEPTOR T2R76 THAT
SPECIFICALLY RESPONDS TO
BRUCINE AND PROP BITTER
LIGANDS
SENOMYX, INC.
US
11/182942
18/07/2005
PCT/US/2006/027656
WO/2007/011859
103
C07C
C07K
T2R76 ‫זיהוי של רצפטור חדש לטעם מר‬
‫אשר מגיב ספציפית לליגנדים המרים‬
PROP –‫ברוצין ו‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
19/10/2006
187828
CHIMERIC HUMAN SWEET -UMAMI
AND UMAMI-SWEET TASTE
RECEPTORS
SENOMYX, INC.
US
60/728324
20/10/2005
PCT/US/2006/041158
WO/2007/047988
09/06/2006
–‫רצפטורים אנושיים כימריים לטעם מתוק‬
‫אומאמי ואומאמי–מתוק‬
187831
ALPHA-(ARYL-OR HETEROARYLMETHYL)-BETA PIPERIDINO
PROPANAMIDE COMPOUNDS AS
ORL1-RECEPTOR ANTAGONISTS
PFIZER INC.
US
60/691939
17/06/2005
PCT/IB/2006/001642
WO/2006/134486
13/06/2006
187832
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫שיטות וחומרי ביניים להכנה של‬
‫ אופציונאלי מסומן‬IMATINIB
‫רדיואקטיבית‬
187833
BOUNCING MODE OPERATED
SCANNING MICRO-MIRROR
TERRAOP LTD.
US
11/144842
06/06/2005
PCT/IL/2006/000657
WO/2006/131916
C07D
–‫תרכובות אלפא– (אריל או הטרואריל‬
‫מתיל)–ביטא פיפרידינו פרופאנאמיד‬
ORL 1 ‫כאנטגוניסטים של קולטני‬
METHODS AND INTERMEDIATES
FOR THE PREPARATION OF
OPTIONALLY RADIO- LABELED
IMATINIB
NOVARTIS AG
GB
0512091.0
14/06/2005
PCT/EP/2006/005676
WO/2006/133904
06/06/2006
C07K
G02F
‫מיקרו–מראה המיועדת לסריקה באמצעות‬
‫החזרה‬
‫טרהאופ בע"מ‬
104
08/06/2006
187834
SYSTEM AND METHOD FOR
DISPLAYING A DRIVING PROFILE
DRIVE DIAGNOSTICS LTD.
US
60/688696
09/06/2005
PCT/IL/2006/000672
WO/2006/131926
03/12/2007
187836
TECHNIQUE FOR GENERATING
MULTILEVEL CODED OPTICAL
SIGNALS
ECI TELECOM LTD.
02/06/2006
‫מערכת ושיטה להצגת פרופיל נהיגה‬
‫דרייב דיאגנוסטיקה בע"מ‬
H04L
‫טכנולוגיה ליצירת אותות אופטיים‬
‫ בעלי מספר רמות‬,‫מקודדים‬
‫ טלקום בע"מ‬.‫ איי‬.‫ סי‬.‫אי‬
187837
PROVIDING AND RECEIVING
NETWORK ACCESS
CONTIGO MOBILITY INC.
US
60/687463
03/06/2005
60/728918
21/10/2005
US
60/772084
09/02/2006
US
60/776444
23/02/2006
US
11/441827
25/05/2006
US
PCT/US/2006/021508
WO/2006/132991
105
G08B
G06F
‫אספקה וקבלת גישה לרשת‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
01/06/2006
187838
PRODUCTION OF IL-18 BINDING
PROTEIN
ARES TRADING S.A.
EP
05104878.3 03/06/2005
60/687631
03/06/2005
US
05106429.3
13/07/2005
EP
PCT/EP/2006/062851
WO/2006/128908
02/06/2006
02/06/2006
A61K
BP 18 – IL ‫שימוש באיזופורמים של‬
‫או מניעה של מחלות נוירולוגיות‬/‫לטיפול ו‬
‫ודלקתיות‬
187840
AGENT FOR REGENERATION
AND/OR PROTECTION OF NERVES
ONO PHARMACEUTICAL CO., LTD.
2005JP
03/06/2005
164458
PCT/JP/2006/311084
WO/2006/129788
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
IL – 18 ‫יצור של חלבון הקושר‬
187839
USE OF IL-18BP ISOFORMS FOR THE
TREATMENT AND/OR PREVENTION
OF NEUROLOGICAL AND
INFLAMMATORY DISEASES
LABORATOIRES SERONO SA
EP
05104863.5 03/06/2005
60/688057
07/06/2005
US
PCT/EP/2006/062864
WO/2006/128911
C07K
A61K
‫או הגנה של עצבים‬/‫גורם ליצירה מחדש ו‬
106
05/06/2006
187841
NANOPARTICULATE IMATINIB
MESYLATE FURMULATIONS
ELAN PHARMA INTERNATIONAL
LTD.
US
60/687146
03/06/2005
PCT/US/2006/021657
WO/2006/133046
05/06/2006
‫פורמולציות אימטיניב מסילאט ננוחלקיקי‬
187842
NANOPARTICULATE
ACETAMINOPHEN FORMULATIONS
ELAN PHARMA INTERNATIONAL
LTD.
US
60/687114
03/06/2005
PCT/US/2006/021656
WO/2007/053197
26/07/2006
187843
METHOD AND APPARATUS FOR
CONTROL OF ENHANCED
DEDICATED CHANNEL
TRANSMISSIONS
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/704273
01/08/2005
11/444751
31/05/2006
US
PCT/US/2006/028899
WO/2007/016117
107
A61K
A61K
‫פורמולציות של אצטאמינופן ננוחלקיקי‬
H04B
‫שיטה ומערכת לבקרה של שידורי ערוץ‬
‫מוגדרים‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
23/06/2006
187844
B65D
FOOD CONTAINER AND METHOD OF
STORING FOOD
EZEE WHIP ICE-CREAM LIMITED
GB
0513030.7
25/06/2005
PCT/GB/2006/002326
WO/2007/000577
01/06/2006
‫מיכל למזון ושיטה לאחסון מזון‬
187845
POLYMORPHS OF ETHYL 3-[(2-{[4(HEXYLOXYCARBONYLAMINOIMINOMETHYL)
PHENYLAMINO]METHYL}-1-METHYL1H-BENZIMIDAZOLE-5CARBONYL)PYRIDIN-2YLAMINO]PROPIONATE
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102005025728.3 04/06/2005
PCT/EP/2006/062847
WO/2006/131491
20/04/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
–4({ 2([ –3 ‫צורות מופע שונות של אתיל‬
–‫(הקסילאוקסי קרבונילאמינו‬
1–‫–מתיל‬1–}‫אימינומתיל)פנילאמינו]מתיל‬
–2–‫–קרבוניל)פירידין‬5–‫ –בנזאימידזול‬H
‫אילאמינו] פרופיונאט‬
187846
X-RAY ARRANGEMENT FOR THE
IMAGE REPRESENTATION OF AN
EXAMINATION OBJECT AND USE OF
THE X-RAY ARRANGEMENT
BAYER SCHERING PHARMA AG
DE
102005026940.0 06/06/2005
PCT/EP/2006/003908
WO/2006/131175
14/09/1998
C07D
187847
A61B
‫ להצגת דמות של בחינת‬X ‫סידור קרני‬
X ‫אובייקט ושימוש בסידור של קרני‬
C07K
108
‫ של קולטן‬TIE ‫הומולוגים של ליגנדים‬
‫טירוזין קינאז‬
TIE RECEPTOR TYROSINE KINASE
LIGAND HOMOLOGUES
GENENTECH, INC.
US
08/934494
19/09/1997
PCT/US/1998/019094
WO/1999/015654
06/12/2000
187848
METHODS OF USING RANDOMIZED
LIBRARIES OF ZINC FINGER
PROTEINS FOR THE
IDENTIFICATION OF GENE
FUNCTION
SANGAMO BIOSCIENCES, INC.
US
456100
06/12/1999
PCT/US/2000/033086
WO/2001/040798
09/06/2006
SHIFTABLE BUILDING
VAB
FR
0505908
PCT/FR/2006/001313
WO/2006/131661
‫שיטות להשתמש בספריות אקראיות של‬
‫חלבוני אצבע עם אבץ לזיהוי פעולה של גן‬
187849
E04B
‫מבנה הניתן להזזה‬
10/06/2005
13/06/2006
187851
BLISTER BASE PART AND BLISTER
PACK
ALCAN TECHNOLOGY &
MANAGEMENT LTD.
EP
EP05405383 15/06/2005
PCT/EP/2006/005635
WO/2007/104344
22/05/2006
HEAT EXCHANGER FOR SOLAR
ENERGY GENERATORS
109
C40B
B32B
‫בסיס אריזת בועה ואריזת בועה‬
187852
F24J
‫מחליף חום למחוללי אנרגיה סולרית‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
WILLIAMS, REGINALD, IAN
IT
MI2005A001062 09/06/2005
PCT/IT/2006/000382
WO/2006/131946
08/06/2006
187853
PLANT AID, WATER COLLECTION
SHEET AND METHOD
P.M.M. HOFF HOLDING B.V.
NL
1029216
08/06/2005
1029307
21/06/2005
NL
PCT/NL/2006/000282
WO/2006/132526
25/11/2003
187854
AREAL METAL ELEMENT AND
PROFILE ELEMENT
PROTEKTORWERK FLORENZ
MAISCH GMBH & CO. KG
DE
10259307.8 18/12/2002
PCT/EP/2003/013249
WO/2004/055289
08/06/2006
187855
PROCESSES FOR THE PREPARATION
OF DOCETAXEL
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
E03B
‫ יריעת אסוף מים ושיטה‬,‫עזר לצמח‬
E04C
‫אלמנט מתכת אזורי ופרופיל אלמנט‬
C07D
‫תהליכים להכנת דוסטקסל‬
110
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC.
US
60/689425
10/06/2005
60/708931
17/08/2005
US
60/708929
17/08/2005
US
60/724527
07/10/2005
US
60/788943
04/04/2006
US
PCT/US/2006/022335
WO/2006/135692
08/06/2006
187856
‫סינתזה של– ? לקטמים‬
?-LACTAM SYNTHESIS
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC.
US
60/689425
10/06/2005
60/708929
17/08/2005
US
PCT/US/2006/022267
WO/2006/135670
08/06/2006
187857
RESOLUTION OF ENANTIOMERIC
MIXTURES OF ?-LACTAMS
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC.
US
60/689425
10/06/2005
60/708931
17/08/2005
US
PCT/US/2006/022266
WO/2006/135669
01/06/2006
111
C07D
C07D
?– ‫רזולוציה של תערובות אננטיומריות של‬
‫לקטמים‬
187858
C08K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
FLAME RETARDANT COMPOSITION
EXHIBITING SUPERIOR THERMAL
STABILITY AND FLAME RETARDING
PROPERTIES AND USE THEREOF
ALBEMARLE CORPORATION
US
60/688467
07/06/2005
60/688385
07/06/2005
US
PCT/US/2006/021227
WO/2006/132900
12/06/2006
‫הרכבים מעכבי בערה עם יציבות תרמית‬
‫ותכונות עיכוב בערה טובות יותר והשימוש‬
‫בהם‬
187859
DIAGNOSIS AND PROGNOSIS OF
DIABETES
THE REGENTS OF THE UNIVERSITY
OF CALIFORNIA
US
60/689612
10/06/2005
PCT/US/2006/022915
WO/2006/135879
08/06/2006
187860
PROCESSES FOR THE PRODUCTION
OF POLYCYCLIC FUSED RING
COMPOUNDS
FLORIDA STATE UNIVERSITY
RESEARCH FOUNDATION, INC.
US
60/689425
10/06/2005
60/724527
07/10/2005
US
60/788943
04/04/2006
US
PCT/US/2006/022213
WO/2006/135655
03/12/2007
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187861
A61K
‫דיאגנוזה ופרוגנוזה של סוכרת‬
C07F
‫תהליכים לייצורן של תרכובות בעלות‬
‫טבעות פוליציקליות דחוסות‬
H04L
112
METHOD AND SYSTEM FOR
FLOODING AND MULTICAST
ROUTING IN AN AD-HOC NETWORK
ELBIT SYSTEMS LTD.
03/12/2007
‫שיטה ומערכת להצפה וניתוב מרובב‬
‫ברשתות אד–הוק‬
‫אלביט מערכות בע"מ‬
187862
)UWB( ‫מקלט אולטרה–רחב סרט‬
‫אלביט מערכות בע"מ‬
ULTRA WIDEBAND RECEIVER
ELBIT SYSTEMS LTD.
05/06/2006
187864
METHODS AND APPARATUS FOR
READING A FULL-SWING MEMORY
ARRAY
QUALCOMM INCORPORATED
US
11/152982
14/06/2005
PCT/US/2006/022374
WO/2006/138150
02/06/2006
113
G11C
‫שיטות והתקנים לקריאת מערך זיכרון‬
‫בתנופה מלאה‬
187865
METHOD AND APPARATUS FOR
MANAGING INSTRUCTION
FLUSHING IN A MICROPROCESSOR'S
INSTRUCTION PIPELINE
QUALCOMM INCORPORATED
US
11/149773
10/06/2005
PCT/US/2006/021617
WO/2006/135590
08/06/2006
H04B
G06F
‫שיטה והתקן לניהול הוראות פלאש בצינור‬
‫עיבוד נתונים במיקרו מעבד ראשי‬
187866
C07H
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHODS AND KITS FOR SENSE
RNA SYNTHESIS
DATASCOPE INVESTMENT CORP.
US
11/150794
10/06/2005
PCT/US/2006/022317
WO/2006/135684
21/06/2006
RNA SENSE ‫שיטות וערכות לייצור‬
187867
G01N
‫ חלבונים‬:‫סמנים ביולוגיים לסרטן שחלתי‬
‫הקשורים‬
CTAP 3‫ל‬
BIOMARKER FOR OVARIAN
CANCER: CTAP3-RELATED
PROTEINS
THE JOHNS HOPKINS UNIVERSITY
US
60/693324
22/06/2005
PCT/US/2006/024269
WO/2007/002264
26/07/2006
187868
‫קוטלי פטריות קרבוקסאמידים‬
FUNGICIDAL CARBOXAMIDES
E.I. DU PONT DE NEMOURS AND
COMPANY
US
60/702579
26/07/2005
PCT/US/2006/029175
WO/2007/014290
31/05/2006
187871
ARRANGEMENT FOR ESTABLISHING A
CONNECTION BETWEEN TWO CABLE
SUPPORT DEVICE ELEMENTS AND
CONNECTING ELEMENTS
OBO BETTERMANN GMBH & CO. KG
DE
202005010108.7 28/06/2005
PCT/EP/2006/062801
WO/2007/000384
08/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
187872
H02G
‫סידור להקמת חיבור בין שני התקני‬
‫תמיכה לכבלים ויחידות חיבור‬
A47C
114
‫מכלל רהיט מודולרי‬
MODULAR FURNITURE ASSEMBLY
SAC ACQUISITION LLC
US
11/149913
10/06/2005
PCT/US/2006/017591
WO/2006/135509
06/06/2006
187873
SURFACE FUNCTIONAL ELECTROTEXTILE WITH FUNCTIONALITY
MODULATION CAPABILITY,
METHODS FOR MAKING THE SAME,
AND APPLICATIONS
INCORPORATIING THE SAME
TEXTRONICS, INC.
US
11/150525
10/06/2005
PCT/IB/2006/001477
WO/2006/131810
22/06/2006
03/08/2006
‫אלקטרו–אריג פעיל שטח עם יכולת איפנון‬
‫ שיטות ליצורו ויישומים‬,‫תיפקודית‬
‫המכילים אותו‬
187876
EFFICIENT FORMATION OF AD HOC
NETWORKS
MICROSOFT CORPORATION
US
11/172154
30/06/2005
PCT/US/2006/024452
WO/2007/005331
115
H04B
‫יצור יעיל של מערכות תקשורת תכליתיות‬
187877
METHOD AND SYSTEM FOR
REPORTING A SHORT MESSAGE
CAPABILITY VIA AN IP
MULTIMEDIA SUBSYSTEM
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/705911
05/08/2005
11/444844
31/05/2006
US
PCT/US/2006/030186
WO/2007/019203
15/06/2006
D03D
187878
H04Q
‫שיטה ומערכת יכולת לדיווח מסר קצר‬
IP ‫באמצעות תת–מערכת מולטימדיה‬
C07H
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHOD FOR THE SYNTHESIS OF
ANTHOCYANINS
BIOSYNTH AS
GB
0512206.4
15/06/2005
PCT/GB/2006/002172
WO/2006/134352
22/06/2006
187880
MEDICAL DEVICES COMPRISING A
RETICULATED COMPOSITE
MATERIAL
CINVENTION AG
US
60/696255
01/07/2005
PCT/EP/2006/063450
WO/2007/003516
15/06/2006
‫שיטה להכנת אנתוציאנינים‬
‫מכשירים רפואיים המכילים חומר מרוכב‬
‫רשתי‬
187881
187882
A CARRIER COMPRISING ONE OR
MORE DI AND/OR MONO(ELECTRON TRANSFER AGENT)
PHOSPHATE DERIVATIVES OR
COMPLEXES THEREOF
VITAL HEALTH SCIENCES PTY LTD.
AU
2005903198 17/06/2005
2005904737
30/08/2005
AU
2006902726
19/05/2006
AU
PCT/AU/2006/000839
WO/2006/133506
14/07/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07C
‫מעכבי ספינגוסין קינאז‬
SPHINGOSINE KINASE INHIBITORS
APOGEE BIOTECHNOLOGY
CORPORATION
US
60/691563
17/06/2005
PCT/US/2006/023645
WO/2006/138660
16/06/2006
A61L
A61K
‫נשא המכיל תולדת פוספאט אחת או יותר‬
)‫או מונו (גורם להעברת אלקטרון‬/‫של די ו‬
‫או קומפלקסים שלה‬
187883
G10K
116
FREQUENCY SEGMENTATION TO
OBTAIN BANDS FOR EFFICIENT
CODING OF DIGITAL MEDIA
MICROSOFT CORPORATION
US
11/183087
15/07/2005
PCT/US/2006/027420
WO/2007/011749
14/06/2006
‫חלוקת תדירויות לקבלת פסים להצפנה‬
‫יעילה של תווך דיגיטלי‬
187884
PROCESS OF PRODUCING BLEACH
BOOSTERS
BASF AKTIENGESELLSCHAFT
EP
05013132.5 17/06/2005
05013136.6
17/06/2005
EP
05013129.1
17/06/2005
EP
PCT/EP/2006/063237
WO/2006/134143
07/06/2006
13/12/2006
117
‫תהליך להכנת מגבירי הלבנה‬
187885
SUSCEPTIBILITY GENES FOR AGERELATED MACULOPATHY (ARM) ON
CHROMOSOME 10q26
UNIVERSITY OF PITTSBURGH-OF
THE COMMONWEALTH SYSTEM OF
HIGHER EDUCATION
US
60/688572
08/06/2005
PCT/US/2006/022114
WO/2006/133295
C07D
C12Q
‫גנים בלתי עמידים לכתמים הנובעים מגיל‬
Q1026 ‫ ) על כרומוזום‬ARM(
187886
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
CRYSTAL FORM OF ATORVASTATIN
HEMI -CALCIUM AND PROCESSES
FOR PREPARATION THEREOF
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/749603
13/12/2005
PCT/US/2006/047834
WO/2007/070667
22/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים‬
A61K
‫מלחים חדישים של תרופות פסיכטרופיות‬
‫ותהליכים לייצורם‬
187893
TOPICAL UNGUAL FORMULATIONS
C07K
‫חומרים ושיטות למניעה או טיפול בהדבקה‬
HIV–‫ב‬
187892
NOVEL SALTS OF CONJUGATED
PSYCHOTROPIC DRUGS AND
PROCESSES OF PREPARING SAME
RAMOT AT TEL-AVIV UNIVERSITY
LTD.
US
60/687851
07/06/2005
60/794501
25/04/2006
US
PCT/IL/2006/000666
WO/2006/131923
06/06/2006
‫טבע תעשיות פרמצבטיות בע"מ‬
187889
COMPOSITIONS AND METHODS FOR
PREVENTING OR TREATING HIV
INFECTION
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
US
60/693057
23/06/2005
PCT/IL/2006/000741
WO/2006/137075
07/06/2006
–‫צורות קריסטליניות של אטורבסטטין המי‬
‫קלציום ותהליכים להכנתן‬
‫אביב בע"מ‬-‫רמות ליד אוניברסיטת תל‬
A61K
‫תכשירים טופיקליים לציפורניים‬
118
MEDPHARM LIMITED
GB
0511499.6
PCT/GB/2006/002064
WO/2006/131721
21/06/2006
ALKYL SULFONAMIDE
DERIVATIVES
H. LUNDBECK A/S
US
11/159794
PCT/US/2006/024043
WO/2007/002126
22/06/2006
06/06/2005
187894
‫נגזרות אלקיל סולפונמיד‬
23/06/2005
187895
BENZOCYCLOHEPTAPYRIDINES AS
INHIBITORS OF THE RECEPTOR
TYROSINE KINASE MET
MERCK & CO. INC.
US
60/693229
23/06/2005
60/729061
21/10/2005
US
60/789473
05/04/2006
US
PCT/US/2006/024256
WO/2007/002258
07/06/2006
187896
DIELECTRIC CERAMIC CAPACITOR
COMPRISING NON-REDUCIBLE
DIELECTRIC
KEMET ELECTRONICS
CORPORATION
US
11/146847
07/06/2005
PCT/US/2006/022185
WO/2006/133320
12/06/2006
PARP MODULATORS AND
TREATMENT OF CANCER
119
C07D
187898
C07D
‫בנזוציקלוהפטפרידינים כמעכבים של‬
MET ‫רצפטור טירוזין קינאז‬
H01G
‫קבל קרמי דיאלקטרי הכולל רכיבים‬
‫שאינם ניתנים לפריקה‬
C07D
‫ וטיפול בסרטן‬PARP ‫מודולטורים של‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
BIPAR SCIENCES, INC.
US
60/689178
PCT/US/2006/022907
WO/2006/135873
10/06/2005
23/06/2006
187899
BIOMARKER FOR OVARIAN
CANCER:?-2 MICROGLOBULIN
CIPHERGEN BIOSYSTEMS, INC.
US
60/693679
24/06/2005
PCT/US/2006/024677
WO/2007/002527
29/06/2006
187900
DERIVATIVES OF PYRIDO[2,3-D]
PYRIMIDINE, THE PREPARATION
THEREOF, AND THE THERAPEUTIC
APPLICATION OF THE SAME
SANOFI-AVENTIS
FR
0507032
01/07/2005
PCT/FR/2006/001518
WO/2007/003765
26/06/2006
187901
PROLONGED RELEASE
FORMULATION OF ACTIVE
PRINCIPLES HAVING A PHDEPENDENT SOLUBILITY
SANOFI-AVENTIS
FR
0506539
28/06/2005
PCT/FR/2006/001466
WO/2007/003746
08/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187902
G01N
2– ?:‫סמנים ביולוגיים לסרטן שחלתי‬
‫מיקרוגלובולין‬
C07D
,‫] פירימידין‬D –3 ,2 [‫תולדות של פירידו‬
‫ ויישומים רפואיים שלהן‬,‫הכנתן‬
A61K
‫פורמולציה של חומרים פעילים בעלי‬
PH–‫שחרור מושהה עם מסיסות תלויית‬
C12Q
120
TREATMENT OF CNS DISORDERS
ASSOCIATED WITH MUTATIONS IN
GENES ENCODING LYSOSOMAL
ENZYMES
AMICUS THERAPEUTICS, INC.
US
60/689120
08/06/2005
PCT/US/2006/022754
WO/2006/133446
06/06/2006
‫ הקשורות במוטציות‬CNS ‫טיפול בהפרעות‬
‫בגנים המקודדים לאנזימים ליזוזומליים‬
187904
QUINOLINE DERIVATIVES AS
ANTIBACTERIAL AGENTS
JANSSEN PHARMACEUTICA N.V.
EP
05105023.5 08/06/2005
11/296918
08/12/2005
US
PCT/EP/2006/062934
WO/2006/131519
06/06/2006
06/06/2006
121
‫תולדות קווינולין כגורמים נגד חיידקים‬
187905
IMMEDIATE-RELEASE AND HIGHDRUG-LOAD PHARMACEUTICAL
FORMULATIONS OF NONMICRONISED (4-CHLOROPHENYL)[4(4-PYRIDYLMETHYL)PHTHALAZIN1-YL]AND SALTS THEREOF
BAYER SCHERING PHARMA AG
EP
05090166.9 07/06/2005
PCT/EP/2006/005600
WO/2006/131393
C07D
A61K
–4[)‫–כלורופניל‬4( ‫פורמולציות רוקחיות של‬
‫–יל]שאינו‬1–‫–פירידילמתיל)פתאלזין‬4(
‫מיקרוני ומלחיו המשתחררות באופן מיידי‬
‫ובעלות כמות גבוהה של התרופה‬
187906
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
IMMEDIATE-RELEASE AND HIGHDRUG-LOAD PHARMACEUTICAL
FORMULATIONS OF MICRONISED (4CHLOROPHENYL)[4-(4PYRIDYLMETHYL)PHTHALAZIN-1YL] AND SALTS THEREOF
BAYER SCHERING PHARMA AG
EP
05090167.7 07/06/2005
PCT/EP/2006/005601
WO/2006/131394
07/12/1999
–4[)‫–כלורופניל‬4( ‫פורמולציות רוקחיות של‬
‫–יל]מיקרוני‬1–‫–פירידילמתיל)פתאלזין‬4(
‫ומלחיו המשתחררות באופן מיידי ובעלות‬
‫כמות גבוהה של התרופה‬
187907
ANALOGUES OF GLP-1 AND USES
THEREOF
SOCIETE DE CONSEILS DE
RECHERCHES ET D'APPLICATIONS
SCIENTIFIQUES S.A.S.
US
09/206601
07/12/1998
60/111255
07/12/1998
US
PCT/EP/1999/009660
WO/2000/034331
01/06/2006
‫ ושימושים שלהם‬GLP–1 ‫אנלוגים של‬
187908
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A23G
‫תוצר אכילה קפוא‬
FROZEN EDIBLE PRODUCT
UNILEVER PLC
EP
05253816.2 20/06/2005
PCT/EP/2006/005382
WO/2006/136283
14/06/2006
C07K
187909
D04H
122
FIBRE COMPOSITE THAT CAN BE
DISSOLVED OR DECOMPOSED IN
WATER, AND PRODUCTS THEREOF
KELHEIM FIBRES GMBH
DE
102005027795.0 15/06/2005
102005029597.5
23/06/2005
DE
PCT/EP/2006/063224
WO/2006/134132
06/06/2006
187912
MULTI-LEVEL THIN-CLIENT
MANAGEMENT SYSTEM AND
METHOD
CHIP PC ISRAEL LTD
US
60/688241
06/06/2005
PCT/IL/2006/000655
WO/2006/131914
06/06/2006
123
H02G
‫התקן ושיטה לניהול מחשב רזה רב–שלבי‬
.CHIPC ISRAEL LTD
187914
INTEGRATED CHEMICAL
MECHANICAL POLISHING
COMPOSITION AND PROCESS FOR
SINGLE PLATEN PROCESSING
ADVANCED TECHNOLOGY
MATERIALS, INC.
US
60/687721
06/06/2005
PCT/US/2006/022037
WO/2006/133249
14/06/2006
‫סיב מרוכב הניתן להמסה או פירוק‬
‫במים ותצוריו‬
B24B
‫תרכובת כימית משולבת להברקה מיכנית‬
‫והליך עבור הליך לעיבוד גליל דיו יחיד‬
187915
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
1,2-DI(CYCLIC GROUP)SUBSTITUTED
BENZENE DERIVATIVE
EISAI R&D MANAGEMENT CO. LTD.
2005JP
14/06/2005
174072
PCT/JP/2006/311900
WO/2006/134955
21/06/2006
)‫–די(קבוצה ציקלי‬2,1 ‫נגזר בינזין מותמר עם‬
187916
TABLET CONTAINING HARDLY
SOLUBLE ACTIVE INGREDIENT
TAKEDA PHARMACEUTICAL
COMPANY LIMITED
2005JP
22/06/2005
182415
PCT/JP/2006/312419
WO/2006/137443
14/07/2006
187917
ANTIARRHYTHMIC PRECURSOR
COMPOUNDS, METHODS OF
SYNTHESIS AND METHODS OF USE
ARYX THERAPEUTICS, INC.
US
60/699780
15/07/2005
PCT/US/2006/027599
WO/2007/011835
03/07/2006
187919
4C
ERASMUS UNIVERSITY MEDICAL
CENTER
GB
0513676.7
04/07/2005
0605449.8
17/03/2006
GB
PCT/IB/2006/002268
WO/2007/004057
08/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187920
A61K
‫טבלייה המכילה מרכיב שכמעט ואינו‬
‫מסיס‬
C07D
‫ שיטות‬,‫תרכובות מוצא אנטיאריטמיות‬
‫לייצרן ולשימוש‬
C12Q
C4
D06F
124
CLOTHES IRON WITH MEANS FOR
INDUCING ORBITAL OSCILLATORY
MOTION INTO THE SOLE PLATE
AKHTER, PERVEZ
GB
0512380.7
17/06/2005
0517857.9
01/09/2005
GB
PCT/GB/2006/002098
WO/2006/134323
23/06/2006
‫מגהץ בגדים עם אמצעים לגרימת תנועה‬
‫מסלולית מתנדנדת בלוח היחיד‬
187924
‫תכשיר אימונוגני‬
IMMUNOGENIC COMPOSITION
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0513071.1
27/06/2005
0513069.5
27/06/2005
GB
0515556.9
28/07/2005
GB
0524204.5
28/11/2005
GB
0526040.1
21/12/2005
GB
0526041.9
21/12/2005
GB
PCT/EP/2006/006188
WO/2007/000314
13/06/2006
A61K
187925
A62C
‫מערכת לכיבוי שריפות המשתמשת‬
‫בחומרים הפוליטים קרינה במהירות‬
‫גבוהה תחת לחץ נמוך‬
FIE SUPPRESSION SYSTEM USING
HIGH VELOCITY LOW PRESSURE
EMITTERS
VICTAULIC COMPANY OF AMERICA
US
60/689864
13/06/2005
60/776407
24/02/2006
US
PCT/US/2006/023014
WO/2006/135891
11/07/2006
125
187926
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫קומפלקסים המכילים‬
‫ שיטה לייצורם‬,‫פרפלואורואלקיל‬
‫ושימוש בהם‬
COMPLEXES CONTAINING
PERFLUOROALKYL, METHOD FOR THE
PRODUCTION AND USE THEREOF
EPIX PHARMACEUTICALS, INC.
DE
102005033902.6 15/07/2005
PCT/EP/2006/006777
WO/2007/009638
24/05/2006
187928
NOVEL WORKING MEDIA FOR
REFRIGERATION PROCESSES
EVONIK DEGUSSA GMBH
DE
102005028451.5 17/06/2005
PCT/EP/2006/062567
WO/2006/134015
08/06/2006
187935
PROCESS FOR THE PURIFICATION
OF IL-18 BINDING PROTEIN
ARES TRADING S.A.
EP
05105124.1 10/06/2005
60/690414
14/06/2005
US
PCT/EP/2006/063029
WO/2006/131550
09/06/2005
187936
JOINING DEVICE OF PASSAGE
BLOCK
AKIRA YAMADA
C09K
‫מדית עבודה חדשה עבור תהליכי קירור‬
C07K
IL– 18 ‫תהליך לטיהור של חלבון הקושר‬
F17D
‫התקן חיבור עבור גוש מעביר‬
PCT/JP/2005/010988
WO/2006/131989
13/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187938
G01P
126
METHOD OF MANUFACTURING A
CAPACITIVE ACCELERATION
SENSOR AND A CAPACITIVE
ACCELERATION SENSOR
VTI TECHNOLOGIES OY
FI
20055323
17/06/2005
PCT/FI/2006/050257
WO/2006/134232
13/06/2006
187939
METHOD OF MANUFACTURING A
MICROMECHANICAL MOTION
SENSOR AND A
MICROMECHANICAL MOTION
SENSOR
VTI TECHNOLOGIES OY
FI
20055324
17/06/2005
PCT/FI/2006/050258
WO/2006/134233
08/06/2006
‫שיטה ליצור רגש תאוצה קיבולי ורגש‬
‫תאוצה קיבולי‬
‫שיטה ליצור רגש תנועה מיקרו–מכני ורגש‬
‫תנועה מיקרו–מכני‬
187940
COMPACT AND LOW PROFILE
SATELLITE COMMUNICATION
ANTENNA SYSTEM
X-ETHER, INC.
US
11/160162
10/06/2005
PCT/US/2006/022244
WO/2006/135661
06/06/2006
127
H01L
187941
H01Q
‫מערכת משושת תיקשורת לווינים‬
‫קומפקטית בעלת פרופיל נמוך‬
H05B
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
DIMMER SWITCH FOR USE WITH
LIGHTING CIRCUITS HAVING
THREE-WAY SWITCHES
LUTRON ELECTRONICS CO., INC.
US
60/687690
06/06/2005
PCT/US/2006/021883
WO/2006/133168
19/06/2006
‫מתג עמעם אור לשימוש עם מעגלי‬
‫תאורה בעלי מתגים תלת–דרכיים‬
187942
ANTI-CLOTTING INDWELLING
CATHETER
ASH ACCESS TECHNOLOGY, INC.
US
11/156793
20/06/2005
11/388726
24/03/2006
US
PCT/US/2006/023769
WO/2007/001966
19/06/2006
06/06/2006
‫צנתר בעל אמצעים נוגדי קרישה‬
187943
METHODS AND SYSTEMS FOR
REDESIGNING PRE-EXISTING
CONCRETE MIX DESIGNS AND
MANUFACTURING PLANTS AND
DESIGN-OPTIMIZING AND
MANUFACTURING CONCRETE
ICRETE, LLC
US
60/691916
17/06/2005
PCT/US/2006/023863
WO/2006/138732
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G05B
‫שיטות ומערכות לתיכנון מחודש של‬
‫תערובות בטון קיימות ומפעלי ייצור וייטוב‬
‫תכנון וייצור בטון‬
187944
CONTROLLED ELECTROCHEMICAL
POLISHING METHOD
CABOT MICROELECTRONICS
CORPORATION
US
11/150944
13/06/2005
PCT/US/2006/021887
WO/2006/138110
08/06/2006
A61M
187946
C25F
‫שיטת ליטוש אלקטרוכימית מבוקרת‬
C12N
128
NOVEL NUCLEOTIDE AND AMINO
ACID SEQUENCES, AND ASSAYS
AND METHODS OF USE THEREOF
FOR DIAGNOSIS
COMPUGEN LTD.
US
60/688320
08/06/2005
60/699427
15/07/2005
US
60/704414
02/08/2005
US
PCT/IL/2006/000676
WO/2006/131928
19/12/2006
‫רצפים חדשים של נוקלאוטידים וחומצות‬
‫אמינו והשימוש בהם בשיטות ומבחנים‬
‫דיאגנוסטיים‬
187947
NOVEL FORMS OF TIOTROPIUM
BROMIDE AND PROCESSES FOR
PREPARATION THEREOF
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/752672
19/12/2005
60/754530
27/12/2005
US
60/761437
23/01/2006
US
60/774051
15/02/2006
US
60/780310
07/03/2006
US
60/832189
20/07/2006
US
60/851223
12/10/2006
US
60/852740
18/10/2006
US
PCT/US/2006/048734
WO/2007/075858
04/10/2006
PREPARATION OF ROSUVASTATIN
129
187948
‫קומפיוג'ן בע"מ‬
C07D
‫פורמים חדשים של טיאוטרופיום ברומיד‬
‫ותהליכים להכנתם‬
‫טבע תעשיות פרמצבטיות בע"מ‬
C07D
‫הכנה של רוזובסטטין‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/723875
04/10/2005
60/732979
02/11/2005
US
60/751079
15/12/2005
US
60/760506
19/01/2006
US
60/762348
25/01/2006
US
11/360725
22/02/2006
US
PCT/US/2006/038921
WO/2007/041666
12/09/2006
187949
DIASTEREOMERIC PURIFICATION
OF ROSUVASTATIN
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/723491
03/10/2005
60/732979
02/11/2005
US
PCT/US/2006/035711
WO/2007/040940
09/06/2006
187951
TRANSPARENT CERAMIC
COMPOSITE
SAINT-GOBAIN CERAMICS &
PLASTICS, INC.
US
60/689688
10/06/2005
60/761814
25/01/2006
US
PCT/US/2006/022667
WO/2006/135832
13/05/2006
187955
CLAMPING DEVICE FOR A TOOL OR
A WORKPIECE
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫טבע תעשיות פרמצבטיות בע"מ‬
C07D
‫ניקוי דיאסטריומרי של רוזובסטטין‬
‫טבע תעשיות פרמצבטיות בע"מ‬
F41H
‫חומר מרוכב קרמי שקוף‬
B23Q
‫מתקן הידוק עבור מכשיר או כלי יצירתי‬
130
SYSTEM 3R INTERNATIONAL AB
EP
05014919.4 09/07/2005
PCT/EP/2006/004512
WO/2007/006360
07/06/2006
187956
METAL AND DIELECTRIC
COMPATIBLE SACRIFICIAL ANTIREFLECTIVE COATING CLEANING
AND REMOVAL COMPOSITION
ADVANCED TECHNOLOGY
MATERIALS, INC.
US
60/688204
07/06/2005
PCT/US/2006/022049
WO/2006/133253
01/06/2006
‫תרכובת מתכתית תואמת לניקוי והסרה‬
‫שאינה מוליכה מקריבה ושאינה‬
‫רפלקטיבית‬
187962
METHOD AND DEVICE FOR
MANUFACTURING ARTICLES IN THE
FORM OF SLABS OF CONGLOMERATE
STONE OR STONE-LIKE MATERIAL
TONCELLI, LUCA
IT
TV2005A000090 21/06/2005
PCT/EP/2006/062836
WO/2006/136489
21/06/2005
G03F
187964
B29C
‫שיטה ומכשיר לייצור פריטים בצורת‬
‫פרוסות עבות של חומר דמוי–אבן או‬
‫תלכיד אבן‬
F42B
‫קליע או ראש נפץ‬
PROJECTILE OR WARHEAD
GUNTER WEIHRAUCH
PCT/EP/2005/006678
WO/2006/136185
09/06/2006
POLYAMIDE YARNS, FILAMENTS
AND FIBERS WITH ENHANCED
PROPERTIES
131
187965
D01F
‫צמר חוטים וסיבים של פוליאמיד בעלי‬
‫תכונות משופרות‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
RHODIA CHIMIE
FR
0505915
PCT/FR/2006/001309
WO/2006/131658
10/06/2005
21/06/2006
187966
NEW AZETIDINE DERIVATIVES AS
NEUROKININ RECEPTOR
ANTAGONISTS FOR THE
TREATMENT OF
GASTROINTESTINAL DISEASES
ASTRAZENECA AB
SE
0501494-9
23/06/2005
PCT/SE/2006/000759
WO/2006/137790
07/07/2006
‫תולדות חדשות של אזטידין כאנטגוניסטים‬
‫של רצפטור לניורוקינין לטיפול במחלות‬
‫מעיים‬
187967
THERMOREVERSIBLE IMMUNOADJUVANT EMULSION
SANOFI PASTEUR
FR
0507240
07/07/2005
0508310
04/08/2005
FR
PCT/FR/2006/001635
WO/2007/006939
09/06/2006
187968
THERMOPLASTIC POLYMER
COMPOSITIONS INCLUDING SILICACONTAINING NUCLEATING AGENTS
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
A61K
‫תחליב מסייע–אימונית הפיך–טרמית‬
C08K
‫תכשירים של פולימר תרמופלסטי‬
‫שכוללים חומרים מכילי סיליקה בעלי‬
‫גרעין‬
132
BEAULIEU GROUP. LLC D/B/A
BEAULIEU OF AMERICA
US
60/688759
09/06/2005
PCT/US/2006/022625
WO/2006/135809
09/06/2006
187969
C12N
–‫אתר פוספוריליציה חדש של מיטוגן‬
‫ חלבונים‬,‫משופעל פרוטאין קינאז‬
‫מותאמים ושימושים‬
NEW PHOSPHORYLATION SITE OF
MITOGEN-ACTIVATED PROTEIN
KINASES, MODIFIED PROTEINS AND
APPLICATIONS
UNIVERSIDAD AUTONOMA DE
MADRID
ES
P200501404 10/06/2005
PCT/EP/2006/005542
WO/2007/028430
03/06/2006
187970
A SEMI-CONTINUOUS
CHROMATOGRAPHIC METHOD AND
CORRESPONDING DEVICE FOR THE
SEPARATION OF BINARY AND MULTICOMPONENT MIXTURES
BAYER TECHNOLOGY SERVICES
GMBH
DE
102005026486.7 09/06/2005
PCT/EP/2006/005341
WO/2006/131286
09/06/2006
133
187971
G01N
‫שיטה כרומטוגרפית רציפה למחצה‬
‫והתקן מתאים להפרדת תערובות‬
‫בינריות ורבות מרכיבים‬
C12N
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
DRIED AND/OR
MICROENCAPSULATED
SACCHAROMYCES CEREVISIALE
CELLS WITH A HIGH CONTENT OF
(S)-(+)-S-ADENOSYL -LMETHIONINE, PROCESS FOR THEIR
PREPARATION, AND COMPOSITIONS
CONTAINING SAID CELLS
GNOSIS S.P.A
EP
05425413.1 09/06/2005
PCT/EP/2006/005521
WO/2006/131382
09/06/2006
SACCHAROMYCES ‫תאי‬
‫או‬/‫ מיובשים ו‬CEREVISIALE
‫מיקרומתורמלים עם תכולה גבוהה של‬
‫ תהליך‬,‫–מתיונין‬L–‫–אדנוזיל‬S–(+)–S(
‫להכנתם ותכשירים המכילים תאים אלו‬
187972
PIPERAZINE-PIPRIDINE
ANTAGONISTS AND AGONISTS OF
THE 5-HT1A RECEPTOR
WYETH
US
60/689469
10/06/2005
PCT/US/2006/022719
WO/2006/135839
14/08/2006
ATOMISER
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
DE
102005039921.5
PCT/EP/2006/008029
WO/2007/022898
23/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫פיפראזין–פיפרידין המהווים אנטגוניסטים‬
A1HT–5 ‫ואגוניסטים של קולטן‬
187974
B05B
‫מרסס‬
24/08/2005
187975
C07C
134
METHOD FOR PRODUCTION OF
SUBSTITUTED PHENYLMALONATE
ESTERS INTERMEDIATE COMPOUNDS
AND THE USE THEREOF FOR THE
PRODUCTION OF 5,7-DIHYDROXY-6(2,4,6-TRIFLUOROPHENYL)(1,2,4)TRIAZOLO(1,5-A)PYRIMIDINES
BASF AKTIENGESELLSCHAFT
DE
102005030059.6 27/06/2005
PCT/EP/2006/063487
WO/2007/000412
08/06/2006
187976
GLUCOCORTICOID MIMETICS,
METHODS OF MAKING THEM,
PHARMACEUTICAL COMPOSITIONS,
AND USES THEREOF
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
US
60/689412
10/06/2005
PCT/US/2006/022651
WO/2006/135826
09/06/2006
187977
METHODS FOR SYNTHESIS OF
ENCODED LIBRARIES
PRAECIS PHARMACEUTICALS, INC.
US
60/689466
09/06/2005
60/731041
28/10/2005
US
PCT/US/2006/022555
WO/2006/135786
16/06/2006
135
187978
‫שיטה ליצור אסטרים מותמרים של‬
‫פניל מלונאט כחומרי ביניים והשימוש‬
–6–‫–דיהידרוקסי‬7,5 ‫בהם ליצור‬
–)‫–טריפלואורופניל‬6 ,4 ,2(
‫)פירימידינים‬A–5,1( ‫)טריאזולו‬4,2,1(
C07D
‫ שיטות‬,‫מחקי גלוקוקורטיקואידים‬
‫ תכשירי רוקחות ושימוש בהם‬,‫להכנתם‬
C12N
‫שיטות לסינתיזה של ספריות מקודדות‬
H03M
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
DATA ENTRY SYSTEM
FIROOZ GHASSABIAN
US
60/691107
60/693176
US
60/695840
US
60/695841
US
60/697394
US
60/704243
US
60/704531
US
60/710352
US
60/718949
US
60/724368
US
60/727158
US
60/732829
US
60/737813
US
60/741556
US
60/786835
US
60/797405
US
PCT/US/2006/023524
WO/2007/114833
‫מערכת להכנסת מידע‬
16/06/2005
23/06/2005
29/06/2005
30/06/2005
06/07/2005
29/07/2005
01/08/2005
22/08/2005
20/09/2005
06/10/2005
14/10/2005
01/11/2005
17/11/2005
30/11/2005
28/03/2006
02/05/2006
16/06/2006
187979
MANUFACTURING PROCESS FOR
TIGECYCLINE
WYETH
US
60/691173
16/06/2005
PCT/US/2006/023613
WO/2006/138641
07/06/2006
187980
DIGITAL PLAYBACK DEVICE AND
METHOD AND APPARATUS FOR
SPECTRALLY MODIFYING A
DIGITAL AUDIO SIGNAL
NEUROMONICS PTY LTD.
US
60/689088
10/06/2005
PCT/AU/2006/000777
WO/2006/130909
09/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
187981
A61K
‫תהליך לייצור טיגציקלין‬
A61B
‫התקן הקלטה דיגיטלי ושיטה ומכשיר‬
‫למודיפיקציה ספקטרלית של אות אודיו‬
‫דיגיטלי‬
C07D
136
CRYSTALLINE FORMS OF A
PYRROLOTRIAZINE COMPOUND
BRISTOL-MYERS SQUIBB COMPANY
US
11/149525
10/06/2005
PCT/US/2006/022577
WO/2006/135796
08/06/2006
187982
HUMAN PLACENTAL COLLAGEN
COMPOSITIONS, PROCESSES FOR
THEIR PREPARATION, METHODS OF
THEIR USE AND KITS COMPRISING
THE COMPOSITIONS
CELGENE CORPORATION
US
60/689331
10/06/2005
PCT/US/2006/022729
WO/2006/135843
01/06/2006
‫צורות גבישיות של תרכובת פירולוטריאזין‬
,‫הרכבים של קולגן אנושי המופק משיליה‬
‫ שיטות לשימוש‬,‫תהליכי הכנה שלהם‬
‫בהם וערכות המכילות את ההרכבים‬
187983
ACID-THICKENED FOOD
COMPOSITIONS AND PRODUCTS
DAZZLEPIE PARTNERS, LTD
US
60/688654
08/06/2005
60/728210
18/10/2005
US
11/263815
31/10/2005
US
PCT/US/2006/021563
WO/2006/133014
19/06/2006
137
A61L
187984
A23C
‫הרכבים למזון בעלי כושר עיבוי חומצי‬
‫ומוצרים‬
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫נגזרות פיפרידין היעילות כאנטגוניסטים‬
H3 ‫של היסטמין‬
PIPERIDINE DERIVATIVES USEFUL
AS HISTAMINE H3 ANTAGONISTS
SCHERING CORPORATION
US
60/692110
20/06/2005
PCT/US/2006/023800
WO/2007/001975
08/06/2006
187985
STABILIZATION OF TRIFLATED
COMPOUNDS
AMICUS THERAPEUTICS INC.
US
60/689131
08/06/2005
PCT/US/2006/022757
WO/2006/133448
08/06/2006
‫ייצוב תרכובות הכילות קבוצת טריפליט‬
187986
CRYSTALLINE SUGAR
COMPOSITIONS AND METHOD OF
MAKING
AMICUS THERAPEUTICS INC.
US
60/689119
08/06/2005
PCT/US/2006/022755
WO/2006/133447
14/05/1999
11/01/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07H
‫תרכובות סוכר גבישיות ושיטות לייצרן‬
187987
USE OF A CPG OLIGONUCLEOTIDE
TO PREPARE A MEDICAMENT FOR
INDUCING AN ANTIGEN-SPECIFIC
IMMUNE RESPONSE
COLEY PHARMACEUTICAL GROUP
INC.
US
60/085516
14/05/1998
241653
02/02/1999
US
PCT/IB/1999/001285
WO/1999/058118
C07H
C12N
‫ להכין‬CpG ‫שימוש באוליגונוקלאוטיד מסוג‬
‫תרופה לגרום לתגובה חיסונית לאנטיגן‬
‫ספציפי‬
187994
A47J
138
‫מכונת סחיטה אוטומטית‬
AUTOMATIC SQUEEZING MACHINE
ORANGE JUICE HOME, S.L.
ES
P200501489 13/06/2005
PCT/IB/2006/000033
WO/2006/048850
05/07/2006
187995
METHOD OF SUPPORTING MEDIA
INDEPENDENT HANDOVER WITH
RESOURCE MANAGEMENT
FUNCTION IN A MOBILE
COMMUNICATION SYSTEM
LG ELECTRONICS INC.
10-2005KR
05/07/2005
0060186
PCT/KR/2006/002622
WO/2007/004846
28/12/2006
‫שיטה לתמיכת העברה עצמאית של מדיה‬
‫עם יכולת ניהול משאב במערכת תיקשורת‬
‫ניידת‬
187996
SYSTEM AND METHOD FOR
ADVERTISING IN A
COMMUNICATION SYSTEM
GLOBAL DIRECT MANAGEMENT
CORP.
US
60/754819
28/12/2005
60/754746
29/12/2005
US
60/773270
13/02/2006
US
60/782132
13/03/2006
US
60/781978
13/03/2006
US
60/782131
13/03/2006
US
60/787800
31/03/2006
US
60/792717
18/04/2006
US
PCT/US/2006/049487
WO/2007/084246
09/06/2006
139
H04Q
187997
G06F
‫מערכת ושיטה לפרסום במערכת‬
‫תיקשורת‬
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
INDANE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VERTEX PHARMACEUTICALS
INCORPORATED
US
60/688919
09/06/2005
PCT/US/2006/022818
WO/2006/133459
09/06/2006
187998
TRANSPARENT CONDUCTIVE
COATINGS AND METHODS FOR
MAKING THEM
CIMA NANO TECH ISRAEL LTD.
US
60/690062
10/06/2005
PCT/US/2006/022456
WO/2006/135735
08/06/2006
‫תולדות אינדן ותכשירי רוקחות המכילים‬
‫אותן‬
‫ציפויים מוליכים שיקופים ושיטות להכנתם‬
187999
COMPOSITIONS FOR THE
TREATMENT OF PERSISTENT
INFECTIONS
THE BRIGHAM AND WOMEN'S
HOSPITAL, INC.
US
60/688872
08/06/2005
PCT/US/2006/022423
WO/2006/133396
09/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C25D
188000
A61K
‫תכשירים לטיפול במחלות מתמידות‬
G01B
140
METHOD AND APPARATUS FOR
DETERMINING LIQUID CRYSTAL
CELL PARAMETERS FROM FULL
MUELLER MATRIX MEASUREMENTS
AXOMETRICS, INCORPORATED
US
11/150363
10/06/2005
PCT/US/2006/022313
WO/2006/135681
08/06/2006
188001
SYSTEMS AND METHODS FOR
SEMANTIC EDITORIAL CONTROL
AND VIDEO/AUDIO EDITING
VISIBLE WORLD
US
60/688612
08/06/2005
PCT/US/2006/022308
WO/2006/133364
09/06/2006
188002
PREFERRED CONTACT GROUP
CENTRIC INTERFACE
T-MOBILE USA, INC.
US
60/689581
10/06/2005
11/400925
10/04/2006
US
PCT/US/2006/022645
WO/2007/008321
26/04/2006
141
188003
‫שיטה והתקן לבדיקת מאפיינים של תא‬
‫גביש נוזלי על בסיס מדידות מלאות של‬
MUELLER ‫מטריצת‬
H04N
‫מערכות ושיטות לבקרה סמנטית של‬
‫אודיו‬/‫עריכה ועריכת וידאו‬
G09G
‫ממשק מרכזי לקבוצת מגע מועדפת‬
C12P
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A COMPOSITION FOR WOUND
HEALING AND USE THEREOF
WU, HUA-LIN
US
11/149378
09/06/2005
11/361560
24/02/2006
US
PCT/US/2006/015662
WO/2006/135493
09/06/2006
‫הרכב לריפוי פצעים ושימוש בו‬
188004
‫ארכיטקטורת רדאר גנרי‬
GENERIC RADAR ARCHITECTURE
THALES
FR
0505927
10/06/2005
PCT/EP/2006/063059
WO/2006/131561
09/06/2006
188005
METHOD OF USE OF ANTAGONISTS
OF ZONULIN TO PREVENT THE LOSS
OF OR TO REGENERATE
PANCREATIC CELLS
UNIVERSITY OF MARYLAND,
BALTIMORE
US
60/688693
09/06/2005
PCT/US/2006/022629
WO/2006/135811
14/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61K
‫שיטות לשימוש באנטגוניסטים של זונולין‬
‫על מנת למנוע אבדן או ליצור רגנרציה של‬
‫תאים פנקריאטיים‬
188006
CYLINDER LOCK WITH MODIFIED
CAM
DOLEV MOSHE
US
60/690938
16/06/2005
PCT/IL/2006/000687
WO/2006/134594
08/06/2006
H04J
188007
E05B
‫מנעול צילינדר עם זיז ייעודי‬
C07H
142
OLIGORIBONUCLEOTIDES AND
METHODS OF USE THEREOF FOR
TREATMENT OF FIBROTIC
CONDITIONS AND OTHER DISEASES
QUARK PHARMACEUTICALS, INC.
US
60/689616
10/06/2005
PCT/IL/2006/000671
WO/2006/131925
23/11/2006
188008
COATED CEMENTED CARBIDE
CUTTING TOOL INSERT AMD
METHODS FOR MAKING THE SAME
SANDVIK INTELLECTUAL
PROPERTY AB
SE
0502777-6
16/12/2005
PCT/SE/2006/001330
WO/2007/069973
13/06/2006
‫אוליגונוקלאוטידים ושיטות לשימוש בהם‬
‫לטיפול במצבים פיברוטיים ובמחלות‬
‫אחרות‬
‫תותבת קארביד מודבק עבור מכשיר חיתוך‬
‫ושיטות להכנתה‬
188011
SPIRO-BENZIMIDAZOLE
DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
NYCOMED GMBH
EP
05105330.4 16/06/2005
PCT/EP/2006/063163
WO/2006/134111
16/06/2006
143
C23C
188012
C07D
‫תולדות ספירו–בנזאמידאזול ותכשירי‬
‫רוקחות המיכלים אותן‬
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
POLYMERIC REAGENTS AND
CONJUGATES FORMED THEREWITH
NEKTAR THERAPEUTICS AL,
CORPORATION
US
60/691516
16/06/2005
60/705968
04/08/2005
US
60/751082
16/12/2005
US
60/751121
16/12/2005
US
60/752825
21/12/2005
US
PCT/US/2006/023504
WO/2006/138572
20/06/2006
188013
AMIDE DERIVATIVES AND
INSECTICIDES CONTAINING THE
SAME
MITSUI CHEMICALS, INC.
2005JP
21/06/2005
180660
PCT/JP/2006/312281
WO/2006/137376
21/06/2006
188014
DIAPHRAGM LATCH VALVE
VICTAULIC COMPANY OF AMERICA
US
11/172353
30/06/2005
PCT/US/2006/024105
WO/2007/005286
19/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188015
‫מגיבים פולימריים וצמדים שהופקו מהם‬
C07C
‫תולדות אמיד וקוטלי חרקים מזיקים‬
‫המכילים אותן‬
A62C
‫סגר שסתום לסרעפת‬
A61B
144
ABLATION CATHETER WITH
CONTOURED OPENINGS IN
INSULATED ELECTRODES
ST. JUDE MEDICAL, ATRIAL
FIBRILLATION DIVISION, INC.
US
11/172647
30/06/2005
PCT/US/2006/023853
WO/2007/018751
13/06/2006
‫צנתר לקטיעה עם מתווה פתיחה‬
‫לאלקטרודות מבודדות‬
188016
STABLE FIXED-DOSE UNITARY
FORMULATIONS CONTAINING
TENOFOVIR, A SURFACTANT,
EFAVIRENZ AND EMTRICITABINE
BRISTOL-MYERS SQUIBB & GILEAD
SCIENCES, LLC.
US
60/690010
13/06/2005
60/771279
07/02/2006
US
PCT/US/2006/023223
WO/2006/135933
13/06/2006
09/06/2006
145
‫פורמולציות יציבות עם מינון קבוע‬
,‫ חומר פעיל שטח‬,‫המכילות טנופוביר‬
‫אפאווירנז ואמטריקיטאבין‬
188017
HIGH VELOCITY LOW PRESSURE
EMITTER
VICTAULIC COMPANY OF AMERICA
US
60/689864
13/06/2005
60/776407
24/02/2006
US
PCT/US/2006/023013
WO/2006/135890
A61K
A62C
‫חומר הפולט קרינה במהירות תחת לחץ‬
‫נמוך‬
188018
H04J
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ארכיטקטורה כללית לרדא"ר‬
GENERIC RADAR ARCHITECTURE
THALES
FR
0505927
10/06/2005
PCT/EP/2006/063059
WO/2006/131561
07/07/2006
188019
‫פפטידים חדשים לשימוש בטיפול‬
‫בהשמנה‬
NOVEL PEPTIDES FOR USE IN THE
TREATMENT OF OBESITY
NOVO NORDISK A/S
EP
05106554.8 18/07/2005
PCT/EP/2006/064027
WO/2007/009894
19/06/2006
188020
SUPPORT FOR INTERVERTEBRAL
PROSTHESES
CERVITECH, INC.
DE
202005009755.1 21/06/2005
PCT/EP/2006/005866
WO/2006/136356
22/06/2006
188021
NON-STEROIDAL PROGESTERONE
RECEPTOR MODULATORS
BAYER SCHERING PHARMA AG
DE
102005030292.0 24/06/2005
PCT/EP/2006/006531
WO/2006/136461
22/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07K
188022
A61F
‫תומך לפרוטזות בין–חולייתיות‬
C07D
‫מאפנני קולטן פרוגסטרון שאינם‬
‫סטרואידים‬
C07D
146
BENZOFURANONE DERIVATIVES AS
NONSTEROIDAL PROGESTERONE
RECEPTOR MODULATORS
BAYER SCHERING PHARMA AG
DE
102005030294.7 24/06/2005
PCT/EP/2006/006532
WO/2006/136462
30/03/2006
188024
FILM(S) AND/OR SHEET(S) MADE
FROM POLYESTER COMPOSITIONS
CONTAINING CYCLOBUTANEDIOL
AND ARTICLES MADE THEREFROM
EASTMAN CHEMICAL COMPANY
US
60/691567
17/06/2005
60/731389
28/10/2005
US
60/731454
28/10/2005
US
60/738869
22/11/2005
US
60/739058
22/11/2005
US
60/750547
15/12/2005
US
60/750682
15/12/2005
US
60/750692
15/12/2005
US
60/750693
15/12/2005
US
PCT/US/2006/012062
WO/2007/001570
30/03/2006
147
‫תולדות בנזופורנון כמאפנני קולטן‬
‫פרוגסטרון שאינם סטרואידים‬
C08G
‫יריעות שיוצרו‬/‫או יריעה‬/‫פילמים ו‬/‫פילם‬
‫מתכשירי פוליאסטר המכילים‬
‫ציקלובוטאנדיאול ופריטים המיוצרים מהם‬
188025
C08G
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
FILM(S) AND/OR SHEET(S)
COMPRISING POLYESTER
COMPOSITIONS WHICH COMPRISE
CYCLOBUTANEDIOL AND HAVE A
CERTAIN COMBINATION OF
INHERENT VISCOSITY AND
MODERATE GLASS TRANSITION
TEMPERATURE
EASTMAN CHEMICAL COMPANY
US
60/691567
17/06/2005
60/731389
28/10/2005
US
60/731454
28/10/2005
US
60/738869
22/11/2005
US
60/739058
22/11/2005
US
60/750547
15/12/2005
US
60/750682
15/12/2005
US
60/750692
15/12/2005
US
60/750693
15/12/2005
US
PCT/US/2006/012065
WO/2007/001572
30/03/2006
188026
FILM(S) AND/OR SHEET(S) MADE
USING POLYESTER COMPOSITIONS
CONTAINING LOW AMOUNTS OF
CYCLOBUTANEDIOL
EASTMAN CHEMICAL COMPANY
US
60/691567
17/06/2005
60/731389
28/10/2005
US
60/731454
28/10/2005
US
60/738869
22/11/2005
US
60/739058
22/11/2005
US
60/750547
15/12/2005
US
60/750682
15/12/2005
US
60/750692
15/12/2005
US
60/750693
15/12/2005
US
PCT/US/2006/011968
WO/2007/001568
28/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫יריעות המכילים‬/‫או יריעה‬/‫פילמים ו‬/‫פילם‬
‫תכשירי פוליאסטר המכילים‬
‫ציקלובוטאנדיאול ובעלי שילוב מסויים של‬
‫צמיגות אינהרטית וטמפרטורת מעבר‬
‫זכוכית מתונה‬
C08G
‫יריעות שיוצרו ע"י‬/‫או יריעה‬/‫פילמים ו‬/‫פילם‬
‫שימוש בתכשירי פוליאסטר המכילים‬
‫כמויות קטנות של ציקלובוטאנדיאול‬
188027
C07D
148
BICYCLIC DERIVATIVES AS P38
KINASE INHIBITORS
PALAU PHARMA S.A.
EP
05380141.1 29/06/2005
PCT/EP/2006/006256
WO/2007/000340
12/04/2006
188030
FORCE-BASED INPUT DEVICE
QSI CORPORATION
US
60/689731
10/06/2005
60/708867
16/08/2005
US
11/402694
11/04/2006
US
PCT/US/2006/013918
WO/2007/035190
22/06/2006
188032
DERIVATIVES OF 4,5DIARYLPYRROLE, PREPARATION
METHOD THEREOF AND USE OF
SAME IN THERAPEUTICS
SANOFI-AVENTIS
FR
0506609
27/06/2005
PCT/FR/2006/001416
WO/2007/000505
21/06/2006
188034
QUINOLINE 3-SULFONATE ESTERS
AS NK3 RECEPTOR MODULATORS
ASTRAZENECA AB
US
60/693281
23/06/2005
PCT/SE/2006/000758
WO/2006/137789
20/06/2006
149
188035
P38 ‫תולדות ביציקליות המעכבות קינאז‬
G09G
‫מכשיר קלט המבוסס על כוח‬
C07D
‫ שיטה‬,‫–דיארילפירול‬5,4 ‫תולדות של‬
‫ ושימושים רפואיים שלהן‬,‫להכנתן‬
C07D
‫–סולפונאט‬3 ‫אסטרים של קווינולין‬
NK3 ‫כמווסתי קולטן‬
G01N
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
IDENTIFICATION OF HUMAN T2R
RECEPTORS THAT ARE ACTIVATED
BY BITTER MOLECULES IN COFFEE
(CHLOROGENIC LACTONES) AND
RELATED ASSAYS FOR
IDENTIFYING HUMAN BITTER
TASTE MODULATORS
SENOMYX, INC.
US
60/692558
22/06/2005
PCT/US/2006/023892
WO/2007/002026
13/06/2006
‫ אנושיים שמופעלים על‬T2R ‫זיהוי רצפטורי‬
‫ידי מולקולות מרות בקפה (לקטונים‬
‫כלורוגנים) וניסויים קשורים לזיהוי‬
‫מאפננים אנושיים לטעם מר‬
188036
METHODS AND APPARATUS FOR
IMPROVING THE SENSITIVITY OF
CAPILLARY ZONE
ELECTROPHORESIS
BECKMAN COULTER, INC.
US
60/693047
23/06/2005
11/446130
05/06/2006
US
PCT/US/2006/023007
WO/2007/001834
12/06/2006
188037
(6-FLUORO-BENZO[1,3]DIOXOLYL)MORPHOLIN-4-YL-METHANONES
AND THEIR USE AS CB1 LIGANDS
G01N
‫שיטות ומכשיר לשיפור הרגישות של‬
‫אלקטרופורזת איזור קפילרית‬
C07D
–)‫]דיאוקסוליל‬3,1[‫–פלואורו–בנזו‬6(
–‫–יל‬4–‫מורפולין‬
CB1 ‫מתאנונים ושימושם כליגנדים של‬
F. HOFFMANN-LA ROCHE AG
EP
05105516.8 22/06/2005
PCT/EP/2006/063075
WO/2006/136502
08/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188038
C10M
150
ADDITIVE COMPOSITION
COMPRISING AN AMIDIZED OR
IMIDIZED POLYMER
DSM IP ASSETS B.V.
EP
05076382.0 13/06/2005
PCT/EP/2006/005482
WO/2006/133848
22/06/2006
188039
OXINDOLE DERIVATIVES
F. HOFFMANN-LA ROCHE AG
US
60/693752
24/06/2005
60/795616
27/04/2006
US
PCT/EP/2006/063475
WO/2006/136606
10/06/2006
188040
HIGH SENSITIVITY, HIGH
RESOLUTION DETECTOR DEVICES
AND ARRAYS
‫הרכב תוסף המכיל פולימר אמידיזד או‬
‫אימידיזד‬
C07D
‫תולדות אוקסינדול‬
H01J
‫מכשירי ומערכי גילוי בעלי רגישות‬
‫ורזולוציה גבוהה‬
AMPLIFICATION TECHNOLOGIES,
INC.
US
60/689417
10/06/2005
60/691931
17/06/2005
US
PCT/US/2006/022316
WO/2006/135683
18/05/2006
188041
DENGUE SEROTYPE 1 ATTENUATED
STRAIN
SANOFI PASTEUR
US
60/691243
17/06/2005
PCT/IB/2006/001313
WO/2006/134433
16/06/2006
151
188042
C07K
1 ‫זן מוחלש של נגיף קדחת דנגה סרוטיפ‬
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
ESTROGEN COMPOSITIONS FOR
VAGINAL ADMINISTRATION
WARNER CHILCOTT COMPANY, INC
US
60/691442
16/06/2005
PCT/US/2006/023688
WO/2006/138686
16/06/2006
188043
ESTROGEN COMPOSITIONS FOR
VAGINAL ADMINISTRATION
WARNER CHILCOTT COMPANY, INC
US
60/691440
16/06/2005
PCT/US/2006/023789
WO/2006/138715
16/06/2006
188044
GEL COMPOSITIONS FOR TOPICAL
ADMINISTRATION
WARNER CHILCOTT COMPANY, INC
US
60/691441
16/06/2005
PCT/US/2006/023945
WO/2006/138735
23/06/2006
188045
IMMUNOGENIC COMPOSITION
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0513069.5
27/06/2005
0513071.1
27/06/2005
GB
0515556.9
28/07/2005
GB
0524204.5
28/11/2005
GB
0526041.9
21/12/2005
GB
0526040.1
21/12/2005
GB
PCT/EP/2006/006268
WO/2007/000341
23/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188046
‫תכשירי אסטרוגן למתן וגינאלי‬
A61K
‫תכשירי אסטרוגן למתן וגינאלי‬
A61K
‫תכשירי ג'ל למתן מקומי‬
A61K
‫תכשיר אימונוגני‬
A61K
152
IMMUNOGENIC COMPOSITION
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0513069.5
27/06/2005
0513071.1
27/06/2005
GB
0515556.9
28/07/2005
GB
0524204.5
28/11/2005
GB
0526040.1
21/12/2005
GB
0526041.9
21/12/2005
GB
PCT/EP/2006/006269
WO/2007/000342
28/06/2005
188047
DELIVERY OF ACTIVE PROTEINS TO
THE CENTRAL NERVOUS SYSTEM
USING PHAGE VECTORS
THE SCRIPPS RESEARCH INSTITUTE
‫תכשיר אימונוגני‬
A01N
‫מתן חלבונים פעילים למערכת העצבים‬
'‫המרכזית באמצעות וקטורי פאג‬
PCT/US/2005/022955
WO/2007/001302
13/06/2005
188049
G01S
‫תמיכה במיקום המבוסס על תמיכה‬
‫לווינית‬
SUPPORTING AN ASSISTED
SATELLITE BASED POSITIONING
NOKIA CORPORATION
PCT/IB/2005/001641
WO/2006/134414
22/06/2006
153
188050
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
AZAINDAZOLE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
CHEMOCENTRYX, INC.
US
60/693525
22/06/2005
PCT/US/2006/024313
WO/2007/002293
26/04/2001
188052
A DEFECATION PROMOTING AGENT
HAVING ADENOSINE A2 RECEPTOR
ANTAGONISM AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
EISAI R&D MANAGEMENT CO., LTD.
2000JP
26/04/2000
126489
2000-220124 21/07/2000
JP
PCT/JP/2001/003643
WO/2001/080893
06/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫גורם המעודד הרקת המעים עם אנטגוניזם‬
‫ ותכשירי רוקחות‬A2 ‫לקולט אדנוזין‬
‫המכילים אותן‬
188053
APPARATUS AND METHODS FOR
DETECTION AND MANAGEMENT OF
UNAUTHORIZED EXECUTABLE
INSTRUCTIONS ON A WIRELESS
DEVICE
QUALCOMM INCORPORATED
US
60/690222
13/06/2005
PCT/US/2006/022057
WO/2006/138123
16/06/2006
‫תולדות אזאאינדאזול ותכשירי רוקחות‬
‫המכילים אותן‬
G07F
‫מתקנים ושיטות לזיהוי וניהול של הוראות‬
‫שאינן מורשות בקובץ מחשבים בהתקן‬
‫אלחוטי‬
188054
H04Q
154
SERVING BASE STATION SELECTION
IN A WIRELESS COMMUNICATION
SYSTEM
QUALCOMM INCORPORATED
US
60/691435
16/06/2005
60/793115
18/04/2006
US
PCT/US/2006/023502
WO/2006/138570
16/06/2006
‫שירות בחירת תחנת בסיס במערכת‬
‫תקשורת אלחוטית‬
188055
A METHOD AND APPARATUS FOR
ADAPTIVE REGISTRATION AND
PAGING AREA DETERMINATION
QUALCOMM INCORPORATED
US
60/691705
16/06/2005
PCT/US/2006/023505
WO/2006/138573
28/06/2006
‫שיטה ומתקנים לרישום מותאם והחלטה‬
‫באשר לאיתור אזור‬
188057
A ROTOR FOR AN ELECTRICAL
MACHINE
SPAL AUTOMOTIVE S.R.L.
IT
BO2005A000437 30/06/2005
PCT/IB/2006/001764
WO/2007/004009
03/07/2006
155
H04Q
188059
H02K
‫רוטור למכונה חשמלית‬
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
HETEROARYL BENZAMIDE
DERIVATIVES FOR USE AS GLK
ACTIVATORS IN THE TREATMENT
OF DIABETES
ASTRAZENECA AB
GB
0514173.4
09/07/2005
0516297.9
09/08/2005
GB
0523862.1
24/11/2005
GB
0524589.9
02/12/2005
GB
0607977.6
22/04/2006
GB
PCT/GB/2006/002471
WO/2007/007041
24/07/2006
188062
FRAGRANCE COMPOSITION
KAO CORPORATION
2005JP
25/07/2005
213659
PCT/JP/2006/314567
WO/2007/013394
14/06/2006
188063
BENZO[B]FURANE AND
BENZO[B]THIOPHENE DERIVATIVES
H. LUNDBECK A/S
DK
PA200500895 17/06/2005
PCT/IB/2006/003395
WO/2007/023395
14/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188064
‫נגזרות הטרואריל בנזאמיד לשימוש‬
‫ בטיפול בסוכרת‬GLK ‫כמשפעלי‬
C11B
‫תרכובת ריחנית‬
C07D
‫]תיופן‬B[‫]פוראן ובנזו‬B[‫נגזרות של בנזו‬
C07D
156
2-(1H-INDOLYLSULFANYL)-ARYL
AMINE DERIVATIVES
H. LUNDBECK A/S
US
60/692009
17/06/2005
PCT/IB/2006/002785
WO/2006/134499
12/12/2007
‫–אינדולילסולפניל)–אריל‬H1(–2 ‫נגזרות של‬
‫אמין‬
188066
F41G
GUNSHOT DETECTION SYSTEM AND
METHOD
OPTIGO SYSTEMS LTD
07/06/2006
‫מערכת ושיטה לזיהוי ירי‬
‫אלתא מערכות בע"מ‬
188068
DENGUE SEROTYPE 2 ATTENUATED
STRAIN
SANOFI PASTEUR
US
60/691274
17/06/2005
PCT/IB/2006/001513
WO/2006/134443
30/05/2006
157
‫ של קדחת דנגה‬2 ‫זן מוחלש של סרוטיפ‬
188069
PROCESS FOR PREPARING NEW
TIOTROPIUM SALTS, NEW
TIOTROPIUM SALTS AS SUCH AND
PHARMACEUTICAL COMPOSITIONS
THEREOF
BOEHRINGER INGELHEIM
INTERNATIONAL GMBH
EP
05105270.2 15/06/2005
PCT/EP/2006/062688
WO/2006/134021
26/06/2006
C12N
C07D
,‫תהליך להכנת מלחי טיאוטרופיום חדשים‬
‫מלחי טיאוטרופיום חדשים ותכשירי‬
‫רוקחות המכילים אותם‬
188070
C07C
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
PROCESS FOR THE PREPARATION OF 1[CYANO-(4HYDROXYPHENYL)METHYL]CYLOHEXANOL
COMPOUNDS
WYETH
CH
01101/05
29/06/2005
PCT/EP/2006/006126
WO/2007/000294
22/08/2006
188071
METHOD AND APPARATUS FOR
ADJUSTING CHANNEL QUALITY
INDICATOR FEEDBACK PERIOD TO
INCREASE UPLINK CAPACITY
INTERDIGITAL TECHNOLOGY
CORPORATION
US
60/710986
24/08/2005
PCT/US/2006/032604
WO/2007/024780
23/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
H04B
‫שיטה ומערכת לכיוון מחזור משוב‬
‫לאינדיקטור איכות ערוץ להגדלת קיבולת‬
‫רוחב פס של שידור‬
188072
PROCESS FOR MANUFACTURING
VACCINES
GLAXOSMITHKLINE BIOLOGICALS
S.A.
GB
0513071.1
27/06/2005
0513069.5
27/06/2005
GB
0515556.9
28/07/2005
GB
0524204.5
28/11/2005
GB
0526040.1
21/12/2005
GB
0526041.9
21/12/2005
GB
PCT/EP/2006/006270
WO/2007/000343
29/06/2006
–1 ‫תהליך להכנת תרכובות של‬
–4(‫[ציאנו‬
‫הידרוקסיפניל)מתיל]ציקלוהקסנול‬
188073
C07K
‫תהליך לייצור חיסונים‬
C07D
158
THERMALLY-PROCESSED COCOA
PRODUCTS USEFUL FOR VASCULAR
HEALTH IMPROVEMENT
MARS, INCORPORATED
US
60/695361
29/06/2005
PCT/US/2006/025422
WO/2007/002851
14/06/2006
‫מוצרי קקאו מעובדים טרמית המשמשים‬
‫לשיפור הבריאות הווסקולרית‬
188075
C07D
SYNTHESIS OF HYDROQUINONE
DERIVATIVES
GIRINDUS AG
EP
05105307.2 16/06/2005
60/692248
21/06/2005
US
PCT/EP/2006/063194
WO/2006/134124
19/06/2006
‫סינתיזה של תולדות הידרוקווינוניות‬
188076
ELECTRODE FOR AN ELECTRICAL
COMPONENT, COMPONENT WITH THE
ELECTRODE, AND MANUFACTURING
METHOD FOR THE COMPONENT
KEMET ELECTRONICS CORPORATION
DE
102005028262.8 17/06/2005
11/339276
25/01/2006
US
PCT/EP/2006/005870
WO/2006/133971
04/04/2006
188078
NANO-IONIC LIQUIDS AND
METHODS OF USE
MICHAEL, H. GURIN
US
60/595167
13/06/2005
PCT/US/2006/012419
WO/2006/137957
159
H01G
‫ רכיב עם‬,‫אלקטרודה לרכיב חשמלי‬
‫ ושיטת ייצור לרכיב‬,‫האלקטרודה‬
C09K
‫נוזלים ננו–יוניים ושיטות לשימוש בהם‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
13/06/2006
188082
COMPOSITIONS AND METHODS FOR
SELECTIVE REMOVAL OF METAL
ALLOY AFTER METAL SILICIDE
FORMATION
ADVANCED TECHNOLOGY
MATERIALS, INC.
US
60/690115
13/06/2005
PCT/US/2006/022859
WO/2006/138235
16/06/2006
‫תרכובות ושיטות עבור הסרה סלקטיבית‬
‫של מתכת או סגסוגת מתכתית לאחר‬
‫היווצרות סיליסידית‬
188085
QUICK PAGING CHANNEL WITH
REDUCED PROBABILITY OF MISSED
PAGE
QUALCOMM INCORPORATED
US
60/691469
16/06/2005
60/731037
27/10/2005
US
PCT/US/2006/023587
WO/2006/138625
20/11/2003
188086
METHOD AND APPARATUS FOR
MAKING PARTICLES USING SPRAY
DRYER AND IN-LINE JET MILL
ACUSPHERE, INC.
US
10/324943
PCT/US/2003/037108
WO/2004/060547
H01L
H04Q
‫לוח איתור ערוץ עם הסתברות נמוכה‬
‫לאיתור מוטעה‬
B01J
‫שיטות וציוד לעשות חלקיקים בשימוש‬
‫במייבש בתרסיס ובמטחנת סילון בתוך‬
‫הקו‬
19/12/2002
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
160
07/06/2006
188087
METHOD FOR ANTI-MISSILE
PROTECTION OF VEHICLES AND
IMPLEMENTING DEVICE
THALES
FR
0506178
17/06/2005
PCT/EP/2006/062972
WO/2006/134050
20/06/2006
‫שיטה להגנה נגד טילים של כלי רכב‬
‫ומתקן ביצוע‬
188088
188090
PENETRATION ASSISTING KIT
EQUIPPING A BOMB, IN
PARTICULAR ANTIINFRASTRUCTURE, PENETRATING
PROJECTILE EQUIPPED WITH SUCH
A KIT, AND METHOD FOR
PENETRATING INTO A TARGET
TDA ARMEMENTS S.A.S.
FR
05/06016
14/06/2005
PCT/EP/2006/063233
WO/2006/134139
13/06/2006
161
C07K
‫ ושימושיהן‬CD19 ‫נוגדני‬
CD19 ANTIBODIES AND THEIR USES
MEDAREX, INC.
US
60/692531
20/06/2005
60/748956
08/12/2005
US
60/804083
06/06/2006
US
PCT/US/2006/024183
WO/2007/002223
14/06/2006
F41H
F42B
,‫ציוד לעזרה בחדירה לציוד המלווה פצצה‬
‫ חדירה לקליע מצויד‬,‫בעיקר אנטי–תשתית‬
‫ ושיטה לחדירה לתוך מטרה‬,‫בציוד שכזה‬
188091
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHODS OF PROTECTING
AGAINST APOPTOSIS USING
LIPOPEPTIDES
THE CLEVELAND CLINIC
FOUNDATION
US
60/689810
13/06/2005
PCT/US/2006/022865
WO/2006/138238
10/06/2006
‫שיטות להגנה מפני אפופטיזיס על–ידי‬
‫שימוש בליפופפטידים‬
188092
SUBSTITUTED HETEROCYCLES, THEIR
USE AS MEDICAMENT, AND
PHARMACEUTICAL PREPARATIONS
COMPRISING THEM
SANOFI AVENTIS
DE
102005028862.6 22/06/2005
PCT/EP/2006/005578
WO/2006/136304
19/06/2006
188093
NANOPARTICULATE AND
CONTROLLED RELEASE
COMPOSITIONS COMPRISING ARYLHETEROCYCLIC COMPOUNDS
ELAN PHARMA INTERNATIONAL
LTD.
US
60/692096
20/06/2005
11/372857
10/03/2006
US
PCT/US/2006/023695
WO/2007/027273
21/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188094
C07D
,‫תרכובות הטרוציקליות מותמרות‬
‫שימוש בן כתרופות ותכשירים רוקחיים‬
‫המכילים אותן‬
A61K
‫תכשירים ננוחלקיקיים בעלי שחרורו‬
‫מבוקר המכילים תרכובות הטרוציקליים‬
‫ארילים‬
C07K
162
IL-1? BINDING ANTIBODIES AND
FRAGMENTS THEREOF
XOMA TECHNOLOGY LTD.
US
60/692830
21/06/2005
PCT/US/2006/024261
WO/2007/002261
10/06/2006
‫? ומקטעים שלהם‬IL–1 ‫נוגדנים קושרי‬
188095
SUBSTITUTED PYRROLIDIN-2-ONES,
PIPERIDIN-2-ONES AND
ISOTHIAZOLIDINE-1,1-DIOXIDES,
THEIR USE AS KV1.5 POTASSIUM
CHANNEL BLOCKERS AND
PHARMACEUTICAL PREPARATIONS
COMPRISING THEM
SANOFI AVENTIS
DE
102005028845.6 22/06/2005
PCT/EP/2006/005579
WO/2006/136305
19/06/2006
188096
MOTOR FUEL BASED ON GASOLINE
AND ETHANOL
SHE BLENDS HOLDING B.V.
US
60/595284
21/06/2005
PCT/NL/2006/000298
WO/2006/137725
02/06/2006
163
188100
C07D
‫ פיפרידינים‬,‫–און–מותמרים‬2 ‫פירולידינים‬
–1,1 ‫–און ואיזותיאזידולידינים‬2
‫ שימוש בהם כחוסמי‬,‫דיאוקסידים‬
‫ ותכשירים‬KV1.5 ‫תעלות אשלגן‬
‫רוקחיים המכילים אותם‬
C10L
‫דלק המבוסס על בנזין ואתנול‬
C09K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫נוזל הידראולי של אסטר פוספטי בעל‬
‫ביצועים טובים‬
HIGH PERFORMANCE PHOSPHATE
ESTER HYDRAULIC FLUID
SOLUTIA INC.
US
11/152361
14/06/2005
PCT/US/2006/021407
WO/2006/138081
08/06/2006
188102
SELF-BUFFERING PROTEIN
FORMULATIONS
AMGEN INC.
US
60/690582
14/06/2005
PCT/US/2006/022599
WO/2006/138181
14/06/2006
14/06/2006
‫פורמולציות חלבוניות עם בפר–עצמי‬
188103
PRODRUGS OF A2B ADENOSINE
RECEPTOR ANTAGONISTS
CV THERAPEUTICS, INC.
US
60/691408
16/06/2005
PCT/US/2006/023167
WO/2006/138376
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫מטרימי תרופות לאנטגוניסטים של קולטן‬
B 2 A ‫אדנוסין‬
188105
COMPOSITE MATERIAL FOR STAB,
ICE PICK AND ARMOR
APPLICATIONS
HONEYWELL INTERNATIONAL INC.
US
11/154454
16/06/2005
PCT/US/2006/023218
WO/2007/058679
06/06/2006
A61K
F41H
‫ דוקרן קרח‬,‫חומר מרוכב עבור דוקרן‬
‫ויישומי שיריון‬
188106
H04L
164
METHOD FOR SETTING UP A
MULTIMEDIA CONNECTION IN CASE
OF CASCADE CONNECTION TRANSFER
NOKIA SIEMENS NETWORKS GMBH &
CO. KG
DE
102005031410.4 05/07/2005
PCT/EP/2006/062922
WO/2007/003482
16/06/2006
188107
MULTIVALENT ENTRAIN-ANDAMPLIFY IMMUNOTHERAPEUTICS
FOR CARCINOMA
MANNKIND CORPORATION
US
60/691581
17/06/2005
PCT/US/2006/023499
WO/2006/138568
16/06/2006
188108
EPITOPE ANALOGUES
MANNKIND CORPORATION
US
60/691889
17/06/2005
PCT/US/2006/023489
WO/2006/138562
16/06/2006
188109
CHLORO-SUBSTITUTED
GUANIDINES
F. HOFFMANN-LA ROCHE AG
EP
05105697.6 27/06/2005
PCT/EP/2006/063267
WO/2007/000392
23/05/2002
165
188110
‫שיטה לכיוון חיבור מולטימדיה במקרה‬
‫של העברת קשר הדרגתית‬
A61K
–‫טיפול–אימוני רב ערכי של העברה‬
‫והגברה לגידול ממאיר‬
C07K
‫אנאלוגים של אפיטופ‬
C07D
‫גואנידינים מותמרים עם כלור‬
C07C
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHOD OF TREATING HAIR LOSS
USING THYROMIMETIC
COMPOUNDS
PFIZER PRODUCTS, INC.
US
60/294962
31/05/2001
13/06/2006
‫שיטה לטיפול בנשירת שיער על–ידי‬
‫שימוש בתרכובות טירומימטיות‬
188111
2,5-BIS-DIAMIMNE [1,4]
BENZOQUINONE-DERIVATIVES
ALMA MATER STUDIORUMUNIVERSITA' DI BOLOGNA
IT
BO2005A000402 14/06/2005
PCT/IB/2006/001561
WO/2006/134457
12/10/2004
188112
MUSCARINIC ACETYLCHOLINE
RECEPTOR ANTAGONISTS
GLAXO GROUP LIMITED
US
60/511009
14/10/2003
PCT/US/2004/033638
WO/2005/037280
16/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188113
C07C
]1 ,4 [‫–ביס–דיאמימן‬2 ,5 ‫תולדות של‬
‫בנזוקווינון‬
C07D
‫אנטגוניסטים של קולטן מוסקריני של‬
‫אצטילכולין‬
C07K
166
METHODS AND COMPOSITIONS TO
ELICIT MULTIVALENT IMMUNE
RESPONSES AGAINST DOMINANT
AND SUBDOMINANT EPITOPES,
EXPRESSED ON CANCER CELLS AND
TUMOR STROMA
MANNKIND CORPORATION
US
60/691579
17/06/2005
PCT/US/2006/023498
WO/2006/138567
10/07/2006
‫שיטות ותכשירים להפקת תגובות‬
‫אימוניות רב–ערכיות כנגד אפיטופים‬
‫ המבוטאים על תאי‬,‫שולטים ותת–שולטים‬
‫סרטן וסטרומת גידול‬
188114
PROCESS FOR THE PREPARATION
OF SULFONAMIDE DERIVATIVES
PFIZER LIMITED
US
60/700098
18/07/2005
PCT/IB/2006/001958
WO/2007/010356
16/06/2006
188115
8-ALKOXY-4-METHYL-3,4-DIHDROQUINAZOLIN-2YL AMINES AND THEIR USE AS 5HT5A RECEPTOR LIGANDS
C07C
‫תהליך להכנת תולדות סולפונאמיד‬
C07D
–3,4–‫–מתיל‬4–‫–אלקוקסי‬8 ‫אמינים‬
‫–יל ושימושם‬2–‫דיהידרו–קווינאזולינ‬
‫כליגנדים‬
HT5A–5 ‫לרצפטור‬
F. HOFFMANN-LA ROCHE AG
EP
05105699.2 27/06/2005
PCT/EP/2006/063269
WO/2007/000393
28/09/2001
167
188116
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
SODIUM SALTS OF 5-[4-[2-(NMETHYL-N-(2-PYRIDYL) AMINO)
ETHOXY] BENZYL] THIAZOLIDINE2,4-DIONE
–N–‫–מתיל‬N(–2[–4[–5 ‫מלחי סודיום של‬
– 2(
–‫פירידיל)אמינו)אתוקסי]בנזיל]תיאזולידין‬
‫–דיאון‬4,2
SMITHKLINE BEECHAM P.L.C.
GB
0023971.5
29/09/2000
PCT/GB/2001/004334
WO/2002/026735
13/12/2006
188119
PROCESS FOR IMPROVING SHELF
LIFE OF REFRIGERATED FOODS
DWC HERMETICA PTY LTD
AU
2005903090 14/06/2005
PCT/AU/2006/000812
WO/2006/133485
13/06/2005
188120
NITROGEN HETEROCYCLE BIARYLS
FOR OSTEOPOROSIS AND OTHER
DISEASES
PHARMACOPEIA, INC.
A23L
‫תהליך לשיפור חיי מדף של מזון מקורר‬
C07D
‫ביארילים הטרוציקלים המכילים חנקן‬
‫עובר אוסטיופורוזיס ומחלות אחרות‬
PCT/US/2005/020656
WO/2007/001249
14/06/2006
188123
METHODS FOR SELECTIVE N-9
GLYCOSYLATION OF PURINES
BRIGHAM YOUNG UNIVERSITY,
TRANSFER TECHNOLOGY OFFICE
US
60/690307
14/06/2005
PCT/US/2006/023193
WO/2006/138396
30/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188124
A01N
‫שיטות לגליקוליזציה סלקטיבית של‬
N–9 ‫פורינים בעמדה‬
C07K
168
HUMAN MONOCLONAL
ANTIBODIES TO PROGRAMMED
DEATH LIGAND 1 (PD-L1)
MEDAREX, INC.
US
60/696426
01/07/2005
PCT/US/2006/026046
WO/2007/005874
09/06/2006
‫נוגדני אדם חד–שבטיים נגד ליגנד‬
LPD–L1)1( "‫"מוות מתוכנן‬
188125
PILOT AND DATA TRANSMISSION IN
A MIMO SYSTEM APPLYING
SUBBAND MUTIPLEXING
H04L
‫שידור נתונים ניסיוני במערכת של מודל‬
‫מתמטי לתקשורת באמצעות מספר‬
‫) ביישום פס משנה בשידור‬MIMO( ‫אנטנות‬
‫מרובב‬
QUALCOMM INCORPORATED
US
60/691701
16/06/2005
60/702033
22/07/2005
US
60/710366
22/08/2005
US
11/242115
30/09/2005
US
PCT/US/2006/022728
WO/2006/138206
16/06/2006
188126
QUICK PAGING CHANNEL WITH
REDUCED PROBABILITY OF MISSED
PAGE
QUALCOMM INCORPORATED
US
60/691901
16/06/2005
60/731037
27/10/2005
US
PCT/US/2006/023483
WO/2006/138556
14/06/2006
169
H04Q
‫ערוץ מספור עמודים מהיר עם הסתברות‬
‫מופחתת של השמטת עמודים‬
188127
A01K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHODS FOR TREATING
DEMYELINATION DISORDERS
THE UNIVERSITY OF CHICAGO
US
60/690691
14/06/2005
60/744826
13/04/2006
US
60/792007
14/04/2006
US
11/431601
09/05/2006
US
11/431372
09/05/2006
US
11/431782
09/05/2006
US
PCT/US/2006/023215
WO/2006/138412
16/06/2006
–‫שיטות לטיפול באי–סדרים הנובעים מדה‬
‫מילניאציה‬
188129
NEW REGIMENS FOR CONTROLLED
DRUG DELIVERY DEVICES FOR
CONTRACEPTION
N.V. ORGANON
EP
05105481.5 21/06/2005
PCT/US/2006/023383
WO/2007/001888
22/06/2006
A61F
‫משטרים חדשים להתקנים למתן מבוקר‬
‫של תרופות למניעת הריון‬
188131
APPLICATION SECURITY IN AN
INTERACTIVE MEDIA
ENVIRONMENT
MICROSOFT CORPORATION
US
60/695944
01/07/2005
11/354800
15/02/2006
US
PCT/US/2006/024034
WO/2007/005281
13/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G06F
‫אבטחת יישום בסביבת מדיה‬
‫אינטראקטיבית‬
188132
C03B
170
TRANSPARENT GLASS PANE
PROVIDED WITH A SURFACE
STRUCTURE
SAINT-GOBAIN GLASS FRANCE
DE
102005027799.3 16/06/2005
PCT/FR/2006/050551
WO/2006/134301
13/06/2006
‫שמשה בעלת זכוכית שקופה עם פני‬
‫שטח מובנים‬
188133
‫שמשת זכוכית עם מבנה פני שטח‬
‫הלוכד אור‬
GLASS PANE WITH LIGHT-CAPTURING
SURFACE STRUCTURE
SAINT-GOBAIN GLASS FRANCE
DE
102005027737.3 16/06/2005
PCT/FR/2006/050550
WO/2006/134300
19/06/2006
188134
METHOD FOR STIFFENING
SYNTHETIC RIBBONS OF A
SYNTHETIC TURF SURFACE
FIELDTURF TARKETT INC.
US
60/691595
17/06/2005
PCT/IB/2006/003933
WO/2007/069076
14/06/2006
16/06/2006
171
E01C
‫שיטה להקשות רצועות סינתטיות של פני‬
‫שטח סינתטיים‬
188135
TRAFFIC PREEMPTION SYSTEM
WITH HEADWAY MANAGEMENT
GLOBAL TRAFFIC TECHNOLOGIES,
LLC
US
11/154347
16/06/2005
PCT/US/2006/023190
WO/2006/138393
G02B
G08G
‫מערכת זכות קדימה תעבורתית עם ניהול‬
‫התקדמותי‬
188136
H01L
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A SOLAR CELL INTERCONNECTION
PROCESS
THE AUSTRALIAN NATIONAL
UNIVERSITY A BODY CORPORATE
ESTABLISHED BY THE AUSTRALIAN
AU
2005903172 17/06/2005
PCT/AU/2006/000840
WO/2006/133507
14/06/2006
188137
MULTI-ENVIRONMENT ENGINE
AEROART LIMITED
FR
0506119
16/06/2005
PCT/FR/2006/001340
WO/2006/134267
14/06/2006
188138
PATTERN ENCODED DICTIONARIES
LUMEX AS
NO
20052966
16/06/2005
PCT/NO/2006/000227
WO/2006/135252
28/06/2004
188139
COLLISION AVOIDANCE SYSTEM
AND A METHOD THEREOF
ISRAEL AEROSPACE INDUSTRIES
LTD.
10/05/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫תהליך לחברור של תא סולרי‬
B64C
‫מנוע רב–סביבתי‬
G06K
‫מילונים בעלי תבנית מוצפנת‬
G08G
‫שיטה ומערכת למניעת התנגשות‬
‫התעשייה האוירית לישראל בע"מ‬
188140
A61B
172
TOURNIQUET CUFF WITH
IMPROVED PNEUMATIC
PASSAGEWAY
WESTERN CLINICAL ENGINEERING
LTD
US
11/153667
15/06/2005
PCT/CA/2006/000743
WO/2006/133539
02/06/2006
‫חוסם שרוולי עם מעבר פניאומאטי משופר‬
188141
DEVICE AND METHOD FOR THE
PRODUCTION OF BIOLOGICALLY
ACTIVE COMPOUNDS BY
FERMENTATION
MERZ PHARMA GMBH & CO. KGAA
DE
102005028171.0 17/06/2005
PCT/EP/2006/005272
WO/2006/133818
13/06/2006
188142
SINGLE MOLECULE ARRAYS FOR
GENETIC AND CHEMICAL ANALYSIS
CALLIDA GENOMICS, INC.
US
60/690771
15/06/2005
60/725116
07/10/2005
US
60/776415
24/02/2006
US
PCT/US/2006/022895
WO/2006/138257
14/06/2006
173
188143
C12M
‫מתקן ושיטה לייצור על–ידי תסיסה‬
‫תרכובות פעילות בדרך ביולוגית‬
C12Q
‫מערכי מולקולות יחידות לאנליזה כימית‬
‫וגנטית‬
C07K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
USE OF MODIFIED PORE-FORMING
PROTEINS FOR THE PREPARATION
OF A MEDICAMENT FOR TREATING
OR PREVENTING BENIGN
PROSTATIC HYPERPLASIA
PROTOX THERAPEUTICS
INCORPORATED
US
60/690269
14/06/2005
PCT/CA/2006/000971
WO/2006/133553
19/06/2006
188145
PERMEANT DELIVERY SYSTEM AND
METHODS FOR USE THEREOF
ALTEA THERAPEUTICS
CORPORATION
US
60/691898
17/06/2005
PCT/US/2006/023640
WO/2006/138658
16/06/2006
188147
GENERIC VARIANTS IN THE TCF7L2
GENE AS DIAGNOSTIC MARKERS
FOR RISK OF TYPE 2 DIABETES
MELLITUS
DECODE GENETICS EHF
US
60/692174
20/06/2005
60/757155
06/01/2006
US
PCT/IS/2006/000014
WO/2006/137085
14/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188148
‫שימוש בחלבונים יוצרי נקבוביות שעברו‬
‫שינוי לצורך הכנת תרופה לטיפול או‬
‫מניעה של גידול שפיר בערמונית‬
A61B
‫מערכת למתן חומר מתפשט ושיטות‬
‫לשימוש בה‬
C12Q
‫ כסמני‬TCF7L2–‫ואריאנטים גנטים בגן ה‬
2 ‫אבחון לסיכון בסכרת מסוג‬
C07D
174
FUSED BICYCLOHETEROCYCLE
SUBSTITUTED QUINUCLIDINE
DERIVATIVES
ABBOTT LABORATORIES
US
11/153762
15/06/2005
PCT/US/2006/023091
WO/2007/018738
13/06/2006
‫נגזרות מאוחות של קוינוקלידין המותמרות‬
‫בביציקלוהטרוציקל‬
188149
PROTECTED PLUG SOCKET FOR
DISTRIBUTION DEVICES IN
TELECOMMUNICATIONS AND DATA
TECHNOLOGY
ADC GMBH
DE
102005029012.4 21/06/2005
PCT/EP/2006/005681
WO/2006/136315
14/06/2006
188150
CANNABINOID ACTIVE
PHARMACEUTICAL INGREDIENT
FOR IMPROVED DOSAGE FORMS
EURO-CELTIQUE S.A.
US
60/691361
16/06/2005
60/726509
12/10/2005
US
PCT/EP/2006/005761
WO/2006/133941
19/06/2006
175
188151
H01T
‫שקע מוגן לפלאג עבור התקני סעף‬
‫בתקשורת ובטכנולוגיית מידע‬
A61P
‫מרכיב פרמצבטי אקטיבי של קנאבינויד‬
‫לצורות מינון משופרות‬
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
ANTIBODIES THAT BIND TO HUMAN
PDGFRd AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
UNIVERSITY OF WASHINGTON
US
60/691920
17/06/2005
PCT/US/2006/023856
WO/2006/138729
16/06/2006
‫ אנושי‬PDGFRd ‫נוגדנים המחברים ל‬
‫ותכשירי רוקחות המכילים אותם‬
188152
COMPOUNDS WHICH INTERFERE
WITH HELIX 12 OF THE ANDROGEN
RECEPTOR AND PHARMACEUTICAL
COMPOSITIONS CONTAINING THE
SAME
ENDORECHERCHE, INC.
US
60/691391
17/06/2005
11/452545
14/06/2006
US
PCT/CA/2006/000992
WO/2006/133567
23/06/2006
‫ של‬12 ‫תרכובות המפריעות עם הילקס‬
‫קולט אנדרוגן ותכשירי רוקחות המכילים‬
‫אותן‬
188153
SUPRAVALENT PEPTIDE COMPOUNDS
AND PROCESSOR FOR THE
PREPARATION THEREOF
APLAGEN GMBH
EP
05013594.6
23/06/2005
05020035.1
14/09/2005
EP
EP
PCT/EP2005/12075 10/11/2005
05028310.0
24/12/2005
EP
06004833.7
09/03/2006
EP
60/780568
09/03/2006
US
06010174.8
17/05/2006
EP
60/747515
17/05/2006
US
PCT/EP/2006/006097
WO/2006/136450
16/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
188154
C07K
‫תרכובות פפטידיות סופרא–ערכיות‬
‫ותהליכים להכנתן‬
C07K
176
METHODS AND COMPOSITIONS FOR
LIGATING COMPONENTS THROUGH
AN AMIDE BOND
AMYLIN PHARMACEUTICALS, INC.
US
60/691396
16/06/2005
PCT/EP/2006/005815
WO/2006/133962
13/06/2006
188157
ROBUST RANK PREDICTION FOR A
MIMO SYSTEM
QUALCOMM INCORPORATED
US
60/691723
16/06/2005
PCT/US/2006/023095
WO/2006/138337
14/06/2006
177
H04Q
‫פתרון קונפליקטים של הקצאת משאבים‬
‫לגישה למסופים‬
188159
OFDMA CONTROL CHANNEL
INTERLACING
QUALCOMM INCORPORATED
US
60/691436
16/06/2005
PCT/US/2006/023094
WO/2006/138336
13/06/2006
H04L
‫חיזוי דירוג חסון עבור מערכת של כניסות‬
MIMO ‫רבות ויציאות רבות‬
188158
RESOLVING RESOURCE
ALLOCATION CONFLICTS FOR
ACCESS TERMINALS
QUALCOMM INCORPORATED
US
60/691433
16/06/2005
PCT/US/2006/023170
WO/2006/138379
13/06/2006
‫שיטות ותכשירים לחיבור מרכיבים דרך‬
‫קשר אמידי‬
188160
H04Q
‫ חלוקת תדר אנכי עם‬OFDMA ‫שליטת‬
‫גישות מרובות‬
H01L
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
ELECTRON BOMBARDED IMAGE
SENSOR ARRAY DEVICE AS WELL
AS SUCH AN IMAGE SENSOR ARRAY
PHOTONIS-DEP B.V.
EP
05076388.7 14/06/2005
PCT/EP/2006/005654
WO/2006/133890
13/06/2006
‫התקן המציב חיישן עצמים יורה‬
‫אלקטרונים כמו גם המציב חיישן עצמים‬
188161
ELECTRON BOMBARDED IMAGE
SENSOR ARRAY DEVICE AND ITS
MANUFACTURING METHOD
PHOTONIS-DEP B.V.
EP
05076385.3 14/06/2005
PCT/EP/2006/005655
WO/2006/133891
23/06/2006
21/07/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫התקן המציב חיישן עצמים יורה‬
‫אלקטרונים ושיטת הייצור שלו‬
188162
STABILIZED LIQUID YEAST
PREPARATION AND METHOD FOR
PRODUCING THE SAME, AND
THEREOF
LALLEMAND, INC.
US
60/694098
24/06/2005
PCT/US/2006/024522
WO/2007/008370
H01L
C12N
‫נוזל תכשירי שמרים מיוצב ושיטה להפקת‬
‫ ומכך‬,‫דבר דומה‬
188163
A61P
178
,‫שימוש של תולדות תיאזול ואנלוגים‬
‫בהפרעות הנובעות מחומצות שומן‬
‫חופשיות‬
USE OF THIAZOLE DERIVATIVES
AND ANALOGUES IN DISORDERS
CAUSED BY FREE FATTY ACIDS
BETAGENON AB
US
60/595620
0501721-5
SE
60/744422
US
PCT/GB/2006/002743
WO/2007/010281
07/06/2006
21/07/2005
21/07/2005
07/04/2006
188164
PHARMACEUTICAL FORMULATION
OF THE TUBULIN INHIBITOR
INDIBULIN FOR ORAL
ADMINISTRATION WITH IMPROVED
PHARMACOKINETIC PROPERTIES,
AND PROCESS FOR THE
MANUFACTURE THEREOF
ZIOPHARM ONCOLOGY, INC.
US
11/151459
14/06/2005
PCT/EP/2006/005423
WO/2006/133835
17/05/2006
188165
METHOD FOR THE DIAGNOSIS OF
ALZHEIMER'S DISEASE
FINA BIOTECH, S.L.U.
ES
P200501469 16/06/2005
PCT/ES/2006/000255
WO/2006/134185
16/06/2006
179
188166
A61K
‫פורמולציה רוקחית של אינדיבולין מעכב‬
‫טובולין למתן דרך הפה עם תכונות‬
‫ ושיטה‬,‫פארמאקוקינטיות משופרות‬
‫להכנתה‬
C07K
‫שיטה לאבחנה של מחלת האלצהיימר‬
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHODS FOR TREATING
DERMATITIS USING MUTANT
HUMAN IL-4 COMPOSITIONS
AEROVANCE, INC.
US
11/156221
17/06/2005
PCT/US/2006/023657
WO/2006/138668
06/06/2006
‫שיטות לטיפול בדלקת עור באמצעות‬
IL–4 ‫שימוש בתכשירים של מוטנט אנושי‬
188167
G01C
‫מכשיר ניווט עם מצלמה להצגת‬
‫אינפורמציה‬
NAVIGATION DEVICE WITH
CAMERA-INFO
TOM TOM INTERNATIONAL B.V
PCT/NL/2005/000405
WO/2006/132522
06/06/2006
IMPROVED M-4 RIFLE
COLT DEFENSE LLC
US
11/154738
11/352036
US
PCT/US/2006/021817
WO/2006/138106
188168
F41A
‫ משופר‬M–4 ‫רובה‬
16/06/2005
09/02/2006
19/06/2006
188171
PRESSURE-FLOW REDUCER FOR
AEROSOL FOCUSING DEVICES
LAWRENCE LIVERMORE NATIONAL
SECURITY, LLC
US
60/691521
17/06/2005
60/714689
06/09/2005
US
PCT/US/2006/023839
WO/2006/138724
20/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188172
G01N
‫מפחית לחץ זרימה עבור מערכת מיקוד‬
‫של ספריי‬
C07C
180
‫אצילאוקסיאלקיל קרבמאט כמטרימי‬
‫ שיטות‬,‫תרופות של חומצה טראנקסאמית‬
‫להכנתם ושימוש בהם‬
ACYLOXYALKYL CARBAMATE
PRODRUGS OF TRANEXAMIC ACID,
METHODS OF SYNTHESIS AND USE
XENOPORT, INC.
US
60/692625
PCT/US/2006/023873
WO/2007/002013
20/06/2005
07/06/2006
METHOD FOR PRODUCING
CARBOXAMIDES
BAYER CROPSCIENCE AG
DE
102005028294.6
PCT/EP/2006/005436
WO/2006/136288
07/06/2006
METHOD FOR PRODUCING
CARBOXAMIDES
BAYER CROPSCIENCE AG
DE
102005028293.8
PCT/EP/2006/005435
WO/2006/136287
09/05/2006
181
188173
C07D
‫שיטה לייצור קרבוקסאמידים‬
18/06/2005
188174
C07D
‫שיטה לייצור קרבוקסאמידים‬
18/06/2005
188175
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
2-N-(5-[[4-(2-METHYL-2PYRIDINYLAMINO)ETHOXY]
PHENYL] METHYL]-2,4THIAZOLIDINEDIONE)BUTANEDIOIC
ACID, METHODS OF PREPARATION
AND COMPOSITIONS WITH
ROSIGLITAZONE MALEATE
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
–2–‫–מתיל‬N–(5–[[4–(2–2
]‫פירידינילאמינו)אתוקסי]פניל‬
‫–תיאזולידינדואון) בוטאנדיואיק‬4 ,2–]‫מתיל‬
‫ שיטות להכנה הרכבים עם‬,‫אסיד‬
‫רוסיגליטזון מלאט‬
‫טבע תעשיות פרמצבטיות בע"מ‬
PCT/US/2006/017994
WO/2007/130064
17/01/2006
188176
STABLE PHARMACEUTICAL
COMPOSITION COMPRISING
LINEZOLID FORM IV
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
US
60/701438
20/07/2005
PCT/US/2006/001514
WO/2007/018588
15/07/2005
188177
NOVEL GRANULATION PROCESS
AND GRANULATE PRODUCED
THEREFROM
TEVA PHARMACEUTICAL
INDUSTRIES LTD.
A61K
‫ של‬IV ‫הרכב רוקחי יציב המכיל פורם‬
‫לינזוליד‬
‫טבע תעשיות פרמצבטיות בע"מ‬
A61K
‫תהליך גרנולציה חדש והגרנולט שנוצר‬
‫ממנו‬
‫טבע תעשיות פרמצבטיות בע"מ‬
PCT/US/2005/025326
WO/2007/011349
19/12/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188178
C07D
182
PURE AND STABLE TIOTROPIUM
BROMIDE
SICOR INC
US
60/752672
19/12/2005
60/754530
27/12/2005
US
60/761437
23/01/2006
US
60/774051
15/02/2006
US
60/780310
07/03/2006
US
60/830231
10/07/2006
US
60/832189
20/07/2006
US
60/835200
03/08/2006
US
60/835201
03/08/2006
US
60/836037
07/08/2006
US
60/851223
12/10/2006
US
60/852740
18/10/2006
US
PCT/US/2006/048690
WO/2007/075838
29/06/2006
188181
A PYRIDIN QUINOLIN SUBSTITUTED
PYRROLO [1,2-B]PYRAZOLE
MONOHYDRATE AS TGF-BETA
INHIBITOR
ELI LILLY AND COMPANY
US
60/701641
22/07/2005
PCT/US/2006/025377
WO/2007/018818
26/06/2006
‫טיאוטרופיום ברומיד נקי ויציב‬
‫]פיראזול מונוהידרט המותמר‬B–1,2[ ‫פירולו‬
‫–בטא‬TGF ‫בפירידין קווינולין כמעכב של‬
188182
PYRIDAZINE DERIVATIVES
F. HOFFMANN-LA ROCHE AG
EP
05106098.6 05/07/2005
PCT/EP/2006/063533
WO/2007/003521
07/02/2001
183
C07D
188183
C07D
‫נגזרות פירידאזין‬
C07D
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
DIBENZO (B,F) AZEPINE
INTERMEDIATES
NOVARTIS AG
GB
0002740.9
PCT/EP/2001/001330
WO/2001/056992
‫) אזפין‬F,B( ‫חומרי ביניים של דיבנזו‬
07/02/2000
04/07/2006
188184
PYRAZOLO [3,4-D] AZEPINE
DERIVATIVES AS HISTAMINE H3
ANTAGONISTS
GLAXO GROUP LIMITED
GB
0513886.2
06/07/2005
PCT/EP/2006/006613
WO/2007/025596
02/08/2006
‫]אזפיין‬D–3,4[‫תולדות של פיראזולו‬
H3 ‫כאנטגוניסטים להיסטמין‬
188185
PHENYLPYRIDINE DERIVATIVES,
THEIR MANUFACTURE AND USE AS
PHARMACEUTICAL AGENTS
F. HOFFMANN-LA ROCHE AG
EP
05016956.4 04/08/2005
PCT/EP/2006/007646
WO/2007/017169
27/06/2006
18/07/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫ ייצורן ושימושן‬,‫נגזרות פנילפירידין‬
‫כחומרים פרמצבטיים‬
188187
CONTAINER FOR RESUSPENDING
SEDIMENTED MEDICAMENT
NORTON HEALTHCARE LIMITED
GB
0513581.9
01/07/2005
PCT/GB/2006/002367
WO/2007/003891
C07D
B01F
‫מיכל להרחפה מחדש של תרופה ממשקע‬
188189
C07D
184
CRYSTALLINE FORMS OF 4METHYL-N-[3-(4-METHYLIMIDAZOL-1-YL)-5TRIFLUOROMETHYL-PHENYL]-3-(4PYRIDIN-3-YL-PYRIMIDIN-2YLAMINO)-BENZAMIDE
NOVARTIS AG
US
60/701405
20/07/2005
60/716214
12/09/2005
US
PCT/US/2006/027875
WO/2007/015870
10/07/2006
–‫–מתיל‬N–[3–(4–‫–מתיל‬4 ‫קריסטלים של‬
–‫–טריפולואורומתיל‬5–)‫–יל‬1–‫אימידזול‬
–2–‫–יל–פירימידינ‬3–‫–פירידינ‬4(–3–]‫פניל‬
‫ילאמינו)–בנזאמיד‬
188190
METAL SALTS OF 2'-(1H-TETRAZOL5-YL)-1.1'-BIPHENYL-4CARBOXALDEHYDE
NOVARTIS AG
GB
0514206.2
11/07/2005
PCT/EP/2006/006730
WO/2007/006531
15/06/2006
SOLENOID VALVE
R.P.E.S.r.l
IT
MI2005A001148
PCT/IB/2006/001600
WO/2006/134479
19/06/2006
185
C07D
–)‫–יל‬5–‫–טטראזול‬H1(–2' ‫מלחי מתכת של‬
‫–קרבוקסאלדהיד‬4–‫–ביפניל‬1.1'
188191
F16K
‫שסתום סולונואיד‬
17/06/2005
188193
H04L
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
METHOD FOR BLIND
DEMODULATION AT HIGHER
ORDERS OF SEVERAL LINEAR
WAVEFORM TRANSMITTERS
THALES
FR
0506180
17/06/2005
PCT/EP/2006/063304
WO/2006/134172
07/07/2006
‫שיטה לפענוח עיוור בפקודות גבוהות יותר‬
‫של מעבירי צורת גל קווית‬
188194
PREPARATION OF POLYMER
CONJUGATES OF THERAPEUTIC,
AGRICULTURAL, AND FOOD
ADDITIVE COMPOUNDS
ELAN PHARMACEUTICAL, INC.
US
60/697726
08/07/2005
PCT/US/2006/026292
WO/2007/008563
23/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫הכנת תצמידים פולימריים של תרכובות‬
‫ חקלאיים ותוספות מזון‬,‫רפואיים‬
188196
TARGET DETECTION AND
TRACKING FROM OVERHEAD VIDEO
STREAMS
OBJECTVIDEO INC.
US
11/165435
24/06/2004
PCT/US/2006/024485
WO/2007/002404
21/06/2006
A61K
G06K
‫איתור ומעקב אחרי מטרה משידור וידאו‬
‫המצולם ממבט על‬
188199
C07C
186
SUBSTITUTED CYCLIC COMPOUND, ITS
PREPARATION PROCESS AND ITS
MEDICAL USE
SHANGHAI INSTITUTE OF MATERIA
MEDICA, CHINESE ACADEMY OF
SCIENCES
CN
200510027131.X 24/06/2005
PCT/CN/2006/001410
WO/2006/136101
03/07/2006
‫ תהליך‬,‫תרכובות ציקליות מותמרות‬
‫הכנתן ושימושן הרפואי‬
188201
PROCESSES FOR THE
MANUFACTURE OF ROSUVASTATIN
AND INTERMEDIATES
ASTRAZENECA UK LIMITED
GB
0514078.5
08/07/2005
PCT/GB/2006/003543
WO/2007/007119
20/06/2006
15/06/2006
187
‫תהליכים לייצור רוזוואסטאטין וחומרי‬
‫ביניים‬
188202
METHODS AND COMPOSITIONS FOR
EXPRESSING NEGATIVE-SENSE
VIRAL RNA IN CANINE CELLS
MEDIMMUNE VACCINES, INC.
US
60/692978
21/06/2005
60/692965
21/06/2005
US
60/699556
15/07/2005
US
60/699555
15/07/2005
US
60/702006
22/07/2005
US
60/793522
19/04/2006
US
60/793525
19/04/2006
US
PCT/US/2006/023867
WO/2007/002008
C07D
C12Q
RNA ‫שיטות ותכשירים לביטוי אנטי–סנס‬
‫ויראלי בתאי כלב‬
188204
A61F
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
COMBINATION THERAPY FOR THE
TREATMENT OF
IMMUNOINFLAMMATORY
DISORDERS
COMBINATORX, INC.
US
60/691766
17/06/2005
PCT/US/2006/023414
WO/2006/138518
12/09/2002
188205
A DRUM FILTER ASSEMBLY
CUMMINSCORP LIMITED
AU
PR7600
12/09/2001
17/12/2001
AU
PR9474
04/04/2002
AU
PS1509
PCT/AU/2002/001245
WO/2003/022041
30/06/2006
188206
MATERIALS AND METHODS FOR
TRANSCRIBING NUCLEIC ACIDS
ARCHEMIX CORP
US
60/696292
30/06/2005
PCT/US/2006/025653
WO/2007/005645
29/06/2006
188207
PYRROLIDINE DERIVATIVES AND
PHARMACEUTICAL COMPOSITIONS
CONTAINING THE SAME
VIROBAY, INC.
US
60/695767
30/06/2005
11/478337
28/06/2006
US
PCT/US/2006/025996
WO/2007/005838
23/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188220
‫תרפיה משולבת לטיפול בהפרעות‬
‫חיסוניות דלקתיות‬
A01K
‫הרכב מסנן תופי‬
C12Q
‫חומרים ושיטות לטרנסקריפטזיה של‬
‫חומצות גרעין‬
A61K
‫תולדות פירולידין ותכשירי רוקחות‬
‫המכילים אותן‬
A61K
188
AIRWAY ADMINISTRATION OF
TISSUE FACTOR PATHWAY
INHIBITOR IN INFLAMMATORY
CONDITIONS AFFECTING THE
RESPIRATORY TRACT
DRUGRECURE APS
US
60/693968
24/06/2005
PCT/IB/2006/002602
WO/2006/136962
23/06/2006
‫מתן דרך נתיבי אוויר של מעכב נתיב גורם‬
‫רקמה אשר משפיע על נתיב האוויר‬
‫בדלקת‬
188221
AIRWAY ADMINISTRATION OF
ACTIVATED PROTEIN C IN
INFLAMMATORY CONDITIONS
AFFECTING THE RESPIRATORY
TRACT
DRUGRECURE APS
US
60/693968
24/06/2005
PCT/IB/2006/002773
WO/2007/012976
20/06/2006
‫ משופעל‬C ‫מתן דרך נתיבי אוויר של חלבון‬
‫בתנאים דלקתיים המשפיעים על נתיב‬
‫הנשימה‬
188222
IMPROVED TUBERCULOSIS
VACCINES
STATENS SERUM INSTITUT
DK
PA200500924 23/06/2005
DK
PA200501393 05/10/2005
PCT/DK/2006/000356
WO/2006/136162
28/06/2006
189
A61K
188223
C07K
‫חיסונים משופרים לשחפת‬
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
FORMULATIONS OF CONJUGATED
ESTROGENS AND BAZEDOXIFENE
WYETH
US
60/694889
29/06/2005
PCT/US/2006/025348
WO/2007/002823
28/06/2006
188224
REINFORCING BAR BINDING
MACHINE
MAX CO. LTD
2005JP
01/07/2005
194206
PCT/JP/2006/312918
WO/2007/004491
30/06/2006
DOT PATTERN
GRID IP PTE LTD
2005JP
194295
PCT/SG/2006/000185
WO/2007/004994
188225
‫הרכבים של אסטרוגנים מצומדים‬
‫ובאזדוקסיפן‬
B65B
‫חיזוק למכונת הלחמה‬
G06K
‫דוגמת נקודות‬
01/07/2005
07/07/2006
188226
DICYCLOALKYL UREA
GLUCOKINASE ACTIVATORS
NOVO NORDISK A/S
EP
05106284.2 08/07/2005
05106519.1
15/07/2005
EP
05110779.5
16/11/2005
EP
PCT/EP/2006/064026
WO/2007/006760
28/07/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
188227
C07D
‫דיציקלואלקיל אוריאה כמשפע'ילי‬
‫גלוקוקינאז‬
C07D
190
MACROCYCLIC INHIBITORS OF
HEPATITIS C VIRUS
TIBOTEC PHARMACEUTICALS LTD.
EP
05107074.6 29/07/2005
05107417.7
11/08/2005
EP
06101280.3
03/02/2006
EP
PCT/EP/2006/064820
WO/2007/014926
16/06/2006
‫מעכבים מאקרוציקליים של וירוס הפטיטס‬
C
188228
BULLET PROOF LAMINATE AND
TRAUMA PACK
TEIJIN ARAMID GMBH
EP
05013518.5 23/06/2005
PCT/EP/2006/005772
WO/2006/136323
26/06/2006
188229
ARTIFICIAL GRAFT TUBING
VERYAN MEDICAL LIMITED
GB
0512936.6
24/06/2005
60/694220
27/06/2005
US
0525137.6
09/12/2005
GB
60/749973
13/12/2005
US
PCT/GB/2006/002354
WO/2006/136861
03/10/2000
191
188230
B32B
‫לאמינאט עמיד לירי וערכת טראומה‬
A61F
‫צנרת שתל מלאכותית‬
A61K
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
STABILIZED LIQUID POLYPEPTIDECONTAINING PHARMACEUTICAL
COMPOSITIONS
CHIRON CORPORATION
US
60/157696
04/10/1999
PCT/US/2000/027156
WO/2001/024814
26/06/2006
188231
METHODS AND COMPOSITIONS FOR
DIAGNOSIS AND MONITORING OF
ATHEROSCLEROTIC
CARDIOVASCULAR DISEASE
THE BOARD OF TRUSTEES OF THE
LELAND STANFORD JUNIOR
UNIVERSITY
US
60/693756
24/06/2005
11/473826
23/06/2006
US
PCT/US/2006/025003
WO/2007/002677
21/06/2006
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G01N
‫שיטות והרכבים לאבחון וניטור של מחלה‬
‫קרדיווסקולרית טרשתית‬
188233
DIAGNOSING PATHOLOGICAL
CONDITIONS USING INTERALLELIC
EPIGENETIC VARIATIONS
ALLELIS DIAGNOSTICS LTD.
US
60/692255
21/06/2005
60/702635
27/07/2005
US
PCT/IL/2006/000725
WO/2006/137066
24/11/2003
‫תכשירי רוקחות נוזליים מיוצבים המכילים‬
‫פוליפפטיד‬
C12Q
‫דיאגנוזה של מצבים פתולוגיים תוך שימוש‬
‫בוריאציות אפיגנטיות בין אללים‬
188249
‫אלליס דאגנוסטיקה בע"מ‬
C12Q
192
‫תרכובות דומות לספלוספורין לשימוש‬
‫ברפואה‬
CEPHALOSPORIN RELATED
COMPOUNDS FOR USE IN THERAPY
THE JOHNS HOPKINS UNIVERSITY
US
60/428229
22/11/2002
PCT/US/2003/038191
WO/2004/048551
20/12/2001
188250
DOSAGE UNIT FOR INHIBITING
OVULATION COMPRISING
DROSPIRENONE AND A COMPLEX
BETWEEN ETHINYL ESTRADIOL
AND CYCLODEXTRINE
BAYER SCHERING PHARMA
AKTIENGESELLSCHAFT
EP
00610135.6 20/12/2000
60/256484
20/12/2000
US
PCT/IB/2001/002605
WO/2002/049675
10/10/2002
‫יחידת מינון למניעת ביוץ המכילה‬
‫דרוספירנון ותצמיד בין אתניל אסטראדיאול‬
‫וציקלודקסטרין‬
188266
SELF EXTRACTING SUBMUNITION
TEXTRON SYSTEMS CORPORATION
US
10/008923
16/11/2001
PCT/US/2002/032319
WO/2003/083399
16/02/2005
193
A61K
188267
F41C
‫תת–תחמושת בעלת מיצוי עצמי‬
H04Q
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
APPARATUS AND METHOD FOR
CONTROLLING REVERSE LINK
INTERFERENCE AMONG ACCESS
TERMINALS IN WIRELESS
COMMUNICATIONS
QUALCOMM INCORPORATED
US
10/789516
27/02/2004
PCT/US/2005/004981
WO/2005/094112
05/04/2002
188286
PEPTIDE-BASED IMMUNIZATION
THERAPY FOR TREATMENT OF
ATHEROSCLEROSIS AND
DEVELOPMENT OF PEPTIDE-BASED
ASSAY FOR DETERMINATION OF
IMMUNE RESPONSES AGAINST
OXIDIZED LOW DENSITY
LIPOPROTEIN
FORSKARPATENT I SYD AB
SE
0101232-7
05/04/2001
0103754-8
09/11/2001
SE
PCT/SE/2002/000679
WO/2002/080954
11/06/1999
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
A61P
‫טיפול חיסוני מבוסס על פפטידים לטיפול‬
‫בטרשת עורקים ופיתוח בוחן המבוסס על‬
‫פפטדים לקביעת התגובה החיסונית נגד‬
‫ליפופרוטאינים מחומצנים בעלי משקל‬
‫סגולי נמוך‬
188362
ATTENUATED NEGATIVE STRAND
VIRUSES WITH ALTERED
INTERFERON ANTAGONIST
ACTIVITY FOR USE AS VACCINES
AND PHARMACEUTICALS
MOUNT SINAI SCHOOL OF
MEDICINE OF NEW YORK
UNIVERSITY
US
60/089103
12/06/1998
60/108832
18/11/1998
US
60/117683
29/01/1999
US
PCT/US/1999/013144
WO/1999/064068
03/08/2001
‫מערכת ושיטה לשליטה בהפרעת חיבור‬
‫בין מסופי גישה בתקשורת אלחוטית‬
C12N
‫וירוסים מוחלשים בעלי סיב נגדי בעלי‬
‫פעילות אנטגוניסטית מופרעת לאינטרפרון‬
‫לשימוש בתרכיבי חיסון ובתכשירי רוקחות‬
188364
A61P
194
9 ,‫ אלפא‬6 ‫–פלואורו מתיל אסטר של‬S
–2('–‫ אלפא‬17–‫אלפא–דיפלואורו‬
‫ ביטא‬11–‫פוראנילקרבוקסיל)אוקסי‬
–‫–אוקסו‬3–‫אלפא–מתיל‬16–‫הידרוקסי‬
‫–קרבותיאויק‬17–‫–דיאן‬,4,1–‫אנדרוסט‬
‫חומצה כגורם נוגד דלקת‬
6 ALPHA ,9 ALPHA -DIFLUORO-17
ALPHA-'(2-FURANYLCARBOXYL)
OXY-11 BETA -HYDROXY-16 ALPHAMETHYL-3-OXO-ANDROST-1,4,DIENE-17-CARBOTHIOIC ACID SFLUOROMETHYL ESTER AS AN ANTI
INFLAMMATORY AGENT
GLAXO GROUP LIMITED
GB
0019172.6
05/08/2000
0108800.4
07/04/2001
GB
PCT/GB/2001/003495
WO/2002/012265
21/05/2001
188369
METHOD FOR MAKING
ACYLAMIDES BY SYNTHESIZING
AND ACYLATING BENZOXAZINES
SYNGENTA PARTICIPATIONS AG
US
09/576457
23/05/2000
PCT/EP/2001/005835
WO/2001/090088
13/09/2002
195
‫שיטה להכנת אצילאמידים על–ידי סינתיזה‬
‫ואצילציה של בנזאוקסאזינים‬
188374
UREA COMPOUNDS ACTIVE AS
VANILLOID RECEPTOR
ANTAGONISTS FOR THE
TREATMENT OF PAIN
SMITHKLINE BEECHAM P.L.C.
GB
0122156.3
13/09/2001
0130547.3
20/12/2001
GB
0130503.6
20/12/2001
GB
0130505.1
20/12/2001
GB
PCT/GB/2002/004206
WO/2003/022809
C07D
C07D
‫תרכובות שיתנן הפעילות כאנטגוניסטים‬
‫של קולטן ונילואיד לטיפול בכאב‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
25/09/2002
188455
LOW HYGROSCOPIC ARIPIPRAZOLE
DRUG SUBSTANCE AND PROCESSES
FOR THE PREPARATION THEREOF
OTSUKA PHARMACEUTICAL CO,
LTD
2001JP
25/09/2001
290645
2001-348276 14/11/2001
JP
2379005
27/03/2002
CA
PCT/JP/2002/009858
WO/2003/026659
22/11/2002
19/06/2001
‫חומר תרופתי של אריפיפראזול בעל יכולת‬
‫נמוכה לספיגת לחות ותהליכים להכנתו‬
188457
THE USE OF ANTI-HISTAMINICS FOR
ACUTE REDUCTION OF ELEVATED
INTRACRANIAL PRESSURE
JANSSEN PHARMACEUTICA N.V.
EP
01204574.6 23/11/2001
PCT/EP/2002/013180
WO/2003/044023
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C07D
‫שימוש באנטיהיסטמינים להפחתה‬
‫משמעותית של לחץ תוך–גולגולתי מוגבר‬
188471
COMBINATIONS OF DIPEPTIDYL
PEPTIDASE IV INHIBITORS AND
OTHER ANTIDIABETIC AGENTS FOR
THE
TREATMENT OF DIABETES
MELLITUS
SMITHKLINE BEECHAM P.L.C.
GB
0014969.0
19/06/2000
PCT/GB/2001/002696
WO/2001/097808
06/12/2002
C07D
188472
C07D
‫שילובים של מעכבי דיפפטידיל פפטידאז‬
‫ וחומרים נוגדי סכרת אחרים לטיפול‬IV
‫בסכרת‬
C12N
196
ISLET CELLS FROM HUMAN
EMBRYONIC STEM CELLS
GERON CORPORATION
US
60/338885
07/12/2001
PCT/US/2002/039089
WO/2003/050249
02/03/2001
188473
TRANSMITTER ARCHITECTURES
FOR COMMUNICATIONS SYSTEMS
QUALCOMM INCORPORATED
US
519734
04/03/2000
PCT/US/2001/006740
WO/2001/067621
04/02/2002
H04B
‫ארכיטקטורות משדר למערכות תקשורת‬
188485
NEW USE OF ILOPERIDONE
NOVARTIS AG
GB
0102841.4
05/02/2001
PCT/EP/2002/001130
WO/2002/064141
197
‫תאים איים מתאי גזע עובריים אנושיים‬
A61K
‫שימוש חדש באילופרידון‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
NOTICE UNDER SECTION 26 OF THE
PATENTS LAW, 5727-1967
The applications, particulars of which are set
out below, have been accepted pursuant to
Section 17 of the Patents Law. Any person
wishing to oppose the grant of a patent on any
of the applications published here, may,
within three months from the date of this
journal, give to the Commissioner of Patents
notice under Section 30 of the Patents Law, in
the manner prescribed in regulations 57 et seq
of the Patents Regulations, 5728-1968
Particulars of the applications, where
applicable, are given in the following order:
[11] [21] Number of application
[54] Title of invention
[22] Application date
[31] [32] [33] Number and date of foreign
application – convention country.
*[51] Int.Cl.
[61] Application for patent of addition
[62] Divisional application
[71] Applicant
[72] Inventor
[87] International Publication Number
[74] Address for service
[57] Abridgement of invention (in the
language in which the specification is drawn
up)
*Note: As from Patents and Designs Journal
No.1/06, patent applications are classified
according to the Eighth Edition of the
International Patent Classification (2006)
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
- ‫ לחוק הפטנטים תשכ"ז‬26 ‫הודעה לפי סעיף‬
1976
‫הבקשות שפרטיהן מתפרסמים להלן קובלו‬
‫ כל המעונין‬.‫ לחוק הפטנטים‬17 ‫לפי סעיף‬
‫להתנגד למתן פטנט על פי בקשה מהבקשות‬
‫ תוך שלושה חדשים‬,‫המתפרסמות רשאי‬
‫ להגיש לרשם הפטנטים‬,‫מתאריך יומן זה‬
‫ לחוק‬30 ‫הודעת התנגדות לפי סעיף‬
‫ ואילך‬57 ‫הפטנטים בדרך הקבועה בתקנה‬
.1968 – ‫ תשכ"ח‬,‫לתקנות הפטנטים‬
‫פרטי הבקשות במידה ויישימים מובאים לפי‬
:‫סדר זה‬
‫מספר הבקשה‬
‫שם האמצאה‬
‫תאריך הבקשה‬
‫מספר ותאריך של בקשות החוץ – מדינת‬
‫האגוד‬
‫*סיווג בינלאומי – מהדורה שביעית‬
‫בקשה לפטנט מוסף‬
‫בקשת חלוקה‬
‫המבקש‬
‫הממציא‬
‫מס' פרסום של בקשה הבינלאומית‬
‫מען למסירת מסמכים‬
)‫תקציר האמצאה (בשפה בה ערוך הפירוט‬
'‫ החל מיומן הפטנטים והמדגמים מס‬:‫*הערה‬
‫ ניתן ציון לבקשות פטנטים הסיווג לפי‬1/06
‫המהדורה השמינית של הסיווג הבינלאומי‬
)2006 ‫של פטנטים (משנה‬
198
]11[]21[
106271
‫ והכנתו‬TNF ‫ של‬P75 ‫ליגנד לקולטן‬
]54[
LIGAND TO THE P75 TNF
RECEPTOR AND ITS
PREPARATION
]22[
]51[
]61[
]71[
08.07.1993
Int. Cl.8 A61K 039/395, C07K 016/28, C12N 015/12, 015/13
103051
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
‫ יבנה‬,18 ‫הקישון‬
YAVNE 81220
]74[
[57] A ligand (as defined in the
specification) to the p75 TNF-R which
inhibits effects of TNF, but not its binding
to the p75 TNF-R, which binds to the
region of the C-terminal cysteine loop
including the amino acid sequence cys-163
to thr-179 in the p75 TNF-R.
__________
]11[]21[
106591
ALPHA/BETA ‫חלבון הקושר אינטרפון‬
‫הכנתו ותכשירי רוקחות המכילים אותו‬
]54[
INTERFERON ALPHA/BETA
BINDING PROTEIN, ITS
PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
IT
]22[
]51[
]61[
]71[
04.08.1993
Int. Cl.8 A61K 038/17, C07K 014/715, C12N 015/12, 015/20
103052
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
‫ יבנה‬,18 ‫הקישון‬
YAVNE 81220
]74[
[57] An INF-α/β binding protein,
including the sequence:
Met-Val-Lys-Phe-Pro-Ser-Ile-Val-GluGlu-Glu-Leu-Gln-Phe-Asp-Leu-Ser-IleVal-Ile-Glu-Glu-Gln
199
and its muteins and fused proteins, their
salts, functional derivatives and active
fractions which have the same activity.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
108584
‫שיבוט של חלבון הקושר אינטרפרון‬
ALPHA/BETA
]54[
CLONING OF INTERFERON –
ALPHA/BETA BINDING
PROTEIN
]22[
]51[
]71[
07.02.1994
Int. Cl.8 A61K 038/17, C07K 014/715, C12N 015/12, 015/20
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
‫ יבנה‬,18 ‫הקישון‬
YAVNE 81220
]74[
[57] An isolated DNA molecule which
includes a nucleotide sequence encoding a
portion of an IFN- α/β binding protein
which portion includes the sequence of
residue 30-237 of SEQ ID NO: 2 or
residues 30-237 of SEQ ID NO:14 and
binds to one or more of the interferons
selected from the group consisting of IFNα2, IFN-αB, IFN-αC and IFN-β.
__________
]11[]21[
117483
MENINGITIDIS ‫חלבון מעטפת של‬
K ‫ עמיד לפרוטאינאז‬NEISSERIA
]54[
PROTEINASE K RESISTANT
SURFACE PROTEIN OF
NEISSERIA MENINGITIDIS
]22[
]31[
14.03.1996
406362
]32[ 17.03.1995
]33[ US
001983
04.08.1995
US
Int. Cl.8 A61K 038/16, 039/095, C07K 014/195, 014/22, C12N 001/21, 015/31, C12Q
001/08
ID BIOMEDICAL CORPORATION,
CANADA
BERNARD BRODEUR, DENIS
MARTIN, JOSEE HAMEL,
CLEMENT RIOUX
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]72[
]74[
[57] An isolated polynucleotide
comprising a DNA sequence encoding a
Neisseria surface protein, and any
fragments thereof, wherein the DNA
sequence is capable of hybridizing to the
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
complement of a polynucleotide that
comprises the nucleotide sequence set forth
in SEQ ID NO:1, SEQ ID NO:3, SEQ ID
NO:5, or SEQ ID NO:7 under stringent
conditions, wherein said stringent
200
conditions comprise hybridization at 42˚C
in a solution comprising 50% formamide,
and wherein the Neisseria surface protein,
and any fragments thereof, are antigenic
and capable of eliciting antibodies that
specifically bind to Neisseria.
,160346
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
______________
]11[]21[
122408
TNF–‫ המקודד לליגנד דומה ל‬DNA
‫) והכנתו‬TRAIL (‫המשרה אפופטוזה‬
]54[
DNA ENCODING A TNF
RELATED APOPTOSIS INDUCING
LIGAND (TRAIL) PEPTIDE AND
ITS PREPARATION
]22[
]31[
25.06.1996
496632
]32[ 29.06.1995
]33[ US
548368
01.11.1995
US
Int. Cl.8 A61K 038/19, A61P 035/00, C07H 021/04, C07K 014/435, 014/52, 014/705,
C12N 015/09, 015/19, 015/63
IMMUNEX CORPORATION, U.S.A.
WO/1997/001633
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] An isolated DNA comprising a
nucleotide sequence encoding a TNF
related apoptosis inducing ligand (TRAIL)
polypeptide, wherein said TRAIL
polypeptide comprises an amino acid
sequence that is at least 80% identical to an
amino acid sequence selected from amino
acids 1 to 281 of SEQ ID NO:2 or a
The applications for division
from this application have
not yet been published
fragment thereof that is capable of inducing
apoptosis of Jurkat cells, or amino acids 1
to 291 of SEQ ID NO:6, or a fragment
thereof that is capable of inducing
apoptosis of Jurkat cells, wherein said
TRAIL polypeptide is capable of inducing
apoptosis of Jurkat cells.
,184699
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
______________
201
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
124153
‫תכשירי אנדוסטטין נוגדי היווצרות כלי דם‬
‫חדשים ושיטות לשימוש בהם‬
]54[
ANTIANGIOGENIC ENDOSTATIN
COMPOSITIONS AND METHODS
OF USE
]22[
]31[
23.10.1996
60/005835
]32[ 23.10.1995
]33[ US
60/023070
02.08.1996
US
60/026263
17.09.1996
US
08/740168
22.10.1996
US
Int. Cl.8 A61K 038/17, 039/395, 048/00, A61P 035/00, C07K 014/78, 016/18,
016/42, C12N 015/12, 015/63
THE CHILDREN'S MEDICAL
CENTER CORPORATION, U.S.A.
WO/1997/015666
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] Isolated endostatin protein, wherein
the endostatin protein is a fragment of a Cterminal non-collagenous region of a
collagen protein and wherein the endostatin
protein is further characterized by its
ability to inhibit angiogenesis.
__________
]11[]21[
128193
‫גן לרמנוזיל–טרנספראז ושימושיו‬
]54[
RHAMNOSYL-TRANSFERASE
GENE AND USES THEREOF
]22[
]51[
]71[
22.01.1999
Int. Cl.8 A01H 005/00, C12N 001/19, 001/21, 005/00, 015/54, 015/82
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
‫ משרד החקלאות ופיתוח‬- ‫מדינת ישראל‬
THE STATE OF ISRAEL‫ מרכז‬,‫ מינהל המחקר החקלאי‬,‫הכפר‬
MINISTRY OF AGRICULTURE &
‫ בית דגן‬,‫וולקני‬
RURAL DEVELOPMENT,
AGRICULTURAL RESEARCH
ORGANIZATION VOLCANI
CENTER
JONATHAN GRESSEL, YORAM
‫ רוברט פלור‬,‫ יורם אייל‬,‫יונתן גרסל‬
EYAL, ROBERT FLUHR
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]72[
]74[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
202
[57] An isolated polynucleotide
comprising a nucleotide sequence encoding
a polypeptide having at least 95% sequence
identity with SEQ ID NO:21 as determined
using a sequence analysis software package
developed by the Genetic Computer Group
at the University of Wisconsin with gap
creation penalty of 12 and gap extension
penalty of 4, said polypeptide having a
flavanone-7-O-glucoside-2"-O-rhamnosyltransferase catalytic activity.
__________
]11[]21[
128999
‫חלבונים המקימים אינטראקציה עם הגן‬
‫ ושימושים המתיחסים להם‬HEDGEHOG
]54[
HEDGEHOG INTERACTING
PROTEINS AND USES RELATED
THERETO
]22[
]31[
]51[
19.09.1997
60/026155
]32[ 20.09.1996
]33[ US
Int. Cl.8 A01K 067/00, A61K 038/17, C07K 014/435, 014/46, C12N 015/12, 015/67,
C12Q 001/68, G01N 033/53
PRESIDENT AND FELLOWS OF
HARVARD COLLEGE, U.S.A.
WO/1998/012326
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]71[
]87[
]74[
[57] An isolated or recombinantly
produced Hedgehog Interacting Protein
(HIP) polypeptide, wherein said HIP
polypeptide comprises a HIP amino acid
sequence encoded by a nucleic acid which
hybridizes under stringent conditions,
The applications for division
from this application have
not yet been published
including a wash step of 0.2X SSC at 65˚
C, to a sequence selected from any of SEQ
ID. Nos. 1, 2, 3, 4, 10, 11, 12, 13, or 14,
and wherein said HIP amino acid sequence
binds to a hedgehog protein.
,181578
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
____________
203
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
129649
‫דבקים רגישי לחץ המכילים פולימרים‬
,‫בעלי רמה נמוכה של שרידי מונומרים‬
‫שיטה להכנתם ושימוש בהם למערכות‬
‫העברה דרך העור‬
]54[
PRESSURE SENSITIVE
ADHESIVES COMPRISING
POLYMERS HAVING A LOW
LEVEL OF RESIDUAL MONOMER
CONTENT, A PROCESS FOR
THEIR MANUFACTURE AND USE
THEREOF AS TRANSDERMAL
SYSTEMS
]22[
]31[
14.10.1997
19643959.0
]32[ 31.10.1996
]33[ DE
08/928313
12.09.1997
US
Int. Cl.8 A61K 009/06, A61L 015/16, C08F 006/00, 008/04, C09J 123/00
NATIONAL STARCH AND
CHEMICAL INVESTMENT
HOLDING CORPORATION, U.S.A.
LTS LOHMANN THERAPIESYSTEME GMBH, GERMANY
WO/1998/018829
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A process for the manufacture of an
adhesive comprising one or more olefinic
polymers wherein the content of the free
monomers is less than 1% by weight, the
process comprising after completion of
polymerization or copolymerization of the
polymer or polymers, the hydrogenation of
the adhesive in an organic solvent in the
presence of a heterogeneous or
homogeneous catalyst.
__________
]11[]21[
]54[
POLYSACCHARIDE
SEQUENCING AND STRUCTURE
DETERMINATION
]22[
]51[
]71[
]72[
]74[
06.05.1999
Int. Cl.8 C12Q 001/34
PROCOGNIA (ISRAEL) LTD.
OFER MARKMAN
DR. D. GRAESER LTD.,
P.O.B. 2496,
RAANANA
43650
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
129835
‫קביעת רצף ומבנה של פוליסאכאריד‬
‫ אשדוד‬,
‫עופר מרקמן‬
,‫ גרייזר בע"מ‬.‫ד"ר ד‬
‫ רעננה‬,2496 .‫ד‬.‫ ת‬,
204
[57] A method for the structural analysis
of a saccharide, comprising:
(a) providing on a surface of a substrate a
plurality of different essentially sequenceand/or site-specific binding agents having
different binding specificities, wherein a
number of the plurality of said essentially
sequence-and/or site-specific agents are
immobilized on the same surface of said
substrate;
(b) contacting said surface with a
saccharide to be analyzed, or with a
mixture comprising a plurality of
fragments of said saccharide;
(c) washing or otherwise removing
unbound saccharide or saccharide
fragments;
(d) adding to the surface obtained in step
(c) an essentially sequence- and/or sitespecific marker, or a mixture of essentially
sequence-and/or site-specific markers;
(e) acquiring one or more images of the
markers that are bound to said surface; and
(f) deriving information related to the
identity of the saccharide being analyzed
from said image.
__________
]11[]21[
]54[
SYNTHETIC ANTISENSE
OLIGODEOXYNUCLEOTIDES
AND PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]22[
]31[
12.12.1997
60/035266
]32[ 12.12.1996
60/037777
13.02.1997
08/850347
02.05.1997
60/053334
21.07.1997
Int. Cl.8 C12N 015/11, C12Q 001/68
YISSUM RESEARCH
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM
WO/1998/026062
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] A nuclease resistant antisense
oligodeoxynucleotide capable of
selectively modulating human
205
130162
‫אנטיסנס אוליגודאוקסינוקלאוטידים‬
‫סינטטיים ותכשירי רוקחות המכילים אותם‬
]33[
US
US
US
US
‫יישום חברה לפיתוח המחקר של‬
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
acetylcholinesterase (AChE) production
selected from the group consisting of
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
130247
‫וקטורי ביטוי המכילים גנים ולקות עזר‬
‫נקשרות ושימושם באימונומודולציה‬
‫ולטיפול במחלות ממאירות ובמחלות‬
‫אוטואימוניות‬
]54[
EXPRESSION VECTORS
CONTAINING ACCESSORY
MOLECULE LIGAND GENES AND
THEIR USE FOR
IMMUNOMODULATION AND
TREATMENT OF
MALIGNANCIES AND
AUTOIMMUNE DISEASE
]22[
]31[
08.12.1997
60/032145
]32[ 09.12.1996
]33[ US
08/982272
01.12.1997
US
Int. Cl.8 A61K 048/00, C07K 019/00, C12N 015/62
UNIVERSITY OF CALIFORNIA,
U.S.A.
WO/1998/026061
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] Use of a chimeric CD40 ligand
polynucleotide for the preparation of a
pharmaceutical composition for expressing
a chimeric CD40 ligand in a CD40+ human
cell, wherein the chimeric CD40 ligand
includes one or more human domains
derived from a human cD40 ligand gene
and one or more mose domains derived
from a mouse CD40 ligand gene.
__________
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
206
]11[]21[
130960
IFN ‫ של‬1–‫חלבונים שקושרים קולטן‬
‫ – המקודד עבורם‬DNA‫ו‬
]54[
IFN RECEPTOR 1 BINDING
PROTEINS AND DNA ENCODING
THEM
]22[
]31[
]51[
15.01.1998
60/035636
]32[ 15.01.1997
]33[ US
Int. Cl.8 A61K 048/00, C07K 014/715, 016/28, C12N 001/15, 001/19, 005/10,
015/12, 015/63
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
WO/1998/031796
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
‫ יבנה‬,18 ‫הקישון‬
YAVNE 81220
]71[
]87[
]74[
[57] A recombinant DNA molecule
comprising a nucleotide sequence encoding
an IFNAR1 binding protein capable of
being induced by IFN-α or IFN-β and
having the amino acid sequence of SEQ ID
No:2 or SEQ ID NO:8.
__________
]11[]21[
131591
‫מערכת אחיזת ואקום אדפטיבית‬
]54[
SELF ADAPTIVE VACUUM
GRIPPING DEVICE
]22[
]51[
]71[
]72[
25.08.1999
Int. Cl.8 A47J 045/00, B25J 015/00, F15D 001/00, 001/02, 001/04
COREFLOW LTD.
‫ יוקנעם‬,‫קורפלו בע"מ‬
YUVAL YASSOUR, DANIEL B.
‫ לוין‬.‫ דניאל ב‬,‫יובל יסעור‬
LEVIN
MILLER-SIERADZKI,
,‫שרצקי‬-‫מילר‬
P.O.B. 6145,
‫ חיפה‬,6145 .‫ד‬.‫ ת‬, 18‫מחניים‬
HAIFA 31061
]74[
[57] A self adaptive vacuum grip device
comprising: a vacuum source (251); a
vacuum reservoir (254) fluidically
connected to said vacuum source; a contact
surface (256); a plurality of conduits (1)
wherein said conduit has an inlet (2)
positioned on said contact surface and an
outlet (3) fluidically connected to said
vacuum reservoir wherein said conduit is
provided with a plurality of fins (4, 5)
mounted on the internal wall (12) of said
207
conduit said fins arranged in two arrays
substantially opposite each other; wherein
each of the fins of either one of said fin
arrays excluding the fin nearest to the inlet
and the fin nearest to the outlet of said
conduit is positioned substantially opposite
to one of a plurality of cavities each cavity
defined between two consecutive fins of
one of said arrays of fins and a portion of
said conduit internal walls; whereby when
fluid flows through said conduit a plurality
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
of vortices (6, 7) is facilitated within said
cavities and wherein the vortices may exist
at least temporarily during said flow thus
forming an aerodynamic blockage allowing
a central core-flow (8) between tips of said
fins, thus limiting the mass flow rate and
maintaining a substantial pressure drop
within the conduit; whereby when an
object covers the inlet of said conduit the
flow stops, and the pressure drop is
eliminated thus said object is effectively
held by the vacuum to said contact surface
whereas when the inlet is not covered an
aerodynamical blocking is achieved and
the flow rate through the conduit is
substantially reduced thus substantially
reducing the need for powerful vacuum
source and reducing the risk of loosing
vacuum grip of the device when a portion
of the conduits are not covered.
__________
]11[]21[
131929
‫הכנתו והשימוש בו‬, PAR ‫חלבון‬
]54[
RAP PROTEIN, ITS
PREPARATION AND USE
]22[
]31[
]51[
19.03.1998
120485
]32[ 19.03.1997
]33[ IL
Int. Cl.8 A61K 038/17, 039/395, 048/00, C07K 014/47, 016/18, C12N 001/21,
005/10, 015/12, 015/63, C12Q 001/68, G01N 033/50
YEDA RESEARCH AND
‫ רחובות‬,‫ידע חברה למחקר ופיתוח בע"מ‬
DEVELOPMENT CO. LTD.
WO/1998/041624
INTERLAB LTD.,
,‫אינטר לאב בע"מ‬
18 HAKISHON ST.
‫ יבנה‬,18 ‫הקישון‬
YAVNE 81220
]71[
]87[
]74[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
208
[57] A DNA sequence encoding a
polypeptide having the activity of an RIPassociated protein (RAP), said DNA
sequence being obtainable by applying the
yeast two-hybrid procedure, said procedure
comprising the steps:
(a) providing one hybrid vector carrying a
sequence encoding RIP devoid of its death
domain and a second hybrid vector
carrying a sequence from a cDNA or
genomic DNA library;
(b) transforming yeast host cells with the
vectors of step (a);
(c) isolating positive transformed cells, and
(d) extracting from the positive
transformed cells of step (c) the said
second hybrid vector to obtain said DNA
sequence encoding a polyeptide which
binds to said RIP;
wherein said polypeptide does not have a
death domain, a MORT MODULE, a
protease domain, a kinase domain/motif or
a TRAF domain.
__________
]11[]21[
]54[
METHOD FOR DIAGNOSING
PSYCHIATRIC DISORDERS
]22[
]31[
]51[
]71[
14.04.1998
PO6166
]32[ 11.04.1997
Int. Cl.8 A61B 005/02
HEARTLINK LIMITED,
AUSTRALIA
WO/1998/046128
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
[57] A method for diagnosing a
psychiatric disorder in a subject, the
method comprising the steps of: measuring
132186
‫שיטה לאבחון הפרעות פסיכיאטריות‬
]33[
AU
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
a heart rate pattern of the subject; and using
said pattern to diagnose the psychiatric
disorder.
__________
209
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
134978
‫מוטציות בוירוסים קרומיים המשפיעים על‬
‫טווח הפונדקאים ושמוש בוירוסים‬
‫כחומרים חיסוניים‬
]54[
MEMBRANE VIRUS HOST
RANGE MUTATIONS AND THEIR
USES AS VACCINE SUBSTRATES
]22[
]31[
]51[
]71[
18.09.1998
60/059668
]32[ 18.09.1997
]33[ US
Int. Cl.8 A61K 039/12, C07K 014/005, 014/18, C12N 007/04, C12P 021/00
RESEARCH DEVELOPMENT
FOUNDATION, U.S.A.
DENNIS T. BROWN, RACQUEL
HERNANDEZ
WO/1999/013818
DR. MARK FRIEDMAN LTD.,
,‫ד"ר מרק פרידמן בע"מ‬
MOSHE AVIV TOWER, 54TH
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
FLOOR,
‫ גן‬-‫רמת‬
7 JABOTINSKY ST.,
RAMAT GAN 52520
]72[
]87[
]74[
[57] A genetically-engineered, membrane
enveloped virus, wherein said virus codes
for a transmembrane protein having a
deletion of one or more amino acids, and
wherein said deletion provides a
transmembrane protein that is able to span
the membrane when said virus replicates in
insect cells, but that is unable to span the
membrane when said virus replicates in
mammalian cells.
__________
]11[]21[
136290
‫קונג'וגטים פולימריים של אינטרפון‬
]54[
INTERFERON POLYMER
CONJUGATES
]22[
]31[
]51[
]71[
]87[
]74[
16.12.1998
08/994622
]32[ 19.12.1997
]33[ US
Int. Cl.8 A61K 038/21, 047/48, A61P 031/12, 035/00, C07K 001/113, 014/56
SCHERING CORPORATION, U.S.A.
WO/1999/032139
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
[57] A pharmaceutical composition
comprising a mixture of positional isomers
of conjugates of alpha-interferon and an
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
alkoxy-terminated polyalkylene oxide
wherein at least 15% of said positional
isomers comprise an alpha-interferon
210
covalently conjugated to alkoxy-terminated
polyalkylene oxide at a histidine residue on
said alpha-interferon.
__________
]11[]21[
]54[
APPARATUS AND METHOD FOR
BLAST SUPPRESSION
]22[
]31[
]51[
]71[
11.12.1998
60/069533
]32[ 12.12.1997
Int. Cl.8 F42D 005/045
HER MAJESTY THE QUEEN IN
RIGHT OF CANADA A.R.B. THE
SOLICITOR GENERAL ACTING
THROUGH THE COMMISSIONER
OF THE RCMP, CANADA
WO/1999/031457
DR. MARK FRIEDMAN LTD.,
MOSHE AVIV TOWER, 54TH
FLOOR,
7 JABOTINSKY ST.,
RAMAT GAN 52520
]87[
]74[
[57] An apparatus for suppression of a
blast from an explosive device, comprising:
(a) a hemispherical enclosure defined by an
upstanding wall;
(b) positioning means associated with the
enclosure for positioning the explosive
device within the enclosure substantially
equidistant from any point on the wall;
136683
‫מתקן ושיטה להמטת פיצוץ‬
]33[
US
,‫ד"ר מרק פרידמן בע"מ‬
,7 ‫ רח ז'בוטינסקי‬, 54.‫ ק‬,‫מגדל משה אביב‬
‫ גן‬-‫רמת‬
(c) an opening in the wall defining a filling
port; and
(d) an aqueous energy absorbing flowable
foam material having an expansion ratio of
17-49: 1, substantially filling the enclosure
and covering the explosive device,
whereby upon detonation of the explosive
device so positioned, the blast is
suppressed.
__________
211
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
136901
‫תכשיר למתן דרך הפה הנמס בפה באופן‬
‫מיידי‬
]54[
FLASH-MELT ORAL DOSAGE
FORMULATION
]22[
]31[
]51[
]71[
20.06.2000
09/547948
]32[ 12.04.2000
]33[ US
Int. Cl.8 A61K 009/00, 009/16, 009/46, C07D 401/12
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]74[
[57] A flash-melt pharmaceutical dosage
form that will disintegrate in the mouth in
under 25 seconds, comprising a
medicament and a combination of
excipients which comprises, based on the
total weight of the dosage form,
(a) from 4 to 8% by weight of a
superdisintegrant,
(b) from 20 to 70% by weight of a
dispersing agent which is a calcium
silicate,
(c) from 1 to 10% by weight of a
distributing agent selected from amorphous
silica, fumed silica, diatomaceous earth,
talc, kaolin and magnesium aluminium
trisilicate, and
(d) from 10 to 50% by weight of a binder.
__________
]11[]21[
]54[
METHOD AND APPARATUS FOR
MOTION- FREE CARDIAC CT
IMAGING
]22[
]31[
]51[
]71[
19.09.2000
09/409465
]32[ 30.09.1999
Int. Cl.8 A61B 006/03, G01T 001/00
GENERAL ELECTRIC COMPANY,
U.S.A.
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]74[
[57] A method for generating CT images
of a moving body part using a CT imaging
system, said method comprising the steps
of: scanning a portion of a patient's body
including the moving body part utilizing
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
138566
‫שיטה והתקן להדמיית הלב בטומוגרפיה‬
‫ממוחשבת ללא תנועה‬
]33[
US
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
the CT imaging system; collecting image
data representative of a sequence of images
of the scanned portion of the patient's
body; selecting a fixed reference point in
images represented by the image data; and
212
selecting at least one image from the
sequence of images according to a function
of relative positions of the moving body
part and the fixed reference point in the
sequence of images.
__________
]11[]21[
]54[
METHOD FOR PROLONGED
STORAGE OF DNA MOLECULES
AND PACKAGING
IMPLEMENTING SAID METHOD
]22[
]51[
]71[
06.05.1998
Int. Cl.8 C12N 015/10
SOPHIE TUFFET, FRANCE
DAVID GEORGES DE SOUZA,
FRANCE
JOSEPH PORTIER, FRANCE
JACQUES BONNET, FRANCE
GUY CAMPET, FRANCE
THIERRY NOEL, FRANCE
WO/1999/057264
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A process for the long term
preservation of DNA molecules,
comprising the steps of: extracting and
purifying the DNA; and carrying out an
139465
DNA ‫שיטה לאחסון ממושך של מולקולות‬
‫ואריזות לישום שיטה זו‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
encapsulation of said DNA molecules in a
sealed corrosion proof metallic capsule,
said encapsulation being made under
anoxic and dehumidified conditions.
__________
]11[]21[
213
139466
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ באמצעות‬1–3 ‫שיטה להפקת פרופנדיאול‬
‫אורגניזמים מותמרים המכילים גנים‬
B12 ‫לסנתזה שלו ולהעברת ויטמין‬
]54[
METHOD FOR THE
PRODUCTION OF 1, 3 PROPANEDIOL BY
RECOMBINANT ORGANISMS
COMPRISING GENES FOR ITS
SYNTHESIS AND FOR VITAMIN
B12 TRANSPORT
]22[
]31[
]51[
]71[
06.05.1998
60/085190
]32[ 12.05.1998
]33[ US
Int. Cl.8 C12N 001/15, 001/21, 005/10, 015/31, 015/52, C12P 007/18, C12R 001/19
E.I. DU PONT DE NEMOURS AND
COMPANY, U.S.A.
GENENCOR INTERNATIONAL,
INC., U.S.A.
WO/1999/058686
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A process for the bio-production of
1,3-propanediol comprising:
(i) contacting a transformed host cell with
at least one fermentable carbon source and
an effective amount of vitamin B12
whereby 1,3-propanediol is produced, the
transformed host cell comprising:
(a) at least one copy of a gene encoding a
protein having glycerol or diol dehydratase
activity in the production of 1,3propanediol;
(b) at least one copy of a gene encoding a
protein having an oxidoreductase activity
in the production of 1,3-propanediol;
(c) at least one copy of a gene encoding a
vitamin B12 receptor precursor protein;
(d) at least one copy of a gene encoding a
vitamin B12 transport system permease
protein; and
(e) at least one copy of a gene encoding
vitamin B12 transport ATP- or GTPbinding protein; wherein at least one copy
of any of the genes of (c), (d) or (e) is
introduced into the host cell, and
(ii) recovering the 1,3-propanediol
produced from step (i).
__________
]11[]21[
]54[
IL-6 ANTAGONIST PEPTIDES
AND PHARMACEUTICAL
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
139575
‫ ותכשירי‬IL–6 –‫פפטידים אנטגוניסטיים ל‬
‫רוקחות המכילים אותם‬
214
COMPOSITIONS CONTAINING
THEM
]22[
]31[
]51[
]71[
]87[
]74[
18.05.1999
98108997.2
]32[ 18.05.1998
Int. Cl.8 A61K 038/00, C07K 014/00
LABORATOIRES SERONO SA,
SWITZERLAND
WO/1999/060013
INTERPHARM LABORATORIES
LTD.,
18 HAKISHON ST.,
P.O. B. 151,
YAVNE 81220
[57] An IL-6 antagonist peptide, isolatable
from a peptide library by binding to the
intracellular domain of gp130 in a twohybrid system for detecting protein-protein
interaction, said peptide comprising SEQ
]33[
EP
,‫אינטרפארם מעבדות בע"מ‬
‫ יבנה‬,151 .‫ד‬.‫ ת‬, 18 ‫רחוב הקישון‬
ID NO:6, as well as salts, functional
derivatives, and conservatively substituted
analogs thereof having IL-6 antagonist
activity.
__________
]11[]21[
]54[
USE OF A CPG
OLIGONUCLEOTIDE TO
PREPARE A MEDICAMENT FOR
INDUCING AN ANTIGEN SPECIFIC IMMUNE RESPONSE
]22[
]31[
14.05.1999
60/085516
]32[ 14.05.1998
09/241653
02.02.1999
Int. Cl.8 A61K 039/39, C12N 015/11
COLEY PHARMACEUTICAL
GROUP INC., U.S.A.
COLEY PHARMACEUTICAL
GMBH, GERMANY
WO/1999/058118
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]51[
]71[
]87[
]74[
[57] Use of a CpG oligonucleotide having
at least 8 nucleotides, for the manufacture
of a medicament for inducing an antigenspecific immune response, wherein the
CpG oligonucleotide is to be
215
139646
‫ להכין‬CpG ‫שיטות באוליגונוקלאוטיד מסוג‬
‫תרופה לגרום לתגובה חיסונית לאנטיגן‬
‫ספציפי‬
]33[
US
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
administered to a subject and the subject is
to be exposed to an antigen at least 3 days
after administration of the CpG
oligonucleotide to the subject, to produce
an antigen-specific immune response.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
,187987
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
____________
]11[]21[
140049
‫ הכנתו והשימוש בו‬,‫פוליאורתן ביורפואי‬
]54[
BIOMEDICAL POLYURETHANE,
ITS PREPARATION AND USE
]22[
]31[
]51[
]71[
04.06.1999
98201868.1
]32[ 05.06.1998
]33[
Int. Cl.8 A61L 027/00, C08G 018/42, 018/80
POLYGANICS B.V., THE
NETHERLANDS
WO/1999/064491
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
[57] A biomedical biocompatible
polyurethane based on (i) a diisocyanate
linked polyester polymer component and
(ii) a diol component, said polyurethane
having the formula (-A-B-C-B-)n wherein
A denotes said polyester component, B
denotes said diisocyanate moiety, C
denotes said diol component, n denotes the
number of recurring units, and wherein at
EP
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
least 90% of the diol component, C, have
the same block length, wherein the
polyester component is a random
copolyester component and is a copolyester
component having at least two of a moiety
selected from the group consisting of
lactide, glycolide, trimethylene carbonate
and ε-caprolactone.
__________
]11[]21[
]54[
OPTICAL DISC AND OPTICAL
DISC APPARATUS
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
140202
‫דיסקים אופטיים והתקני דיסקים אופטיים‬
216
]22[
]31[
]51[
]71[
]74[
10.12.2000
P11-352091
]32[ 10.12.1999
Int. Cl.8 G11B 003/90
SONY CORPORATION, JAPAN
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] An optical disc which can be utilized
in a recording operation and in which
positional information is embedded in its
guide grooves irradiated with a light spot,
wherein a synchronization pattern of a
signal obtained by reading the positional
information of the optical disc is different
from a synchronization pattern of another
optical disc in a different format and/or
recording mode, wherein the optical disc
]33[
JP
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
has a recording density different than a
recording density of the other optical disc,
and wherein the synchronization pattern
has a high value for a period of 3T or more
immediately followed by a low value for a
period of 3T or more representing one of a
standard recording density and a high
recording density in which T represents a
signal bit.
__________
]11[]21[
217
140264
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫וירוסים מוחלשים בעלי סיב נגדי בעלי‬
‫פעילות אנטגוניסטית מופרעת לאינטרפרון‬
‫לשימוש בתרכיבי חיסון ובתכשירי רוקחות‬
]54[
ATTENUATED NEGATIVE
STRAND VIRUSES WITH
ALTERED INTERFERON
ANTAGONIST ACTIVITY FOR
USE AS VACCINES AND
PHARMACEUTICALS
]22[
]31[
11.06.1999
60/089103
]32[ 12.06.1998
]33[ US
60/108832
18.11.1998
US
60/117683
29.01.1999
US
Int. Cl.8 A61K 039/12, 039/145, A61P 031/12, 031/16, 035/00, C07K 014/11, C12N
007/01, 007/04, 015/86
MOUNT SINAI SCHOOL OF
MEDICINE OF NEW YORK
UNIVERSITY, U.S.A.
WO/1999/064068
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] An attenuated influenza virus
containing a modified NS1 gene and an
altered interferon antagonist phenotype,
The applications for division
from this application have
not yet been published
wherein the attenuated influenza virus is
NS1/99.
,188362
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
____________
]11[]21[
]54[
PHARMACEUTICAL
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
140778
‫ וגורם‬B ‫תכשירי רוקחות המכילים רכיב‬
218
‫גדילה אנושי‬
COMPOSITIONS COMPRISING
COMPONENT B AND A HUMAN
GROWTH FACTOR
]22[
]31[
]51[
]71[
]87[
]74[
02.07.1999
98112775.6
]32[ 09.07.1998
]33[ EP
Int. Cl.8 A61K 038/17, 038/18, A61P 001/04, 017/02, C07K 014/435, 014/475
LABORATOIRES SERONO SA,
SWITZERLAND
WO/2000/002579
INTERPHARM LABORATORIES
,‫אינטרפארם מעבדות בע"מ‬
LTD.,
‫ יבנה‬,151 .‫ד‬.‫ ת‬, 18 ‫רחוב הקישון‬
18 HAKISHON ST.,
P.O. B. 151,
YAVNE 81220
[57] Use of Component B in combination
with a human growth factor for the
preparation of a composition for promoting
angiogenesis.
__________
]11[]21[
141372
‫שיטה להפרדת ואיפיון פונקציות‬
‫שפוטנציאלית נמצאות בדגימה ביולוגית‬
‫המכילה חומצות גרעין‬
]54[
METHOD FOR SEPARATING AND
CHARACTERISING FUNCTIONS
POTENTIALLY PRESENT IN A
BIOLOGICAL SAMPLE
CONTAINING NUCLEIC ACIDS
]22[
]31[
]51[
11.08.1999
98/10337
]32[ 12.08.1998
]33[ FR
Int. Cl.8 A61K 038/02, C12N 015/10, 015/11, 015/63, C12P 021/02, C12Q 001/68,
C40B 004/00200
PROTEUS (S.A.), FRANCE
WO/2000/009747
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]71[
]87[
]74[
[57] A method for screening a determined
function of at least one transcript or protein
obtained from a nucleic acid sample,
comprising the following steps:
(a) preparing nucleic acid fragments from
said sample,
(b) associating each one of said fragments
219
with a vector molecule;
(c) isolating each fragment associated with
a vector molecule or a part of each
construct composed of a fragment
associated with a vector molecule of step
(b);
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
(d) treating in vitro each fragment
associated with a vector molecule or a part
of each construct composed of a fragment
associated with a vector molecule of step
(c) to obtain transcripts; and
(e) testing a function of the transcripts
obtained in step (d) or proteins encoded
thereby after the translation of said
transcripts.
__________
]11[]21[
141860
‫סטנט בעל תכונות משתנות‬
]54[
STENT WITH VARIABLE
FEATURES
]22[
]31[
]51[
]62[
]71[
]74[
20.07.1997
08/716039
]32[ 19.09.1996
Int. Cl.8 A61F 002/06, A61M 029/00
DIVISION FROM 121345
MEDINOL LTD.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] An expandable stent for treating a
lumen having a unique characteristic along
a portion of the lumen, comprising: a
plurality of interconnected flexible cells
(3), the cells comprising a pair of flexible
connectors (4-7) and arranged in a plurality
of interconnected flexible rows (25)
]33[
US
‫אביב‬-‫ תל‬,‫מדינול בע"מ‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
defining a stent having a proximal end and
a distal end and a longitudinal axis,
wherein at least one of the rows is adapted
to accommodate the unique characteristic
of that portion of the lumen in contact with
the adapted row.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
142157
220
‫התקן מיתוג‬
]54[
PATCH PANEL
]22[
]51[
]71[
]74[
21.03.2001
Int. Cl.8 H01R 009/22
RIT TECHNOLOGIES LTD.
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A one-unit (1U) stacked patch panel
comprising: a lower portion (28) having a
first group of front-side cable connectors
arranged in a lower row and back
connectors (24) arranged in a row adjacent
to said lower row, wherein said lower
portion comprises a carrying plate to hold
said first group of front-side cable
connectors and back connectors and a
‫ תל אביב‬,‫ריט טכנולוגיות בע"מ‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
support plate below said carrying plate; and
an upper portion (27) stacked above said
lower portion, said upper portion having a
second group of front-side cable
connectors (21) arranged in an upper row
above said lower row and back connectors
arranged in a row adjacent to said upper
row, wherein said patch panel has a vertical
height of one standard Unit (1U).
__________
]11[]21[
221
142397
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫תהליך ליצור חומצות קרבוקסיליות‬
‫קירליות מניטרילים בעזרת ניטרילאז או‬
‫מיקוראורגניזמים המכילים גן לניטרילאז‬
]54[
METHOD FOR PRODUCING
CHIRAL CARBOXYLIC ACIDS
FROM NITRILES WITH THE
ASSISTANCE OF A NITRILASE
OR MICROORGANISMS WHICH
CONTAIN A GENE FOR THE
NITRILASE
]22[
]31[
]51[
]71[
03.04.2001
19848129.2
]32[ 19.10.1998
]33[ DE
Int. Cl.8 C12N 001/21, 009/78, 015/55, C12P 007/42, 041/00
BASF AKTIENGESELLSCHAFT,
GERMANY
WO/2000/023577
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] An isolated nucleic acid sequence
which codes for a polypeptide having
nitrilase activity, selected from the group
of:
(a) a nucleic acid sequence having the
sequence depicted in SEQ ID NO:1,
(b) nucleic acid sequences which are
derived from the nucleic acid sequence
depicted in SEQ ID NO:1 as a result of the
degeneracy of the genetic code,
(c) homologs of the nucleic acid sequence
depicted in SEQ ID NO:1, which code for
polypeptides having the at least 98%
homology over the entire sequence range,
to SEQ ID NO:2, with no reduction in the
enzymatic action of the polypeptides.
__________
]11[]21[
]54[
1 - (SUBSTITUTED ALKYL)
TRICYCLIC Δ3-PIPERIDINES,
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
142444
‫–פיפרידינים טריציקליים מותמרים‬Δ3
222
THEIR PREPARATION AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THEM
]22[
]31[
]51[
]71[
]87[
]74[
‫ הכנתם ותכשירי‬,1 ‫באלקיל מותמר בעמדה‬
‫רוקחות המכילים אותם‬
01.10.1999
98203371.4
]32[ 06.10.1998
]33[ EP
Int. Cl.8 A61K 031/4355, 031/4365, A61P 003/10, 015/10, 025/00, 027/06, C07D
491/048, 495/04
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2000/020423
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] A compound of the formula
a N-oxide form, a pharmaceutically
acceptable addition or a stereochemically
isomeric form thereof, wherein:
Alk is C1-6 alkanediyl;
n is 1 or 2;
X is –O-, -S-, -S(=O)- or S(=O)2;
each R1 is independently hydrogen,
halogen, C1-6 alkyl, nitro, hydroxy or C1-4
alkyloxy;
D is a radical of the formula
wherein each m independently is 0, 1 or 2;
each Y independently represents –CH2-, -
O-, -S- or –NR3-;
223
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
R2 and R3 each independently are hydrogen
or C1-6 alkyl; and each R4 independently
represents halo or C1-6 alkyl.
__________
]11[]21[
142619
‫גנים מאשכל של גנים‬
]54[
GENES FROM A GENE CLUSTER
]22[
]31[
16.04.2001
2000-116591 ]32[ 18.04.2000
]33[ JP
2000-117458
19.04.2000
JP
Int. Cl.8 C07K 014/47, C12N 001/15, 009/10, 015/31, 015/54, 015/80
DAIICHI SANKYO COMPANY
LIMITED, JAPAN
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]51[
]71[
]74[
[57] A polynucleotide selected from the
group consisting of:
(a) a polynucleotide encoding a protein
having the amino acid sequence of SEQ ID
NO: 42;
(b) a polynucleotide which comprises the
nucleotide sequence of SEQ ID NO: 41, for
use in accelerating the biosynthesis of ML236B;
(c) a polynucleotide which consists of the
nucleotide sequence of SEQ ID NO:41;
(d) a polynucleotide having at least 80%
identity to a polynucleotide of SEQ ID NO:
41 which retains an ability to accelerate the
synthesis of ML-236B;
(e) a polynucleotide which hybridizes with
a polynucleotide according to (a) to (d)
under stringent conditions, and which is
characterized in accelerating the
biosynthesis of ML-236B in a ML-236B
producing micro-organism when being
introduced in said ML-236B producing
micro-organism; and
(f) a mRNA which can hybridize with a
polynucleotide of (e) under stringent
conditions.
__________
]11[]21[
]54[
SECRETED AND TRANSMEMBRANE
POLYPEPTIDES AND NUCLEIC ACIDS
ENCODING THE SAME
]22[
]31[
01.12.1999
60/112851
60/113145
60/113511
60/115565
60/115558
60/115733
60/119341
]32[
16.12.1998
16.12.1998
22.12.1998
12.01.1999
12.01.1999
12.01.1999
09.02.1999
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
142794
‫פוליפפטידים של טרנסממברנה‬
‫וחומצות גרעין המקדדות לכך‬
]33[
US
US
US
US
US
US
US
224
]51[
]71[
]87[
]74[
60/119537
10.02.1999
US
60/119965
12.02.1999
US
PCT/US99/12252
02.06.1999
WO
Int. Cl.8 C07K 014/47, 014/705, 016/18, 016/46, 019/00, C12N 001/19, 001/21,
005/10, 015/12, 015/62, 015/63, C12P 021/02
GENENTECH, INC., U.S.A.
WO/2000/036102
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
‫תל אביב‬
TEL AVIV 61040
[57] Isolated nucleic acid having at least
80% nucleic acid sequence identity to a
nucleotide sequence that encodes an amino
acid sequence selected from the group
The applications for division
from this application have not
yet been published
consisting of the amino acid sequence
shown in SEQ ID NO:7, SEQ ID NO:9,
SEQ ID NO:11, SEQ ID NO:20, and SEQ
ID NO: 22.
,188581,188580,188579,188578,188577,188576
_____________
]11[]21[
]54[
PREPARATION OF
MEDICAMENTS CONTAINING
ALPHA-AMYLASE INHIBITORS
FOR THE TREATMENT OF
RUMEN ACIDOSIS
]22[
]31[
17.05.2001
0012793.6
]32[ 24.05.2000
0012760.5
24.05.2000
0017495.3
17.07.2000
Int. Cl.8 A01N 001/00, A61K 031/702
PFIZER INC., U.S.A.
]51[
]71[
225
‫בקשות‬
‫חלוקה‬
‫מבקשה זו‬
‫שטרם‬
.‫פורסמו‬
143225
–α ‫הכנת תרופות המכילות מעכבים של‬
‫אמילאז לטיפול של יתר חומציות של‬
‫הכרס הפנימי‬
]33[
GB
GB
GB
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]74[
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] The use of an effective inhibitor of
rumen bacterial alpha-amylase and/or
alpha-glucosidase in the preparation of a
medicament for curative, palliative and
prophylactic treatment of rumen acidosis
and secondary conditions of rumen
acidosis, wherein the inhibitor is selected
from acarbose of the formula
and Trestatins of the formula
wherein N is 1, 2 or 3 and when N=2
represents Trestatin A, N=1represents
Trestatin B, and N=3 represents Trestatin
C, and wherein the rumen acidosis or
secondary condition of rumen acidosis is
selected from: chronic rumen acidosis,
acute rumen acidosis, laminitis, chronic
laminitis, intermittent diarrhoea, poor
appetite and cyclic feed intake, a high herd
cull rate for poorly defined health
The applications for division
from this application have
not yet been published
problems, poor body condition, abscesses
without obvious causes, sole ulceration,
white line lesions, sole haemorrhages,
misshapen hooves, lameness, liver
abscesses, respiratory diseases, reduced
fertility rates, reduced weight gain in beef
cattle, reduced feed conversion in beef
cattle and decreased milk yield and quality
in dairy cattle.
,186223
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
___________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
143420
226
]54[
MONITORING VITAL SIGNS
DURING LABOR
]22[
]51[
]71[
]74[
27.05.2001
Int. Cl.8 A61B 005/04, 005/0444
ELAD YOM-TOV
FENSTER & COMPANY,
INTELLECTUAL PROPERTY LTD.,
12 BASEL ST.,
ENTRANCE 1,
P.O.B. 10256 ,
PETACH TIKVA
[57] A method for monitoring the state of
a pregnancy coincident with uterine
contractions, comprising:
(a) acquiring at least one electrical signal
from a skin surface of a pregnant woman;
‫ניתור סימנים חיונים בשעת לידה‬
51971 .‫נ‬.‫ ד‬,‫טוב‬-‫אלעד יום‬
,‫קניין רוחני בע"מ‬,'‫פנסטר ושות‬
,10256 .‫ד‬.‫ ת‬, ‫ קרית אריה‬,1 ‫ כניסה‬12 ‫בזל‬
‫פתח תקוה‬
(b) deriving a fetal heartbeat representing
the fetal heartbeat from said signal in the
presence of electrical signals caused by
said contractions; and
(c) displaying the fetal heartbeat as an
electrocardiogram (ECG).
__________
]11[]21[
]54[
SUBMUNITION FUZE
COMPATIBLE WITH CARGO
INSENSITIVE MUNITIONS
]22[
]51[
]71[
07.06.2001
Int. Cl.8 F42C 015/184, 015/23
ISRAEL MILITARY INDUSTRIES
LTD.
]72[
AMIR LEVY, ISER VEKSLER, RAN
YERUSHALMI
227
143620
‫מרעום של תת–חימוש המותאים לתחמושת‬
‫מצרר בלתי רגישה‬
‫ רמת‬,‫התעשייה הצבאית לישראל בע"מ‬
‫השרון‬
‫ רן ירושלמי‬,‫ איסר וקסלר‬,‫אמיר לוי‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
[57] A fuze for a submunition having a
slider (4) incorporating a stab detonator
(3), comprising: four separate independent
safety systems, each of which
independently engage the slider and are
released in a specific order, only under
accelerations and forces generated during
conditions of firing followed by expulsion
and separation, including: a set-back
mechanism (12) and means for arming
same; a centrifugal locking mechanism (6),
and means for retracting the centrifugal
locking mechanism; an arming-screw
mechanism (10), and means for activating
same; a stationary safety clip (20), and
means for activating same; and means for
activating the safety systems sequentially,
whereby only by sequentially arming the
set-back mechanism, retracting the
centrifugal locking mechanism and arming
both the arming screw mechanism and the
stationary safety clip while the centrifugal
locking mechanism is still open, will the
fuze be ignited.
]74[
__________
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
228
]11[]21[
]54[
METHOD AND APPARATUS FOR
ELIMINATING CLOCK JITTER IN
CONTINUOUS-TIME DELTASIGMA ANALOG - TO -DIGITAL
CONVERTERS
]22[
]31[
]51[
]71[
14.12.1999
09/211716
]32[ 14.12.1998
Int. Cl.8 H03M 003/00
QUALCOMM INCORPORATED,
U.S.A.
WO/2000/036750
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]87[
]74[
[57] A digital-to-analog converter for
generating an analog signal V as a function
of a received digital signal D, wherein the
converter receives a clock signal having a
first and a second phase and wherein the
converter has a ground, the converter
comprising:
(a) a capacitor (28) coupled to the ground;
(b) a first two-position switch (24) coupled
to the capacitor, the first switch receiving
an analog reference signal that is generated
as a function of the digital signal and
wherein the capacitor is charged with the
229
143648
‫שיטה וציוד לסילוק נידנוד שעון בממירים‬
‫מסוג זמן–רציף דלתא–סיגמה אנלוג‬
‫לדיגיטל‬
]33[
US
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
analog reference signal during the first
phase of the clock signal; and
(c) a second two-position switch (54)
coupled to the capacitor, the second switch
generating the analog signal V by
discharging the capacitor during the second
phase of the clock signal;
wherein the first phase and second phase of
the clock are each long enough to ensure
that minor variations in the clock cycle
have a minimal effect on the integral of a
voltage across the capacitor taken over the
second phase of the clock.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
TRANSPARENT TRANSDERMAL
NICOTINE DELIVERY DEVICES
]22[
]31[
14.12.1999
60/112730
]32[ 18.12.1998
60/124679
16.03.1999
60/126798
30.03.1999
Int. Cl.8 A61K 009/70
ALZA CORPORATION, U.S.A.
WO/2000/037058
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] A device for the transdermal
administration of nicotine comprising a
backing layer, a drug reservoir layer
containing nicotine carried by said backing
layer, and means for maintaining the
device in nicotine transmitting relationship
143778
‫מכשירים שקופים על עוריים למתן ניקוטין‬
]33[
US
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
with the skin, wherein the device is
effective for smoke cessation therapy for
16-24 hours and having transparency
allowing skin color to be visible under the
device under exposure to light.
__________
]11[]21[
143875
‫שיטה עבור הכנה של ציטאלופראם‬
]54[
METHOD FOR THE
PREPARATION OF
CITALOPRAM
]22[
]51[
]71[
]87[
]74[
25.10.1999
Int. Cl.8 A61K 031/343, A61P 025/24, C07D 307/87
H. LUNDBECK A/S, DENMARK
WO/2000/012044
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
[57] A method for the preparation of
citalopram comprising reaction of a
compound of the formula
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
230
wherein R is C1-6 alkyl, acyl, C1-6
alkylsulfonyl or arylsulfonyl, with 3-(N, Ndimethylamino)-propyl magnesium halide,
preferably 3-(N,N-dimethylamino) propyl
magnesium chloride to afford citalopram of
the formula
which is isolated as the base or a
pharmaceutically acceptable salt thereof.
,176943
The applications for
division from this
application have not yet
been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_____________
]11[]21[
143929
‫תולדות אציל לטיפול במחלות הקשורות‬
VLA–4 –‫ב‬
]54[
ACYL DERIVATIVES WHICH
TREAT VLA-4 RELATED
DISORDERS
]22[
]31[
21.01.2000
60/116923
]32[ 22.01.1999
]33[ US
60/160999
21.10.1999
US
Int. Cl.8 A61K 031/505, A61P 007/00, 029/00, C07D 239/28, 401/12, 403/12
ELAN PHARMACEUTICALS, INC.,
U.S.A.
WYETH, U.S.A.
WO/2000/043372
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
231
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
[57] A compound of the formula
wherein, R1 and R2, together with the
carbon atom and W to which they are
bound, respectively, are joined to form a
1,3-pyrimidyl ring that is optionally
substituted with 1-3 substituents
independently selected from amino and
substituted amino groups; wherein
substituted amino refers to the group
-NRR, where each R group is
independently selected from the group
consisting of hydrogen, alkyl, alkenyl,
alkynyl, cycloalkyl, aryl, C1-C4 alkylsubstituted aryl or heteroaryl, heterocyclic,
-SO2-alkyl, -SO2-alkenyl, -SO2-cycloalkyl,
-SO2-aryl, -SO2-heteroaryl, -
SO2heterocyclic, provided that both R
groups are not hydrogen;
R15 is benzyl optionally substituted on the
phenyl ring by –OC(O)NRxRy, wherein Rx
and Ry are independently selected from
hydrogen, alkyl or are cyclized to form,
with the N atom bound thereto, an
optionally methyl substituted piperazine
group;
X is selected from the group consisting of
hydroxyl, alkoxy, and substituted alkoxy;
and
W is a carbon or nitrogen; or a
pharmaceutically acceptable salt or ester
thereof.
__________
]11[]21[
144802
‫שסתום נשיכה לשתיה עם קפיץ אינטגרלי‬
]54[
BITE VALVE FOR DRINKING
WITH INTEGRAL SPRING
]22[
]51[
]71[
08.08.2001
Int. Cl.8 A45F 005/00, B65D 037/00, B67D 003/00, F16K 031/14
SOURCE VAGABOND SYSTEMS
‫ טירת הכרמל‬,‫שורש ערכות נוודים בע"מ‬
LTD.
YORAM GILL
‫יורם גיל‬
MILLER-SIERADZKI,
,‫שרצקי‬-‫מילר‬
P.O.B. 6145,
‫ חיפה‬,6145 .‫ד‬.‫ ת‬, 18‫מחניים‬
HAIFA 31061
]72[
]74[
[57] A bite valve for drinking liquids from
a hydration system, said bite valve
comprising: a hollow deformable
impervious body (52) having a receiving
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
opening fluidically connectable to an outlet
of the hydration system for receiving
liquids and a dispensing opening (56)
adapted to selectively dispense received
232
liquids; a resilient piston (60) positioned
within said hollow deformable body, said
resilient piston comprising a plug (62)
normally blocking said dispensing opening,
and a resilient bifurcated member (64)
having longitudinal dimension and lateral
dimension, adapted to shorten its initial
predetermined longitudinal dimension
when a lateral force is exerted on its lateral
dimension, and regain its initial
longitudinal dimension when the lateral
force is not exerted; a restraining member
being provided inside the body, limiting
the biting portion of the valve to a portion
near the dispensing opening, thus
facilitating better performance of the valve,
whereby when a lateral force is exerted on
said resilient bifurcated member the piston
is retracted inwardly thus allowing liquid to
flow through said dispensing opening.
__________
]11[]21[
145453
‫הכנת תרופות המכילות‬
‫אנטגוניסט של אסטרוגן לטיפול‬/‫אגוניסט‬
‫באוסטאוארתריטיס‬
]54[
PREPARATION OF
MEDICAMENTS CONTAINING
AN ESTROGEN
AGONIST/ANTAGONIST FOR
TREATING OSTEOARTHRITIS
]22[
]31[
]51[
]71[
]74[
13.09.2001
60/234398
]32[ 21.09.2000
]33[ US
Int. Cl.8 A61K 031/138, 031/454, 045/00
PFIZER PRODUCTS, INC., U.S.A.
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] Use of a therapeutically effective
amount of an estrogen agonist/antagonist
of the formula
233
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
in the preparation of a medicament for
treating osteoarthritis, wherein:
A is CH2;
B, D and E are CH;
Y is (a) phenyl, optionally substituted with
1-3 substituents independently selected
from R4;
(b) naphthyl, optionally substituted with 13 substituents independently selected from
R4;
(c) C3-C8 cycloalkyl, optionally substituted
with 1-2 substituents independently
selected from R4;
(d) C3-C8 cycloalkenyl, optionally
substituted with 1-2 substituents
independently selected from R4;
(e) a five membered heterocycle containing
up to two heteroatoms selected from the
group consisting of –O-, -NR2- and –S(O)n, optionally substituted with 1-3
substituents independently selected from
R4;
(f) a six membered heterocycle containing
up to two heteroatoms selected from the
group consisting of –O-, -NR2- and –S(O)noptionally substituted with 1-3 substituents
independently selected from R4; or
(g) a bicyclic ring system consisting of a
five or six membered heterocyclic ring
fused to a phenyl ring, said heterocyclic
ring containing up to two heteroatoms
selected from the group consisting of –O-, NR4- and –S(O)n-, optionally substituted
with 1-3 substituents independently
selected from R4;
Z1 is (a) –(CH2)pW(CH2)q-;
(b) –O(CH2)pCR5R6-;
(c) –O(CH2)pW(CH2)q;
(d) –OCHR2CHR3; or
(e) –SCHR2CHR3-;
G is (a) –NR7R8;
(b)
wherein n is 0, 1 or 2; m is 1, 2 or 3; Z2 is –
NH-, -O-, -S-, or –CH2-; optionally fused
on adjacent carbon atoms with one or two
phenyl rings and, optionally independently
substituted on carbon with one to three
substituents and, optionally, independently
on nitrogen with a chemically suitable
substituent selected from R4; or
(c) a bicyclic amine containing five to
twelve carbon atoms, either bridged or
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
234
fused and optionally substituted with 1-3
substituents independently selected from
R4; or
Z1 and G in combination may be
W is (a) –CH2-;
(b) –CH=CH-;
(c) –O-;
(d) –NR2-;
(e) –S(O)n-;
(g) –CR2(OH)-;
(h) –CONR2-;
(i) –NR2CO-;
(k) -C≡C-;
R is hydrogen or C1-C6 alkyl;
R2 and R3 are independently
(a) hydrogen; or
(b) C1-C4 alkyl;
R4 is (a) hydrogen;
(b) halogen;
(c) C1-C6 alkyl;
(e) C1-C4 acyloxy;
(f) C1-C4 alkylthio;
(g) C1-C4 alkylsulfinyl;
(h) C1-C4 alkylsulfonyl;
(i) hydroxyl (C1-C4) alkyl;
(j) aryl (C1-C4) alkyl;
(k) –CO2H;
(l) –CN;
(m) –CONHOR;
(n) –SO2NHR;
(o) –NH2;
(p) C1-C4 alkylamino;
(q) C1-C4 dialkylamino;
(r) –NHSO2R;
(s) –NO2;
(t) –aryl; or
(u) –OH;
R5 and R6 are independently C1-C8 alkyl or
together form a C3-C10 carbocylic ring;
R7 and R8 are independently
(a) phenyl;
(b) a C3-C10 carbocyclic ring, saturated or
unsaturated;
(c) a C3-C10 heterocyclic ring containing up
to two heteroatoms, selected from –O-, -Nand –S-;
(d) H;
(e) C1-C6 alkyl; or
(f) form a 3 to 8 membered nitrogen
containing ring with R5 or R6;
235
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
R7 and R8 in either linear or ring form may
optionally be substituted with up to three
substituents independently selected from
C1-C6 alkyl, halogen, alkoxy, hydroxy and
carboxy;
a ring formed by R7 and R8 may be
optionally fused to a phenyl ring;
e is 0, 1 or 2;
m is 1, 2 or 3;
n is 0, 1 or 2;
p is 0, 1, 2 or 3;
q is 0, 1, 2 or 3;
or an optical or geometric isomer thereof;
or a pharmaceutically acceptable salt, Noxide, ester, or quaternary ammonium salt
thereof.
__________
]11[]21[
]54[
ISOLATION OF CDNA ENCODING
FOR SECRETED OR
MEMBRANAL PROTEINS
]22[
]31[
]51[
]71[
24.03.2000
60/125975
]32[ 24.03.1999
Int. Cl.8 C12Q 001/68
QUARK PHARMACEUTICALS,
INC., U.S.A.
WO/2000/056935
JUDITH ABRAHAMS,
P.O.B. 4071,
NES ZIONA 70400
]87[
]74[
[57] A method of identifying clones
obtained from a cell type or tissue which
encode membranal or secreted proteins,
comprising the steps of:
(a) preparing cell fractionations obtained
from a cell type or tissue;
(b) isolating membrane bound polysomes
and free polysomes from the cell
fractionations;
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
145539
‫ המקודד לחלבונים‬cDNA ‫בידוד של‬
‫מופרשים או מברנליים‬
]33[
US
,‫ מפעלים בע"מ‬.‫אי‬.‫בי‬.‫ קיו‬,‫יהודית אברהמס‬
‫ נס ציונה‬,4071 .‫ד‬.‫ ת‬,
(c) extracting intact total RNA from
membrane bound polysomes and free
polysomes, respectively;
(d) preparing cDNA probes from template
RNA derived from the respective extracted
polysomes;
(e) hybridizing cDNA probes to a DNA
microarray;
236
(f) performing microarray-based
comparison of the relative abundance of
the different RNA species;
(g)analyzing the results according to
conditional probabilities; and
(h) identifying genes or clones encoding
membranal or secreted proteins.
__________
]11[]21[
‫רצף של פוליניוקליאוטיד המשתמש‬
‫בהליקייס‬
]54[
POLYNUCLEOTIDE
SEQUENCING USING A
HELICASE
]22[
]31[
]51[
]71[
06.04.2000
9907812.3
]32[ 06.04.1999
Int. Cl.8 C12Q 001/533, 001/68
MEDICAL BIOSYSTEMS LTD.,
UNITED KINGDOM
WO/2000/060114
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
145579
[57] A method for sequencing a
polynucleotide, comprising the steps of:
(i) reacting a target polynucleotide with a
helicase/primase enzyme, under conditions
suitable for enzyme activity; and
]33[
GB
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
(ii) detecting the interaction between the
enzyme and a nucleotide on the target, by
measuring radiation.
__________
]11[]21[
]54[
PRODUCTION OF PANCREATIC
PROCARBOXY-PEPTIDASE B,
ISOFORMS AND MUTEINS
THEREOF
]22[
]31[
]51[
]71[
23.03.2000
19915938.6
]32[ 09.04.1999
Int. Cl.8 C12N 009/48, C12P 021/02
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2000/061727
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
237
145646
B ‫ייצור של פרוקרבוקסי–פפטידאז‬
‫ איזופורמים ומוטאינים‬,‫מהפנקריאס‬
‫שלהם‬
]33[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
[57] A process for the preparation of
mature insulin or a mature insulin
derivative, where
(a) a natural or unnatural precursor form of
carboxypeptidase B or an isoform or a
mutein of carboxypeptidase B is expressed
in a microorganism by secretion,
(b) the precursor form expressed by
secretion is purified and
(c) the purified precursor form is converted
into the active carboxypeptidase B or the
isoform or the mutein of carboxypeptidase
B by means of an enzymatic treatment,
where step (c) proceeds under suitable
reaction conditions in the presence of an
insulin precursor form comprising the B, C
and A chains of insulin or of an insulin
derivative and in this process mature
insulin or a mature insulin derivative is
formed, which is isolated from the reaction
mixture.
__________
]11[]21[
]54[
DIFFERENTIALLY ACTING OP
DETOXIFYING SPONGES
]22[
]31[
]51[
]71[
26.04.2000
60/130988
]32[ 26.04.1999
Int. Cl.8 C08G 018/00
U.S. ARMY MEDICAL RESEARCH
AND MATERIAL COMMAND,
U.S.A.
WO/2000/064957
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] A reusable polymeric sponge or foam
for the detoxification of a diverse array of
organophosphorus and/or organosulfur
compounds comprising a plurality of
enzymes or a cross-linked enzyme complex
of said plurality of enzymes immobilized
on the sponge or foam, said plurality of
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
146192
‫ספוגים נוטלי רעל אורגאנו–פוספט בעלי‬
‫פעולה דיפרנציאלית‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
enzymes comprising multiple-enzymes
selected from the group consisting of
acetylcholinesterase (AChE),
butyrylcholinesterase (BChE), triesterase,
pseudocholinesterase, choline oxidase,
peroxidase, organophosphate hydrolase
(OPH), phosphotriesterase, paraoxonase,
238
and laccase and an indicator embedded in
the sponge or foam for measuring the
capacity of the sponge or foam for
detoxification of organophosphorus and/or
organosulfur compounds, wherein the
indicator is fluorescent, chemilimunescent
or visible chromogen or is an electrode,
and said indicator is encapsulated in a
liposome or is in a crushable packet.
__________
]11[]21[
146309
‫נגזרות מטיפוס אינדול ותכשירי רוקחות‬
p38 ‫המכילים אותן כמעכבים של קינאז‬
]54[
INDOLE-TYPE DERIVATIVES
AND PHARMACEUTICAL
COMPOSITIONS COMPRISING
THEM AS INHIBITORS OF P38
KINASE
]22[
]31[
19.05.2000
316761
]32[ 21.05.1999
]33[ US
60/154594
17.09.1999
US
60/202608
09.05.2000
US
Int. Cl.8 A61K 031/395, A61P 043/00, C07D 401/12, 403/12, 405/12, 413/12
SCIOS INC., U.S.A.
WO/2000/071535
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A compound of the formula
239
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
or a pharmaceutically acceptable salt
thereof, or a pharmaceutical composition
thereof, wherein
represents a single or double bond;
one Z2 is CA or CR8A and the other is CR1,
CR12, NR6 or N
wherein each R1 is independently hydrogen
or is selected from the group consisting of
alkyl, alkenyl, alkynyl, aryl, arylalkyl, acyl,
aroyl, heteroaryl, heteroalkyl,
heteroalkenyl, heteroalkynyl,
heteroalkylaryl, NH-aroyl, halo, OR, NR2,
SR, SOR, SO2R, OCOR, NRCOR,
NRCONR2 NRCOOR, OCONR2, RCO,
COOR, alkyl- OOCR, SO3R, CONR2,
SO2NR2, NRSO2NR2, CN, CF3, R3Si, and
NO2, wherein each R is independently H,
alkyl, alkenyl, or aryl or the heteroatomcontaining forms thereof;
R6 is H, alkyl, alkenyl, alkynyl, aryl,
arylalkyl, acyl, aroyl, heteroalkyl,
heteroalkenyl, heteroalkynyl,
heteroalkylaryl, or heteroaryl, or is SOR,
SO2R, RCO, COOR, alkyl COR, SO3R,
CONR2, SO2NR2, CN, CF3 or R3Si wherein
each R is independently H, alkyl, alkenyl
or aryl or the heteroarom-containing forms
thereof;
R8 is H, halo, alkyl or alkenyl;
A is –Wi-COXJY wherein Y is COR2
wherein R2 is hydrogen or is straight or
branched chain alkyl, heteroalkyl, alkenyl,
alkynyl, aryl, arylalkyl, heteroaryl, or
heteroarylalkyl, each optionally substituted
with halo, alkyl, heteroalkyl, SR, OR, NR2,
OCOR, NRCOR NRCONR2, NRSO2R,
NRSO2NR2, OCONR2, CN, COOR,
CONR2, COR, or R3Si wherein each R is
independently H, alkyl, alkenyl or aryl or
the heteroatom-containing forms thereof,
or wherein R2 is OR, SR, NR2,
NRCONR2, OCONR2, NRSO2NR2,
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
heteroarylalkyl, COOR, NRNR2,
heteroaryl-COOR, heteroaryloxy,
heteroaryl-NR2, or NROR wherein each R
is independently H, alkyl, alkenyl or aryl,
or the heteroatom-containing forms thereof
and wherein two R attached to the same N
atom may form a 3-8 member ring wherein
said ring may further be substituted by
alkyl, heteroalkyl, alkenyl, alkynyl, aryl,
arylalkyl, heteroaryl, heteroarylalkyl, each
optionally substituted with halo, SR, OR,
NR2, OCOR, NRCOR, NRCONR2,
NRSO2R, NRSO2NR2, OCONR2, or R3Si
wherein each R is independently H, alkyl,
alkenyl or aryl or the heteroatomcontaining forms thereof, and wherein two
R attached to the same N atom may form a
3-8 member ring, optionally substituted as
above defined,
or Y is tetrazole, 1,2,3-triazole; 1,2,4triazole; or imidazole, each of which is
optionally substituted with Br, NO2, SCH3,
COCH3, SOCH3, or SO2CH3;
each of W and X is substituted or
unsubstituted alkylene, alkenylene or
alkynylene, each of 2-6Å;
and each of i and j is independently 0 or 1;
Z3 is NR7 or O;
R7 is H or is optionally substituted alkyl,
alkenyl, alkynyl, aryl, arylalkyl, acyl,
aroyl, heteroaryl, heteroalkyl,
heteroalkenyl, heteroalkynyl, or
heteroalkylaryl, or is SOR, SO2R, RCO,
COOR, alkyl-COR, SO3R, CONR2,
SO2NR2, CN, CF3, NR2, OR, alkyl-SR,
alkyl-SOR, alkyl-SO2R, alkyl-OCOR,
alkyl-COOR, alkyl-CN, alkyl-CONR2, or
R3Si, wherein each R is independently H,
alkyl, alkenyl, or aryl or heteroforms
thereof,;
each R3 is independently halo, alkyl,
OCOR, OR, NRCOR, SR, OR or, NR2,
240
wherein R is H, alkyl or aryl or the
heteroatom-containing forms thereof;
n is 0-3;
L1 is CO, SO, SO2CHOH, or alkylene (14C);
L2 is alkylene (1-4C) or alkenylene (2-4C)
optionally substituted with one or two
moieties selected from the group consisting
of alkyl, alkenyl, alkynyl, aryl, arylalkyl,
acyl, aroyl, heteroaryl, heteroalkyl,
heteroalkenyl, heteroalkynyl,
heteroalkylaryl, NH-aroyl, halo, OR, NR2,
SR, SOR, SO2R, OCOR, NRCOR,
NRCONR2 NRCOOR, OCONR2, RCO,
COOR, alkyl-OOCR, SO2R, CONR2,
SO2NR2, NRSO2NR2, CN, CF3, R3Si, and
NO2, wherein each R is independently H,
alkyl, alkenyl or aryl or the heteroatomcontaining forms thereof, and wherein two
substituents on L2 can be joined to form a
non-aromatic saturated or unsaturated ring
that includes 0-3 heteroatoms which are O,
S and/or N and which contains 3 to 8
members or said two substituents can be
joined to form a carbonyl moiety or an
oxime, oximeether, oximeester or ketal of
said carbonyl moiety;
each R4 is independently selected from the
group consisting of alkyl, alkenyl, alkynyl,
aryl, arylalkyl, acyl, aroyl, heteroaryl,
heteroalkyl, heteroalkenyl, heteroalkynyl,
heteroalkylaryl, NH-aroyl, halo, OR, NR2,
SR2, SR, SOR, SO2R, OCOR, NRCOR,
NRCONR2, NRCOOR, OCCNR2, RCO,
COOR, alkyl-OOCR, SO3R, CONR2,
SO2NR2, NRSO2NR2, CN, CF3, R3Si and
NO2, wherein each R is independently H,
alkyl, alkenyl or aryl or the heteroatom-
containing forms thereof, and two of R4 on
adjacent positions can be joined to form a
fused, optionally substituted aromatic or
nonaromatic, saturated or unsaturated ring
which contains 3-8 members, or R4 is =O
or an oxime, oximeether, oximeester or
ketal thereof;
m is 0-4;
Z1 is CR5 or N wherein R5 is hydrogen or
halo, alkyl, alkoxy, aryl, arylalkyl, aryloxy,
heteroaryl, acyl, carboxy, or NR2, OR or
SR where R is H or alkyl, and where R5
can be joined with an R4 substituent to
form an optionally substituted nonaromatic saturated or unsaturated ring
which contains 3-8 members and 0-3
heteroatoms chosen from N, O and S;
each of l and k is an integer from 0-2
wherein the sum of l and k is 0-3;
Ar is an aryl group substituted with 0-5
substituents selected from the group
consisting of alkyl, alkenyl, alkynyl, aryl,
arylalkyl, acyl, aroyl, heteroaryl,
heteroalkyl, heteroalkenyl, heteroalkynyl,
heteroalkylaryl, NH-aroyl, halo, OR, NR2,
SR, SOR, SO2R, OCOR, NRCOR,
NRCONR2, NRCOOR, OCONR2, RCO,
COOR, alkyl-OOCR, SO3R, CONR2,
SO2NR2, NRSO2NR2, CN, CF3, R3Si, and
NO2, wherein each R is independently H,
alkyl, alkenyl or aryl or the heteroatomcontaining forms thereof, and wherein two
of said optional substituents on adjacent
positions can be joined to form a fused,
optionally substituted aromatic or
nonaromatic, saturated or unsaturated ring
which contains 3-8 members.
__________
]11[]21[
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
ECTEINASCIDIN 743
]22[
]31[
15.05.2000
9911183.3
241
]32[
13.05.1999
146434
‫תכשירי רוקחות המכילים אקטינאסידין‬
347
]33[
GB
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]51[
]71[
]87[
]74[
9911346.6
14.05.1999
9918534.0
05.08.1999
9927005.0
15.11.1999
9927106.6
16.11.1999
0007637.2
29.03.2000
Int. Cl.8 A61K 003/600000 031/495, 035/00
PHARMA MAR, S.A., SPAIN
WO/2000/069441
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] The use of ET743 in the preparation
of a pharmaceutical composition for the
treatment of the human body for cancer,
wherein the ET743 is formulated to be
GB
GB
GB
GB
GB
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
provided in cycles by intravenous infusion
at intervals of 1 to 6 weeks with an
infusion time of 2 to 24 hours, leading to
clinical improvement.
__________
]11[]21[
]54[
SIGNAL PROCESSING FOR
OBJECT DETECTION SYSTEM
]22[
]31[
25.05.2000
09/318196
]32[ 25.05.1999
09/346857
02.07.1999
Int. Cl.8 G01S 013/88
SAFE ZONE SYSTEMS, INC., U.S.A.
WO/2000/075892
EITAN MEHULAL LAW GROUP,
10 ABBA EBEN BLVD.,
P.O. BOX 2081
HERZLIYA 46120
]51[
]71[
]87[
]74[
[57] A method of detecting an object, the
method comprising the steps of:
illuminating a target person with
horizontally polarized radiation over a
band of frequencies; collecting radiation
reflected from said target which has a
polarization which is the same as the
radiation used to illuminate said target;
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
146734
‫עיבוד–אות עבור מערכת לאיתור עצמים‬
]33[
US
US
‫ עורכי‬- ‫ מהולל עורכי דין‬- ‫קבוצת איתן‬
,‫פטנטים‬
‫ הרצליה‬,2081 .‫ד‬.‫ ת‬, 10 ‫שדרות אבא אבן‬
collecting radiation reflected from said
target which has a polarization that is
orthogonal to that of said radiation which is
used to illuminate said target; calculating a
difference between a collected radiation
level of radiation reflected from said target
which has a polarization that is orthogonal
to that of said radiation which is used to
242
illuminate said target and a predetermined
average radiation level, which, if positive,
indicates that the object is present; and
calculating one or more differences
between collected radiation levels and
predetermined average radiation levels,
which, if positive, indicates that there is a
false alarm.
,171814
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________
]11[]21[
146851
– 1 –‫– פירוזלינים המותמרים ב‬2 ‫– אריל‬5
‫ כמעכבי‬3 – )‫ – סולפאמילריל‬4(
2 –‫ציקלוקסיגינאס‬
]54[
1 - (4-SULFAMYLARYL) - 3 SUBSTITUTED - 5 - ARYL - 2 PYRAZOLINES AS INHIBITORS
OF CYCLOOXYGENASE - 2
]22[
]31[
]51[
]71[
16.06.2000
60/139416
]32[ 16.06.1999
]33[ US
Int. Cl.8 A61K 031/415, C07D 231/00, 231/06, 403/04
TEMPLE UNIVERSITY-OF THE
COMMONWEALTH SYSTEM OF
HIGHER EDUCATION, U.S.A.
WO/2000/076503
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]87[
]74[
[57] A compound of the formula:
243
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
wherein: X is trifluoromethyl; and
Z is a substituted or unsubstituted aryl
group other than substituted or
unsubstituted phenyl; and wherein aryl
includes aromatic carbocyclic systems, and
also aromatic systems containing one or
more non-carbon atoms as ring atoms, said
systems containing one, two or three rings
which may be attached together in a
pendent manner, or which may be fused; or
a pharmaceutically acceptable salt of such
a compound.
__________
]11[]21[
]54[
THERAPEUTIC VEHICLE
INTEGRAL WITH A CELL
CULTURE SURFACE FOR
REVERSIBLE CELL
ATTACHMENT
]22[
]31[
]51[
]71[
23.06.2000
9914616.9
]32[ 23.06.1999
Int. Cl.8 C12N 005/00
CELLTRAN LIMITED, UNITED
KINGDOM
WO/2000/078928
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A therapeutic vehicle for use in tissue
engineering wherein said vehicle has
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
146933
‫נשא רוקחי הוכלל משטח תאי תרכיב‬
‫להדבקה הפוכה של תאים‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
integral therewith, or applied thereto, a cell
culture surface obtained by plasma
244
polymerization, to which at least one cell
can reversibly attach characterized in that
the surface contains an acid functionality of
at least 5%.
__________
]11[]21[
]54[
MONO- AND DISUBSTITUTED 3PROPYL GAMMAAMINOBUTYRIC ACIDS
]22[
]31[
]51[
]71[
31.05.2000
60/138485
]32[ 10.06.1999
Int. Cl.8 C07C 229/00
WARNER-LAMBERT COMPANY
LLC, U.S.A.
WO/2000/076958
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
146969
‫מונו וחומצות אמינובוטיריות דו–מותמרות‬
‫–פרופיל גאמא‬3 ‫של‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A compound of the formula
R2 is straight or branched alkyl of from 1 to
8 carbon atoms; and the stereochemistry is
(3S, 5R);
with the proviso that R2 is not methyl or
ethyl.
or a pharmaceutically acceptable salt
thereof wherein:
R1 is hydrogen;
__________
]11[]21[
]54[
NEEDLELESS SYRINGE
OPERATING WITH AN IMPACT
WAVE GENERATOR THROUGH
A WALL
]22[
]31[
30.06.2000
99/09255
245
]32[
16.07.1999
147267
‫מזרק ללא מחט הפועל עם מחולל גלים‬
‫דרך דופן‬
]33[
FR
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]51[
]71[
]87[
]74[
Int. Cl.8 A61M 005/00, 005/30
CROSSJECT, FRANCE
WO/2001/005451
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
[57] A needleless syringe for injecting an
active principle, comprising: a propelling
system including a shock wave generator
device (3); an application guide (8) for
applying said syringe to the skin of the
subject to be treated; and a resistant barrier
(4) which ensures a good propagation of
the shock wave, located entirely within the
application guide, comprising an upstream
face and downstream face, said
downstream face having at least one blind
cavity in which the active principle is
accommodated, the resistant barrier
remaining fixed within the syringe or
trapped in the syringe without any
possibility of being expelled, wherein the
shock wave generator device is in contact
with the upstream face of the barrier.
__________
]11[]21[
]54[
BENZOFURAN DERIVATIVES
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
147494
‫תולדות בנזופורן‬
246
]22[
]31[
]51[
]71[
]87[
]74[
29.06.2000
19932314.3
]32[ 10.07.1999
]33[ DE
Int. Cl.8 A61K 031/34, 031/42, A61P 025/00, C07D 405/00, 405/02
MERCK PATENT GMBH,
GERMANY
WO/2001/004112
EITAN, MEHULAL, PAPPO,
,‫ קוגלר‬,‫ פאפו‬,‫ מהולל‬,‫איתן‬
KUGLER,
‫ הרצליה‬,11‫המנופים‬
11 HAMENOFIM ST.,
HERZLIYA 46120
[57] A benzofuran derivative of the formula
wherein R is 1-piperazinyl, 4-R1piperazinyl or L,
R' is 2-R2 -5-R3 –pyrrol-l-ylcarbonyl, 4-R4piperazin-1-ylcarbonyl, N,N-di(tertbutyloxycarbonyl) aminocarbonyl, CH=C(R5 R6), benzofuran-2-yl-C≡C-,
C(Hal)3, -CO-C(Hal)3, 1,4dihydrobenzo[d][1,2]oxazin-3-ylcarbonyl
or 3,4-dihydrobenzo-1H-phthalazin-2ylcarbonyl,
L is Cl, Br, I or an OH or a reactive
functionally modified OH group,
R1, R4 in each case independently of one
another are H, benzyl or another amino
protective group,
R2, R3 in each case independently of one
another are H or alkyl having 1-6C atoms,
R5, R6 in each case independently of one
another are alkyl having 1-6 C atoms, and
Hal is F, Cl, Br or I, or a salt thereof.
__________
]11[]21[
147523
‫שיטה והרכב לשיפור תכונות מניעת‬
‫העברת גז של מיכלים ושכבות פולימרים‬
]54[
METHOD AND COMPOSITION
FOR IMPROVING GAS BARRIER
PROPERTIES OF POLYMERIC
CONTAINERS AND FILMS
]22[
]31[
10.08.2000
60/148537
]32[ 12.08.1999
]33[ US
09/634288
09.08.2000
US
Int. Cl.8 B65D 065/38, C08K 005/09, 005/134
ADVANSA BV,
WO/2001/012521
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]71[
]87[
]74[
247
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
[57] A method for reducing gas
permeability of shaped thermoplastic
polymeric articles wherein the polymer
from which the article is formed is selected
from the group consisting of polyesters,
polycarbonates, polyetherimides and
polyethersulfones and wherein the method
comprises the steps of: (1) incorporating
into the polymer an amount of a barrierenhancing additive or a mixture of barrierenhancing additives effective to reduce gas
permeability and selected from the group
consisting of:
(a) monoesters of hydroxybenzoic acid and
hydroxynaphthoic acid of the formula
wherein R is C1-C4 alkyl, benzyl, phenyl or
naphthyl;
Ar is substituted or unsubstituted
phenylene or naphthylene; or formula (AA)
where M is a cation such as, but not limited
to, sodium, ammonium, tetraalkyl
ammonium, potassium, calcium,
magnesium or zinc;
(b) diesters of hydroxybenzoic acid of the
formula
wherein Ar is as defined above, and R1 is
C1-C4 alkyl (CH2CH2O)kCH2CH2 where k
is 1 or more, benzyl, phenyl or naphthyl; or
formula (BB) where M is as defined above;
(c) monoamides of hydroxybenzoic acid
and hydroxynaphthoic acid of the formula
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
248
wherein R and Ar are as defined above; or
formula (CC) where M is as defined above;
(d) diamides of hydroxybenzoic acid of the
formula
wherein Ar is as defined above, and R2 is
C1-C4 alkyl, (CH2CH2O)kCH2CH2 where k
is 1 or more, benzyl, phenyl or naphthyl; or
formula (DD) where M is as defined
above; and
(e) ester-amides of hydroxybenzoic acid of
the formula
where Ar is as defined above and R3 is C1C4 alkyl, C1-C8 dialkyl,
(CH2CH2O)kCH2CH2 where k is 1 or
greater, benzyl, phenyl or naphthyl, or
formula (EE) where M is as defined above
by first forming a physical mixture
comprising the polymer and one or more of
the gas barrier enhancing additives, (2)
heating the mixture to a temperature
sufficiently high to melt the polymer but
low enough to maintain the one or more
gas barrier enhancing additives
substantially in its or their original
molecular form, and (3) forming the article.
__________
249
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
INFORMATION CARRIER AND
DEVICES FOR SCANNING THE
INFORMATION CARRIER
]22[
]31[
]51[
]71[
25.04.2001
00201728.3
]32[ 16.05.2000
Int. Cl.8 G11B 007/007
KONINKLIJKE PHILIPS
ELECTRONICS N.V., THE
NETHERLANDS
WO/2001/088908
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] An information carrier comprising a
recording area for writing patterns (40)
which represent user information and
header areas (3) comprising patterns which
represent header information, said
recording area comprising synchronization
areas which comprise a predetermined
synchronization pattern for synchronizing a
clock frequency in a device in which the
information carrier is used, the user
information being converted into patterns
in de recording area according to a (1,7)
Run Length Limited modulation code, the
predetermined synchronization pattern
being composed of marks and of spaces
between the marks and the length of each
mark and each space being expressed as a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
147610
‫נשא של מידע והתקנים לסריקת הנשא‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
number of channel bit lengths (T),
characterized in that the predetermined
synchronization pattern comprises a first
part containing marks having a length of 2
times the channel bit length and spaces
having a length of 2 times the channel bit
length and spaces having a length of 2
times the channel bit length, and also
comprises a second part containing marks
having a length of 5 times the channel bit
length and spaces having a length of 5
times the channel bit length, and also
comprises a third part containing marks
having a length of 3 times the channel bit
length and spaces having a length of 3
times the channel bit length.
250
The applications for division
from this application have
not yet been published
,182995,182994
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
___________
]11[]21[
147924
– ‫תולדות ארילמתיל – קרבוניל אמינו‬
‫תיאזול והשימוש בהם בטיפול במחלות‬
‫התרבות תאים הקשורים לפעילות קינאז‬
‫חריגה‬
]54[
ARYLMETHYL CARBONYLAMINO - THIAZOLE
DERIVATIVES AND THEIR USE
IN CELL PROLIFERATIVE
DISORDERS ASSOCIATED WITH
AN ALTERED CELL DEPENDENT
KINASE ACTIVITY
]22[
]31[
]51[
]71[
]87[
]74[
11.08.2000
09/372832
]32[ 12.08.1999
]33[ US
Int. Cl.8 A61K 031/427, A61P 035/00, C07D 277/48, 417/12, 417/14, 451/14
PFIZER ITALIA S.R.L., ITALY
WO/2001/014353
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] Compounds of the formula
251
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
wherein L is a phenyl group or a 5 or 6membered aromatic heterocycle with one
or more heteroatoms selected from the
group consisting of nitrogen, oxygen and
sulfur;
R1 is a hydrogen atom or a straight or
branched C1-C4 alkyl group optionally
substituted with one or more hydroxy,
alkoxy, amino, alkylamino, or
dialkylamino group;
R2 and R3, which may be the same or
different, are a hydrogen atom, a cycloalkyl
group, a straight or branched C1-C6 alkyl
group or an aryl group, which are each
optionally substituted as described above
for R; or
R2 and R3, together with the nitrogen atom
to which they are bonded, form a 4-
morpholinyl, 1-piperazinyl, N-alkylpiperazinyl, N-aryl-piperazinyl, Narylalkyl-piperazinyl, piperidinyl,
pyrrolidinyl, 2-oxo-1-pyrrolidinyl,
imidazolyl or 3-azabicyclo[3.2.2]nonyl
ring;
R4 is carboxy, a perfluorinated alkyl group,
a C2-C4 alkenyl group, C2-C4 alkynyl
group, 2-oxo-pyrrolidinyl, piperidinyl or a
straight or branched C1-6 alkyl group or an
aryl group, which is optionally substituted
as described above for R;
or a pharmaceutically acceptable salt
thereof for the preparation of a medicament
for treatment of cell proliferative disorders
associated with an altered cell dependent
kinase activity, substantially as described
in the specification.
__________
]11[]21[
]54[
HUMAN ROTAVIRUS
POPULATION AND A VACCINE
COMPRISING THE SAME
147926
‫אוכלוסיית רןטאוירוס אנושי וחיסון המכיל‬
‫אותה‬
]22[
]31[
15.08.2000
9919468.0
]32[ 17.08.1999
]33[ GB
9927336.9
18.11.1999
GB
]51[ Int. Cl.8 A61K 039/00, 039/15, C12N 007/00
]71[ SMITHKLINE BEECHAM
BIOLOGICALS S.A., BELGIUM
]87[ WO/2001/012797
]74[ REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] An attenuated human rotavirus
nucleotide sequence encoding at least one
population, characterized in that it
of the major viral proteins designated as
comprises a single variant or substantially a
VP4 and VP7.
single variant, said variant defined by a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
252
,188686
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
____________
]11[]21[
]54[
OXAZOLE AND THIAZOLE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
]51[
]71[
19.09.2000
60/155400
]32[ 22.09.1999
Int. Cl.8 C07D 413/00
BRISTOL-MYERS SQUIBB
COMPANY, U.S.A.
WO/2001/021602
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
147939
‫תולדות אוקסאזול ותיאזול ותכשירי‬
‫רוקחות המכילים אותן‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
[57] A compound of the formula
wherein x is 1, 2, 3 or 4; m is 1 or 2; n is 1
or 2;
Q is C or N;
A is O or S;
Z is O or a bond;
R1 is H or lower alkyl;
X is CH;
R2 is H, alkyl, alkoxy, halogen, amino or
substituted amino;
R2a, R2b and R2c are the same or different
and are selected from H, alkyl, alkoxy,
halogen, amino or substituted amino;
R3 is aryloxycarbonyl, alkyloxycarbonyl,
253
alkynyloxycarbonyl, alkenyloxycarbonyl,
alkyl(halo)aryloxycarbonyl,
alkyloxy(halo)aryloxycarbonyl,
cycloalkylaryloxycarbonyl,
cycloalkyloxycaryloxycarbonyl,
alkylcarbonylamino, arylcarbonylamino,
heteroarylcarbonylamino,
alkoxycarbonylamino,
aryloxycarbonylamino,heteroaryloxycarbonylamino, alkylsulfonyl, alkenylsulfonyl,
heteroaryloxycarbonyl,
cycloheteroalkyloxycarbonyl,
heteroarylalkenyl, hydroxyalkyl, alkoxy,
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
alkoxyaryloxycarbonyl,
arylalkyloxycarbonyl,
alkylaryloxycarbonyl, alkynyloxycarbonyl,
haloalkoxyaryloxycarbonyl,
aryloxyaryloxycarbonyl,
alkoxycarbonylaryloxycarbonyl,
heteroaryloxyarylalkyl,
aryloxyarylalkyloxycarbonyl,
arylalkenyloxycarbonyl,
aryloxyalkyloxycarbonyl,
arylalkylsulfonyl, arylthiocarbonyl,
arylalkenylsulfonyl, heteroarylsulfonyl,
arylsulfonyl, heteroarylalkoxycarbonyl,
heteroarylalkyloxyarylalkyl,
arylalkenylarylalkyl,
arylalkoxycarbonylheteroarylalkyl,
heteroaryloxyarylalkyl,
polyhaloalkylaryloxycarbonyl or
arylalkenylheteroarylalkyl;
Y is CO2R4 where R4 is H or alkyl, or a
prodrug ester, or Y is a C-linked 1tetrazole, a phosphinic acid of the structure
P(O)(OR4a)R5 where R4a is H or a prodrug
ester, R5 is alkyl or aryl, or a phosphonic
acid of the structure P(O)(OR4a)2 where R4a
is H or a prodrug ester;
or stereoisomers thereof, prodrug esters
thereof, and pharmaceutically acceptable
salts thereof, with the proviso that where X
is CH, A is O, Q is C, Z is O and Y is
CO2R4, then R3 is other than H or alkyl
containing 1 to 5 carbons in the normal
chain.
,171033
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
___________
]11[]21[
]54[
ANAL INCONTINENCE
TREATMENT APPARATUS WITH
ENERGY TRANSFORMING
MEANS
]22[
]31[
01.08.2000
60/148345
]32[ 12.08.1999
09/502073
10.02.2000
Int. Cl.8 A61B 017/12, A61F 002/04
POTENCIA MEDICAL AG,
SWITZERLAND
WO/2001/012075
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]51[
]71[
]87[
]74[
[57] An anal incontinence treatment
apparatus, comprising an energy
transmission means for wireless
transmission of energy of a first form from
outside a patient's body, an operable
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
147962
‫מערכת לטפול בבעיות התאפקות אנאליות‬
‫עם אמצעי המרת אנרגיה‬
]33[
US
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
restriction device implantable in a patient
for engaging the colon or rectum to form a
restricted faecal passageway in the colon or
rectum, the restriction device operable in
response to energy of a second form
254
different than the energy of the first form to
vary the restricted passageway, and an
energy transforming means implantable in
the patient for transforming energy of the
first form wirelessly transmitted by the
energy transmission means into energy of
the second form, which is used for the
operation of the restriction device,
characterized in that the energy
transforming means comprises at least one
element (58) having a positive region (60)
and a negative region (62), and is adapted
to create an energy field between the
positive and negative regions (62, 62)
when exposed to the energy of the first
form transmitted by the energy
transmission means, so that the energy
field produces the energy of the second
form.
__________
]11[]21[
]54[
HIGH SPEED DATA CABLE
HAVING INDIVIDUALLY
SHIELDED TWISTED PAIRS
]22[
]31[
]51[
]71[
24.08.2000
09/386636
]32[ 31.08.1999
Int. Cl.8 H01B 011/02
BELDEN WIRE AND CABLE
COMPANY, U.S.A.
WO/2001/016964
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A high speed data cable having a
plurality of individual twisted pairs (15),
each individual twisted pair includes a first
insulated conductor (23) twisted about a
second insulated conductor (24), a jacket
255
148239
‫כבל להעברת נתונים במהירות גבוהה בעל‬
‫זוגות מפותלים המסוככים בנפרד‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
(17) surrounding said plurality of
individual twisted pairs, at least two of said
twisted pairs each being laterally wrapped
with a metal composite shield (22) having
a polymer layer (29) and a metal layer (27),
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
and said metal layer having a thickness of
from about 0.0003 inches to 0.001 inches,
each of said shields has an inner surface
and an outer surface opposite the inner
surface and said outer surface facing said
jacket, each shield has a first overlapping
longitudinal side (43) and a second
overlapping longitudinal side (43);
characterized by: said first and second
overlapping sides are bonded together by
an adhesive and wherein bonding of each
of said shields effects improved resistance
to deformation and impedance stability.
__________
]11[]21[
148343
‫תרכובות להזרקה המכילות חלקיקי‬
‫ ושימושיהן‬,‫בופרנורפין זעירות‬
]54[
INJECTABLE BUPRENORPHINE
MICROPARTICLE
COMPOSITIONS AND THEIR USE
]22[
]31[
]51[
]71[
25.08.2000
60/151112
]32[ 27.08.1999
]33[ US
Int. Cl.8 A61K 009/00, 009/16, 009/50, A61P 025/32, 025/36
BROOKWOOD
PHARMACEUTICALS, INC., U.S.A.
WO/2001/015699
G.E. EHRLICH (1995) LTD.,
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
AYALON TOWER, 15TH FLOOR,
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
11 MENACHEM BEGIN ST.,
‫רמת גן‬
RAMAT GAN 52521
]87[
]74[
[57] A microparticle composition
comprising a buprenorphine free base in an
amount in the range of 10 to 70 weight %,
poly(D,L-lactide) as an excipient, and less
than about 3 weight % ethyl acetate,
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
capable of providing a physiologically
effective level of buprenorphine to reduce
the consumption of heroin and/or alcohol
when administered intramuscularly in a
mammal over a period of about 28 days, at
256
least 90 weight % of said microparticle
composition comprising microparticles
having a diameter in the range of 20 to 125
μm.
__________
]11[]21[
]54[
SHAVING SYSTEM AND
METHOD
]22[
]31[
]51[
]62[
]71[
]87[
]74[
08.04.1997
630437
]32[ 10.04.1996
Int. Cl.8 B26B 021/22
DIVISION FROM 126354
THE GILLETTE COMPANY, U.S.A.
WO/1997/037819
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A replaceable shaving cartridge (14)
characterized by a housing (16) carrying
one or more blades (18), a guard (20), a
cap (22), and an interconnect member
having a pivotal support structure (28) that
pivotally supports said housing about a
pivot axis and a base structure (27) adapted
to be removably and fixedly attached to an
extension at an end of a handle (12), said
extension having outer side surfaces, said
257
148537
‫מכשיר גילוח ושיטה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
base structure having a recess with
inwardly directed side surfaces that engage
a sufficient number of said outer side
surfaces so as to immovably position said
base with respect to said extension, said
base structure having a handle extension
entryway to said recess along a recess axis
that is nonparallel with respect to said pivot
axis.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
POLYMERIC STENT USEFUL
FOR THE TREATMENT OF THE
SALIVARY GLAND DUCTS
]22[
]51[
]71[
]74[
11.03.2002
Int. Cl.8 A61F 002/04, A61M 029/00
ODED NAHLEILI
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A stent, for use in the oral cavity,
comprising an elongate member (1) and an
enlarged proximal portion at a proximal
end of the elongate member, and further
comprising a bore (4) extending through
said stent, said enlarged proximal portion
comprising a funnel-like form (2) having a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
148616
‫סטנט פולימרי היעיל לטיפול בצינורות של‬
‫בלוטות הרוק‬
,‫עודד נחליאלי‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
substantially continuous proximal rim
adapted for being located adjacent an oral
cavity and at least one hole (5b) in the wall
of the enlarged portion spaced from said
rim and adapted for suturing said stent to
said oral cavity, when in use.
258
__________
]11[]21[
148751
‫מערכת רוחב פס הניתנת להתאמה ושיטה‬
‫לשידור מידע‬
]54[
ADAPTIVE BANDWIDTH
SYSTEM AND METHOD FOR
BROADCAST DATA
]22[
]31[
27.10.2000
60/163046
]32[ 28.10.1999
]33[ US
699236
27.10.2000
US
Int. Cl.8 G08C 015/00, H04B 007/212, H04H 007/00, H04J 003/16, H04L 012/18,
H04N 007/173
NCUBE CORPORATION, U.S.A.
WO/2001/031605
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A dynamic bandwidth allocation
device, comprising: a dynamic bandwidth
allocator that allocates the bandwidth of a
system between a plurality of different
customer service providers to a plurality of
259
service nodes wherein the bandwidth
assigned to each customer service provider
for each service node is dynamically
adjustable based at least in part on the
usage of the services by the customers and
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
the bandwidth requests of each service
provider; the dynamic bandwidth allocator
further comprising a bandwidth nanager
that receives bandwidth requests from the
service nodes and assigns bandwidth to
each of the customer service providers
based upon the bandwidth requests from
the service nodes and a remultiplexer
module, based on the bandwidth allocation
decisions of the bandwidth manager, that
generates the digital data multiplex for
each service node based on the bandwidth
allocations.
__________
]11[]21[
]54[
REAL TIME MILLIMETER
WAVE SCANNING IMAGER
]22[
]51[
]71[
]87[
]74[
29.10.1999
Int. Cl.8 G01V 008/00
MICROVISION, INC., U.S.A.
WO/2001/033258
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] An imaging apparatus, comprising: a
millimeter wave detector (46) having an
input port and an electrical output, the
detector being responsive to millimeter
waves at the input port to produce an
electrical signal indicative of the intensity
of the millimeter waves; a scanner (44)
having a scanner output aligned to the
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
149092
‫סורק באורכי גל מילימטר להדמיה בזמן‬
‫אמת‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
input port and a scanner input aligned to an
external environment, the scanner
including a plurality of reflectors (224)
mounted to synchronously scan
periodically through a selected scan angle
in response to a drive signal, the plurality
of reflectors including a material reflective
to millimeter waves; a signal source (not
260
shown) coupled to the scanner and
operative to provide the drive signal; and
an electronic controller (48) having an
electronic input coupled to the electrical
output, the controller being responsive to
the electrical signal indicative of the
intensity of the millimeter waves to
generate image data.
__________
]11[]21[
149401
–‫–אמינו‬1 ‫אנטגוניסטים לרצפטור‬
NMDA ‫אלקילציקלוהקסאן‬
]54[
1-AMINOALKYLCYCLOHEXANE NMDA
RECEPTOR ANTAGONISTS
]22[
]51[
]71[
01.11.1999
Int. Cl.8 A61K 031/40, A61P 025/08, C07D 295/033
MERZ PHARMA GMBH & CO.
KGAA, GERMANY
WO/2001/032640
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]87[
]74[
261
[57] Use of a 1-cyclic aminoalkylcyclohexane selected from the group
consisting of those of the formula
wherein R* is –(CH2)n-(CR6R7)m-NR8R9
wherein n+m=0, 1 or 2
wherein R1 through R7 are independently
selected from the group consisting of
hydrogen and lower-alkyl (1-6C), wherein
R8 and R9 together represent loweralkylene –(CH2)x- wherein x is 2 to 5,
inclusive, and optical isomers,
enantiomers, hydrates, and
pharmaceutically-acceptable salts thereof,
in the manufacture of a medicament to treat
a living animal for alleviation of
convulsions or seizures.
__________
]11[]21[
]54[
SEMICONDUCTOR
NANOCRYSTALLINE
MATERIALS AND THEIR USES
]22[
]31[
]51[
]71[
03.09.2001
138471
]32[ 14.09.2000
Int. Cl.8 H01L 033/00
YISSUM RESEARCH
DEVELOPMENT COMPANY OF
THE HEBREW UNIVERSITY OF
JERUSALEM
WO/2002/025745
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] Semiconductor core/shell nanocrystal
comprising a semiconductor nanocrystal
core that is luminescent in the near infra
red (NIR), and having a crystalline shell
encapsulating said core, said shell having a
bandgap and/or crystallographic structure
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
149461
‫חומרים מוליכים למחצה נאנוקריסטאליים‬
‫ושימושם‬
]33[
IL
‫יישום חברה לפיתוח המחקר של‬
‫ ירושלים‬,‫האוניברסיטה העברית בירושלים‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
such that emittance wavelength of the core
material encapsulated therein is
substantially not modified, said core/shell
nanocrystal having a changed quantum
yield and/or chemical and/or photostability
that is different from that of the non-
262
encapsulated nanocore, wherein said
nanocrystal is coated with organic ligand
on the outer surface thereof and said core is
a nanocrystal core comprising a first cation
species and a first anion species and
optionally one or more additional ionic
species which may be cationic or anionic,
the ratio of total cationic species to total
anionic species being substantially
equimolar; said cationic species is/are
selected from In, Ga, or Al; said anionic
species is/are selected from As, Sb, and P;
and said nanocrystal is soluble and/or
dispersible in an organic solvent.
__________
]11[]21[
149554
‫שילובים קוטלי פטריות של חומרים‬
‫פעילים‬
]54[
FUNGICIDAL COMBINATIONS
OF ACTIVE SUBSTANCES
]22[
]31[
30.11.2000
19959947.5
]32[ 13.12.1999
]33[ DE
10021412.6
03.05.2000
DE
Int. Cl.8 A01N 043/00, C01B 025/16, C07C 211/12, 233/57, 233/59, 233/76, 233/92,
235/18, 237/28, 251/32, 251/50, 255/49, 255/63, 271/16, 271/20, 313/36, 333/16,
333/32, C07D 209/30, 209/48, 209/52, 213/60, 213/74, 215/16, 233/52, 233/56,
233/80, 233/84, 239/28, 239/46, 249/08, 249/10, 249/12, 263/04, 263/44, 277/62,
285/14, 295/16, 317/72, 405/04, 405/06, 413/12, 417/12, C07F 009/40
BAYER AKTIENGESELLSCHAFT,
GERMANY
WO/2001/044215
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] Fungicidal combinations, comprising
at least one compound of the formula
263
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
and one or more compounds selected from
60 other active compounds as defined in
the specification.
__________
]11[]21[
149720
‫סינטזות מתזה של פרומונים או מרכיביהם‬
]54[
METATHESIS SYNTHESES OF
PHEROMONES OR THEIR
COMPONENTS
]22[
]31[
]51[
17.11.2000
60/166543
]32[ 18.11.1999
]33[ US
Int. Cl.8 C07B 061/00, C07C 002/00, 006/04, 011/02, 017/37, 021/073, 029/09,
029/44, 041/48, 043/303, 045/51, 051/353, 057/03, 067/293, 067/333, 067/475,
069/00, 069/007, 069/22, C07D 309/30, C07F 005/05, 009/50
RICHARD L. PEDERSON, U.S.A.
ROBERT H. GRUBBS, U.S.A.
]71[
]87[
]74[
WO/2001/036368
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
[57] A method for synthesizing a
metathesis product, comprising: selecting a
first reactant, wherein the first reactant is
selected from a first terminal olefin or a
first internal olefin; selecting a second
reactant, wherein the second reactant is
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
selected from a second terminal olefin or a
second internal olefin; cross-metathesizing
the first reactant and the second reactant in
a reaction chamber in the presence of a
metathesis catalyst selected from
metathesis catalyst Classes I-IV to form the
264
metathesis product and a side product; and
applying conditions of sufficiently high
temperature and/or sufficiently low
pressure such that the side product
evaporates out of the reaction chamber to
deter the formation of a methylidene
ruthenium catalyst intermediate.
__________
]11[]21[
150248
‫מעכבי סטרומליזין‬
]54[
STROMELYSIN INHIBITORS
]22[
]31[
]51[
05.12.2000
19960640.4
]32[ 16.12.1999
]33[ DE
Int. Cl.8 A61K 031/70, A61P 001/02, 001/04, 009/10, 017/02, 019/00, 019/02,
019/04, 019/08, 029/00, 031/04, 035/00, 035/04, 037/02, 043/00, C07H 005/06,
007/04, C12P 017/06
SANOFI-AVENTIS DEUTSCHLAND
GMBH, GERMANY
WO/2001/044264
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]71[
]87[
]74[
[57] A compound of the formula
265
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
wherein R1 is selected from a (C3-C10)
linear or branched alkyl group which is
unsubstituted, monosubstituted,
disubstituted, or trisubstituted with a group
selected from –OR3 where R3 is selected
from hydrogen and (C1-C4)-alkyl;
NR4R5 where R4 and R5 are independently
selected from hydrogen and a (C1-C4)alkyl; a halogen; =O; and –COOH; and a
(C3-C10) linear or branched alkenyl group
which is unsubstituted, monosubstituted,
disubstituted, or trisubstituted with a group
selected from –OR3 where R3 is selected
from hydrogen and a (C1-C4)-alkyl; NR4 R5
where R4 and R5 are independently selected
from hydrogen and a (C1-C4)-alkyl; a
halogen; =O; and –COOH;
R2 is selected from a (C3-C10) linear or
branched alkyl group which is
unsubstituted, monosubstituted,
disubstituted, or trisubstituted with a group
selected from –OR3 where R3 is selected
from hydrogen and a (C1-C4)-alkyl;
NR4R5, where R4 and R5 are independently
selected from hydrogen and a (C1-C4)alkyl; a halogen; =O; and –COOH; and a
(C3-C10) linear or branched alkenyl group
which is unsubstituted or monosubstituted,
disubstituted, or trisubstituted with a group
selected from –OR3 where R3 is selected
from hydrogen and a (C1-C4)-alkyl; NR4R5,
where R4 and R5 are independently selected
from hydrogen and a (C1-C4)-alkyl; a
halogen; =O; and –COOH; and
Z is a hexose which is in pyranoid form via
a C-glycosidic bond, or a stereoisomer or
physiologically tolerable salt thereof.
__________
]11[]21[
]54[
FLUORESCENT INTENSITY
ASSAY FOR DUPLEX AND
TRIPLEX NUCLEIC ACID
HYBRIDIZATION IN SOLUTION
UTILIZING FLUORESCENT
INTERCALATORS
]22[
]31[
]51[
]71[
]87[
]74[
21.12.2000
468679
]32[ 21.12.1999
Int. Cl.8 C12Q 001/68
INGENEUS INC., BARBADOS
WO/2001/046467
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
150284
‫בדיקה של עוצמת פלואורסצנציה עבור‬
‫הכלאות כפולות ומשולשות של חומצת‬
‫גרעין בתמיסה באמצעות מקשרים‬
‫פלואורסצנטים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
266
TEL AVIV 61040
[57] A method for assaying binding, said
method comprising: providing a target
comprising at least one nucleic acid
sequence; providing a probe comprising a
nucleic acid or nucleic acid analog
sequence incompletely complementary to
at least a portion of said target; providing
an intercalating agent, wherein either said
probe or said intercalating agent comprises
a fluorophore; adding said probe, said
target and said intercalating agent to a
hybridization medium to provide a test
sample comprising triplexes of said probe
and said target, wherein said triplexes
comprise base triplets, and all said base
triplets of said triplexes are members
selected from the group consisting of A-TA, T-A-T, U-A-T, T-A-U, A-U-U-A-T, TA-U, U-A-U or C-G-C, and at least one
other said base triplets is A-T-A, G-C-G or
A-U-A;
irradiating said test sample with exciting
radiation to cause said fluorophore to emit
fluorescent radiation; detecting an intensity
of said fluorescent radiation, wherein said
intensity increases with increasing binding
affinity between said probe and said target;
and determining from said intensity a
number of mismatched bases, an identity of
a mismatched base and/or a location of a
mismatch between said probe and said
target to assay binding, wherein said
determining is accomplished by calibrating
said intensity against intensities against
intensities exhibited by reference probes
combined with said target and said
intercalating agent, said reference probes
differing from each other by at least one
base, wherein said method is conducted
without denaturing said target or said
probe.
__________
]11[]21[
150449
‫תולדות אנילין ותכשירי רוקחות המכילים‬
‫אותן כליגנדים לקולטי בלוטת התריס‬
]54[
ANILINE DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME AS THYROID
RECEPTOR LIGANDS
]22[
]31[
]51[
]71[
12.01.2001
60/183223
]32[ 17.02.2000
]33[ US
Int. Cl.8 A61K 031/16, 045/06, A61P 003/00, 043/00, C07C 235/72, 323/30
BRISTOL-MYERS SQUIBB
PHARMA COMPANY, U.S.A.
WO/2001/060784
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]87[
]74[
[57] A compound of the formula
267
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
wherein X is oxygen (-O-), sulfur (-S-),
carbonyl (-CO-), methylene –(CH2-), or –
NH-;
Y is –(CH2)n, where n is an integer from 1
to 5, or –C=C-, which is cis or trans;
R1 is halogen, trifluoromethyl, or alkyl of 1
to 6 carbons or cycloalkyl of 3 to 7
carbons;
R2 and R3 are the same or different and are
hydrogen, halogen, alkyl of 1 to 4 carbons
or cycloalkyl of 3 to 6 carbons, at least one
of R2 and R3 being other than hydrogen;
R4 is hydrogen or alkyl of 1 to 4 carbons;
R5 is hydrogen or alkyl of 1 to 4 carbons;
R6 is carboxylic acid, or ester thereof;
R7 is hydrogen, or an alkanoyl or aroyl
group, or other group capable of
bioconversion to generate the free phenol
structure (wherein R7 = H); including all
stereoisomers thereof, or a
pharmaceutically acceptable salt thereof.
__________
]11[]21[
]54[
KEY AND ASSOCIATED LOCK
CYLINDER
]22[
]31[
]51[
]71[
23.11.2001
10058590.6
]32[ 25.11.2000
Int. Cl.8 E05B 019/08
DOM-SICHERHEITSTECHNIK
GMBH & CO. KG, GERMANY
WO/2002/042582
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] Turnkey (2) for a lock cylinder with a
bit comprising lock recesses (12)
cooperating with the core pins of the lock
cylinder, in which bit a spacer (9) is
movably mounted, wherein the direction of
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
150462
‫מפתח וצילינדר למנעול המתאים למפתח‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
movement (D) of the spacer extends
obliquely to the broadside face of the key,
characterized in that the spacer is a ring
arranged in an oblique slot (15) of the bit,
which ring is traversed with play, by a
268
journal (16), wherein the oblique slot is
arranged in the centre of the cross-section
of the key.
__________
]11[]21[
150566
‫חומצות גרעין ופוליפפטידים וחלבונים‬
‫קולטי נוגו‬
]54[
NUCLEIC ACIDS AND
POLYPEPTIDES AND NOGORECEPTOR PROTEINS
]22[
]31[
12.01.2001
60/175707
]32[ 12.01.2000
]33[ US
60/207366
26.05.2000
US
60/236378
29.09.2000
US
Int. Cl.8 A61K 038/17, 039/395, A61P 025/28, C07K 014/705, 016/28, C12N 015/12
YALE UNIVERSITY, U.S.A.
WO/2001/051520
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] An isolated polynucleotide
comprising a nucleic acid sequence which
encodes a polypeptide at least 80%
identical to a reference polypeptide
selected from the group consisting of: a
269
polypeptide comprising amino acids 1 to
348 of SEQ ID NO: 4; wherein said
polypeptide inhibits Nogo-receptormediated neurite outgrowth inhibition.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
DEVICE FOR PREVENTING OR
RELIEVING PAIN IN THE LOWER
BACK
]22[
]31[
]51[
]71[
]87[
]74[
14.12.2000
09/479661
]32[ 10.01.2000
Int. Cl.8 A61H 001/00
BACKLIFE LTD.
WO/2001/051000
G.E. EHRLICH (1995) LTD.,
AYALON TOWER, 15TH FLOOR,
11 MENACHEM BEGIN ST.,
RAMAT GAN 52521
[57] A device for preventing or relieving
pain in the lower back of a human subject
while the subject lies in a supine position
on an underlying surface, the device
comprising:
(a) a body-engaging element (12)
configured for engaging the two legs of the
subject inferior to the subject's lumbar
vertebrae while the subject lies in a supine
position on the underlying surface; and
(b) a drive mechanism (14) mechanically
linked to said body-engaging element, said
drive mechanism being configured to move
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
150593
‫מכשיר למניעת או הקלת כאבי גב תחתון‬
]33[
US
‫יהודה‬-‫ אור‬,‫בקלייף בע"מ‬
,‫) בע"מ‬1995( ‫ארליך‬.‫אי‬.‫ג'י‬
,11 ‫רחוב מנחם בגין‬, 15 ‫ קומה‬,‫מגדל אילון‬
‫רמת גן‬
said body-engaging element, through a
repetitive cyclic motion including:
(a) an operative motion along a first path in
a direction parallel to the subject's legs
operative to move both legs of the subject
engaged by said body-engaging element
together through said first path parallel to
the subject's legs to apply tension to the
lower back of the subject, and (b) a return
motion along a second path, said second
path being different from, and lying
generally below, said first path.
270
__________
]11[]21[
]54[
BED CONSTRUCTION WITH
REDUCED SAGGING
]22[
]31[
10.01.2001
482591
]32[ 13.01.2000
742126
22.12.2000
Int. Cl.8 A47C 023/043, 027/05, 027/06
DREAMWELL LTD., U.S.A.
WO/2001/050925
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A one-sided inner spring mattress
assembly (30) comprising: a central core
(12) comprising a wire spring assembly
having a lower border wire (44); an upper
padding layer (34) extending over a top
surface of the core and defining a sleeping
surface; and a lower rigid layer (38)
secured to the lower border wire and being
271
150596
‫מבנה מיטה ללא התקערות‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
disposed underlying and against the central
core, wherein the lower layer contacts and
supports the central core to reduce
permanent deflection from within the
sleeping surface arising from compaction
of a lower compressible layer by the wire
spring assembly of the central core.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
ORDNANCE FIRING SYSTEM
]22[
]31[
]51[
]71[
16.03.2001
60/190458
]32[ 17.03.2000
Int. Cl.8 F42B 003/10
ENSIGN-BICKFORD AEROSPACE &
DEFENSE COMPANY, U.S.A.
WO/2001/071272
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] An ordnance firing system for an
aerospace device or land vehicle
comprising a plurality of reactive effectors,
the system comprising: firing control
system circuitry (312) for controlling the
firing of a plurality of initiators (16-22), the
firing control system circuitry comprising a
low-energy power source for arming the
initiators and an input port for receiving
150652
‫מערכת ירי תחמושת‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
low-energy power for powering the firing
control system circuitry and for receiving
firing control signals; the plurality of
initiators comprising planar, low-energy
initiation elements connected to the firing
control circuitry, and at least one sensor
(24) for sensing a condition precedent to
arming or firing at least one of the plurality
of initiators.
__________
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
272
]11[]21[
]54[
METHOD FOR PRODUCING 6 - (4
- CHLOROPHENYL) - 2,2 DIMETHYL - 7 - PHENYL - 2,3 DIHYDRO - 1H -PYRROLIZINE - 5
- YL ACETIC ACID
]22[
]31[
]51[
]71[
]87[
]74[
26.01.2001
001047
]32[ 28.01.2000
Int. Cl.8 C07D 487/04
MERCKLE GMBH, GERMANY
WO/2001/055149
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
150752
– 2,2 – )‫ – כלורופניל‬4( – 6 ‫שיטה לייצור‬
‫ פירוליזין‬H1 – ‫ – פניל – דיהידר‬7 – ‫דימתיל‬
2 ,3 ‫ – איל חומצה אצטית‬5 –
]33[
MX
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
[57] Process for the preparation of the
compound of the formula
where the compound of the formula
is reacted with oxalyl chloride and the
product obtained is treated with hydrazine
and an alkali metal hydroxide in the
aqueous phase at from 120 to 180˚C in the
presence of an aliphatic mono- or dialcohol
having a boiling point of at least 140˚C,
after treatment is complete a three-phase
system is produced by addition of an ether
and the compound of the formula I is
obtained by acidifying the middle phase.
__________
273
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
HYDROSTATIC GAS BEARING,
HYDROSTATIC GAS BEARING
DEVICE FOR USE IN VACUUM
ENVIRONMENT AND GAS
RECOVERY METHOD FOR THE
HYDROSTATIC GAS BEARING
DEVICE
]22[
]31[
24.01.2001
2000-024313 ]32[ 01.02.2000
2000-269703
06.09.2000
2000-390858
22.12.2000
Int. Cl.8 F16C 032/06
TOTO LTD., JAPAN
WO/2001/057409
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A hydrostatic gas bearing for use in a
vacuum, which is formed of a moving body
(1) and a fixed body (2) in which the fixed
body is provided with a guide shaft (2a) in
a position opposed to said moving body,
wherein the hydrostatic gas bearing has a
structure in which the moving body and the
guide shaft of the fixed body are supported
in a non-contact state by supplying
flotation gas to a gap between the moving
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
150889
‫ התקן מסב‬,‫מסב הדרוסטאטי לגזים‬
‫הדרוסטאטי לגזים לשימוש בסביבת ריק‬
‫ושיטה להשבת גז עבור מסב הידרוסטאטי‬
‫לגזים‬
]33[
JP
JP
JP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
body and the guide shaft of the fixed body,
and wherein a coating (3) is applied to at
least one of a surface of the moving body
and a surface of the guide shaft so as to
substantially maintain the pressure in a
vacuum chamber when the hydrostatic gas
bearing is being moved in a case where the
hydrostatic gas bearing is used in the
vacuum chamber.
274
,175392
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________
]11[]21[
151057
‫הרכבים למתן דרך הפה של אגוניסט‬
‫אופיואידי‬
]54[
TAMPER-RESISTANT ORAL
OPIOID AGONIST
FORMULATIONS
]22[
]31[
]51[
]71[
08.02.2001
60/181369
]32[ 08.02.2000
]33[ US
Int. Cl.8 A61K 009/14, 009/20, 009/48, 009/50, 045/00
EURO-CELTIQUE S.A.,
LUXEMBOURG
275
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]72[
]87[
]74[
BENJAMIN OSHLACK, CURTIS
WRIGHT
WO/2001/058451
SOROKER-AGMON,
14 SHENKAR ST.,
HERZLIYA PITUAH 46725
,‫אגמון‬-‫סורוקר‬
‫ הרצליה פיתוח‬,14 ‫ רחוב שנקר‬,‫בית נולטון‬
[57] An oral dosage form comprising:
(a) an opioid agonist;
(b) an opioid antagonist; and
(c) means for sequestering the opioid
antagonist in the intact dosage form,
wherein the intact dosage form releases
36% or less of the antagonist after 36 hours
The applications for division
from this application have
not yet been published
based on the in-vitro dissolution of the
dosage form in 900 ml of Simulated
Gastric Fluid using a USP Type II (paddle)
apparatus at 75 rpm and 37 degrees C. with
a switch to Simulated Intestinal Fluid at 1
hour.
,181356
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________
]11[]21[
]54[
METHOD AND SYSTEM FOR
COMBINING MULTI-SPECTRAL
IMAGES
151085
–‫שיטה ומערכת לשילוב דמויות רב‬
‫ספקטרליות‬
]22[
]31[
]51[
]71[
]87[
]74[
20.02.2001
09/528552
]32[ 20.03.2000
]33[ US
Int. Cl.8 G02B 013/14, 023/12, 027/10, G02F 001/01, H04N 005/33
LITTON SYSTEMS, INC., U.S.A.
WO/2001/072033
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A system for combining multidisplaying a displayed image in the first
spectral images of a scene, the system
spectral band; a collimator for receiving
comprising: a channel for transmitting a
and collimating the displayed image; a
scene image in a first spectral band; a
beam mixer for combining the transmitted
focusing lens for focusing a scene image in
scene in the first spectral band with the
a second spectral band on a detector; the
collimated image, and conveying the
detector for sensing the scene in a second
combined multi-spectral images to an
spectral band, the detector having an image
output; and a viewing system coupled to
output representative of the scene; a
the output and comprising an image
display for receiving the image output and
intensifier system.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
276
__________
]11[]21[
]54[
COATING AND BINDING AGENT
FOR PHARMACEUTICAL
FORMULATIONS HAVING
IMPROVED STORAGE
STABILITY
]22[
]51[
]71[
27.02.2001
Int. Cl.8 A61K 009/00, 009/28
ROHM GMBH & CO. KG,
GERMANY
277
151151
‫גורם מקשר ומצפה בעל יציבות משופרת‬
‫לאחסון להרכבי רוקחות‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]87[
]74[
WO/2002/067906
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
[57] Process for the production of a
coating and binding agent for oral or
dermal pharmaceutical forms, essentially
consisting of
(a) a copolymer consisting of free-radicalpolymerized C1 to C4 esters of acrylic or
methacrylic acid and further (meth)
acrylate monomers which contain
functional tertiary ammonium groups, the
copolymer being present in powder form
having an average particle size of 1-40 μm,
(b) 3 to 15% by weight, based on (a), of an
emulsifier having an HLB of at least 14
(c) 5 to 50% by weight, based on (a), of a
C12- to C18-monocarboxylic acid or a C12to C18 hydroxyl compound where the
components (a), (b) and (c) are blended or
mixed with one another with or without
addition of water and if appropriate with
addition of a pharmaceutical active
compound and further customary additives
and the coating and binding agent is
produced from the mixture by melting,
casting, spreading, spraying or granulating.
__________
]11[]21[
]54[
PHARMACEUTICAL
COMPOSITIONS SUITABLE FOR
ORAL ADMINISTRATION IN
FORM OF AN EMULSION PRECONCENTRATE AND UNIT
DOSAGE FORMS FILLED WITH
SAID COMPOSITION
]22[
]31[
]51[
06.03.2001
0000774-0
]32[ 08.03.2000
Int. Cl.8 A61K 009/00, 009/113
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
151380
,‫תכשירים רוקחיים המתאיים למתן אוראלי‬
‫בצורת אמולסיה פרה–מרוכזת וקפסולות‬
‫המלאות בהם‬
]33[
SE
278
]71[
]72[
]87[
]74[
NICOX SA
CHRISTINA HOLMBERG, BRITTA
SIEKMANN
WO/2001/066087
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] A pharmaceutical composition
suitable for oral administration, in form of
an emulsion pre-concentrate, comprising
(i) a compound of the formula
(ii) one or more surfactants, said
composition forming in-water emulsion of
small droplets of nanometer to micron size
upon contact with aqueous media.
__________
]11[]21[
]54[
]22[
]31[
]51[
]71[
]72[
279
PHARMACEUTICAL
COMPOSITIONS SUITABLE FOR
ORAL ADMINISTRATION IN
FORM OF AN EMULSION PRECONCENTRATE AND UNIT
DOSAGE FORMS FILLED WITH
SAID COMPOSITION
06.03.2001
0000773-2
]32[ 08.03.2000
Int. Cl.8 A61K 009/00, 009/113
NICOX SA
CHRISTINA HOLMBERG, BRITTA
SIEKMANN
151427
‫תכשירים רוקחיים המתאימים למתן‬
‫ בצורת אמולסיה פרה–מרוכזת‬,‫אוראלי‬
‫וקפסולות המלאות בהם‬
]33[
SE
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]87[
]74[
WO/2001/066088
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A pharmaceutical composition
suitable for oral administration, in form of
an emulsion pre-concentrate, comprising
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(i) one or more NO-releasing NSAID(s),
wherein the NO-releasing NSAID is a
compound of the formula
wherein X is a spacer; and
M is selected from any one of
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
280
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫‪281‬‬
(ii) one or more surfactants;
(iii) optionally an oil or semi-solid fat; said
composition forming an in-situ oil-in-water
emulsion upon contact with aqueous media
such as gastrointestinal fluids.
__________
]11[]21[
151533
‫תולדות של אמיד ציקלי ותכשירי רוקחות‬
‫וליגנדים מסוג סיגמה שלהם‬
]54[
CYCLIC AMIDE DERIVATIVES
AND MEDICAMENTS AND
SIGMA LIGANDS THEREOF
]22[
]31[
]51[
26.02.2001
2000-54674
]32[ 29.02.2000
]33[ JP
Int. Cl.8 A61K 031/395, A61P 043/00, C07D 401/06, 401/12, 401/14, 405/06,
405/12, 405/14, 409/06, 409/12, 409/14, 413/06, 413/12, 413/14, 471/04, 491/048,
495/04
MITSUBISHI PHARMA
CORPORATION, JAPAN
WO/2001/064670
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]71[
]87[
]74[
[57] A compound or a salt thereof, or a
hydrate or a solvate thereof of the formula
wherein: X represents an alkyl group, a
cycloalkyl-substituted alkyl group, an arylsubstituted alkyl group, an aryl-substituted
alkenyl group, an aryl-substituted alkynyl
group, a monocyclic or polycyclic
cycloalkyl group which may be substituted
with an alkyl group, an aryl group, a
heterocyclic group, or a substituted or
unsubstituted amino group;
Q represents a group represented by –CO-,
-O-, -S-, -CH(OR7)-, -C(=CH2)- or –
C(=NR8)- wherein R7 represents a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
hydrogen atom, an alkyl group, a
hydroxyalkyl group, or an acyl group, and
R8 represents a hydroxyl group, an alkoxyl
group, an aralyloxy group, an acyloxy
group, an acylamino group, or an
alkoxycarbonyl amino group;
n represents an integer of from 0 to 5;
R1 and R2 each independently represent a
hydrogen atom or an alkyl group, or R1 and
R2 combine to form an alkylene group;
B represents either of the following groups:
282
wherein R3, R4, R5 and R6 each
independently represent a substituent
selected from the group consisting of a
hydrogen atom, a halogen atom, a nitro
group, an alkyl group, a halogenated alkyl
group, a hydroxyl group, an alkoxyl group,
a halogenated alkoxyl group, and a cyano
group;
m represents 1 or 2; and
the ring of:
represents a 5- or 6-membered aromatic
heterocyclic ring containing one or two
heteroatoms which may be substituted.
__________
]11[]21[
151588
IV ‫מעכבי דיפפטידיל פפטידאז‬
]54[
INHIBITORS OF DIPEPTIDYL
PEPTIDASE IV
]22[
]31[
]51[
26.04.2001
0010183.2
]32[ 26.04.2000
]33[ GB
Int. Cl.8 A61K 031/40, 031/4025, 031/425, A61P 005/50, C07D 207/16, 277/06,
295/18, 401/12, 403/12, 405/12, 409/12, 413/12, 417/12, 471/04
FERRING BV, THE NETHERLANDS
WO/2001/081304
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]71[
]87[
]74[
[57] Compounds of the formula
283
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
tautomers and stereoisomers thereof, and
pharmaceutically acceptable salts of said
derivatives, tautomers and isomers
wherein:
X1 is selected from a sulphur atom, an
oxygen atom, a sulphinyl group, a
sulphonyl group and a methylene group;
X2 is selected from O, S and methylene;
X3 is either NR5 or a carbonyl or
thiocarbonyl group;
R1 is either a hydrogen atom or a nitrle
group;
R2 and R3 are independently selected from
H and C1-C6 alkyl, or together may be –
(CH2)p-;
R4 is R4A when X3 is NR5 and R4B when X3
is a carbonyl or thiocarbonyl group;
R4A is selected from R6R7NC(=O),
R6R7NC(=S); R8(CH2)qC(=O),
R8(CH2)qC(=S), R8(CH2)qSO2,
R8(CH2)qOC(=O) and R8(CH2)qOC(=S);
R4B is R6R7N;
R5 is H or C1-C6 alkyl;
R6 and R7 are selected independently from
R8(CH2)q or together they are –(CH2)2-Z1(CH2)2- or –CHR9-Z2-CH2-CHR10-;
R8 is selected from H, C1-C4 alkyl, benzofused cycloalkyl, acyl, dialkylcarbamoyl,
dialkylamino, N-alkylpiperidyl, optionally
substituted aryl, optionally substituted αalkylbenzyl, optionally substituted aroyl,
optionally substituted arylsulphonyl and
optionally substituted heteroaryl;
R9 and R10 are selected independently
from H, carbamoyl, hydroxymethyl and
cyanomethyl;
Z1 is selected from a covalent bond, (CH2)r-, -O-, -SOt- and –N((CH2)qR8)-;
Z2 is an optionally substituted orthophenylene moiety;
m is 1-3;
n is 0-4;
p is 2-5;
q is 0-3
r is 1 or 2; and
t is 0-2;
provided that when X2 is CH2, X3 is NH
and R4 is R8CH2O(CO) then R8 is not
unsubstituted phenyl or nitrophenyl; and
that when X1 is CH2, R1 is H, X2 is CH2, X3
is NH and R4 is R8(CH2)qC(=O) then
R8(CH2)q is not methyl or ethyl.
__________
]11[]21[
]54[
PROCESS FOR THE
PREPARATION OF CAPSULES
]22[
]31[
]51[
]71[
15.03.2001
0006430.3
]32[ 17.03.2000
Int. Cl.8 A61J 003/07
STANELCO RF TECHNOLOGIES
LIMITED, UNITED KINGDOM
WO/2001/068032
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A process for making capsules from
films (18) of polymeric material, the
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
151645
‫תהליך להכנת כמוסות‬
]33[
GB
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
process comprising the steps of deforming
the films to form a multiplicity of recesses,
284
filling the recesses with a flowable filling
material, welding the films together to
form a multiplicity of enclosures
containing the filling material, and
separating the filled enclosures from the
remaining parts of the films so as to form
the said multiplicity of capsules, wherein
the welding process is dielectric welding
performed between a pair of rotary dies,
and characterized in that the process uses
films of a water-soluble or digestible
polymeric material.
__________
]11[]21[
]54[
METHOD AND APPARATUS FOR
DISTINGUISHING REACHABLE
OBJECTS AND NON-REACHABLE
OBJECTS IN AN OBJECT-BASED
APPLICATION
]22[
]31[
]51[
]71[
]87[
]74[
09.03.2001
00810253.5
]32[ 24.03.2000
Int. Cl.8 G06F 012/02
IBM CORPORATION, U.S.A.
WO/2001/071506
IBM LABORATORIES,
HAIFA UNIVERSITY
HAIFA 31905
[57] A method for distinguishing, within a
set of objects, reachable objects and notreachable objects in an object-based
application in a system with a volatile
memory and a non-volatile memory, said
object-based application operating in said
285
151740
‫שיטה וכלי לזיהוי עצמים נגישים ולא‬
‫נגישים ביישום מבוסס–עצמים‬
]33[
EP
,‫מעבדות יבמ‬
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
non-volatile memory on said objects,
wherein at least one of the objects is a root
object, said method comprising the steps
of: determining for each of the root objects,
which of the objects are reachable from
said root object; writing, for each of the
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
reachable objects, a positive reachability
information into said volatile memory; and
marking the objects, for which no positive
reachability information is present in said
volatile memory, in said non-volatile
memory as reusable memory.
__________
]11[]21[
151895
‫מפשק יעיל למערכות תקשורת מפוזרות‬
‫ספקטרום‬
]54[
EFFICIENT SPREADER FOR
SPREAD SPECTRUM
COMMUNICATION SYSTEMS
]22[
]31[
]51[
]71[
14.12.2000
60/191884
]32[ 23.03.2000
]33[ US
Int. Cl.8 H04B 001/707, H04J 013/00, 013/04
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/071938
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A communication system having a
spreader for spreading a data signal
comprising at least a plurality of data
symbols; the system assigning at least one
of a plurality of spreading codes where at
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
least one of said plurality of spreading
codes is complex, the spreader
characterized by: a data input for receiving
said data symbol; a control input, for
receiving an assigned spreading factor for
286
the data signal; a processor for defining a
group of symbols for spreading based upon
said assigned spreading factor; an
intermediate code generator for computing
a spreading code based upon said assigned
spreading factor and at least one code from
a plurality of real codes derived from said
plurality of assigned spreading codes, said
intermediate code generator outputting an
intermediate code; and rotator for
performing a phase rotation of each symbol
in said group to generate a complex
quantity, said complex quantity being
spread with said intermediate code and
output as a spread data signal.
__________
]11[]21[
]54[
HERBICIDAL
BENZOYLPYRAZOLE
DERIVATIVES AND
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
]51[
]71[
17.03.2001
10016116.2
]32[ 31.03.2000
Int. Cl.8 A01N 043/56, C07D 231/20
BAYER CROPSCIENCE AG,
GERMANY
WO/2001/074785
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
151986
‫נגזרות בנזואילפירזוליות קוטלות עשבים‬
‫ותכשירים המכילים אותן‬
]33[
DE
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
[57] A benzoylpyrazole or a salt thereof of
the formula
287
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
in which R1 is methyl or ethyl;
R2 is trifluoromethyl;
R3 is hydrogen, methyl or ethyl;
R4 is methyl, ethyl or n-propyl;
R5 is hydrogen, (C1-C6)alkylkcarbonylmethyl, (C1-C4)alkylsulfonyl, phenylsulfonyl, benzyl,
benzoylmethyl, (C1-C3)-alkylsulfonyl
which is mono- or polysubstituted by
halogen, phenylsulfonyl which is
monosubstituted by methyl or halogen,
benzyl which is substituted by halogen,
nitro, methyl or methoxy or benzoylmethyl
which is mono- or polysubstituted by
halogen, nitro, methyl or methoxy and n is
0, 1, or 2.
__________
]11[]21[
152020
D– ‫–נור–ויטמין‬19–‫–אלקילאדין‬2–‫תולדות‬
‫ותכשירי רוקחות המכילים אותן‬
]54[
2-ALKYLIDENE-19-NORVITAMIN-D DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
]51[
]71[
29.03.2001
09/540686
]32[ 31.03.2000
]33[ US
Int. Cl.8 A61K 031/593, A61P 017/06, 019/10, 035/00, C07C 401/00
WISCONSIN ALUMNI RESEARCH
FOUNDATION, U.S.A.
WO/2001/074766
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]87[
]74[
[57] A compound selected from:
20(S)-1α-,25-dihydroxy-2-methylene-26,
27-dihomo-19-norvitamin D3,
20(S)-26, 27-dimethylene-25-methoxy-2methylene-19-norvitamin D3,
20(S)-1α, 25-dihydroxy-26, 27dimethylene-2-methylene-19-norvitamin
D3, and
20(S)-26, 27-dimethylene-1α-hydroxy-2methylene-24-dehydro-19-norvitamin D3.
__________
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
288
]11[]21[
]54[
]22[
]31[
]51[
]71[
]87[
]74[
152099
SYNCHRONIZATION OF TIMING
‫סינכרון סטיות של עיתוי‬
ADVANCE AND DEVIATION
05.04.2001
60/195087
]32[ 06.04.2000
]33[ US
Int. Cl.8 H04B 007/26, H04J 003/00, 003/06, H04Q 007/36, 007/38
INTERDIGITAL TECHNOLOGY
CORPORATION, U.S.A.
WO/2001/078259
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
[57] A communication system for
supporting base station (BS)/mobile
terminal (MT) wireless bi-directional
communications via the utilization of a
radio frame format having sequentially
identified system radio frames comprising
a BS having a transmitter for transmitting
selectively formatted communication data
to MTs within system radio frames, and a
receiver for receiving communication data
from MTs within system radio frames, and
a timing advance (TA) signal generator
associated with the BS for providing TA
command signal for transmission by the BS
to selected Mts, the communications
system characterized in that:
the BS receiver has an associated processor
for measuring timing deviation (TD) of
received MT transmissions in identified
radio frames in which communication data
is received from a selected MT;
said TA command signal generator
generates TA command signals which
include:
TA data which is calculated based upon
measured TD in an identified radio frame
for a selected MT, and
a Connect Frame Number (CFN)
specifying a particular radio frame for
effectuating a timing adjustment by the
selected MT; and the BS processor
measures the TD for communication data
received from selected MT to which a TA
command signal had been transmitted in
the frame specified in the CFN of the
transmitted TA command signal.
__________
289
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
METAL CUTTING TOOL
]22[
]31[
]51[
]71[
]72[
07.10.2002
148228
]32[ 19.02.2002
Int. Cl.8 B23C 005/12
ISCAR LTD.
JACOB FRIEDMAN, BARUCH
BOOKS
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
]74[
[57] A metal cutting tool (10) comprising:
an indexable cutting insert (12), comprising
two opposing side surfaces (24), and a
peripheral edge surface (26) extending
therebetween and having an insert axis of
rotational symmetry passing through the
side surfaces; the peripheral edge surface
having a plurality of abutment sections
(28), each abutment section lying on a
portion of a side wall of an imaginary
regular polygon having a plurality of side
walls, a plurality of cutting portions
extending outwardly from the imaginary
polygon, the plurality of cutting portions
being equal in number to the number of
side walls of the imaginary polygon, each
cutting portion having a cutting edge, each
abutment section being located between
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
152161
‫כלי לחיתוך מתכת‬
]33[
IL
‫ תפן‬,‫ישקר בע"מ‬
‫ ברוך בוקס‬,‫יעקב פרידמן‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
two cutting portions; and an insert holder
(14) comprising an insert pocket (16) in
which the cutting insert is retained with the
peripheral edge surface being abutted at
two abutment sections only, the insert
pocket comprising a lower support wall
abutting a first abutment section, and an
upper support wall abutting a second
abutment section; the lower support wall
and the upper support wall having a
unitary, one-piece construction, wherein
each cutting edge is located at an
intersection of a relief surface and a rake
surface, wherein the rake surface is located
on the peripheral edge surface; and wherein
the upper support wall and the lower
support wall define an acute angle (α)
between them.
290
__________
]11[]21[
]54[
TWO STAGE OPTICAL
AMPLIFIER
]22[
]51[
]71[
]72[
09.10.2002
Int. Cl.8 H04J 014/02
ECI TELECOM LTD.
ILAN HALEVI, IDAN KASPIT,
DAVID HARRIS
ECI TELECOM LTD.,
30 HASIVIM STREET
PETACH TIKVA 49517
]74[
[57] A two-stage optical amplifier
comprising a 1st stage (24) and a 2nd stage
(26), wherein each stage of said two stages
is formed by at least one optical amplifying
unit, the amplifier assembly: being adapted
for inserting OADM in a mid-stage thereof
(43) formed between said two stages, being
provided with a local controlcommunication circuit comprising a
291
152193
‫דרגי‬-‫מגבר אופטי דו‬
‫ פתח תקוה‬,‫ טלקום בע"מ‬.‫איי‬.‫סי‬.‫אי‬
‫ דיויד האריס‬,‫ עידן כספית‬,‫אילן הלוי‬
,‫ טלקום בע"מ‬.‫איי‬.‫סי‬.‫אי‬
‫ פתח תקוה‬,30 ‫רחוב הסיבים‬
control-communication channel between
the two stages, for controlling said 1st and
2nd stages so as to allow dynamic matching
at least one optical characteristic of one
stage to respective at least one
characteristic of the other stage among the
two stages, and prevent automatic shutting
down of one of the stages whenever the
other of the stages is shut down.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
152393
‫תהליך להכנת תולדות אציטל של חומצת‬
‫אספרטית‬
]54[
PROCESS FOR MAKING
ASPARTIC ACID ACETAL
DERIVATIVES
]22[
]31[
]51[
]71[
19.04.2001
60/199329
]32[ 24.04.2000
]33[ US
Int. Cl.8 C07D 307/00, 307/32, 307/66, 405/12, 407/12, C07F 005/02, 009/535
VERTEX PHARMACEUTICALS
INCORPORATED, U.S.A.
WO/2001/081330
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]87[
]74[
[57] A process for making a compound of
the formula
wherein R1 is an optionally substituted
group selected from an aliphatic group,
aralkyl group, heterocyclylalkyl group or
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
aryl group, and R2 is an organic radical,
said process comprising the steps of:
(a) providing a butenolactone of the
formula
292
(b) treating II with an azide N3-Y, where Y
is hydrogen, a silyl group, or a counterion,
to form an azidolactone
(c) converting III to an aminolactone IV or
an iminophosphorane V:
where each R is a radical of a phosphine or
a phosphinite reducing agent; and
(d) coupling either IV or V with R2COOH,
or a reactive equivalent thereof, to form I.
__________
293
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
FUNGICIDAL COMPOSITION
CONTAINING N - (ALPHACYANO- 2- THENYL)- 4 -ETHYL- 2
- (ETHYLAMINO) - 5 THIAZOLECARBOXAMIDE
]22[
]31[
]51[
]71[
09.05.2001
2000-25096
]32[ 10.05.2000
Int. Cl.8 A01N 025/30, C07D 417/00
LG LIFE SCIENCES LTD.,
REPUBLIC OF KOREA
WO/2001/084930
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
152403
– N – ( a ‫תרכובות קוטלי חרקים המכילה‬
– 2 – ‫ – אתיל‬4 – )‫ – תיניל‬2 – ‫ציאנו‬
‫ – תיאזולקרבוקסאמין‬5 – )‫(אתילאמינו‬
]33[
KR
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
[57] A fungicidal composition which
comprises N-(α-cyano-2-thenyl)-4-ethyl-2-
(ethylamino)-5-thiazolecarboxamide
(ethaboxam) of the formula
and polyoxyalkylene alkyl ether wherein
the weight ratio of ethaboxam to
polyoxyalkylene alkyl ether is from about
1:0.5 about 1:10.
__________
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
294
]11[]21[
]54[
DEVICE FOR THE EXTRACTION
OF A SUBSTANCE HAVING A
MOVEABLE COMPONENT
]22[
]31[
]51[
]71[
10.04.2001
00109495.2
]32[ 04.05.2000
Int. Cl.8 A47J 031/44, 031/46
SOCIETE DES PRODUITS NESTLE
S.A., SWITZERLAND
WO/2001/082760
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
[57] Device for the extraction of a
substance for the preparation of a beverage,
comprising: a fixed first part (1), a second
part (2) moveable relative to the first part
along an axis of rotation (3) arranged at the
rear of said two parts, the front of each part
forming a housing (4, 5) for the substance
or cartridge to be extracted, and means (8)
for closing and opening the two
components, said device being
characterized in that it comprises a control
152442
‫מתקן עבור הוצאה של חומר בעל רכיב בר‬
‫הנעה‬
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
(15) and a valve (14) associated with said
control, which are placed on the upper part
of the moveable second component, in
such a way that said control and said valve
are near to the housing for the substance to
be extracted and wherein the valve is
designed to direct hot water arriving via a
conduit (16) for rejection via a conduit (17)
or towards the housing or cartridge via a
conduit (21) upon operation by the control.
__________
295
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
152453
‫גורם לעצירת דימום המכיל מלח של‬
‫חומצה מחמצנת‬
]54[
HEMOSTATIC AGENT
INCLUDING AN OXYACID SALT
]22[
]31[
27.04.2001
60/200207
]32[ 28.04.2000
]33[ US
09/592344
13.06.2000
US
09/766513
19.01.2001
US
Int. Cl.8 A61K 009/00, 031/14, 033/00, A61L 015/18, 015/22
BIOLIFE, L.L.C., U.S.A.
WO/2001/082896
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] A hemostatic agent adapted to be
applied directly onto a bleeding wound
comprising: an effective amount of an
oxyacid salt combined with an effective
amount of an insoluble cation exchange
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
material, said oxyacid salt combining with
blood to promote blood clotting at the
wound, said cation exchange material
forming a protective cover over the wound
as blood is thereby clotted.
__________
]11[]21[
]54[
SUSPENDED CONTAINER FOR
ESSENCES WITH MEANS FOR
THEIR ABSORPTION AND
DIFFUSION OF THEIR PERFUME
TO THE SURROUNDING AMBIENT
]22[
]31[
]51[
]71[
]87[
]74[
17.04.2001
CO2000U000005 ]32[ 28.04.2000
Int. Cl.8 A61L 009/12
ALBERTO GIOVANNONE, ITALY
WO/2001/082982
EITAN, PEARL, LATZER AND COHEN
ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
[57] A container (1) comprising: a cavity
(2) containing perfumed essence; a stopper
(4) enclosing said perfumed essence within
said cavity and defining a space between
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
152462
‫מיכל תלוי לתמציות עם אמצעים‬
‫לספיגתן ולשחרור של ניחוחן לסביבה‬
]33[
IT
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
said stopper and said perfumed essence;
and a cord (5) extending into said stopper,
into said space and extending through said
stopper, outside said space without
296
contacting said perfumed essence, wherein
said cord is one of natural and synthetic
materials suitable to absorb said perfumed
essence and diffuse said perfumed essence
through capillary action.
__________
]11[]21[
]54[
METHOD AND COMPOSITION FOR
ANALYZING A CARBOHYDRATE
POLYMER
]22[
]31[
]51[
]71[
]87[
]74[
03.11.2000
PCT/IL00/00256 ]32[ 04.05.2000
Int. Cl.8 C12Q 001/34
PROCOGNIA (ISRAEL) LTD.
WO/2001/084147
DR. D. GRAESER LTD.,
P.O.B. 2496,
RAANANA
43650
[57] A method for characterizing a
carbohydrate polymer, the method
comprising:
(a) providing a substrate comprising at
least one first saccharide-binding agent
297
152639
‫שיטה ותכשיר לבחינת פולימר סוכרי‬
]33[
WO
‫ אשדוד‬,‫פרוקוגניה (ישראל) בע"מ‬
,‫ גרייזר בע"מ‬.‫ד"ר ד‬
‫ רעננה‬,2496 .‫ד‬.‫ ת‬,
attached to a predetermined location on a
surface of said substrate;
(b) contacting said substrate with a
carbohydrate polymer under conditions
allowing for the formation of a first
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
complex between said first saccharidebinding agent and said carbohydrate
polymer;
(c) contacting said substrate with at least
one second saccharide-binding agent under
conditions allowing for formation of a
second complex between said first complex
and said second saccharide-binding agent
in a second complex, wherein at least one
of said first and second saccharide-binding
agents comprises a plurality of different
saccharide-binding agents;
(d) identifying said first saccharide-binding
agent and second saccharide-binding agent
in said second complex; and (e)
determining a fingerprint of binding of said
first saccharide-binding agent and said
second saccharide-binding agent, wherein
said fingerprint is a compilation of the
binding status of the carbohydrate polymer
and the plurality of first saccharide-binding
agents and second saccharide-binding
agents, thereby characterizing said
carbohydrate polymer.
__________
]11[]21[
152797
‫שיטה ומערכת להפחתה יעילה של נתוני‬
‫תצוגה גרפית לשידור באמצעות מנגנון‬
‫פרוטוקול תובלה רוחב פס נמוך‬
]54[
METHOD AND SYSTEM FOR
EFFICIENTLY REDUCING
GRAPHICAL DISPLAY DATA FOR
TRANSMISSION OVER A LOW
BANDWIDTH TRANSPORT
PROTOCOL MECHANISM
]22[
]31[
29.05.2001
60/207532
]32[ 26.05.2000
]33[ US
60/225217
14.08.2000
US
Int. Cl.8 G06F 003/14, 003/153, 017/30, H04L 029/06
CITRIX SYSTEMS, INC., U.S.A.
WO/2001/092973
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] A method of efficiently reducing the
amount of repetitive graphical data
transmitted to a remote display device, the
method comprising the steps of: searching
a table for an index associated with a
graphical data element, the presence of the
index in the table indicative of a prior
transmission of the graphical data element,
characterized in that the method further
comprises the steps of: upon failing to
locate the index in the table, searching a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
fuzzy database for a fuzzy key associated
with the graphical data element, the
presence of the fuzzy key in the fuzzy
database indicative of a likelihood that the
graphical data element is stored within a
persistent storage memory coupled to the
remote display device, and upon locating
the fuzzy key, transmitting the fuzzy key to
an agent associated with the persistent
storage memory and remote display device.
298
,184891
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
_________
]11[]21[
]54[
TISSUE APPROXIMATION
DEVICE AND A METHOD USING
IT
]22[
]31[
17.05.2001
574603
]32[ 19.05.2000
788118
16.02.2001
816641
22.03.2001
Int. Cl.8 A61B 017/08
COAPT SYSTEMS, INC., U.S.A.
WO/2001/089392
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] An implantable device for placement
on a tissue surface and interior to an
exterior tissue surface comprising:
(a) a biodegradable supportive backing
having:
299
152817
‫התקן לקירוב רקמה ושיטה להשתמש בו‬
]33[
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
(i) at least a first area with a plurality of
biodegradable attachment points extending
from the first area for attaching to a
selected tissue and
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
(ii) a second area discrete from the first
area, wherein the backing has physical
characteristics sufficient to approximate or
to support the selected tissue adjacent the
first area with respect to the second area,
and
(b) the plurality of biodegradable
attachment points extending from the first
area, wherein the plurality of biodegradable
attachment points are configured to attach
to the selected tissue and to distribute
tension between the first area and the
selected tissue.
__________
]11[]21[
]54[
METHOD, SYSTEM AND
COMPUTER PROGRAM
PRODUCT FOR PROVIDING A
DIGITAL VERSION OF A MASSPRODUCED PRINTED PAPER
]22[
]31[
22.05.2001
60/208015
]32[ 26.05.2000
09/690366
16.10.2000
09/690367
16.10.2000
09/690677
16.10.2000
09/690368
16.10.2000
09/690680
16.10.2000
09/690199
16.10.2000
Int. Cl.8 G06F 017/21
NEWSSTAND, INC., U.S.A.
WO/2001/092986
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] A method performed by a computer
system, the method comprising: on a
display device, displaying at least a part of
a likeness of a mass-produced printed
paper, and while first and second
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
152843
‫ מערכת ומוצר תוכנת מחשב‬,‫שיטה‬
‫להמצאת גירסה ספרתית של נייר מודפס‬
‫מיוצר המונית‬
]33[
US
US
US
US
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
predetermined portions of the displayed
part of the likeness are being concurrently
displayed on the display device,
highlighting the first predetermined portion
as being selectable by a user for copying,
300
and preventing the second predetermined
portion from being selectable by the user
for copying.
__________
]11[]21[
152856
‫שיטה סינטטית למתילציה פלואורית של‬
‫כוהלים שעברו הלוגנציה‬
]54[
SYNTHETIC METHOD FOR THE
FLUOROMETHYLATION OF
HALOGENATED ALCOHOLS
]22[
]31[
]51[
]71[
]87[
]74[
30.05.2001
09/587414
]32[ 01.06.2000
]33[ US
Int. Cl.8 C07C 041/00, 041/22, 041/28, 041/50, 043/12
ABBOTT LABORATORIES, U.S.A.
WO/2001/092192
DR. SHLOMO COHEN & CO.,
,'‫ד"ר שלמה כהן ושות‬
124 IBN GABIROL ST.,
‫ תל אביב‬,11490 .‫ד‬.‫ ת‬, 124 ‫אבן גבירול‬
P.O.B. 11490,
TEL AVIV 62038
[57] A method for fluoromethylating
halogenated alcohols, said method
comprising the steps of: providing a
halogenated alcohol of the formula
R1C(CX3)2OH, wherein R1 is selected from
the group consisting of hydrogen, alkyl
groups, alkenyl groups, and alkynyl
groups, and wherein X is selected from the
group consisting of fluorine, bromine,
chlorine, and iodine;
reacting said halogenated alcohol with a
dialkoxymethane of the formula
CH2(OR2)2 in the presence of an acid
catalyst to form an acetal of the formula
R1C(CX3)2OCH2OR3, wherein R2 is an
alkyl group, an alkenyl group, or an
alkynyl group;
chlorinating said acetal with a chlorinating
agent to form a chloromethyl ether of the
formula R1C(CX3)2OCH2Cl; and
fluorinating said chloromethyl ether with a
fluorinating agent to produce a fluoride
compound of the formula
R1C(CX3)2OCH2F.
__________
301
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
CAPSULE CAGE FOR COFFEE
MACHINE
]22[
]31[
]51[
]71[
25.06.2001
00113879.1
]32[ 30.06.2000
Int. Cl.8 A47J 031/40, 031/44
SOCIETE DES PRODUITS NESTLE
S.A., SWITZERLAND
WO/2002/000073
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
[57] A capsule cage (1) which can be
fitted in a coffee machine, comprising: a
water intake channel (4) and a housing (5)
with a longitudinal central axis which is
configured for receiving a capsule to be
extracted; a piercing system (6) for
piercing the capsule being placed
independent from the intake and
comprising at least one blade that is
153129
‫תא לקפסולה עבור מכונת קפה‬
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
configured for piercing at least one slit
having substantially parallel sides into the
capsule with a length and a smaller width,
wherein the blade comprises two side
edges (22, 23) and a cutting edge, at least
one of the two side edges of the blade
having a direction parallel to the
longitudinal central axis of the housing.
__________
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
302
]11[]21[
153158
1 ‫ מטיפוס‬II ‫שימוש חדש בנוגדי אנגיוטנסין‬
‫או תרפויטי‬/‫בייצור תרופה לטיפול מניעתי ו‬
‫של כאבי – ראש וסקולאריים שאינם‬
‫נגרמים מיתר לחץ–דם‬
]54[
USE OF ANGIOTENSIN II TYPE 1
RECEPTOR ANTAGONIST IN
THE MANUFACTURE OF A
MEDICAMENT FOR THE
PROPHYLACTIC AND/OR
THERAPEUTIC TREATMENT OF
A VASCULAR HEADACHE
CONDITION NOT CAUSED BY
HYPERTENSION
]22[
]31[
]51[
]71[
]72[
]87[
]74[
15.06.2001
0002353-1
]32[ 22.06.2000
]33[ SE
Int. Cl.8 A61K 031/395, 031/433, 045/06, C07D 403/10, 403/12
ASTRAZENECA AB, SWEDEN
HARALD SCHRADER
WO/2001/097807
S. HOROWITZ & CO.,
,'‫ הורוביץ ושות‬.‫ש‬
ZION HOUSE,
‫ תל אביב‬,41-45 ‫ שדרות רוטשילד‬,‫בית ציון‬
41-45 ROTHSCHILD BLVD.,
TEL AVIV 65784
[57] Use of an angiotensin II type 1
receptor antagonist for the manufacture of
a medicament for the treatment of a
vascular headache condition not caused by
hypertension, wherein said angiotensin II
type 1 receptor antagonist is a candesartan
cilexetil, as well as pharmaceutically
acceptable salts, solvates and
stereochemical isomers of any of these, and
solvates of such salts.
__________
303
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
EXTRUDED FOAM
REINFORCEMENT
STRUCTURES FOR
INNERSPRING
ASSEMBLIES AND MATTRESSES
]22[
]31[
]51[
]71[
]72[
10.04.2001
09/586164
]32[ 02.06.2000
Int. Cl.8 A47C 027/05
SEALY TECHNOLOGY LLC, U.S.A.
SAID DIMITRY, WILLIAM
FREEMAN
WO/2001/093726
SHIBOLETH, YISRAELI, ROBERTS,
ZISMAN & CO.,
MUSEUM TOWER,
4 BERKOWITZ ST.,
TEL AVIV
64238
]87[
]74[
[57] An innerspring (20) having a plurality
of interconnected coils (22) in a generally
rectangular array and upper and lower
border wires (24, 26) located at top and
bottom ends of coils of the array about a
perimeter of the innerspring, a corner coil
reinforcement member (12) positioned
about each corner coil of the rectangular
array of the innerspring, the corner coil
reinforcement member having a generally
cylindrical body portion dimensioned to
extend from an upper border wire to a
lower border wire, and having a cylindrical
internal cavity (42) configured to fit
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
153233
‫מבני גומאוויר המופקים באקסטרוזיה‬
‫לחיזוק מכלולי קפיצים פנימיים‬
‫ומזרונים‬
]33[
US
,'‫ זיסמן ושות‬,‫ רוברטס‬,‫ ישראלי‬,‫שיבולת‬
‫ תל אביב‬,4'‫ רחוב ברקוביץ‬,‫מגדל המוזיאון‬
substantially entirely about an outer
circumference of the coil, an exterior wall
(41) having an external surface configured
to be generally aligned with a bend in the
upper and lower border wire at the corners
of the innerspring, and an interior wall (43)
configured to fit between a corner coil and
at least two coils adjacent to a corner coil,
the exterior wall having a radius of
curvature different than a radius of
curvature of the interior wall, and the
exterior wall having a thickness greater
than a thickness of the interior wall.
304
__________
]11[]21[
]54[
APPARATUS FACILITATING USE
OF COTS ELECTRONICS IN
HARSH ENVIRONMENTS
]22[
]31[
]51[
]71[
24.05.2001
09/590209
]32[ 08.06.2000
Int. Cl.8 H05K 007/20
LOCKHEED MARTIN
CORPORATION, U.S.A.
WO/2001/095686
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
[57] Apparatus for permitting commercialoff-the-shelf (COTS) electronics to be
utilized in harsh environments for which
305
153274
‫התקן המאפשר שימוש באלקטרוניקה‬
‫מהמדףבסביבות בעלות תנאים קשים‬
]33[
US
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
said COTS electronics are not designed
including: an environmentally sealed
enclosure (10); mounts (22) in said
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
enclosure for holding said COTS
electronics; a temperature sensor within
said enclosure; an environmental control
unit (25) (ECU) in said enclosure, said
ECU including a cooler (52) which, when
operated, cools fluid passing thereover, a
heater (54) which, when operated, heats
fluid passing thereover, and controls, at
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
least in part responsive to said temperature
sensor, for selectively operating said cooler
and said heater; and a mechanism (60) for
circulating fluid in said enclosure through
said mounts and said ECU, the temperature
of the fluid being appropriately controlled
as it circulates through the ECU.
306
‫__________‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫‪307‬‬
]11[]21[
]54[
METHOD FOR PREPARING A
PHARMACEUTICAL
COMPOSITION
]22[
]31[
]51[
]71[
18.06.2001
00113535.9
]32[ 27.06.2000
Int. Cl.8 A61K 009/00, 009/20
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2002/000201
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] A method for the preparation of a
pharmaceutical composition comprising
the steps of
(a) preparing a solution or a homogeneous
dispersion of a liquid and a compound
selected from the group consisting of one
or more pharmaceutically active
compounds, one or more pharmaceutically
suitable excipients, and mixtures thereof,
followed by
153282
‫שיטה להכנת תכשיר תרופתי‬
]33[
EP
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(b) expansion of the solution or
homogeneous dispersion by exposing it to
a reduction in pressure to between about 30
and about 150 Torr under conditions such
that the solution or homogeneous
dispersion does not boil; and
(c) stabilization of the expanded solution or
homogeneous dispersion to form the
pharmaceutical composition.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
153406
308
‫ תכשירים המכילים‬,‫ציקלופנטאן אינדולים‬
‫תרכובות אלו ושימוש בהם להכנת תרופות‬
‫לטיפול במחלות מתווכות פרוסטגלנדין‬
]54[
CYCLOPENTANOINDOLES,
COMPOSITIONS CONTAINING
SUCH COMPOUNDS AND USE
THEREOF FOR PREPARING
MEDICAMENTS FOR TREATING
PROSTAGLANDIN MEDIATED
DISEASES
]22[
]31[
]51[
23.07.2001
60/220683
]32[ 25.07.2000
]33[ US
Int. Cl.8 A61K 031/404, 031/407, A61P 011/00, C07D 209/80, 209/96, 405/10,
409/10, 413/10, 491/22
MERCK FROSST CANADA LTD
WO/2002/008186
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]71[
]87[
]74[
[57] Compounds of the formula
and pharmaceutically acceptable salts,
hydrates and esters thereof, wherein:
R1, R2 and R3 are each independently
selected from the group consisting of:
(1) hydrogen, and
(2) Rc,
R4 and R5 are each independently selected
from the group consisting of:
(1) H,
(2) F,
(3) CN,
(4) C1-6 alkyl,
(5) ORa, and
(6) S(O)nC1-6 alkyl,
wherein each of said alkyl groups is
optionally substituted with halogen, or
309
R4 and R5 on the same carbon atom may
represent an oxo, or
R4 and R5 on the same carbon atom or on
adjacent carbon atoms taken together form
a 3- or 4-membered ring containing 0 or 1
heteroatom selected from N, S, or O
optionally substituted with one or two
groups selected from F, CF3 and CH3;
R6 is selected from the group consisting of:
(1) H,
(2) C1-6 alkyl optionally substituted with
one to six groups independently selected
from ORa and halogen, and
(3) heterocyclyl optionally substituted with
one to four halogen; or
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
R5 and R6 attached on adjacent carbon
atoms together form a 3- or 4-membered
ring containing 0 or 1 heteroatom selected
from N, S, or O optionally substituted with
one or two groups selected from F, CF3 and
CH3;
X is selected from the group consisting of:
C=O, SO2, and C1-4 alkyl wherein said
alkyl is optionally substituted with one to
six halogen;
Ar is aryl or heteroaryl each optionally
substituted with one to four groups
independently selected from Rc;
Q is C1-6 alkyl optionally substituted with
one to six groups independently selected
from:
(1) halogen,
(2) aryl,
(3) heteoraryl,
(4) OH,
(5) OC1-6 alkyl,
(6) COOH,
(7) CONRaRb,
(8) C(O)NSO2R7,
(9) tetrazolyl,
wherein aryl, heteroaryl and alkyl are each
optionally substituted with one to six
groups independently selected from
halogen, CF3, and COOH; or
Q and R6 together form a 3- or 4membered ring optionally containing a
heteroatom selected from N, S and O, and
optionally substituted with one or two
groups independently selected from:
(1) halogen,
(2) oxo,
(3) ORa,
(4) COOH,
(5) C(O)NHSO2R7, and
(6) tetrazolyl,
R7 is selected from the group consisting of:
(1) C1-6 alkyl optionally substituted with
one to six halogen,
(2) aryl, and
(3) heteroaryl,
wherein said aryl and heteroaryl are
optionally substituted with halogen, OC1-5
alkyl, C1-5 alkyl and wherein said alkyl is
optionally substituted with one to six
halogen;
Ra and Rb are independently selected from
hydrogen and C1-6 alkyl optionally
substituted with one to six halogen;
Rc is
(1) halogen,
(2) CN,
(3) C1-6 alkyl optionally substituted with
one to six groups independently selected
from halogen, NRaRb, C(O)Ra,
C(ORa)RaRb, and ORa,
(4) C2-6 alkenyl optionally substituted with
one to six groups independently selected
from halogen and ORa,
(5) heterocyclyl,
(6) aryl,
(7) heteroaryl,
(8) C(O)Ra,
(9) C(ORa)RaRb,
(10) C(O)ORa,
(11) CONRaRb,
(12) OCONRaRb,
(13) S(O)nR7,
(14) NRaC(O)OC1-6 alkyl, wherein alkyl is
optionally substituted with one to six
halogen and
(15) S(O)nNRaRb, wherein heterocyclyl,
aryl, heteroaryl are optionally substituted
with one to four groups independently
selected from halogen;
n is 0, 1 or 2.
__________
]11[]21[
]54[
METHOD OF PRODUCTION OF
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
153495
‫שיטת ייצור של בנזנים מותמרים‬
310
SUBSTITUTED BENZENES
]22[
]31[
]51[
]71[
]74[
17.12.2002
2002-003180 ]32[ 10.01.2002
]33[ JP
Int. Cl.8 C07C 041/26, 043/23, 069/00, 069/63
SUMITOMO CHEMICAL
COMPANY, LIMITED, JAPAN
DR. YITZHAK HESS & PARTNERS,
,‫ד"ר יצחק הס ושותפיו‬
279 HAYARKON ST.,
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
P.O.B. 6451,
TEL AVIV 61063
[57] Method of production of an ester of
the formula
wherein R represents a 3,3-dihal-2propenyl group or a benzyl group
optionally substituted by at least one
halogen atom, which comprises reacting a
compound of the formula
wherein X is a chlorine atom or bromine
atom and R is as defined above. with an
alkali metal salt of acetic acid in the
presence of an aromatic hydrocarbon.
__________
]11[]21[
311
153541
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
USE OF 7-ALPHA
HYDROXYEPIANDROSTERONE
FOR THE MANUFACTURE OF
PHARMACEUTICAL
COMPOSITIONS
]22[
]31[
]51[
]71[
29.06.2001
0016022.6
]32[ 29.06.2000
Int. Cl.8 C07J 001/00
HUNTER-FLEMING LIMITED,
UNITED KINGDOM
WO/2002/000225
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] The use of 7αhydroxyepiandrosterone for the
manufacture of a medicament for
‫–אלפא‬7–‫שימוש ב‬
‫הידרוקסיאפיאפיאנדרוסטירון להכנת‬
‫תכשירי רוקחות‬
]33[
GB
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
protection against acute or chronic
neuronal damage.
__________
]11[]21[
153559
‫תרכובות לטיפול בהרפיה פונדית פגומה‬
]54[
COMPOUNDS FOR TREATING
IMPAIRED FUNDIC
RELAXATION
]22[
]31[
]51[
13.06.2001
00202180.6
]32[ 22.06.2000
]33[ EP
Int. Cl.8 A61K 031/4353, 031/4985, 031/5025, 031/519, A61P 001/00, C07D 491/04,
497/04, 498/04
JANSSEN PHARMACEUTICA N.V.,
BELGIUM
WO/2001/098306
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]71[
]87[
]74[
[57] Compounds of the formula
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
312
a stereochemically isomeric form thereof,
an N-oxide form thereof, a
pharmaceutically acceptable acid addition
salt thereof, or a quaternary ammonium salt
thereof, wherein
-a1=a2=a3=a4- is a bivalent radical of the
formula
N=CH-CH=CH-CH=N-CH=CH-CH=CH-N=CH-CH=CH-CH=N-N=N-CH=CH-N=CH-N=CH-N=CH-CH=N-CH=N-N=CH-CH=N-CH=N-CH=CH-N=N-
(a-1),
(a-2),
(a-3),
(a-4),
(a-5),
(a-6),
(a-7),
(a-8),
(a-9), or
(a-10);
-Z1-Z2- is a bivalent radical of the formula
-Y1-CH(R4)-CH2-Y1-CH(R4)-O-Y1-CH(R4)-CH2-O-Y1-CH(R4)-CH2-S-Y1-CH(R4)-CH2-NH-Y1-CH(R4)-CH2-CH2-Y1-CH(R4)-CH2-CH2-CH2-Y1-CH(R4)=CH-Y1-CH(R4)=CH-CH2-Y1-CH(R4)-CH=CH-Y1-CH(R4)=CH-CH2-CH2
-Y1-CH2-CH(R4)wherein, where possible, optionally one or
two hydrogen atoms on the same or a
different carbon or nitrogen atom may be
replaced by hydroxy, C1-4 alkyloxy C1-4
alkyl, C1-4 alkylcarbonyl, or C1-6 alkyl
optionally substituted with halo, hydroxy,
C3-6 cycloalkyl or phenyl;
Y1 is oxygen or sulfur;
Alk1 is C1-4 alkylcarbonyl, carbonyl C1-4
alkyl, C1-4 alkylcarbonyl C1-4 alkyl,
carbonyl, or C1-6 alkanediyl optionally
substituted with hydroxy, halo, amino,
aminocarbonyl, mono- or di(C1-4 alkyl)
aminocarbonyl, C1-4 alkyloxy C1-4 alkyl, C14 alkylcarbonyloxy, C1-4 alkylcarbonyloxy
C1-4 alkyloxycarbonyloxy, C1-4
alkyloxyimino, phenyl C1-4
313
(b-1),
(b-2),
(b-3),
(b-4),
(b-5),
(b-6),
(b-7),
(b-8),
(b-9),
(b-10), or
(b-11), or
(b-12),
alkylamino, C1-4 alkyloxycarbonyl C1-4
alkenyl, cyano C1-6 alkenyl or C1-6
cycloalkylcarbonyloxy C1-4
alkyloxycarbonyloxy;
R1, R2 and R3 are each independently
selected from hydrogen, C1-6 alkyl, C3-6
alkenyl, C1-6 alkyloxy, hydroxycarbonyl,
trihalomethyl, trihalomethoxy, halo,
hydroxy, cyano, nitro, amino, C1-6
alkylcarbonylamino, C1-6 alkyloxycarbonyl,
C1-4 alkylcarbonyloxy, aminocarbonyl,
mono- or di(C1-6 alkyl) aminocarbonyl,
amino C1-6 alkyl, mono- or di(C1-6 alkyl)
amino C1-6 alkyl, C1-4 alkylcarbonyloxy C1-4
alkyloxy-carbonyloxy, or C3-6
cycloalkylcarbonyloxy C1-4
alkyloxycarbonyloxy;
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
R4 is hydrogen, hydroxycarbonyl, phenyl,
aminocarbonyl, mono- or di(C1-4 alkyl)
aminocarbonyl, C1-4 alkyloxy C1-4 alkyl, C14 alkyloxycarbonyl, N-pyrolidinylcarbonyl,
N-piperidinylcarbonyl, Nhomopiperidinylcarbonyl, C1-4
alkylcarbonyloxy C1-4 alkyloxycarbonyl,
C1-4 alkyloxycarbonyl C1-4 alkyl, C3-6
cycloalkylcarbonyloxy C1-4
alkyloxycarbonyloxy, or C1-6 alkyl
optionally substituted with hydroxy, cyano,
amino, phenyl, mono- or di(C1-4 alkyl)
amino, or mono- or di(C1-4 alkyl)
aminocarbonyl;
-A- is a bivalent radical of the formula
wherein m is 0 or 1;
Alk2 is a bivalent radical independently
selected from C1-4 alkylcarbonyl C1-4 alkyl;
phenyl; C3-6 cycloalkylcarbonyloxy C1-4
alkyloxycarbonyloxy; C3-8 cycloalkanediyl
optionally substituted with one or more
halo, hydroxy, hydroxycarbonyl, hydroxy
C1-4 alkyl, C1-4 alkyloxy, C1-4 alkyloxy C1-4
alkyl, C1-4 alkyloxycarbonyl, C1-4
alkylcarbonyloxy C1-4
alkyloxycarbonyloxy, C3-6
cycloalkylcarbonyloxy C1-4
alkyloxycarbonyloxy, phenyl; or C1-6 alkyl
optionally substituted with one or more
hydroxy, halo, amino, hydroxycarbonyl,
hydroxy C1-4 alkyl, C1-4 alkyloxy, C1-4
alkyloxy C1-4 alkyl, C1-4 alkyloxycarbonyl,
C1-4 alkylcarbonyloxy C1-4
alkyloxycarbonyloxy, C3-6 cycloalkyl,
aminocarbonyl, mono- or di(C1-4 alkyl)
aminocarbonyl, or C1-6 alkyl wherein the
C1-6 alkyl together with the carbon atom to
which it is attached may form a C3-6
cycloalkyl;
R6 is hydrogen, C1-4 alkyl, halo, hydroxy,
hydroxy C1-4 alkyl, C1-4 alkyloxy, amino C14 alkyl, C1-4 alkyloxycarbonyl, C1-4
alkylcarbonyloxy C1-4 alkyloxycarbonyl,
amino, hydroxycarbonyl, aminocarbonyl,
mono- or di(C1-4 alkyl) aminocarbonyl, or
C3-6 cycloalkylcarbonyloxy C1-4
alkyloxycarbonyloxy;
R5 is a radical of the formula
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
314
wherein n is 1 or 2;
p1 is 0, and p2 is 1 or 2; or p1 is 1 or 2, and
p2 is 0;
X is oxygen, sulfur, NR9 or CHNO2;
Y2 is oxygen or sulfur;
R7 is hydrogen, C1-6 alkyl, C3-6 cycloalkyl,
phenyl or phenylemthyl;
R8 is C1-6 alkyl, C3-6 cycloalkyl, phenyl or
phenylmethyl;
R9 is cyano, C1-6 alkyl, C3-6 cycloalkyl, C1-6
alkoxycarbonyl or aminocarbonyl;
R10 is hydrogen or C1-6 alkyl;
or R9 and R10 taken together with the
nitrogen atom to which they are attached
may form a pyrrolidinyl, piperidinyl,
homopiperidinyl, piperazinyl, or
morpholinyl group, optionally substituted
with C1-4 alkyl or C1-4 alkyloxy; and
Q is a bivalent radical of the formula
wherein optionally one or two hydrogen
atoms on the same or different carbon atom
may be replaced by C1-4 alkyl, hydroxy or
phenyl, or
Q is a bivalent radical of the formula
__________
]11[]21[
]54[
HEMOGLOBIN SENSOR
]22[
]31[
12.07.2001
616556
615691
315
]32[
14.07.2000
14.07.2000
153582
‫חיישן להמוגלובין‬
]33[
US
US
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]51[
]71[
]87[
]74[
616433
14.07.2000
616512
14.07.2000
Int. Cl.8 G01N 027/327
LIFESCAN, INC., U.S.A.
WO/2002/006828
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A device for detecting a presence or
an absence of hemoglobin in an aqueous
sample, the device comprising an
electrochemical cell (1) having a sensing
chamber (4), a first electrode (2), a second
electrode (6), an aperture (8) for admitting
the sample into the sensing chamber, and a
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
single redox reagent and a lysing agent
contained within the sensing chamber
wherein the single redox reagent is capable
of being reduced by hemoglobin to
generate an electrical signal indicative of
the presence or absence of hemoglobin.
__________
]11[]21[
]54[
ANTIOXIDANT SENSOR
]22[
]31[
12.07.2001
616512
616556
]32[
14.07.2000
14.07.2000
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
153584
‫גלאי למדידת נוגדי חמצון‬
]33[
US
US
316
]51[
]71[
]87[
]74[
615691
14.07.2000
616433
14.07.2000
Int. Cl.8 G01N 033/14
LIFESCAN, INC., U.S.A.
WO/2002/006806
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A device for detecting a presence or
an absence of a redox reactive analyte in an
aqueous sample, the device comprising an
electrochemical cell having a sensing
chamber, a first electrode, a second
electrode, an aperture for admitting the
sample into the sensing chamber, and a
reagent contained within the sensing
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
chamber, wherein the electrochemical cell
is designed to be disposed of after use in a
single experiment, and wherein the reagent
is capable of undergoing a redox reaction
directly with the analyte to generate an
electrical signal indicative of the presence
or absence of the analyte.
__________
]11[]21[
]54[
MARKING DEVICE FOR
ELECTRONIC PRESENTATION
BOARD
]22[
]31[
]51[
]62[
]71[
]87[
]74[
26.02.1998
808570
]32[ 28.02.1997
Int. Cl.8 G08C 021/00
DIVISION FROM 131373
LUIDIA, INC., U.S.A.
WO/1998/038596
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] An eraser device for use with a
presentation board digitizer system, the
eraser device comprising: a handle; an
eraser element having a substantially flat
eraser surface; and a pivot joint connecting
between said handle and said eraser
element, said pivot joint having two
317
153694
‫התקן מחיקה עבור לוח מצגת אלקטרוני‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
degrees of rotational freedom such that, in
use, said eraser element assumes an
orientation with said eraser surface parallel
to a surface of the presentation board
substantially independent of the orientation
at which said handle is held.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
]22[
]31[
]51[
]71[
]87[
]74[
USE OF OSPEMIFENE FOR THE
MANUFACTURE OF A
PHARMACEUTICAL
COMPOSITION FOR THE
TREATMENT OF CLIMACTERIC
DISORDERS DURING OR AFTER
THE MENOPAUSE
02.05.2001
09/625199
]32[ 21.07.2000
Int. Cl.8 C07C 217/00
HORMOS MEDICAL
CORPORATION, FINLAND
WO/2002/007718
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
[57] The use of the compound
(deaminohydroxy) toremifene or a
pharmaceutically acceptable salt or ester or
metabolite thereof for the manufacture of a
153823
‫שימוש באוספימיפן עבור הייצור של‬
‫תרכובת תכשיר רוקחות עבור הטיפול של‬
‫הפרעות קלימקטריות בנשים בזמן או‬
‫לאחר גיל הבלות‬
]33[
US
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
pharmaceutical composition for the
treatment of vaginal dryness or sexual
dysfunction in women during or after the
menopause.
_____________
]11[]21[
]54[
METHOD OF PRODUCTION OF
AN ETHER COMPOUND
]22[
15.01.2003
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
153962
‫שיטת ייצור של תרכובת אתר‬
318
]31[
]51[
]71[
]74[
2002-016613 ]32[ 25.01.2002
Int. Cl.8 C07D 213/62
SUMITOMO CHEMICAL
COMPANY, LIMITED, JAPAN
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]33[
JP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
[57] Method of production of an ether
compound of the formula
wherein R1 represents a benzyl group
optionally substituted with a halogen
atom(s) or 3,3-dihalo-2-propenyl group and
R2 represents a hydrogen atom or halogen
atom, which comprises reacting an alcohol
compound of the formula
with a pyridine compound of the formula
in a hydrocarbon solvent in the presence of
an alkali hydroxide or alkaline earth
hydroxide with distilling off water from the
reaction mixture.
__________
]11[]21[
319
153995
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫–אמינופירידין ותכשירי רוקחות‬2 ‫תולדות‬
‫המכילים אותן‬
]54[
2-AMINOPYRIDINE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS CONTAINING
THE SAME
]22[
]31[
]51[
09.08.2001
2000-245056 ]32[ 11.08.2000
]33[ JP
Int. Cl.8 A61K 031/455, 031/695, A61P 001/00, 003/00, 025/00, 043/00, C07D
213/22, 213/73, 401/04, 405/04, 405/14, 409/04, 417/04, C07F 007/08
EISAI R&D MANAGEMENT CO.,
LTD., JAPAN
WO/2002/014282
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]71[
]87[
]74[
[57] Compounds of the formula
(wherein R1 represents cyano group,
carboxyl group or an optionally substituted
carbamoyl group;
R2 represents hydrogen atom, hydroxyl
group, an optionally substituted C1-6 alkoxy
group, an optionally substituted C6-14
aromatic hydrocarbon cyclic group or an
optionally substituted 5- to 14-membered
aromatic heterocyclic group; and R3 and R4
are the same as or different from each other
and each represents a C3-8 cycloalkyl
group, a C3-8 cycloalkenyl group, a C6-14
aromatic hydrocarbon cyclic group, a 5- to
14-membered non-aromatic heterocyclic
group or a 5- to 14-membered aromatic
heterocyclic group which may have a
substituent group, respectively, provided
that the cases where (1) R1 is cyano group,
R2 is hydrogen atom, and each of R3 and
R4 is phenyl group, (3) R1 is cyano group,
R2 is 4-(3,4-dichlorophenyl)-1-oxo-2(1H)phthalazinyl group, (4) R1 is cyano group,
R2 is hydrogen atom, R3 is 4-pyridyl group
and R4 is 1-piperazinyl group, (5) R1 is
cyano group, R2 is hydrogen atom, R3 is 4pyridyl group and R4 is a 1-pyridyl group,
(6) R1 is cyano group, R2 is hydrogen atom,
R3 is 4-pyridyl group and R4 is
4-diphenylmethyl-1-piperazinyl group, (7)
R1 is cyano group, R2 is hydrogen atom, R3
is 4-pyridyl group and R4 is 4-morpholinyl
group, (8) R1 is cyano group, R2 is 4methylphenyl group, and each of R3 and R4
is phenyl group and (9) R1 is cyano group,
and each of R2, R3 and R4 is phenyl group
are excluded) or salts thereof.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
154079
320
‫–פניל–פירידין המשמשות‬4 ‫תולדות‬
1–‫כאנטגוניסטים לקולטן נאורוקינין‬
]54[
4-PHENYL-PYRIDINE
DERIVATIVES AS NEUROKININ1 RECEPTOR ANTAGONISTS
]22[
]31[
]51[
27.07.2001
00117003.4
]32[ 08.08.2000
]33[ EP
Int. Cl.8 A61K 031/4427, 031/455, A61P 025/00, 029/02, C07D 213/22, 213/24,
213/60, 213/72, 213/78, 401/04, 409/04, 413/04, 417/04
F. HOFFMANN-LA ROCHE AG,
SWITZERLAND
WO/2002/016324
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]71[
]87[
]74[
[57] Compounds of the formula
wherein R is hydrogen or halogen;
R1 is –(C≡C)mR1',
wherein R1' is
(a) cyano, or the following groups:
(b)
with the exception of m = 0;
(c) –C(O)NR'R''
(d) –C(O)O(CH2)mR5,
(e) –C(O)R5,
(f) –N(OH)-(CH2)mR5,
(g) if m for R1 is 0, R1' is –N(CH3)C(O)CH2OH, -NH-(CO)CH2OH or –
NH(CO)CH2OC(O)CH3,
(h) –N[C(O)-R']2,
(i) –OR6,
(j) –(CH2)m-SR6, -(CH2)m-S(O)R6, or –
(CH2)m-S(O)2R6,
(k) aryl, optionally substituted by one or
more substituents, selected from halogen,
trifluoromethyl, C1-7-alkyl, C1-7-alkoxy,
cyano, hydroxy, -NR'R'', nitro, -(CH2)nOR',
-C(O)NR'R'', -C(O)OR' or –C(O)R',
(l) is a five or six membered heteroaryl
group, containing one to four heteroatoms,
selected from N, O or S and may be
optionally substituted by one or more
substituents, selected from halogen,
trifluoromethyl, C1-7-alkyl, C1-7-alkoxy,
cyano, hydroxy, -NR'R'', nitro, -(CH2)nOR',
-C(O)OR', -C(O)NR'R'' or –C(O)R',
321
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
(m) is a five or six membered saturated
cyclic tertiary amine of the group
which may contain one additional
heteroatom, selected from N, O or S;
R'/R'' are independently from each other
hydrogen, hydroxy, C1-7-alkyl, C3-6cycloalkyl or aryl, wherein the C1-7-alkyl,
C3-6-cycloalkyl or aryl group may be
optionally substituted by one or more
substituents, selected from halogen,
trifluoromethyl, C1-7-alkyl, C1-7-alkoxy,
cyano, hydroxy, -NR'''R'''', nitro, (CH2)nOR''', -C(O)NR'''R'''', -C(O)OR''' or –
C(O)R''',
R'''/'''' are independently from each other
hydrogen, C1-7-alkyl, C3-6-cycloalkyl or
aryl,
R5 is hydrogen, cyano, hydroxy, halogen,
trifluoromethyl, -C(O)OR', -OC(O)R or
aryl, optionally substituted by one or more
substituents, selected from halogen,
trifluoromethyl, C1-7-alkyl, C1-7-alkoxy,
cyano, hydroxy, -NR'R'', nitro, -(CH2)nOR',
-C(O)NR'R'', -C(O)OR' or –C(O)R', or is a
five or six membered heteroaryl group,
containing one to four heteroatoms,
selected from N, O or S and may be
optionally substituted by one or more
substituents, selected from halogen,
trifluoromethyl, C1-7-alkyl, C1-7-alkoxy,
cyano, hydroxy, -NR'R'', nitro, -(CH2)nOR'
–C(O)NR'R'', -C(O)OR' or –(C(O)R'
R6 is hydrogen, C1-7-alkyl, trifluoromethyl,
or aryl, wherein the C1-7-alkyl or aryl group
may be optionally substituted by one or
more substituents, selected from halogen,
trifluoromethyl, C1-7-alkyl, C1-7-alkoxy,
cyano, hydroxy, -NR'R'', nitro, C(O)NR'R'', -(CH2)nOR', -C(O)OR' or –
C(O)R', or is a five or six membered
heteroaryl group, containing one to four
heteroatoms, selected from N, O or S and
may be optionally substituted by one or
more substituents, selected from halogen,
trifluoromethyl, C1-7-alkyl, C1-7-alkoxy,
cyano, hydroxy, -NR'R'', nitro, -(CH2)nOR',
-C(O)NR'R'', -C(O)OR' or –C(O)R',
R7 is –C(O)-(CH2)mOH or an oxo group;
R2 is hydrogen, C1-7-alkyl, C1-7-alkoxy,
halogen or CF3;
R3/R3' are independently from each other
hydrogen, C1-7-alkyl or form together with
the carbon atom to which they are attached
a C3-6-cycloalkyl group;
R4/R4' are independently from each other
hydrogen, halogen, CF3, C1-7-alkyl or C1-7alkoxy;
R and R2 or R4 and R4' may be together –
CH=CH-CH=CH-, optionally substituted
by one or two substituents selected from
C1-7-alkyl, halogen or C1-7-alkoxy;
X is –C(O)N(R8)-, -(CH2)PO-, (CH2)pN(R8)-, -N(R8)C(O)- or –N(R8)(CH2)p-;
wherein R8 is hydrogen or C1-7-alkyl;
n is 1 or 2;
m is 0, 1, 2, 3 or 4;
o is 1 or 2;
and p is 1 or 2; and pharmaceutically
acceptable acid addition salts thereof.
__________
]11[]21[
]54[
VCD-ON-DEMAND DEBUG
SYSTEM AND METHOD
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
154481
‫ הפועלת על‬DEBUG VCD ‫מערכת ושיטה‬
322
‫פי דרישה‬
]22[
]51[
]71[
]87[
]74[
14.08.2001
Int. Cl.8 G06F 009/455, 017/50
VERISITY DESIGN, INC., U.S.A.
WO/2003/017099
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A method of creating a record of a
debug session for a hardware modeled
design on demand, comprising: selecting a
simulation session range; selecting a
simulation target range, wherein the
simulation target range is within the
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
simulation session, and generating a value
change dump (VCD) file by dumping state
information from the hardware modeled
design for the selected simulation target
range.
__________
]11[]21[
]54[
323
OPTICAL DISK
154770
‫דיסק אופטי‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]22[
]31[
]51[
]71[
]87[
]74[
13.09.2001
2000-280242 ]32[ 14.09.2000
Int. Cl.8 B32B 003/02, G11B 007/24
ORIENT INSTRUMENT COMPUTER
CO., LTD., JAPAN
WO/2002/023545
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] An optical disk, comprising: a disk
substrate made of transparent synthetic
resins, wherein said disk substrate has a
chucking central aperture (5), and a
peripheral portion of said chucking central
portion constitutes a clamping area (6); and
an elastic film (10) for label printing, said
elastic film being fixed on an upper surface
of said disk substrate so as to cover said
]33[
JP
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
chucking central aperture, whereby at least
a portion (10a) of said film corresponding
to said chucking central aperture expands
when a disk chuck for chucking said
optical disk is inserted into said chucking
central aperture and contracts when said
disk chuck is pulled out of said chucking
central aperture.
__________
]11[]21[
]54[
METHOD AND DEVICE FOR
CONVEYING MEDIA
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
154779
‫שיטה והתקן להעברת תווך‬
324
]22[
]31[
]51[
]71[
]87[
]74[
14.09.2001
10045866.1
]32[ 14.09.2000
10054126.7
31.10.2000
10137798.3
06.08.2001
Int. Cl.8 F04B 043/12
JAN W. BEENKER, GERMANY
WO/2002/023043
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] Method for conveying conveyable, in
particular gaseous, liquid, paste-like or
freeflowing, media within a conveying
chamber (14) having at least one inlet (15)
and an outlet (16) and by means of at least
one resiliently compliant wall element (11),
which is driven transversely or
longitudinally to the conveyance direction
of the medium, of the conveying chamber,
characterized in that the drive is exerted as
a pulsating wave motion, in that the
resiliently compliant wall element is
]33[
DE
DE
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
resistant to bending, in that the force is
introduced into the resiliently compliant
wall element via articulated, discrete force
introduction points, in that, owing to the
bending-resistant configuration of the
resilient wall element, the wave motion
generated by deflection at the discrete force
introduction points continues beyond the
force introduction points, and in that, as a
result, a migrating wave oriented in a
defined direction is generated in the
medium for the conveyance thereof.
__________
]11[]21[
]54[
325
PROCESS FOR THE PRODUCTION
OF OXABISPIDINES
154803
‫תהליך לייצור אוקסביספידינים‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]22[
]31[
]51[
]71[
]87[
]74[
01.10.2001
1-2000-02701
]32[ 02.10.2000
PCT/SE00/01994
13.10.2000
Int. Cl.8 C07D 498/08
ASTRAZENECA AB, SWEDEN
WO/2002/028864
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]33[
PH
WO
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
[57] Process for the preparation of a
compound of the formula
wherein A represents a direct bond –J-, -JN(R19)- or –J-O- (in which latter two
groups, N(R19)- or O- is attached to the
carbon atom bearing R2 and R3);
B represents –Z-, -Z-N(R20)-, -N(R20-Z-, Z-S(O)n-, -Z-O- (in which latter two
groups, Z is attached to the carbon atom
bearing R2 and R3),
-N(R20)C(O)O-Z-, (in which latter group, N(R20) is attached to the carbon atom
bearing R2 and R3) or –C(O)NR(R20)- (in
which latter group,
-C(O) is attached to the carbon atom
bearing R2 and R3);
J represents C1-6 alkylene optionally
substituted by one or more substituents
selected from –OH, halo and amino;
Z represents a direct bond or C1-4 alkylene;
n represents 0, 1 or 2;
R19 and R20 independently represents H or
C1-6 alkyl;
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
G represents CH or N;
and R1, R2, R3, R4, R41 to R46 are as defined
in the specification,
provided that (a) when A represents –JN(R19)- or –J-O-, then:
(i) J does not represent C1 alkylene; and
(ii) B does not represent –N(R20)-, -N(R20)Z- (in which latter group N(R20) is attached
to the carbon atom bearing R2 and R3), S(O)n-, -O- or –N(R20)C(O)O-Z when R2
and R3 do not together represent =O; and
(b) when R2 represents –OR13 or –
N(R14)(R15), then:
(i) A does not represent –J-N(R19)- or –JO-; and
(ii) B does not represent –N(R20)-, -N(R20)Z- (in which latter group N(R20) is attached
to the carbon atom bearing R2 and R3), S(O)n-, -O- or –N(R20)C(O)O-Z-; which
process comprises the dehydrative
cyclisation of a compound of the formula
326
__________
]11[]21[
]54[
VALVE METAL POWDERS AND
PROCESS FOR PRODUCING
THEM
]22[
]31[
]51[
]71[
]74[
10.03.2003
10210876.5
]32[ 12.03.2002
Int. Cl.8 C01G 033/00, C22B 005/00
H.C. STARCK GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] Process for producing a valve metal
powder, including the steps of:
(a) producing a precursor of preformed
morphology;
(b) converting the precursor into an oxide
of the valve metal,
(c) stabilizing the morphology of the oxide
by heat treatment, and
(d) reducing the stabilized oxide while
retaining the morphology, thereby forming
said valve metal powder, wherein said
precursor has a morphology comprising a
154827
‫אבקות מתכת ותהליך ליצורן‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
primary structure, a secondary structure
and a tertiary structure, and said valve
metal powder has a morphology
comprising a primary structure, a
secondary structure and a tertiary structure,
further wherein said stabilization step is
performed such that the secondary
structure of said valve metal powder
corresponds to the secondary structure of
said precursor, and the tertiary structure of
said valve metal powder corresponds to the
tertiary structure of said precursor.
__________
]11[]21[
]54[
DUAL-EDGE M/N COUNTER
]22[
]31[
12.09.2001
09/662080
327
]32[
14.09.2000
154899
)‫תדר נכנס‬/‫ (תדר יוצא‬M/N ‫מונה דו–צדדי‬
]33[
US
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]51[
]71[
]87[
]74[
Int. Cl.8 H03K 023/68
QUALCOMM INCORPORATED,
U.S.A.
WO/2002/023725
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A counter comprising: first means
(12) for receiving a first clock signal
having a frequency of N cycles per second
and outputting a second clock signal
having a frequency of M cycles per second,
each cycle having a rising edge and trailing
edge, and said first means including an
accumulator having a rollover point at
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
which an instantaneous count thereof
exceeds the value of N-M; second means
(14) for ascertaining whether said rising
edge or said trailing edge of said second
clock signal is closer to said rollover point
and outputting an indication with respect
thereto; and third means (16) for utilizing
said indication to provide an output signal.
__________
]11[]21[
]54[
PUMP WITH PRESSUREINDICATION MEANS
]22[
]31[
]51[
17.10.2001
1016421
]32[ 17.10.2000
Int. Cl.8 B65B 031/04
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
155351
‫משאבה עם אמצעי ציון לחץ‬
]33[
NL
328
]71[
]72[
]87[
]74[
VACU VIN INNOVATIONS LTD.,
GIBRALTAR
BART LAMBERTUS THEODORUS
JOHANNES VAN DE BRAAK,
PATRICK LAMBERTUS KERKHOF,
EELCO JAN GERARDUS
WITTEVEEN
WO/2002/032766
GLUCKSMAN - LOWY,
10A ELHANAN ST.,
P.O.B. 6202,
HAIFA 31061
[57] Pump comprising a piston/cylinder
assembly which forms part of or is to be
fitted to a container (3), the pressure in said
container having to be increased or reduced
with respect to the environment by
actuation of said piston, characterized in
that the said piston/cylinder assembly is
provided with a plate-like part (15) which
can adopt at least two positions as a
function of the pressure difference between
,‫ לוי‬- ‫גלוקסמן‬
‫ חיפה‬,6202 .‫ד‬.‫ ת‬, '‫א‬10 ‫רחוב אלחנן‬
container and environment, a first position
where there is little or no pressure
difference and a second position, which is
displaced with respect to the first position,
when the pressure has been increased or
reduced, indicator means being present to
provide an indication of a displacement
from the first position to the second
position or vice versa.
__________
]11[]21[
329
155354
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
SYSTEMS AND METHODS FOR
ROBUST REAL-TIME
MEASUREMENT OF NETWORK
PERFORMANCE
]22[
]31[
04.10.2001
60/241450
]32[ 17.10.2000
60/275206
12.03.2001
09/903423
10.07.2001
Int. Cl.8 H04L 012/24, 012/26, 012/56
AVAYA TECHNOLOGY CORP.,
U.S.A.
WO/2002/033892
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]51[
]71[
]87[
]74[
[57] A method of measuring a
performance of a route in an internetwork,
the route coupling an internetwork server
to a terminal on the internetwork, the
method comprising: at a frequency
trafficked portal on the internetwork,
detecting a request for a web page from the
terminal, wherein the web page is at least
partially stored at the frequently trafficked
portal; in response to the request for the
web page, downloading the web page to
the terminal via the internetwork; from the
web page, retrieving a Uniform Resource
Locator (URL) for a web object referenced
in the web page; resolving the URL to the
‫מערכות ושיטות למדידת זמן אמת אמינה‬
‫של תיפקוד רשת‬
]33[
US
US
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
internetwork server; detecting a request for
the web object from the terminal at the
internetwork server; in response to the
request for the web object, sending the web
object from the internetwork server to the
terminal, wherein the sending of the web
object at least partly employs a transport
protocol between the internetwork server
and the terminal; and concurrent with
sending the web object, measuring one or
more Round Trip Times (RTT) from the
transmission and reception of
corresponding transport protocol packets
sent between the internetwork server and
the terminal.
__________
]11[]21[
]54[
DATA PROCESSING APPARATUS
AND METHOD FOR SAVING
RETURN STATE
]22[
]31[
]51[
]71[
]87[
]74[
24.09.2001
0028869.6
]32[ 27.11.2000
Int. Cl.8 G06F 009/46, 009/48
ARM LIMITED, UNITED KINGDOM
WO/2002/042914
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
155407
‫התקן עבוד נתונים ושיטה לשמירת מצב‬
‫חזרה‬
]33[
GB
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
330
[57] A data processing apparatus,
comprising: a processing unit for executing
data processing instructions, the processing
unit having a plurality of modes of
operation, each mode of operation having a
corresponding stack for storing data
associated with that mode; the processing
unit, responsive to a return state data
processing instruction, for writing return
state data of the processing unit from a
current mode of operation to a stack
corresponding to a mode of operation
different from the current mode of
operation while remaining in the current
mode of operation.
__________
]11[]21[
]54[
APPARATUS AND METHOD FOR
PROTECTING PRINTING HEADS
]22[
]31[
]51[
]71[
22.10.2001
60/242141
]32[ 23.10.2000
Int. Cl.8 B41J 023/00
HEWLETT PACKARD INDUSTRIAL
PRINTING LTD.
DAVID FEINER
WO/2002/034524
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]72[
]87[
]74[
[57] An apparatus (50) comprising: a print
head (58); a movable component attached
to a flexible cable carrier (56), said
movable component being coupled to said
print head; and an isolating component to
isolate uncontrolled movement and
vibration of said flexible cable carrier from
331
155512
‫מתקן ושיטה להגנה על ראשי הדפסה‬
]33[
US
‫דויד פיינר‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
said at least one print head, wherein said
isolating component comprises a linear
bearing track (52) attached to a cable
carrier support and a generally U-shaped
channel attached to said movable
component.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
IN-SITU ADAPTER FOR A
TESTING DEVICE
]22[
]31[
]51[
]71[
16.08.2002
60/313059
]32[ 16.08.2001
Int. Cl.8 A61B 005/00
INVERNESS MEDICAL LIMITED,
UNITED KINGDOM
WO/2003/015627
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] An adapter (10) for a testing device
(11) for testing analytes in bodily fluids
comprising: a housing (12); a lancet
assembly (28) comprising a lancet drive
train (29, 30) for holding and driving a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
155681
‫מתאם תוך–רקמתי להתקן מדידה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
lancet into the skin of a user; a test port
receiving a test strip (20) insertable into the
test port; and a housing connector (17), for
connecting the adapter housing to the
testing device.
332
__________
]11[]21[
155749
‫מערכת לרכישת אמצעי הקלטה אישיים‬
‫וחשבונאות‬
]54[
SYSTEM FOR PURCHASING
PERSONAL RECORDING MEDIA
AND ACCOUNTING THEREOF
]22[
]31[
14.08.1998
9/284084
]32[ 16.10.1997
]33[
10/51115
03.03.1998
Int. Cl.8 G06Q 009/000000 G11B 027/00
DIVISION FROM 135448
DENTSU INC., JAPAN
WO/1999/021186
SELIGSOHN GABRIELI & CO.,
31 YAVNE ST.,
P.O.B. 1426,
TEL AVIV 61013
]51[
]62[
]71[
]87[
]74[
[57] A system for purchasing a personal
recording media, comprising:
(a) a first station for converting at least one
333
JP
JP
,'‫זליגסון גבריאלי ושות‬
‫ תל אביב‬,1426 .‫ד‬.‫ ת‬, 31 ‫רח' יבנה‬
musical composition and a musical
information corresponding to said one
musical composition to predetermined
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
signals, respectively, and for transmitting
said signals;
(b) a card-type storage medium including a
storage device and an integrated circuit;
(c) a receiving device capable of
attaching/detaching said card-type storage
medium, and of listening to a musical
composition by receiving said signals
transmitted from said first station, and of
selectively storing said musical information
corresponding to said musical composition
being transmitted into said storage device
of said card-type storage medium by
predetermined operation when said cardtype storage medium is attached thereto;
(d) a second station including an entering
device capable of attaching/detaching said
card-type storage medium into which said
musical information is stored, and of
reading an identification information stored
in said storage device of said card-type
storage medium when said card-type
storage is attached thereto, and of reading
said musical information stored in said
storage device of said card-type storage
medium;
(e) a third station connected to said second
station and capable of:
(1) identifying whether or not a user of said
system is an authorized user based on said
identification information;
(2) reading said musical composition
information associated with said musical
information by retrieving said plurality of
musical composition information in said
musical composition information storage
means based on said musical information
entered with said entering means,
(3) recording said musical composition
information read from said musical
composition information storage means
into a predetermined recording medium,
and
(4) implementing a predetermined
accounting process based on an accounting
information stored in said card-type storage
medium, in regard with said recording
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
medium into which said musical
composition information is recorded,
(f) a copyright-associated information
storage means for storing a copyrightassociated information regarding said
musical composition information;
(g) an input/output means for
inputting/outputting said musical
composition information;
(h) a musical composition information
registration means for registering and
storing said musical composition
information inputted with said input/output
means into said musical composition
information storage means;
(i) a copyright-associated information
retrieval and discrimination means for
retrieving and discriminating a copyrightassociated information regarding said
musical composition information registered
in said musical composition information
registration means from said copyrightassociated information storage means
based on a musical composition to be used;
(j) an account and royalty determination
means for determining an account for a
user of said musical composition and for
determining a royalty for a copyright
claimant of said musical composition based
on said copyright-associated information
and said accounting information
discriminated by said copyright-associated
information retrieval and discrimination
means;
(k) means for informing said account
determined by said account and royalty
determination means to said user of said
musical composition;
(l) means for informing said royalty
determined by said account and royalty
determination means to said copyright
claimant of said musical composition;
(m) a usage purpose registration means for
registering an information regarding a
usage purpose of said musical composition
to be used;
(n) an account information alteration
means for altering said account information
334
based on an information regarding said
usage purpose of musical composition
registered with said usage purpose
registration means; and
(o) a copyright-associated information
alteration means connected to said entering
means and to said copyright-associated
information storage means and to said
copyright-associated information storage
means, for altering said copyrightassociated information based on said
information of musical composition to be
used, wherein a musical information
corresponding to said musical composition
is stored into said card-type storage
medium by a predetermined operation
when user is listening to a musical
composition being transmitted from said
first station, wherein said user can purchase
said recording medium into which at least
one desired musical composition is
recorded, by inserting said card-type
storage medium of which said musical
information is stored therein into a
predetermined entering means at said
second station, and wherein said a
copyright-associated information alteration
means is only operable by a rightful
claimant or claimants when altering said
copyright-associated information.
__________
]11[]21[
155806
‫בנזאזפינים ונגזרות הטרוציקליות‬
‫הקשורות להם היעילים כאנטגוניסטים‬
‫של קולטן אורקסין‬
]54[
BENZAZEPINES AND RELATED
HETEROCYCLIC DERIVATIVES
WHICH ARE USEFUL AS OREXIN
RECEPTOR ANTAGONISTS
]22[
]31[
]51[
19.12.2001
PCT/EP00/13289 ]32[ 27.12.2000
]33[ WO
Int. Cl.8 A61K 031/55, A61P 043/00, C07D 223/16, 243/14, 267/14, 285/36, 401/12,
403/12, 405/12, 413/12, 417/12
ACTELION PHARMACEUTICALS
LTD., SWITZERLAND
WO/2002/051838
]71[
]87[
335
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]74[
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
,‫ריינהולד כהן ושותפיו‬
‫ תל‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
‫אביב‬
[57] Compounds of the formula
wherein: R1, R2, R3, R4 independently
represent cyano, nitro, halogen, hydroxy,
lower alkyl, lower alkenyl, lower alkoxy,
lower alkenyloxy, trifluoromethyl,
trifluoromethoxy, cycloalkyloxy, aryloxy,
aralkyloxy, heterocyclyloxy,
heterocyclylalkyloxy, R11CO-,
NR12R13CO-, R12R3N-, R11OOC-,
R11SO2NH-, or R14-CO-NH-, or R2 and R3
together as well as R1 and R2 together and
R3 and R4 together may form with the
phenyl ring a five, six or seven-membered
saturated ring containing one or two
oxygen atoms;
R5 represents aryl, aralkyl, lower alkyl,
lower alkenyl, trifluoromethyl, cycloalkyl,
heterocyclyl or heterocyclyl-lower alkyl;
R6 represents hydrogen, aryl, aralkyl, lower
alkyl, lower alkenyl, trifluoromethyl,
cycloalkyl, heterocyclyl or heterocyclyllower alkyl;
R7, R8 independently represent hydrogen,
aryl, aralkyl, lower alkyl, lower alkenyl,
cycloalkyl, heterocyclyl or heterocyclyllower alkyl;
R9, R10 independently represent hydrogen,
aryl, arylcycloalkyl, aralkyl, lower alkyl,
lower alkenyl, lower alkinyl, cycloalkyl,
heterocyclyl or heterocyclyl-lower alkyl, in
which one, several, or all hydrogen atoms
may be replaced by halogen or in which
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
one or two hydrogen atoms may be
replaced by hydroxy, nitro, cyano,
trifluoromethyl, trifluoromethoxy, -Olower alkyl, -NH-lower alkyl, -N(lower
alkyl)2, -S-lower alkyl, -COO-lower alkyl,
-CONH-lower alkyl, -CON(lower alkyl)2, CO-lower alkyl, -NHCO-lower alkyl, -Olower alkenyl with 3 to 5 carbon atoms, NH-lower alkenyl with 3 to 5 carbon
atoms, -N(lower alkenyl with 3 to 5 carbon
atoms)2, -S lower alkenyl with 3 to 5
carbon atoms, -COO-lower alkenyl with 3
to 5 carbon atoms, -CONH-lower alkenyl
with 3 to 5 carbon atoms, CON (lower
alkenyl with 3 to 5 carbon atoms)2, -COlower alkenyl with 3 to 5 carbon atoms, NHCO-lower alkenyl with 3 to 5 carbon
atoms, -O-lower alkinyl with 3 to 5 carbon
atoms, -NH-lower alkinyl with 3 to 5
carbon atoms, -N(lower alkinyl with 3 to 5
carbon atoms)2, -S-lower alkinyl with 3 to
5 carbon atoms, -COO-lower alkinyl with 3
to 5 carbon atoms, -CONH-lower alkinyl
with 3 to 5 carbon atoms, CON(lower
alkinyl with 3 to 5 carbon atoms)2, -COlower alkinyl with 3 to 5 carbon atoms, NHCO-lower alkinyl with 3 to 5 carbon
atoms;
R11 represents lower alkyl, aryl, aralkyl,
heterocyclyl or heterocyclyl-lower alkyl;
336
R12 and R13 independently represent
hydrogen, lower alkyl, cycloalkyl, aryl,
aralkyl, heterocyclyl or heterocyclyl-lower
alkyl;
R14 represents lower alkyl, aryl, cycloalkyl,
heterocyclyl, R12R13N-, R11O-;
-X-Y- independently represents –CH2CH2-, -O-CH2-, -S-CH2-, -SO2-CH2- and –
NR15 –CO-;
R15 represents hydrogen, lower alkyl or
aralkyl;
and optically pure enantiomers, mixtures of
enantiomers such as, for example,
racemates, optically pure diastereoisomers,
mixtures of diastereoisomers,
diastereoisomeric racemates, mixtures of
diastereoisomeric racemates, or meso
forms and pharmaceutically acceptable
salts thereof.
__________
]11[]21[
156183
ATM, ‫שיטות וכלי למיתוג של מידע‬
‫ דרך מתג תקשורת‬PACKET– ‫ו‬,TDM
‫בודד‬
]54[
METHODS AND APPARATUS FOR
SWITCHING ATM, TDM AND
PACKET DATA THROUGH A
SINGLE COMMUNICATIONS
SWITCH
]22[
]31[
20.11.2001
09/717998
]32[ 21.11.2000
]33[ US
09/717147
21.11.2000
US
09/717440
21.11.2000
US
09/717472
21.11.2000
US
09/717999
21.11.2000
US
Int. Cl.8 H04J 003/00, 014/00, H04L 012/28, 012/56, 029/06
TRANSWITCH CORPORATION,
U.S.A.
DANIEL C. UPP, SUBHASH ROY,
SANTANU DAS, WILLIAM B. LIPP,
JITENDER K. VIJ, MICHAEL M.
RENAULT, FREDERICK R.
CARTER, RAJEN S.
RAMCHANDANI, STEVEN E.
BENOIT, DAVID K. TOEBES
WO/2002/043302
]51[
]71[
]72[
]87[
337
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]74[
SHIBOLETH, YISRAELI, ROBERTS,
ZISMAN & CO.,
MUSEUM TOWER,
4 BERKOWITZ ST.,
TEL AVIV
64238
[57] An apparatus for switching ATM,
TDM, and variable length packet data
through a single communications switch,
said apparatus comprising: (a) means for
generating a repeating data frame having a
first plurality of rows, each row having a
second plurality of slots; (b) means for pre-
,'‫ זיסמן ושות‬,‫ רוברטס‬,‫ ישראלי‬,‫שיבולת‬
‫ תל אביב‬,4'‫ רחוב ברקוביץ‬,‫מגדל המוזיאון‬
assigning slots in every row of the frame
for TDM data: (c) means for defining a
PDU (protocol data unit) as a fixed number
of slots in one row; and (d) means for
assigning PDUs to ATM data and variable
length packet data based on an arbitration
scheme.
__________
]11[]21[
]54[
MEDICAL DEVICE AND
LOCKING MECHANISM
THEREFOR
]22[
]31[
]51[
]71[
]87[
]74[
25.01.2001
20000100459 ]32[ 22.12.2000
Int. Cl.8 A61M 005/00, 005/34, 005/50
NICODEL, S.A., SWITZERLAND
WO/2002/026295
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A locking mechanism (10) for
controlling engagement between parts
movable relative to one another in medical
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
156347
‫התקן רפואי ומנגנון נעילה עבורו‬
]33[
GR
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
sharp devices, the mechanism comprising:
a retainer part (12) for retaining a medical
sharp (22), the retainer part having a first
338
formation which is engageable with a
second formation located on a body part of
a medical sharp device and a connector
part (14) which is movable relative to the
body part to a position in which the
connector part and retainer part are in a
mutually engaged configuration, wherein
the connector part, during movement to the
engaged configuration, is adapted to alter
the relative engagement between the first
and second formations to enable release of
the retainer part from the body part, the
retainer part including two flexible legs
(30), each leg having a said first formation
located thereon, the connector part being
adapted to flex the legs, on engagement
with the retainer part, to move the legs
towards one another, characterized by the
legs being integrally formed mutually
joined at respective distal ends (32)
thereof.
__________
]11[]21[
]54[
CHASSIS FOR FRONT AND BACK
INSERTED MODULES
]22[
]31[
]51[
]71[
]87[
]74[
18.12.2001
748746
]32[ 22.12.2000
Int. Cl.8 H05K 007/14
AURORA NETWORKS, INC., U.S.A.
WO/2002/052911
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
339
156396
‫תושבת עבור מודולים מושתלים קדמיים‬
‫ואחוריים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
[57] Apparatus comprising: a chassis
including a front, a back, a first module
bay; a second module bay adjacent the first
module bay, each of the module bays
having a forward section and rearward
section; an intersection board located
between the forward section of the first
module bay and the rearward section of the
first module bay, a first module inserted
into and located at least in-part within the
forward section of the first module bay,
and a second module inserted into and
located at least in-part within the rearward
section of the first module bay, the
intersection board orthogonal to the
insertion direction of the modules,
characterized in that the intersection board
has a height along a first direction that is
less than an interior height of the chassis
along the first direction, in that the first
module is directly connected by a virtual
plane to the second module, and in that the
virtual plane is created by electronic
connectors located at a rear end of the
modules.
__________
]11[]21[
]54[
INFRA-RED EMITTING DECOY
FLARE
]22[
]51[
]71[
13.12.2000
Int. Cl.8 F42B 004/26
THE SECRETARY OF STATE FOR
DEFENCE DSTL, UNITED
KINGDOM
DOMINIC JAMES CALLAWAY,
DOUGLAS TIMOTHY SUTLIEFF
WO/2002/048641
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]72[
]87[
]74[
[57] An infra-red emitting decoy flare
comprising a flare casing (6), two
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
156406
‫נור הטעיה פולט קרינת תת–אדומה‬
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
pyrotechnic components housed within the
flare casing and an ignition means (30) for
340
igniting the pyrotechnic components
characterized in that the two pyrotechnic
components comprise a primer flare (2)
and a spectral flare (4) wherein the primer
flare consists of at least one primer pellet
(8), each primer pellet being composed of a
fast burning pyrotechnic composition and
being adapted such that, in use, ignition of
one primer pellet causes rapid ignition of
all the primer pellets to produce an intense
infra-red source, wherein the spectral flare
consists of at least one spectral pellet (10),
each spectral pellet being of a pyrotechnic
composition adapted such that, in use,
ignition of the spectral pellets produces a
spectral infra-red source wherein the ratio
of the intensity of the infra-red spectrum at
at least two fixed bands is within a fixed
range, and wherein the primer flare, and
spectral flare are adapted such that, in use,
the spectral flare is still burning after the
primer flare has finished burning.
__________
]11[]21[
]54[
COMPOSITIONS OF ESTROGENCYCLODEXTRIN COMPLEXES
HAVING IMPROVED STABILITY
]22[
]31[
20.12.2001
00610135.6
]32[ 20.12.2000
60/256484
20.12.2000
Int. Cl.8 A61K 047/00, 047/40
BAYER SCHERING PHARMA AG,
GERMANY
WO/2002/049675
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A composition comprising:
(i) a complex between an estrogen and a
cyclodextrin in a granulate preparation,
341
156437
–‫תכשירים של קומפלקסי אסטרוגן‬
‫ציקלודקסטרין בעלי יציבות משופרת‬
]33[
EP
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
wherein when said granulate preparation
comprises polyvinylpyrrolidone it is
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
present in a concentration of at the most
2% w/w; and optionally
(ii) one or more excipient(s),
the composition having a stability such that
said estrogen is in amount of at least 85%
The applications for division
from this application have
not yet been published
w/w in relation to the initial content of said
estrogen after storage for 12 months at
40oC and 75% relative humidity (RH).
,188250
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________
]11[]21[
]54[
FLOORBOARD AND LOCKING
SYSTEM
]22[
]31[
14.01.2002
0100100-7
]32[ 12.01.2001
0100101-5
12.01.2001
Int. Cl.8 E04B 001/38, E04F 015/04
VALINGE ALUMINIUM AB,
SWEDEN
WO/2002/055809
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A locking system for mechanical
joining of floorboards at a joint plane, said
floorboards having a core (30), a front side
(2), a rear side (34) and opposite joint edge
portions (4a, 4b) of which one is formed as
a tongue groove (36), which is defined by
upper (39) and lower (40) lips and has a
bottom end (48) and the other is formed as
a tongue (38) with an upwardly directed
portion (8) at its free outer end (69), the
tongue groove, seen from the joint plane,
having the shape of an undercut groove
with an opening, an inner portion (35) and
an inner locking surface (45), and at least
parts of the lower lip being formed
integrally with the core of the floorboard,
and the tongue having a locking surface
(65) which is formed to coact with the
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
156528
‫לוח ריצוף ומערכת נעילה‬
]33[
SE
SE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
inner locking surface in the tongue groove
of an adjoining floorboard, when two such
floorboards are mechanically joined, so
that their front sides are positioned in the
same surface plane and meet at the joint
plane directed perpendicular thereto,
wherein the inner locking surface of the
tongue groove is formed on the upper lip
within the undercut portion of the tongue
groove for coaction with the corresponding
locking surface of the tongue, said locking
surface being formed on the upwardly
directed portion of the tongue to counteract
pulling-apart of two mechanically joined
boards in a direction perpendicular to the
joint plane, the lower lip has a supporting
surface (50) for coaction with a
corresponding supporting surface (71) on
342
the tongue, said supporting surfaces being
intended to coact to counteract a relative
displacement of two mechanically joined
boards in a direction perpendicular to the
surface plane, all parts of the portions of
the lower lip which are connected with the
core, seen from the point where the surface
plane and the joint plane intersect, are
located outside a plane which is positioned
further away from said point than a locking
plane which is parallel therewith and which
is tangent to the coacting locking surfaces
of the tongue groove and the tongue where
these are most inclined relative to the
surface plane and all parts of the portions
of the lower lip which are connected with
the core are shorter than the upper lip and
terminate at a distance from the joint plane,
the lower lip is flexible, and the upper and
lower lips of the joint edge portions are
formed to enable connection of a laid
floorboard with a new floorboard by a
pushing-together motion essentially
parallel with the surface plane of the laid
floorboard for snapping together the parts
of the locking system during downward
bending of the lower lip of the tongue
groove.
__________
]11[]21[
]54[
HEAT CONDUCTING UNIT AND
METHOD OF REGULATING
THE TEMPERATURE OF SAME
]22[
]51[
]71[
]74[
03.07.2003
Int. Cl.8 A47J 036/24, F24C 007/04
MICHAEL LAHYANI
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A heat conducting unit suitable for
transferring heat during the Jewish Sabbath
to a cooking vessel containing food or
liquid placed on said heat conducting
343
156785
‫יחידה מוליכת חום ושיטה לויסות‬
‫הטמפרטורה שלה‬
‫ באר שבע‬,‫מיכאל להיאני‬
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
unit, without violating the religious
regulations of Judaism, comprising a
support surface (3) made of a thermally
conductive material and downwardly
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
extending legs (5) extending such that said
support surface is maintained in a fixed
spaced relation with a covered heat source
(9) placed under said support surface,
wherein said heat conducting unit is not
integrally formed with said heat source or
with a cover of said heat source, wherein
said support surface is displaceable with
respect to said heat source and is heated by
means of a fluid which transfers heat
generated directly or indirectly by said heat
source such that food or liquid contained
within said cooking vessel placed on said
support surface will be heated by said heat
transferring fluid on the Jewish Sabbath
without violating any of the religious
regulations of Judaism.
__________
]11[]21[
]54[
PHARMACEUTICAL
COMPOSITION CONTAINING
ILOPERIDONE
]22[
]31[
]51[
]71[
]87[
]74[
04.02.2002
0102841.4
]32[ 05.02.2001
Int. Cl.8 A61K 031/445
NOVARTIS AG, SWITZERLAND
WO/2002/064141
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A pharmaceutical composition
comprising 1-[4-[3-[4-(6-fluoro- 1, 2benzisoxazol-3-yl)-1-piperidinyl]
propoxy]-3-methoxyphenyl] ethanone or a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
156819
‫תכשיר רוקחות המכיל אילופרידון‬
]33[
GB
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
pharmaceutically acceptable acid addition
salt thereof, in association with at least one
pharmaceutical carrier or diluent, for use in
the treatment of a bipolar disorder.
344
,188485
The applications for division
from this application have
not yet been published
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
__________
]11[]21[
156936
‫שיטה והתקן להעברת מידע ברשת‬
]54[
METHOD AND APPARATUS FOR
TUNNELLING DATA IN A
NETWORK
]22[
]31[
]51[
]71[
28.01.2002
01300935.2
]32[ 02.02.2001
]33[ GB
Int. Cl.8 H04J 003/00, 003/16, H04L 012/46, 012/66
BRITISH TELECOMMUNICATIONS
PUBLIC LIMITED COMPANY,
UNITED KINGDOM
WO/2002/063834
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A method of tunnelling a first frame
which includes data in an overhead area
and in a payload area, from a first network
to a second network via an intermediate
network, a first node (SNA) being disposed
between said first network and a second
node (SNB) being disposed between said
intermediate network and said second
network, the method including the steps of:
(a) at said first node, mapping said data in
said overhead area and said payload area of
the first frame into the payload areas of a
plurality of second frames (SN1-SNM), the
second frames further including an
overhead area which includes overhead
data relating to the transport of the second
frames over the intermediate network,
assigning an identifier (H4) to each
345
overhead area of each of said second
frames, and outputting said second frames
onto said intermediate network;
(b) transporting said second frames across
said intermediate network to said second
node (SNB) in accordance with said
overhead data; and
(c) at said second node, receiving said
plurality of second frames (SN1-SNM),
accessing each of said identifiers (H4),
reassembling said first frame from the
payload areas of said second frames using
the identifiers accessed from said second
frames, the reassembled first frame
including data in an overhead area and in a
payload area, and outputting said
reassembled first frame onto said second
network.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
CARBURETOR, VARIOUS TYPES
OF DEVICES USING THE
CARBURETOR AND METHOD
OF VAPORIZATION
]22[
]31[
18.01.2002
2001-010827 ]32[ 18.01.2001
2001-392833
18.11.2001
Int. Cl.8 H01L 023/31
KABUSHIKI KAISHA WATANABE
SHOKO, JAPAN
TODA MASAYUKI, JAPAN
WO/2002/058141
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A vaporizer provided with a radiation
prevention part having a small hole outside
the gas outlet having:
(1) a dispersion part (8) including: a gas
passage (2) formed internally, a gas inlet
(4) to introduce a carrier gas into the gas
passage, a means (6) to supply a raw
material solution to the gas passage, a gas
outlet (7) to send the carrier gas including
the raw material solution to a vaporization
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
156978
‫ מספר סוגי התקנים‬,‫קרבורטור‬
‫המשתמשים בקרבורטור ושיטה לאיוד‬
]33[
JP
JP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
part, and a means (18) to cool the gas
passage, and
(2) a vaporization part for heating and
vaporizing the carrier gas including the
atomized raw material solution, sent from
said dispersion part, the vaporization part
comprising: a vaporization tube (20) whose
one end is connected to a reaction part of
various units such as deposition, and the
other end is connected to said gas outlet,
346
and a heating means (21) to heat the
vaporization tube.
__________
]11[]21[
]54[
SYSTEM FOR PACKAGING,
STORING AND TRANSPORTING
AGRICULTURAL PRODUCE
]22[
]31[
]51[
]71[
]87[
]74[
17.01.2002
765794
]32[ 19.01.2001
Int. Cl.8 B65D 005/60, 081/20
STEPAC L.A. LTD.
WO/2002/057143
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A package suitable for packing
agricultural produce comprising: a box (10)
having a plurality of ventilation apertures
formed in at least one wall thereof; an
interiorly disposed bag (22) which is a
water vapor permeable plastic bag; at least
one sealable localized atmosphere
347
156996
‫ אחסון ותובלת מוצרים‬,‫מערכת לאריזת‬
‫חקלאיים‬
]33[
US
‫ תפן‬,‫ בע"מ‬.‫א‬.‫סטפאק ל‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
communication aperture (16) formed in a
wall of said box and communicating with
the interior of said bag; and a sealing
element (20) located in said at least one
sealable localized atmosphere
communication aperture, operative to seal
said bag to said box.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
INTEGRATED MEMORY
CONTROLLER CIRCUIT FOR
FIBER OPTICS TRANSCEIVER
]22[
]31[
]51[
]71[
]87[
]74[
04.02.2002
777917
]32[ 05.02.2001
Int. Cl.8 H04B 010/00, 010/04, 010/06
FINISAR CORPORATION, U.S.A.
WO/2002/063800
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] Circuitry for monitoring an
optoelectronic device, comprising:
memory, including one or more memory
arrays for storing information related to the
optoelectronic device; analog to digital
conversion circuitry configured to receive a
plurality of analog signals from the
optoelectronic device, the analog signals
corresponding to operating conditions of
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
157192
‫מעגל בקר זיכרון משולב עבור‬
‫משדר\מקלט מסיבים אופטיים‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
the optoelectronic device, convert the
received analog signals into digital values,
and store the digital values in predefined
locations within the memory; comparison
logic configured to compare the digital
values with limit values to generate flag
values, wherein the flag values are stored
in predefined flag storage locations within
the memory during operation of the
348
optoelectronic device; and an interface
configured to enable a host to read from
host-specified locations within the
memory, including the predefined flag
storage locations, in accordance with
commands received from the host.
__________
349
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
157216
‫צורות גבישיות של תולדות‬
‫נוקלאוסידפירימידיניות ותכשירי רוקחות‬
‫המכילים אותן‬
]54[
CRYSTALLINE FORMS OF
PYRIMIDINE NUCLEOSIDE
DERIVATIVES AND
PHARMACEUTICAL
COMPOSITIONS
CONTAINING THE SAME
]22[
]31[
]51[
]71[
06.02.2002
2001-33128
]32[ 09.02.2001
]33[ JP
Int. Cl.8 A61K 031/7068, A61P 035/00, C07H 019/06, 019/09
DAIICHI SANKYO COMPANY
LIMITED, JAPAN
WO/2002/064609
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]87[
]74[
[57] A crystalline form of a compound or
a hydrate thereof of the formula
wherein said crystalline form has main
peaks at lattice distances of 19.53, 13.03,
9.75, 4.17, 4.00, 3.82, 3.68 and 3.41
angstroms determined by X-ray diffraction
by the powder method using the copper kα
ray (wavelength λ=1.54 angstroms).
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
157248
350
]54[
TUBE FITTING WITH
SEPARABLE TUBE GRIPPING
RING
]22[
]31[
06.02.2002
60/266735
]32[ 06.02.2001
60/329943
17.10.2001
Int. Cl.8 F16L 035/00
SWAGELOK COMPANY, U.S.A.
WO/2002/063195
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A tube fitting (50) for a tube end,
comprising: a female coupling member
(52) and a male coupling member (54) that
can be joined together such that the male
coupling member extends into the female
coupling member to assemble the fitting
‫מתאם לצינור עם טבעת אוחזת צינור‬
‫נתיקה‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
onto a tube end; said female coupling
member having a tube gripping device (80)
attached thereto; said tube gripping device
separating from said female coupling
member during assembly of the fitting to a
pulled-up condition.
__________
]11[]21[
351
157620
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
HOSE CLAMP AND CLOSING
TOOL
]22[
]31[
]51[
]71[
11.03.2002
01106955.6
]32[ 20.03.2001
Int. Cl.8 F16L 033/02
HANS OETIKER AG MASCHINENUND APPARATEFABRIK,
SWITZERLAND
WO/2002/075199
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A hose clamp made of an open band
ring (10) and having overlapping band
ends, an opening (13) disposed in one band
end (11), and a hook (14) disposed in the
other band end (12) for engaging the
opening, characterized in that the band ring
‫מהדק ואמצעי לסגירה‬
]33[
EP
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
is made of the material of a hose clamp
insert that is made of steel according to
DIN 1.4310 with a thickness of up to 0.4
mm, and has border regions (16) raised
outward from a centre portion (15) that
takes a substantial part of the band width.
__________
]11[]21[
]54[
AUTOMOBILE COMPUTER
CONTROL SYSTEM FOR
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
157673
‫שיטה לצמצום השימוש בטלפונים‬
352
LIMITING THE USAGE OF
WIRELESS TELEPHONES IN
MOVING
AUTOMOBILES
]22[
]31[
]51[
]71[
]87[
]74[
‫אלחוטיים במערכת פיקוח ממוחשבת של‬
‫רכב בתנועה‬
15.03.2002
09/810029
]32[ 15.03.2001
]33[ US
Int. Cl.8 B60R 001/00, 011/02, H04M 001/60, 001/67, 001/725
IBM CORPORATION, U.S.A.
WO/2002/074584
IBM LABORATORIES,
,‫מעבדות יבמ מחלקת קנין רוחני‬
HAIFA UNIVERSITY,
‫ חיפה‬,‫אוניברסיטת חיפה הר הכרמל‬
HAIFA 31905
[57] A system for limiting the usage of a
wireless telephone in a moving automobile
comprising; an automobile computer
control system comprising: means for
sensing when the velocity of the
automobile exceeds a predetermined
velocity maximum for cell phone use;
means in said automobile for emitting a
wireless turnoff signal towards the driver
of the automobile when the velocity of the
automobile exceeds said predetermined
velocity; the wireless telephone
comprising: means for sensing when the
wireless telephone is in use by the driver; a
sensor (13) on said wireless telephone for
detecting said emitted wireless turnoff
signal when said wireless telephone is in
use by the driver; and means responsive to
said sensor for limiting use of said wireless
telephone by said driver; characterized by
means for turning off said wireless
telephone when the velocity of said
automobile exceeds said predetermined
velocity; means for storing a set of
emergency telephone numbers; and means
for enabling said turned off wireless
telephone to call any one of said set of
emergency numbers.
__________
]11[]21[
353
157682
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
WRAPAROUND CARTON WITH A
BEAM STRUCTURE AND BLANK
THEREFOR
]22[
]31[
]51[
]71[
04.03.2002
0105223.2
]32[ 02.03.2001
Int. Cl.8 B65D 005/04, 071/06
MEADWESTVACO PACKAGING
SYSTEMS, LLC, U.S.A.
WO/2002/070366
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A wraparound carton for packaging
two or more articles with a recess defined
between adjacent articles, the carton
comprising a plurality of panels for
forming a top wall (18), side wall (20), a
base wall (12) and a beam structure (14),
said plurality of panels and said beam
structure being arranged to form a tubular
structure so as to encircle the articles
wherein the beam structure comprises a
first support panel (38) and a second
support panel (40) separated by the least
one medial fold line (50, 52) disposed
along a common longitudinal edge, the
beam structure further comprising a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫קרטון עטיפה עם מבנה קורה ופריסה‬
‫עבורו‬
]33[
GB
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
bracket panel (34, 36) hinged to the first
and second support panels by an angled
fold line and being disposed at one end of
the beam structure and wherein the beam
structure is hinged, at said one end, to one
of a first one of said plurality of panels and
at a second end to a second one of said
plurality of panels such that each of the
first and second support panels engage with
a respective one of said adjacent articles
for providing a resilient spacer
therebetween to ensure a snug fit is
maintained between the support panels and
the articles.
354
__________
]11[]21[
]54[
PULSE RADAR VARYING
IRREGULAR SPACED
FREQUENCY SPECTRUM FROM
PULSE TO PULSE WHEN
DETECTING JAMMING SIGNALS
]22[
]31[
]51[
]71[
]87[
18.04.2002
09/837679
]32[ 18.04.2001
Int. Cl.8 G01S 007/28, 007/36, 013/10
RAYTHEON COMPANY, U.S.A.
WO/2002/086535
355
157859
‫רדאר פעימה המשנה ספקטרום תדר בעל‬
‫רווחים בלתי סדירים מפעימה לפעימה‬
‫כאשר הוא מגלה סגנלי חסימה‬
]33[
US
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]74[
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A radar for locating and tracking
objects based on the use of a pulsed
waveform, each pulse of the pulsed
waveform being made up of a plurality of
spectral components having different
frequencies, comprising:
(a) an antenna;
(b) a transmitter operatively coupled to the
antenna for generating the plurality of
spectral components;
(c) a receiver operatively coupled to the
antenna for receiving signals at the
frequencies of the plurality of spectral
components;
(d) a signal processor operatively coupled
to the receiver for processing the received
signals in order to generate and output a
radar presentation and to detect the
presence of other signals at particular
frequencies;
(e) a display operatively coupled to the
signal processor for displaying the radar
presentation; and
(f) a controller operatively coupled to the
transmitter and the signal processor for
varying the frequencies at which the
plurality of spectral components are
generated in response to information
received from the signal processor, such
that the transmitter generates spectral
components at frequencies different from
the frequencies of other signals detected by
the signal processor.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
157869
356
]54[
EXTRACTING DEVICE WITH
INTEGRATED CAPSULE
LOADING SYSTEM
]22[
]31[
]51[
]71[
26.03.2002
01108382.1
]32[ 03.04.2001
Int. Cl.8 A47J 031/40
SOCIETE DES PRODUITS NESTLE
S.A., SWITZERLAND
WO/2002/096253
DR. YITZHAK HESS & PARTNERS,
279 HAYARKON ST.,
P.O.B. 6451,
TEL AVIV 61063
]87[
]74[
[57] Device for supplying cartridges
containing a substance to be extracted
comprising a pressurized extraction system
for the preparation of a beverage and
comprising a means of storage (10)
comprising cartridges (5) arranged in
several series, means (20) for individually
discharging a cartridge through a passage
in a receiving part of the extraction system
357
‫מתקן סחיטה עם מערכת העמסת כמוסה‬
‫משולבת‬
]33[
EP
,‫ד"ר יצחק הס ושותפיו‬
‫ תל אביב‬,6451 .‫ד‬.‫ ת‬, 279 ‫רחוב הירקון‬
arranged below the discharge means so as
to enable the freed cartridge to descend
directly into the receiving part
characterized in that the receiving part is
fixed in the alignment of the said passage
and includes means (44, 45) for the
cartridge capable of liberating the liquid
extract and means (46) for conducting this
extract.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
]54[
INJECTOR FOR AN
INTRAOCULAR LENS
]22[
]31[
]51[
]71[
12.03.2002
01/03636
]32[ 16.03.2001
Int. Cl.8 A61F 009/00
LABORATOIRE DE
CONTACTOLOGIE APPLIQUEELCA, FRANCE
WO/2002/074202
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] An assembly comprising an injector
and an intraocular lens (1), said intraocular
lens being made up of an optic (5), of at
least one lower haptic (8), and of at least
one upper haptic (7), said injector
comprising a syringe body (10) having a
main portion (11), a discharge portion that
is preferably of smaller cross-section than
the cross-section of the main portion, and a
conical portion (12) connecting said main
portion to said discharge portion, a plunger
(20) being adapted to move inside said
syringe body so as move said lens from the
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
157928
‫מזרק לעדשה תוך עינית‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
main portion to the discharge portion, and
then to discharge said lens out of said
discharge portion, said plunger being
provided with at least two strands that can
move towards each other while the plunger
is sliding inside said conical portion, said
assembly being characterized in that, when
said plunger reaches the discharge portion
said plunger has a profile at its end in
contact with the lens, said profile defining
at least one space adapted to receive said at
least one upper haptic of said lens.
358
__________
]11[]21[
]54[
TANGENTIAL CUTTING INSERT
AND MILLING CUTTER
]22[
]51[
]71[
]72[
]74[
24.09.2003
Int. Cl.8 B23C 005/16, 005/22
ISCAR LTD.
AMIR SATRAN
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
[57] A tangential cutting insert (10)
comprising: two identical opposing end
surfaces having a generally rectangular
shape in an end view of the cutting insert, a
peripheral side surface (14) extending
between the two opposing end surfaces,
and a peripheral edge (40) formed at the
359
158098
‫שימה טנגציאלית וכרסום‬
‫ תפן‬,‫ישקר בע"מ‬
‫אמיר סטרן‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
intersection of each end surface and the
peripheral side surface, at least two
sections of each peripheral edge
constituting cutting edges, the peripheral
side surface comprising: two opposing
major side surfaces (18) having a generally
isosceles trapezoidal shape in major side
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
views of the cutting insert, each end
surface having four corners (24, 26), two
diagonally opposite raised corners and two
diagonally opposite lowered corners, the
lowered corners being closer to a median
plane M of the cutting insert than the raised
corners, the median plane M passing
between the two opposing end surfaces of
the cutting insert, each end surface being
provided with an abutment surface (30).
__________
]11[]21[
]54[
METHOD OF REDUCING
ANALYSIS TIME OF ENDPOINTTYPE REACTION PROFILES
]22[
]31[
]51[
]71[
]74[
14.10.2003
278167
]32[ 21.10.2002
Int. Cl.8 G01N 021/00
LIFESCAN, INC., U.S.A.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
158399
‫שיטה להקטנת זמן הניתוח הכמותי של‬
‫פרופילים של תגובות מטיפוס נקודת קצה‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
[57] A method for characterizing reaction
end point, comprising:
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
360
(a) initiating a chemical reaction including
an observable A indicative of extent of
reaction,
(b) measuring first, second and third values
A1, A2, and A3 for said observable, at times
t1, t2 and t3 respectively wherein the time
A
interval t2-t1 is substantially equal to the
time interval (t3-t2); and
(c) determining an endpoint value A∞ for
said observable according to the
relationship
(A3–A1)2
2–––––––––––
4(A3–2A2+A1)
__________
]11[]21[
]54[
POLYAMIDE COMPOSITION
]22[
]31[
]51[
]71[
17.05.2002
10125137.8
]32[ 22.05.2001
Int. Cl.8 C08G 069/46, C08K 003/22
BASF AKTIENGESELLSCHAFT,
GERMANY
WO/2002/094921
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] Polymeric material (I) comprising:
(a) a polymer (II) having amide groups
recurring in the polymer main chain and
158403
‫תכשיר פוליאמיד‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
(b) from 0.01 to 5% by weight, based on
this polymer, of a titanium dioxide (III)
having a median particle size d50 of up to
150 nm.
__________
361
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
DEBURRING TOOL AND
CUTTING INSERT THEREFOR
]22[
]51[
]71[
]72[
]74[
20.10.2003
Int. Cl.8 B23B 051/08, 051/10
ISCAR LTD.
GIL HECHT
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
158497
‫כלי להסרת גרדים ושימת חיתוך עבורו‬
‫ תפן‬,‫ישקר בע"מ‬
‫גיל הכט‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
[57] An indexable cutting insert (28),
comprising:
a top surface (30), a bottom surface (32)
and peripheral surface (34) therebetween;
and two identical opposing cutting portions
(36), each cutting portion comprising two
identical cutting edges (38), each cutting
edge being located between a rake surface
(40) and a relief surface (42), the two
cutting portions being reflection symmetric
with respect to a major median plane (P1)
of the cutting insert, the two identical
cutting edges of each cutting portion being
reflection symmetric with respect to a
minor median plane (P2) of the cutting
insert; the bottom surface comprising two
bottom surface sections (52) and a single
guide member (54) therebetween, the guide
member comprising at least one ridge
protruding beyond the bottom surface
sections in a direction away from the top
surface, the guide member having a
longitudinal axis B directed perpendicular
to the major median plane (P1).
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
158755
362
]54[
‫פתח גמיש עבור מנפק ממחטות לחות‬
FLEXIBLE ORIFICE FOR WET
WIPES DISPENSER
]22[
]31[
31.05.2002
870785
]32[ 31.05.2001
870814
31.05.2001
]51[ Int. Cl.8 A47K 010/42, B65D 083/08
]71[ KIMBERLY-CLARK WORLDWIDE,
INC, U.S.A.
]87[ WO/2002/096775
]74[ REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A flexible orifice (20) for pop-up
style dispensing with a wet wipes dispenser
(10) comprising: a flexible, rubber-like
sheet (22) having a top surface (24) and a
bottom surface; a continuous slit (40)
extending across the top and bottom
surfaces of the sheet and through which a
wet wipe can pass from the bottom surface
to the top surface or from the top surface to
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
the bottom surface; characterized in that
the continuous slit has at least one zigzag
portion connected with a pair of end leg
portions; wherein said zigzag portion is
made up of curves and each end leg portion
is straight; and wherein the length of each
straight end leg portion is at least 50%
greater than the diameter of the curve of
said zigzag portion connected thereto.
__________
]11[]21[
363
158934
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
COMPOSITION AND METHOD
FOR TREATING MAGNESIUM
ALLOYS
]22[
]31[
]51[
]71[
31.05.2002
01/07173
]32[ 31.05.2001
Int. Cl.8 C23C 022/34, C23F 011/18
UNIVERSITE PIERRE ET MARIE
CURIE, FRANCE
WO/2002/097164
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A composition for the treatment of a
magnesium alloy, comprising an aqueous
acid solution containing niobium
‫תכשיר ושיטה לטיפול בסגסוגות מגנזיום‬
]33[
FR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
pentoxide, a water-soluble cerium salt and
a zirconium salt.
__________
]11[]21[
]54[
SHOE HAVING REVERSE
OPANKA STITCHING AND
METHOD OF MAKING THE
SHOE
]22[
]31[
]51[
]71[
20.11.2003
300524
]32[ 20.11.2002
Int. Cl.8 A43B 003/14
SOFT SHOE COMPANY, INC.,
U.S.A.
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]74[
[57] A shoe, comprising: an outsole (42)
having a side wall (44) and a bottom (12),
said side wall extending outwardly from
said bottom and being connected to a
peripheral edge of said bottom; an upper
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
158980
‫ הפוכה ושיטה‬OPANKA ‫נעל בעל תפירת‬
‫ליצור הנעל‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
(32), said side wall having a protrusion
(46); and a thread (34) extending through
said upper and said protrusion, without
extending through said bottom, for
connecting said upper to said protrusion.
364
__________
]11[]21[
]54[
TORQUE INDICATING WRENCH
]22[
]51[
]71[
]72[
24.11.2003
Int. Cl.8 B25B 023/142
ISCAR LTD.
HANOCH GUY, YEHOSHUA
WEINSTEIN
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
]74[
[57] A wrench comprising a rod (14) and
a casing, the rod having a driven portion, a
driving tip (34), and a straight section (42)
therebetween; the driven portion having a
clamped section (44), a rotating section
(46) and a cantilever section therebetween;
the clamped section being securely
365
159027
‫מפתח עם חיווי מומנט‬
‫ תפן‬,‫ישקר בע"מ‬
‫ יהושע וינשטיין‬,‫חנוך גיא‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
clamped in the casing; the rotating section
being rotatable between a free position and
a biased position; wherein in the biased
position, the rod closes an electric circuit,
activating an indicator; and wherein the
rotating section is transverse to the straight
section.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫__________‬
‫‪366‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
]11[]21[
]54[
ROTARY SLOT MILLING
CUTTER AND CUTTING INSERT
THEREFOR
]22[
]51[
]71[
]72[
]74[
02.12.2003
Int. Cl.8 B23C 005/08, 005/22
ISCAR LTD.
AMIR SATRAN, ZVIA FISHMAN
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
[57] A rotary slot milling cutter (20)
having an axis of rotation A comprising a
disk shaped tool body having a plurality of
cutting portions (30); each cutting portion
comprising an insert pocket (42) and a
cutting insert; the cutting insert being
removably mounted in the insert pocket;
the cutting insert comprising a top face and
a bottom face; the bottom face comprising
two spaced-apart abutments, with a ceiling
formed therebetween, each abutment
comprising an abutment platform and a
side-slope; the insert pocket having a
159157
‫כרסום חירוץ ושימה עבורו‬
‫ תפן‬,‫ישקר בע"מ‬
‫ ציביה פישמן‬,‫אמיר סטרן‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
pocket base (108) which generally faces a
direction along the axis of rotation and
comprises two support surfaces (110, 110')
and a radially extending rib (112) disposed
therebeween, the rib comprising a roof
(116) and two banks (114); wherein when
the cutting insert is mounted in the insert
pocket, the abutment platforms abut the
support surfaces, and a gap exists between
the roof of the rib and the ceiling, and
between each side-slope and adjacent
banks.
__________
367
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
METHOD OF ENLARGING THE
IMAGE FIELD OF A FOCAL
PLANE ARRAY CAMERA
]22[
]31[
]51[
]71[
03.12.2003
10259667.0
]32[ 18.12.2002
Int. Cl.8 H04N 003/06
LFK-LENKFLUGKORPERSYSTEME
GMBH, GERMANY
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]74[
[57] A method of enlarging the image
field of a focal plane array camera, wherein
the image field, which consists of N pixels,
is produced by combining scanned partial
images which each consists of n pixels,
characterized in that a cycloial scan
pattern, which is in the form of an asteroid,
is formed with the aid of at least two
continuously rotating refractive prisms,
whrein the number of vertexes of the
159170
‫שיטה להגדלת שדה הדמות של מצלמת‬
‫מערך מישור ממוקד‬
]33[
DE
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
asteroid outline, which correspond to the
points of reversal of the scanning
movement, corresponds to the number of
partial images, and that the reversal of
movement at the vertexes of the asteroid
outline is used in order to keep the
unsharpness due to the scanning process
below the size of a pixel during the
recording time of an individual image.
__________
]11[]21[
159318
‫–(אלקיל) ציקלואלקינון‬2 ‫תהליך להכנת‬
]54[
METHOD FOR PRODUCING 2(ALKYL) CYCLOALKENONE
]22[
]31[
]51[
]71[
]74[
11.12.2003
2002-378006 ]32[ 26.12.2002
]33[ JP
Int. Cl.8 C07C 045/66, 045/67, 045/72, 045/74, 049/597, 067/343, 069/716
KAO CORPORATION, JAPAN
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
[57] A method for producing 2-(alkyl)
cycloalkenone of the formula
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
368
comprising dehydrating and isomerizing 2(1-hydroxyalkyl) cycloalkanone of the
formula
wherein n represents an integer of 1 or
2,R1 and R2 each represent a hydrogen
atom or a straight or branched-chain alkyl
group having 1 to 8 carbon(s), or R1 and
R2 may form together with adjacent carbon
atoms a cyclopentane ring or a cyclohexane
ring,
wherein dehydration is conducted using an
acid catalyst, the reaction proceeding until
a conversion ratio of dehydration reaction
based on compound (1) reaches 20 to 90%,
to obtain a mixture containing compound
(1) and 2-(alkylidene) cycloalkanone of the
formula
wherein n,R1 and R2 represent the
meanings as defined above; and compound
(3) is isomerized while dehydrating
remaining compound (1).
__________
369
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
‫מלחציים אלקטרוסטטים לשימוש‬
‫בטמפרטורות גבוהות‬
]54[
HIGH TEMPERATURE
ELECTROSTATIC CHUCK
]22[
]31[
]51[
]71[
05.06.2002
892458
]32[ 28.06.2001
Int. Cl.8 H01L 021/306
LAM RESEARCH CORPORATION,
U.S.A.
WO/2003/003448
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
159497
[57] An electrostatic chuck useful in a
high temperature vacuum processing
chamber comprising: a chuck body (56)
comprising an electrostatic clamping
electrode and an optional heater element,
the electrode being adapted to
electrostatically clamp a substrate on an
outer surface of the chuck body; a heat
transfer body (58) separated from the
chuck body by a plenum located between
spaced apart surfaces of the chuck body
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
and the heat transfer body, the heat transfer
body being adapted to remove heat from
the chuck body by heat conductance
through a heat transfer gas in the plenum;
and, a removably attached expansion
assembly (64) connecting an outer
periphery of the chuck body to the heat
transfer body, the expansion assembly
accommodating differential thermal
expansion of the chuck body and the heat
transfer body.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
159658
370
]54[
SELF-POWERED SWITCH
INITIATION SYSTEM
]22[
]31[
]51[
]71[
03.07.2002
60/302990
]32[ 03.07.2001
Int. Cl.8 H01H 035/00
BRADBURY R. FACE, U.S.A.
CLARK DAVIS BOYD, U.S.A.
]87[
]74[
WO/2003/005388
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A self-powered switching system,
comprising: a flextensional transducer, said
flextensional transducer comprising; a first
electroactive member having opposing first
and second electroded major faces; said
first opposing major face being
substantially convex and said second
opposing major face being substantially
concave; a prestress layer bonded to said
second major face of said first electroactive
member; said prestress layer applying a
compressive force to said electroactive
member; said prestress layer having first
and second ends adjacent said concave face
of said first electroactive member; wherein
said flextensional transducer is adapted to
deform from a first position to a second
position upon application of a force to said
flextensional transducer; and wherein upon
said deformation to said second position,
said flextensional transducer is adapted to
generate a first voltage potential between
said first electroded major face and said
second electroded major face; a mounting
member for retaining said first end of said
prestress layer; said mounting member
comprising a plate adjacent said first end of
said prestress layer and said convex face of
said flextensional transducer; said
mounting member comprising clamping
means adjacent said first end of said
prestress layer and said concave face of
371
‫מערכת תחול מתג עם מקור הזנה פנימי‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
said flextensional tranducer; pressure
application means for application of a force
to said second end of said prestress layer,
said pressure application means being
adapted to apply a force sufficient to
deform said flextensional transducer from
said first position to said second position,
thereby generating said first voltage
potential; a first conductor electrically
connected to said first electroded major
face of said first electroactive member; a
second conductor electrically connected to
said second electroded major face of said
first electroactive member; first signal
transmission means electrically connected
to said first and second conductors; said
first signal transmission means comprising
a first radio frequency generator subcircuit
connected to an antenna; signal reception
means for receiving a first signal
transmitted by said first signal transmission
means; said signal reception means being
adapted to generate a second signal in
response to said first signal transmitted by
said signal transmission means; and a
switch having a first position and a second
position; said switch being in
communication with said signal reception
means; said switch being adapted to change
between said first position and said second
position in response to said second signal.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
–‫תהליך ליצור וטיהור של ביס (טרציארי‬
‫ביטילאמינו) סילאן‬
]54[
PROCESS FOR THE
PRODUCTION AND
PURIFICATION OF
BIS(TERTIARYBUTYLAMINO)SILANE
]22[
]31[
]51[
]71[
08.01.2004
342930
]32[ 15.01.2003
Int. Cl.8 C07F 007/00, 007/18
AIR PRODUCTS AND CHEMICALS,
INC., U.S.A.
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]74[
159769
[57] A process for making an
aminosilane, the process comprising
reacting a stoichiometric excess of at least
one amine selected from the group
consisting of a secondary amine having the
formula (R1)2NH, a primary amine having
the formula R2NH2 or combinations thereof
with at least one chlorosilane having the
formula (R3)n SiCl4-n in the absence of an
organic solvent under anhydrous conditions
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
sufficient such that a liquid comprising the
aminosilane product and an amine
hydrochloride salt is produced and wherein
R1 and R2 is each independently a linear,
cyclic or branched alkyl group having 1 to
20 carbon atoms; R3 can be a hydrogen
atom, an amine group, or a linear, cyclic or
branched alkyl group having 1 to 20 carbon
atoms; and n is a number ranging from 1 to
3.
__________
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
372
]11[]21[
]54[
DEVICE, METHOD AND SYSTEM
FOR THE APPLICATION OF
CONTENT ONTO THE SURFACE
OF A BEVERAGE
]22[
]51[
]71[
21.01.2004
Int. Cl.8 A23L 001/27, A47G 019/14
EYAL ELIAV
DANNY LAVIE
]74[
NAOMI ASSIA & CO. LAW
OFFICES,
32 HABARZEL ST.
RAMAT HACHAYAL
TEL AVIV 69710
[57] A content application system for
applying content onto the surface of a
beverage comprising:
(a) a computing device adapted to receive a
baring signal from a distributed data
network; and
159990
‫ מכשיר ומערכת להטבעת תוכן על‬,‫שיטה‬
‫פני שטחו של משקה‬
‫ תל אביב‬,‫אייל אליאב‬
‫ רמת השרון‬,‫דני לביא‬
,‫נעמי אסיא ושות' משרד עורכי דין‬
‫אביב‬-‫ תל‬,‫ רמת החייל‬32 ‫רח' הברזל‬
(b) a content application head adapted to
apply the received content by agitating the
surface of the beverage in a pattern
correlated to the content.
__________
373
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
DISINFECTANT SOLUTION
BASED ON SODIUM
HYPOCHLORITE, AND PROCESS
FOR PREPARING IT
]22[
]31[
]51[
]71[
23.07.2002
MI01A001702 ]32[ 03.08.2001
Int. Cl.8 A01N 001/00, 025/02, 059/08
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.P.A., ITALY
WO/2003/013250
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A sodium hypochlorite disinfectant
solution, comprising: 0.021 to 5.76% (w/v)
of sodium hypochlorite, from 0.015 to 4%
(w/v) of sodium chloride, and water;
160046
‫תמיסת חיטוי המבוססת על היפוכלוריט‬
‫הנתרן ותהליך ליצורה‬
]33[
IT
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
wherein the solution is buffer-free and
contains not more than 2% of sodium
chlorate relative to the sodium
hypochlorite; and wherein the solution has
a pH that ranges from 10.1 to 10.7.
__________
]11[]21[
]54[
RANDOM ACCESS DECODER
]22[
]31[
]51[
]71[
24.07.2002
0118678.2
]32[ 01.08.2001
Int. Cl.8 G11C 008/10
QINETIQ LIMITED, UNITED
KINGDOM
WO/2003/012794
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
[57] A readout circuit comprising at least
one decoder (114), each decoder
comprising a plurality of decoder circuit
elements (116) and means for applying an
input signal (124) to each of the decoder
circuit elements, wherein each decoder
circuit element has a unique electronic
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
160130
‫מפענח גישה אקראית‬
]33[
GB
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
address and a binary data output (122) and
places data on its binary data output only
when the unique electronic address of a
particular decoder circuit element matches
the applied input signal, the unique
electronic address of each of the plurality
of decoder circuit elements being
374
electronically loadable into each of the
decoder circuit elements characterized in
that the readout circuit is adapted for use
with an imaging array and further
comprises a shift register (140) associated
with each decoder, each decoder being
arranged to load the shift register
associated therewith at any point along its
length.
__________
]11[]21[
]54[
CIGARETTE FILTER
]22[
]31[
30.07.2002
60/309388
]32[ 01.08.2001
60/309435
01.08.2001
011841
30.10.2001
Int. Cl.8 A24D 003/12
BROWN & WILLIAMSON
TOBACCO COMPANY, U.S.A.
WO/2003/015544
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A multiple section cigarette filter
comprising:
(a) a selective adsorbent section
comprising a selective adsorbent material
having an affinity for a predetermined class
of chemical compounds dispersed
throughout a fibrous material, and
375
160150
‫פילטר לסיגריות‬
]33[
US
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
(b) a general adsorbent section comprising
a general adsorbent material having a high
surface area and being capable of
adsorbing smoke constituents without a
high degree of specificity, said selective
adsorbent section, and said general
adsorbent section being co-axially aligned
in tandem.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
160271
EDP4– ‫תכשירי רוקחות המכילים מעכבי‬
NSAID– ‫ו‬
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING
PDE4-INHIBITORS AND
NSAID
]22[
]31[
]51[
17.09.2002
01000473.7
]32[ 19.09.2001
]33[ EP
Int. Cl.8 A61K 031/195, 031/44, 045/00, A61P 011/00, 017/00, 019/00, 029/00, C07C
229/40, C07D 213/72
NYCOMED GMBH, GERMANY
WO/2003/024489
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
]71[
]87[
]74[
[57] A pharmaceutical composition
comprising, in admixture, a first active
ingredient which is a PDE4-inhibitor
selected from 3-Cyclopropylmethoxy-4difluoromethoxy-N-(3,5-dichloropyrid-4yl)-benzamide [INN: ROFLUMILAST] or
a pharmaceutically acceptable salt, solvate,
N-oxide or solvate of a salt or N-oxide
thereof, and a second active ingredient
which is a conventional NSAID selected
from 2-[(2,6-dichlorophenyl) amino]
benzeneacetic acid [INN: DICLOFENAC]
or a pharmaceutically acceptable salt, ester,
solvate or solvate of a salt or ester thereof.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
160272
376
‫ או‬PDE4 ‫תכשירי רוקחות המכילים מעכב‬
‫ ואנטגוניסט לקולט‬PDE3\4 ‫מעכב‬
‫ליקוטריאין‬
]54[
PHARMACEUTICAL
COMPOSITIONS CONTAINING A
PDE4 OR A PDE3/4 INHIBITOR
AND A LEUKOTRIENE
RECEPTOR ANTAGONIST
]22[
]31[
]51[
]71[
]87[
]74[
17.09.2002
01000474.5
]32[ 19.09.2001
]33[ EP
Int. Cl.8 A61K 031/44, 031/47, 045/00, A61P 011/00, C07D 213/72, 215/18
NYCOMED GMBH, GERMANY
WO/2003/024488
WOLFF, BREGMAN AND GOLLER,
,‫ ברגמן וגולר‬,‫וולף‬
P.O.B. 1352,
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
JERUSALEM 91013
[57] A pharmaceutical composition
comprising, in admixture, a first active
ingredient which is a PDE4 inhibitor
selected from 3-Cyclopropylmethoxy-4difluoromethoxy-N-(3,5-dichloropyrid-4yl)-benzamide [INN: Roflumilast] and a
pharmaceutically acceptable salt, solvate,
N-Oxide or solvate of a salt or N-oxide
thereof, and a second active ingredient
which is a leukotriene receptor antagonist
selected from 2-[1-[1(R)-[3-[2(E)-(7chloroquinolin-2-yl) vinyl] phenyl]-3-[2(1-hydroxy-1-methylethyl) phenyl]
propylsulfanylmethyl] cyclopropyl] acetic
acid [INN: MONTELUKAST] and a
pharmaceutically acceptable salt, solvate,
N-Oxide or solvate of a salt or N-oxide
thereof.
__________
]11[]21[
]54[
]22[
]31[
]51[
]62[
]71[
]87[
]74[
[57]
377
CELL HARBOURING NUCLEIC
ACID ENCODING ADENOVIRUS
E1A AND E1B GENE PRODUCTS
160406
‫תא המכיל חומצת גרעין המקודדת לתוצרי‬
E1B– ‫ ו‬E1A ‫גנים של אדנווירוס‬
14.06.1996
95201611.1
]32[ 15.06.1995
]33[ EP
95201728.3
26.06.1995
EP
Int. Cl.8 A61K 035/76, C12N 005/10, 007/01, 015/33, 015/86, 015/861
DIVISION FROM 122614
RIJKSUNIVERSITEIT LEIDEN, THE
NETHERLANDS
CRUCELL HOLLAND B.V., THE
NETHERLANDS
WO/1997/000326
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
Cell harbouring nucleic acid
encoding adenovirus E1A, E1B 21 kDa
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
and E1B55 kDa gene products, wherein
said nucleic acid does not contain
sequences encoding adenovirus pIX gene
product.
122614
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
___________
]11[]21[
]54[
FURNITURE COMBINATION BED
AND DESK
]22[
]31[
]51[
]71[
04.09.2002
U3860
]32[ 14.09.2001
Int. Cl.8 A47C 017/62
JUAN CARLOS MONESTIER,
URUGUAY
ALEJANDRO MONESTIER,
URUGUAY
WO/2003/024279
EITAN, PEARL, LATZER AND
COHEN ZEDEK,
P.O.B. 12688,
HERZLIYA 46733
]87[
]74[
[57] A combination bed (4) and desk (3)
furniture item, movable between a desk use
position, in which the bed is stowed in a
vertical non-use position, and a bed use
position, in which the desk is stowed
beneath the bed next to the floor,
comprising a bed pivotally connected at (6)
to a fixed support, and a desk pivotally
connected at (8) to the bed, the desk also
being guided by connecting rods (9)
pivotally connected at the other end (10) to
the fixed support, wherein the desk remains
horizontal while moving and when
reaching the two end positions, this
arrangement of said combination furniture
item conforming a parallelogram linkage
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
160842
‫הרכבי ריהוט של מיטה ושולחן‬
]33[
UY
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
characterized in that said parallelogram
comprises:
a fixed first substantially upright imaginary
side (10), (6) fixed to furniture side or
support; a skewing second adjacent
imaginary side (6), (8) pertaining to the
bed, a third imaginary side (8), (11),
opposite to the first one, pertaining to the
desk, which side remains parallel to the
first fixed side during the movement, a
skewing fourth side (11), (10) which is a
connecting rod linking a point (11) of the
desk to the low end (10) of above
mentioned first fixed upright side, the
result being obtained that the use and nonuse positions of the desk situates
substantially vertically each other.
378
__________
]11[]21[
]54[
TUNABLE MULTI-ZONE GAS
INJECTION SYSTEM
]22[
]31[
09.10.2002
60/328796
]32[ 15.10.2001
024208
21.12.2001
Int. Cl.8 H01J 037/32
LAM RESEARCH CORPORATION,
U.S.A.
WO/2003/034463
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A plasma processing system
comprising: a plasma processing chamber
(10); a vacuum pump connected to the
processing chamber; a substrate support
(12) on which a substrate (13) is processed
within the processing chamber; a dielectric
member (20) which forms a wall of the
processing chamber and has an interior
surface facing the substrate support; a gas
injector (22) extending through the
379
161297
‫מערכת הזרקת גז רבת איזורים הניתנת‬
‫לכיוון‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
dielectric member such that a distal end of
the gas injector is exposed within the
processing chamber, the gas injector
including a plurality of gas outlets which
are disposed within the processing chamber
below the interior surface of the dielectric
member and supply process gas at flow
rates that are independently variable
between at least some of the gas outlets
into the processing chamber, and an RF
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
energy source (18, 19) which inductively
couples RF energy through the dielectric
member and into the chamber to energize
the process gas into a plasma state to
process the substrate.
__________
]11[]21[
]54[
DISPENSER FOR SHEET
MATERIAL
]22[
]31[
]51[
]71[
05.11.2002
035058
]32[ 28.12.2001
Int. Cl.8 A47K 010/38
KIMBERLY-CLARK WORLDWIDE,
INC, U.S.A.
WO/2003/056994
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A dispenser (10) adapted to dispense
sheet material, the dispenser comprising: a
housing (12) including a platform (18)
configured to support sheet material
thereon, the platform including a
removable orifice plate (64) having an
opening therein positioned on a first axis,
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
161451
‫מנפק עבור יריעת חומר‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
the housing formed to include an exit port
spaced apart from the platform, the exit
port positioned on a second axis; wherein
sheet material disposed in the dispenser
flows between the opening in the platform
and the exit port on a third axis.
380
__________
]11[]21[
]54[
FLUID DELIVERY SYSTEM
]22[
]31[
]51[
]71[
21.10.2002
60/346218
]32[ 19.10.2001
Int. Cl.8 A01K 001/03, 007/00, 007/06
HYDROPAC/LAB PRODUCTS, INC.,
U.S.A.
WO/2003/033396
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
]87[
]74[
[57] A fluid delivery valve assembly (1)
for delivering a fluid (70) from a fluid bag
(60) to an animal caging system (90) for
housing an animal, the valve assembly
comprising: a hollow member defining a
fluid channel (14), the member having a
proximal end for delivery of water to a
cage and a distal end adapted to cooperate
with a fluid bag to deliver water from the
bag through the fluid channel to the caging
system; a stem member (31) disposed in
381
161494
‫מערכת לסניקת ניגרים‬
]33[
US
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
part within said fluid channel, said stem
member having a top surface at a distal end
thereof and a proximal end at or about the
proximal end of the hollow member; a
spring element (20) disposed within said
fluid channel; wherein a portion of said
pring element interacts with said stem
member to apply a biasing force to said
stem member, and a sealing member (32)
disposed in said fluid channel in abutment
with the top surface of said stem member,
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
for preventing fluid from flowing through
the fluid channel, said sealing member
being designed and dimensioned to
facilitate the flow of fluid in the fluid
channel in response to displacement of the
proximal end of the stem member by an
animal.
__________
]11[]21[
]54[
MULTI-STAGE DRUG
ADMINISTRATION DEVICE
]22[
]51[
]71[
21.04.2004
Int. Cl.8 A61M 005/178
SHAI AMISAR
RONEN RADOMSKI
]74[
PYERNIK RUTMAN,
BEIT ETSION,
91 HERZL ST.,
P.O.B. 10012,
BEER SHEVA
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
161552
‫התקן רב–שלבי לאספקת תרופות‬
‫ תל אביב‬,‫שי עמישר‬
‫ חיפה‬,‫רונן רדומסקי‬
,‫פיירניק רוטמן עו"פ‬
‫ באר‬,10012 .‫ד‬.‫ ת‬, 91 ‫ רח' הרצל‬,‫בית עציון‬
‫שבע‬
382
[57] A multi-stage drug administration
device (100) for administering a sequence
of pharmacological agents to a patient,
which includes: a generally cylindrical
housing (110) having distal (112) and
proximal (114) ends, having formed at said
distal end an outlet port (116) for
connection to an IV port; and at least first
and second compressible, mutually sealed
chambers (A, B, C, D) located within said
housing between said distal and proximal
ends, for containing therebetween in
mutual isolation a corresponding plurality
of pharmacological agents for sequential
administration to a patient, wherein a
rupture susceptible portion of a common
dividing wall between adjacent chambers is
adapted to rupture in the presence of a least
a critical pressure differential thereacross,
wherein upon exposure to a predetermined
source (118) of pressure associated with
said proximal end of said housing, said
plurality of sealed chambers becomes
compressed towards said distal end so as to
cause an outflow of the pharmacological
agent in said first chamber through said
outlet port, and wherein, at the time of
empyting of said first chamber, the
pressure differential across said rupture
susceptible portion of said common
dividing wall reaches said critical pressure
differential causing rupture thereof, and a
consequent outflow of the pharmacological
agent contained in said second chamber
through said outlet port.
__________
383
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
162093
‫ בעל רצף‬,‫ מיונקים מבודד‬OB ‫פוליפפטיד‬
‫ טבעי‬OB ‫פוליפפטיד‬
]54[
ISOLATED MAMMALIAN OB
POLYPEPTIDE HAVING THE
SEQUENCE OF A NATURALLY
OCCURRING OB POLYPEPTIDE
]22[
]31[
17.08.1995
08/292345
]32[ 17.08.1994
]33[ US
08/347563
30.11.1994
US
08/438431
10.05.1995
US
08/483211
07.06.1995
US
Int. Cl.8 A61K 038/17, 038/22, C07K 014/435, 014/575, C12N 015/12
DIVISION FROM 114987
THE ROCKEFELLER UNIVERSITY,
U.S.A.
SANFORD T.COLB & CO.,
,'‫ קולב ושות‬.‫סנפורד ט‬
P.O.B. 2273,
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
REHOVOT 76122
]51[
]62[
]71[
]74[
[57] An isolated mammalian OB
polypeptide, said polypeptide having the
sequence of a naturally occurring
mammalian OB polypeptide, having as a
mature protein about 145 amino acids, and
capable of modulating body weight. The
polypeptide preferably comprises
(a) the amino acid sequence set out in SEQ
ID NO:2;
(b) the amino acid sequence set out in
amino acids 22-167 of SEQ ID NO:2;
(c) the amino acid sequence set out in SEQ
ID NO: 4; or
(d) the amino acid sequence set out in
amino acids 22-167 of SEQ ID NO:4.
__________
]11[]21[
]54[
DRILL WITH RELEASABLY
MOUNTED CUTTING HEAD
]22[
]51[
]71[
]72[
]74[
24.05.2004
Int. Cl.8 B23B 051/00
ISCAR LTD.
GIL HECHT, DANNY CHEN
ISCAR LTD.,
P.O.B. 11,
TEFEN 24959
[57] A drill comprising a cutting head
releasably mounted on a forward end of a
tool shank, having a common axis of
rotation defining a direction of rotation, the
cutting head comprising a cap portion and
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
162147
‫מקדח עם ראש מתחלף‬
‫ תפן‬,‫ישקר בע"מ‬
‫ דני חן‬,‫גיל הכט‬
,‫ישקר בע"מ‬
‫ תפן‬,11 .‫ד‬.‫ ת‬,
a fixation portion, the cap portion
comprising a head surface, a head base
surface and a peripheral side surface
extending therebetween, the head base
surface being transverse to the axis of
384
rotation, the fixation portion protruding
rearwrdly from the head base surface away
from the head surface and comprising a
head fixation surface extending
circumferentially relative to the axis of
rotation; at least two head flutes extending
along a periphery of the cap and fixation
portions forming identical head segments
between adjacent pairs of head flutes, each
head segment comprising a cap recess
opening out to the side surface and the
head base surface and dividing the head
base surface into first and second head base
surfaces, a head torque transmission wall
extending along a portion of the cap recess
transverse to the head base surface and
generally facing opposite the direction of
rotation, a head fixation recess dividing the
head fixation surface into first and second
head fixation surfaces; at least two shank
flutes extending along a periphery of the
tool shank forming identical shank
coupling portions between adjacent pairs of
shank flutes, at the forward end of the tool
shank, each shank coupling portion
comprising a forwardly facing shank
support surface and a shank fixation
surface located axially rearwadly relative
to the shank support surface, a shank
fixation recess dividing the shank fixation
surface into first and second shank fixation
surfaces; a protuberance protruding
forwardly from each shank support surface,
the protuberance dividing the shank
support surface into first and second shank
support surfaces, a shank torque
transmission wall extending along a
portion of the protuberance transverse to
the shank support surface and generally
facing the direction of rotation; wherein
pairs of head segments and shank coupling
portions are in mating relationship, and
wherein for each such pair the first head
base surface abuts the first shank support
surface, the second head base surface abuts
the second shank support surface, the head
torque transmission wall abuts the shank
torque transmission wall, the first head
fixation surface abuts the first shank
fixation surface and the second head
fixation surface abuts the second shank
fixation surface.
__________
]11[]21[
385
162217
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
HOT WATER AVAILABILITY
INDICATOR NON CONTACT
]22[
]51[
]71[
]72[
]74[
30.05.2004
Int. Cl.8 F24H 001/00, G01J 005/12
S.D.S.A. TECHNOLOGIES LTD.
AHARON LIPMAN
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
[57] A heated water availability indicator
comprising: a non-contact current sensor
(110) located in propinquity to an electrical
switch (102) through which an electrical
current is supplied to an electrical hot
water heater (100); a processor operative to
receive an output from said current sensor
and to determine characteristics of supply
‫סמן לזמינות מים חמים ללא מגע‬
‫ ראש העין‬,‫ טכנולוגיות בע"מ‬.‫איי‬.‫אס‬.‫די‬.‫אס‬
‫אהרון ליפמן‬
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
of electrical current to said electrical hot
water heater over time which may provide
an indication of heated water availability;
and a visible indicator (118) responsive to
an output of said processor for providing a
visible indication which may be indicative
of heated water availability.
__________
]11[]21[
]54[
SYSTEM FOR CONTROLLING
CRYOGENIC FLUID FLOW
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
162299
‫מערכת לבקרה על קצב זרימת נוזל‬
‫קריאוגני ואמצעי קירור המבוסס על אפקט‬
386
‫ג'אול–תומסון‬
RATE AND JOULE-THOMSON
EFFECT COOLER COMPRISING
SAME
]22[
]31[
]51[
]71[
]87[
]74[
20.11.2002
01/15706
]32[ 05.12.2001
Int. Cl.8 F25B 009/02
L'AIR LIQUIDE SOCIETE
ANONYME A DIRECTOIRE ET
CONSEIL DE SURVEILLANCE
POUR L'ETUDE ET
L'EXPLOITATIONDES PROCEDES
GEORGES CLAUDE
WO/2003/048657
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A cryogenic fluid flow control
system comprising a first element (10)
forming a fluid inlet channel (3) and an
outlet passage (12) that can be selectively
blocked off by a second element (7) that
can move relative to the first element by an
effect due to the difference in expansion
coefficients between the materials of the
]33[
FR
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
first and second elements, characterized in
that the outlet passage comprises a part (6)
extending transversely relative to the inlet
channel and emerging on the periphery (5)
of an end part (2) of the first element, the
second element being placed at least partly
around said end part.
__________
]11[]21[
387
162555
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫תכשיר פומי בעל ניקיון גבוה המכיל‬
‫פלודרה המשחרר את החומר הפעיל‬
‫באופן מהיר‬
]54[
ULTRAPURE ORAL FLUDARA
FORMULATION WITH A FAST
RELEASING ACTIVE
SUBSTANCE
]22[
]31[
]51[
25.11.2002
10164510.4
]32[ 20.12.2001
]33[ DE
Int. Cl.7 A61K 009/20, 009/28, 009/30, 031/7042, 031/7052, 031/7056, 031/7072,
047/12, 047/26, 047/38, A61P 031/00
BAYER SCHERING PHARMA AG,
GERMANY
WO/2003/053418
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]71[
]87[
]74[
[57] Fast-release tablet formulation
comprising from 1 to 100 mg of the active
ingredient Fludara in a purity of > 99.19%,
together with lactose monohydrate,
colloidal silicon dioxide, microcrystalline
cellulose (Avicel), croscarmellose Na
(sodium carboxymethylcellulose), and
magnesium stearate, characterized in that
the impurities in the Fludara do not exceed
a percentage as follows:
0.02% 2-fluoro-9-(β-D-arabinofuranosyl)9H-purin-6-amine;
0.12% 6-amino-9-(5-O-phosphono-β-Darabinofuranosyl)-9H-purin-2-ol;
0.02% 2-fluoro-9H-purin-6-amine;
0.02% 6-amino-9H-purin-2-ol;
0.05% 2-fluoro-9-(5-O-phosphono-β-Dribofuranosyl)-9H-purin-6-amine;
0.1% 9-(3,5-O-diphosphono-β-Darabinofuranosyl)-2-fluoro-9H-purin-6amine;
0.1% 9-(2,5-O-diphosphono-β-Darabinofuranosyl)-2-fluoro-9H-purin-6amine;
0.02% 2-fluoro-9-(5-O-phosphono-β-Darabinofuranosyl)-9H-purin-6-amine;
0.06% 2-ethoxy-9-(5-O-phosphono-β-Darabinofuranosyl)-9H-purin-6-amine;
0.02% 2-(6-amino-9H-purin-2-yl)-9-(5-Ophosphono-β-D-arabinofuranosyl)-9Hpurin-6-amine and O,O'-bis[2-(6-amino-2fluoro-9H-purin-9-yl)-5-deoxy-α-Darabinofuranos-5-yl] phosphate; 0.1% 9-(2chloro-2-deoxy-5-phosphono-β-Darabinofuranosyl)-2-fluoro-9H-purin-6amine; 0.1% 9-(2, 5-anhydro-β-Darabinofuranosyl)-2-fluoro-9H-purin-6amine.
__________
]11[]21[
]54[
GLASS LAMINATION PROCESS
AND APPARATUS
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
162701
‫תהליך והתקן לציפוי זכוכית‬
388
]22[
]31[
]51[
]71[
]87[
]74[
23.12.2002
60/344263
]32[ 27.12.2001
294728
15.11.2002
Int. Cl.8 B32B 017/10, C03C 027/12
SOLUTIA INC., U.S.A.
WO/2003/057478
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
[57] A process for making a laminate
comprising: positioning a plastic material,
having a moisture content below 0.35
percent by weight of the plastic material,
opposite at least one rigid substrate; preheating at least one rigid substrate, or the
plastic material, or any combination
thereof, to a tacking temperature; tacking
the plastic material and substrates through
a short term pressure application with a nip
roll (12) to form a pre-laminate (20);
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
heating the pre-laminate at a temperature
and for a time effective to bond the plastic
material to the substrate, wherein said
heating is conducted at a pressure ranging
from about 1 atmosphere to about 3
atmospheres; wherein said pre-laminate is
not subjected to de-airing with vacuum
treatment at less than about 1 atmosphere;
and wherein said process does not include
a subsequent or preceding autoclave step at
a pressure above about 3 atmospheres.
__________
]11[]21[
389
162868
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ חומרי נשיאה לתרופות‬,‫תרופת איחסון‬
‫ ושיטה לייצורן‬,‫איחסון‬
]54[
DEPOT MEDICAMENT, CARRIER
MATERIALS FOR DEPOT
MEDICAMENTS AND METHOD
FOR THE PRODUCTION
THEREOF
]22[
]31[
]51[
]71[
24.01.2003
10206517.9
]32[ 16.02.2002
]33[ DE
Int. Cl.8 A61K 009/00, 009/16, 047/14, 047/48, C08G 081/00
DEUTSCHE GELATINE-FABRIKEN
STOESS AG, GERMANY
WO/2003/068192
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]87[
]74[
[57] A depot medicament having a
pharmacological active ingredient and a
carrier, in particular for parenteral
administration, characterized in that the
carrier is produced with use of a carrier
material which comprises a carrier polymer
formed from a polypeptide and
biodegradable polyester covalently linked
thereto.
__________
]11[]21[
162958
‫מודול סינון אנטי–ויראלי ואנטי–בקטריאלי‬
‫לשואב אבק ומכשיר אחר‬
]54[
ANTIVIRAL AND
ANTIBACTERIAL FILTRATION
MODULE FOR A VACUUM
CLEANER OR OTHER
APPLIANCE
]22[
]31[
]51[
]71[
]87[
]74[
13.01.2003
10/044381
]32[ 11.01.2002
]33[ US
Int. Cl.8 A47L 005/24, B01D 043/00, 050/00
SHEREE H. WEN, U.S.A.
WO/2003/059492
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
[57] A hand-held vacuum cleaner (10)
comprising: a vacuum cleaner body having
a handle, and housing an electric powered
blower powered by a battery with a switch
disposed between the battery and the
blower; an intake portion releasably
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
connected to the vacuum cleaner body such
that the intake stage forms an airtight seal
with the vacuum body; the vacuum cleaner
having an intake opening, an exhaust
portion, and a filtration system (33)
disposed therebetween to filter
390
contaminated air drawn through the intake
opening, the filtration system including: a
first passive stage (32) to filter out airborne
particles above a predetermined size, an
active stage including an energy source and
at least one agent effective to kill ambient
biological contaminants, and a second
passive stage for removing odors and
hazardous chemical agents, wherein the
first passive stage is sandwiched between
the active stage and the second passive
stage to form an integral filter.
__________
]11[]21[
163057
‫ מערכות‬,‫אמצעי סינון מיקרו–נקבוביים‬
‫ ושיטות להכנתם‬,‫סינון המכילות אותם‬
‫ושימושם‬
]54[
MICROPOROUS FILTER MEDIA,
FILTRATION SYSTEMS
CONTAINING SAME AND
METHODS OF MAKING AND
USING THEM
]22[
]31[
02.01.2003
60/354062
]32[ 31.01.2002
]33[ US
10/286695
01.11.2002
US
Int. Cl.8 A01N 025/26, B01D 071/06, B01J 020/24
KX TECHNOLOGIES LLC, U.S.A.
WO/2003/064013
LUZZATTO & LUZZATTO,
,‫לוצאטו את לוצאטו‬
INDUSTRIAL PARK, OMER,
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] A filter medium comprising: a
microporous structure having a mean flow
path of less than or equal to about 1
micron; and a microbiological interception
enhancing agent comprising a cationic
391
metal complex comprising a cationic
material, having a counter ion associated
therewith, adsorbed on at least a portion of
said microporous structure, capable of
imparting a positive charge on at least a
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
portion of said microporous structure, and
wherein a biologically active metal is
caused to precipitate with at least a portion
of the counter ion associated with the
cationic material.
__________
]11[]21[
]54[
NANOFIBER FILTER MEDIA
]22[
]31[
18.01.2003
60/354062
]32[ 31.01.2002
10/341186
13.01.2003
Int. Cl.8 B01D 039/14, B01J 020/28
KX TECHNOLOGIES LLC, U.S.A.
WO/2003/064006
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
]51[
]71[
]87[
]74[
[57] A filter medium comprising:
fibrillated fibers having a Canadaian
Standard Freeness of less than about 45,
said filter medium having performance
criteria of: a thickness of less than or equal
to about 0.25 millimeters and a Figure of
Merit of greater than about 0.075, and an
efficiency of greater than about 99.9%
when capturing aerosol particles of about
0.18 microns in size and a pressure drop of
less than about 40 millimeters water
163159
‫סיבי‬-‫תווך של מסנן ננו‬
]33[
US
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
column at a flow rate of about 32
liters/minute through a sample 100 cm2 in
size; and wherein if said filter medium is
thinner than 0.25 millimeters, then the
efficiency and pressure drop of the thinner
filter medium is adjusted to account for a
difference in thickness up to 0.25
millimeters thick, to provide a filter
medium that meets or exceeds the
performance criteria.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
163181
392
]54[
PRESSURE COMPENSATING
DRIP IRRIGATION HOSE
]22[
]31[
]51[
]71[
]72[
07.02.2003
10/072315
]32[ 08.02.2002
Int. Cl.8 B05B 001/20
THE TORO COMPANY, U.S.A.
JEFFREY A.VILDBILL, WILLIAM C.
TAYLOR JR.
WO/2003/066228
SIMON LAVIE,
21 HERZOG ST.,
JERUSALEM
]87[
]74[
[57] A pressure compensating drip
irrigation hose for distributing water
comprising:
(a) the hose having a wall (21) with an
inner surface (21a), the inner surface
defining a main water passage;
(b) a continuous elastomeric strip member
(30) operatively connected to the inner
surface, the continuous elastomeric strip
member and the inner surface defining a
plurality of emitter units, the continuous
elastomeric strip member having a bottom
wall operatively connected to first and
second spaced elongated side members, the
bottom wall, sides and inner surface
defining an emitter water passageway;
(c) each emitter unit comprising:
(i) an inlet, wherein water from the main
water passageway enters the emitter unit
through the inlet;
(ii) a pressure reducing section (60)
downstream from the inlet, wherein water
393
‫צינור טפטוף מווסת לחץ להשקייה‬
]33[
US
,‫שמעון לביא‬
‫ ירושלים‬,21 ‫הרצוג‬
flowing through the emitter is slowed and
water pressure is reduced, the pressure
reducing section having a plurality of
second preformed members, the second
preformed members operatively connected
to both the bottom wall and the inner
surface, thereby making the pressure
reducing section more resistant to
deflection; and
(iii) a pressure responsive section (70)
downstream from the pressure reducing
section, wherein with increased pressure in
the main water passage, the bottom wall
deflects towards the inner surface, thereby
decreasing the size of the emitter water
passageway; and
(d) an outlet formed in the hose wall, the
outlet in fluid communication with the
emitter water passageway and downstream
from the pressure responsive unit.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫__________‬
‫‪163327‬‬
‫‪394‬‬
‫[‪]11[]21‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
]54[
SIGNALING DEVICE FOR
ANNUNCIATING A STATUS OF A
MONITORED PERSON OR
OBJECT
]22[
]31[
]51[
]71[
20.03.2003
102219
]32[ 20.03.2002
Int. Cl.8 G08B 023/00
RAULAND-BORG CORPORATION,
U.S.A.
WO/2003/081553
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A signaling device for annuciating in
a hallway of a building a status of a
monitored person or object, the signaling
device comprising: at least two vertically
stacked sections for announcing a status of
the monitored person or object, each
section announcing a status of a different
condition and each section comprising:
(1) a solid-state, light-emitting device
(LED) supported such that when the device
is mounted to the wall of the hallway a
beam of light from the LED is substantially
aimed at a wall opposing the wall to which
the device is mounted;
(2) a pair of opposing planar surfaces
extending along diverging planes and
supported over the LED to receive the
395
‫התקן איתות המודיע על הסטטוס של אדם‬
‫או חפץ‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
LED's beam of light such that each of the
planar surfaces extends at an angle
approximately equal to a characteristic
optical beam angle of the beam of light,
thereby causing light from the light beam
to substantially illuminate an entirety of
each of the planar surfaces when viewed
from an angle approximately perpendicular
to a direction in which the beam of light is
aimed; and
(3) each of the planar surfaces having an
area sufficient to be easily viewed at a
location in the hallway remote from where
the device is mounted; and a lens for
diffusing light reflected from the planar
surfaces.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
__________
]11[]21[
163469
‫ שיטה‬,‫קרומים מכווני למינציה מוצלבת‬
‫ליצורם ותבנית קו–אקסטרוזיה המתאימה‬
‫לתהליך‬
]54[
CROSSLAMINATE OF ORIENTED
FILMS, METHOD OF
MANUFACTURING SAME AND
COEXTRUSION DIE SUITABLE IN
THE PROCESS
]22[
]31[
03.03.2003
0205021.9
]32[ 04.03.2002
]33[ GB
0221961.6
20.09.2002
GB
0224447.3
21.10.2002
GB
Int. Cl.8 B29C 047/06, B32B 003/10, 007/04
OLE-BENDT RASMUSSEN,
SWITZERLAND
WO/2003/074264
REINHOLD COHN AND PARTNERS,
,‫ריינהולד כהן ושותפיו‬
21 AHAD HA'AM ST.,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A crosslaminate comprising mutually
bonded polymer films of which at least two
neighbor films A and B each being
coextruded films are uniaxially oriented or
unbalanced biaxially oriented, whereby the
main direction of orientation (2) in A
crosses the main direction of orientation (3)
in B and each contains a layer consisting of
a polymer material selected for high tensile
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
strength (hereinafter the main layer) and on
each main layer on its side which faces the
neighbor film or at least a first surface
layer, that is a discontinuous layer
consisting of an array of coextruded thin
strands (101, 102), the strands on A being
arranged to cross the strands in B, and the
strands consisting of a material which is
selected to modify the properties in the
396
surface of the respective film, this
modification concerning the bonding
between A and B characterized by a second
surface layer (104, 105) on the main layer
of at least one of the neighbor films and on
the side of the main layer which faces the
other one of the said neighbor films, this
second surface layer being continuous,
located between the main layer and the first
surface layer and selected for control of the
bonding between A and B.
__________
397
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]11[]21[
]54[
AIR PURIFYING FILTER
SYSTEMS FOR BUILDING AIR
SUPPLY AND RESPIRATORS
USEFUL AGAINST NBC ATTACKS
]22[
]31[
]51[
]71[
]87[
]74[
21.02.2003
60/359235
]32[ 22.02.2002
Int. Cl.8 B01D 053/02, F24F 003/16
KX TECHNOLOGIES LLC, U.S.A.
WO/2003/073011
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A filter system (10) comprising: one
or more pleated layers (12, 14) of a high
surface area composite operating in series,
each layer having an air permeability
greater than about 9 m/min at about 1.27
cm water column, and comprising
adsorbent or chemically reactive particles
163567
‫מערכות סינון לטיהור אויר לאספקת אויר‬
‫לבניינים ומסכות גז המשמשות נגד‬
NBC ‫התקפות‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
(16) immobilized into a flexible form and
containing greater than about 300 g/m2 of
said particles, and wherein a pressure drop
of a plurality of layers is less than about 5
cm water column at a rated flow for a
given air purification application.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
164693
398
]54[
THERMAL BEND ACTUATOR
FOR A MICRO ELECTROMECHANICAL DEVICE
]22[
]31[
]51[
]62[
]71[
24.05.2000
PQ1307
]32[ 30.06.1999
Int. Cl.8 B81B 003/00
DIVISION FROM 147356
SILVERBROOK RESEARCH PTY.
LTD., AUSTRALIA
WO/2001/002287
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A thermal bend actuator (28) for a
micro electro-mechanical device (1), the
actuator comprising: an active section (32)
and a passive section (31), the active
section and the passive section being
‫מפעיל תרמי מכופף עבור התקן מיקרו‬
‫אלקטרו–מכאני‬
]33[
AU
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
connected such that there is a thermal
expansion differential between them that
bends the actuator during actuation;
wherein, the passive section is structured to
allow bending in one direction only.
__________
]11[]21[
399
164702
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
HYDRATE-BASED
DESALINATION/ PURIFICATION
USING PERMEABLE SUPPORT
MEMBER
]22[
]31[
07.05.2003
60/378368
]32[ 08.05.2002
429765
06.05.2003
Int. Cl.8 B01D 057/00, C02F 001/22
MARINE DESALINATION
SYSTEMS, L.L.C., U.S.A.
WO/2004/035167
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]51[
]71[
]87[
]74[
[57] A method for separating components
of a fluid system, said fluid system being
(1) a solution comprising a solute dissolved
in a solvent, (2) a suspension comprising
solid material suspended within a
suspension suspending fluid, or (3) an
emulsion comprising liquid material
suspended within an emulsion suspending
fluid, said method comprising: causing or
allowing clathrate to form within said fluid
system (106), said clathrate having a
crystalline structure comprising one or
more guest molecules disposed within a
cage structure formed from a plurality of
host molecules with at least one of said
guest molecules and said host molecules
being supplied to said clathrate from said
fluid system; causing or allowing a
generally solid layer of said clathrate to
form along a surface of a permeable
restraint (102), thereby expelling or
displacing away from said clathrate
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ התפלה המבוססת על הידראט‬/‫טיהור‬
‫באמצעות גורם תומך חדיר‬
]33[
US
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
residual fluid that remains after said
clathrate forms, said generally solid layer
or clathrate being sufficiently impermeable
that it substantially isolates said fluid
system, per se, from said permeable
restraint such that said fluid system does
not pass through said permeable restraint
and said permeable restraint being
sufficiently permeable that said host
molecules and said guest molecules are
able to pass through it upon dissociation of
said clathrate; causing portions of said
generally solid layer of clathrate that are
adjacent to said surface of said permeable
restraint to dissociate, whereby said host
molecules and said guest molecules pass
through said permeable restraint to a
collection region (108) that is located
across said permeable restraint from said
surface thereof; and collecting said host
molecules and/or said juest molecules from
said collection region.
400
__________
]11[]21[
]54[
RECOIL BUFFERING
APPARATUS FOR USE WITH AN
ARTILLERY GUN OF A TYPE
MOUNTED ON A SUPPORT
PLATFORM
]22[
]31[
]51[
]62[
]71[
14.11.2000
9906572-4
]32[ 29.12.1999
Int. Cl.8 F41A 025/22
DIVISION FROM 139668
ORDNANCE DEVELOPMENT AND
ENGINEERING COMPANY OF
SINGAPORE (1996) PTE LTD.,
SINGAPORE
SANFORD T.COLB & CO.,
P.O.B. 2273,
REHOVOT 76122
]74[
[57] A traversing apparatus for an artillery
gun comprising a breech assembly (15)
connected to a barrel (12), the breech
assembly having a firing mechanism, for
firing a projectile through an open end of
the barrel, the traversing apparatus
comprising: a support platform (50) which
is adapted to support the barrel and breech
assembly in such a manner that said barrel
and breech assembly may rotate relative to
the support platform in order to impart a
401
165655
‫שיפורים למערכת ירי ארטילרי‬
]33[
SG
,'‫ קולב ושות‬.‫סנפורד ט‬
‫ רחובות‬,2273 .‫ד‬.‫ ת‬, ‫ מרמורק‬,4 ‫שער הגיא‬
traversing motion to the barrel and breech
assembly, the support platform including:
an arcuate guide member (82) having
support means adapted to support the barrel
and breech assembly so that the support
means follows the guide member during
said traversing motion of the barrel and
breech assembly, and drive means (37)
secured to the support means and adapted
to drive movement of the support means
along the guide member to cause said
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
traversing motion wherein the drive means
comprises: a drive wheel (38) and a drive
cable (39) wrapped around the drive wheel
or in connection therewith, the drive cable
being substantially fixed relative to the
guide member so that rotation of the drive
wheel causes the drive wheel to be driven
along the guide member.
__________
]11[]21[
]54[
WEBS PRODUCED BY A
CONTINUOUS SOLID STATE
WEB COATING PROCESS
]22[
]31[
]51[
]62[
]71[
]87[
]74[
20.07.2000
09/358183
]32[ 20.07.1999
Int. Cl.8 B32B 005/12
DIVISION FROM 147701
KX TECHNOLOGIES LLC, U.S.A.
WO/2001/005583
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A first substrate web (12) having a
first surface upon which is deposited
particulate iodinated resin and particles
(14) of a thermoplastic binder fused to both
of said particulate resin and said first
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
165739
‫אריגים המיוצרים בתהליך ציפוי מתמשך‬
‫של אריג במצב מוצק‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
surface, wherein at least one of said
substrate, said particulate iodinated resin,
and said particles of a thermoplastic binder
is treated with an antibacterial agent.
402
147701
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
__________
]11[]21[
]54[
WEBS PRODUCED BY A
CONTINUOUS SOLID STATE
WEB COATING APPARATUS
]22[
]31[
]51[
]62[
]71[
]87[
]74[
20.07.2000
09/358183
]32[ 20.07.1999
Int. Cl.8 B32B 005/12
DIVISION FROM 147701
KX TECHNOLOGIES LLC, U.S.A.
WO/2001/005583
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A first substrate web (12) having a
first surface upon which is deposited
particulate manganese oxide and particles
(14) of a thermoplastic binder fused to both
of said particulate manganese oxide and
403
165740
‫אריגים המיוצרים בתהליך ציפוי מתמשך‬
‫של אריג במצב מוצק‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
said first surface, wherein at least one of
said substrate, said particulate manganese
oxide, and said particles of a thermoplastic
binder is treated with an antibacterial
agent.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
147701
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
_____________
]11[]21[
]54[
COMPOSITE STRUCTURES
PRODUCED BY A CONTINUOUS
SOLID STATE WEB COATING
PROCESS
]22[
]31[
]51[
]62[
]71[
]87[
]74[
20.07.2000
09/358183
]32[ 20.07.1999
Int. Cl.8 B32B 005/12
DIVISION FROM 147701
KX TECHNOLOGIES LLC, U.S.A.
WO/2001/005583
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A composite structure (34)
comprising a first surface having a first
surface upon which is deposited particulate
carbon and particles (14) of a thermoplastic
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
165741
‫מבנים משולבים המיוצרים בתהליך ציפוי‬
‫מתמשך של אריג במצב מוצק‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
binder, wherein at least one of said
substrate, said particulate carbon, and said
particles of a thermoplastic binder is
treated with an antibacterial agent.
404
147701
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
___________
]11[]21[
]54[
COMPOSITE STRUCTURES
PRODUCED BY A CONTINUOUS
SOLID STATE WEB COATING
PROCESS
]22[
]31[
]51[
]62[
]71[
]87[
]74[
20.07.2000
09/358183
]32[ 20.07.1999
Int. Cl.8 B32B 005/12
DIVISION FROM 147701
KX TECHNOLOGIES LLC, U.S.A.
WO/2001/005583
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A composite structure (34)
comprising a first substrate (12) having a
first surface upon which is deposited a
composite powder (14), said composite
powder having particles of a polymer
liquid absorbent and particles of a
405
165742
‫מבנים משולבים המיוצרים בתהליך ציפוי‬
‫מתמשך של אריג במצב מוצק‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
thermoplastic binder, wherein said particles
of a thermoplastic binder coalesces said
particles of a polymer liquid absorbent, and
wherein said particles of a thermoplastic
binder adhere said particles of a polymer
liquid absorbent to said first surface.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
147701
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
__________
]11[]21[
]54[
COMPOSITE WEBS PRODUCED
BY A CONTINUOUS SOLID
STATE WEB COATING PROCESS
]22[
]31[
]51[
]62[
]71[
]87[
]74[
20.07.2000
09/358183
]32[ 20.07.1999
Int. Cl.8 B32B 005/12
DIVISION FROM 147701
KX TECHNOLOGIES LLC, U.S.A.
WO/2001/005583
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A composite web (34) comprising: a
substrate web (12) having a surface; a
composite powder mixture deposited on
the surface of the substrate web in an
amount up to about 0.36 g/cm2, the
composite powder mixture comprising:
about 5 to 30 weight percent thermoplastic
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
165743
‫אריגים משולבים המיוצרים בתהליך ציפוי‬
‫מתמשך של אריג במצב מוצק‬
]33[
US
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
binder particles which have an effective
diameter in the range of about 5 to 95
microns, and about 70 to 95 weight percent
active agent particles having an effective
diameter in the range of about 5 to 5000
microns.
406
147701
The parent application from which
this application has been divided has
not yet been published
‫בקשת הורה לבקשה זו שטרם‬
‫פורסמה‬
__________
]11[]21[
]54[
METHOD AND INSTALLATION
FOR SUBJECTING CARBON
FABRICS TO HIGH
TEMPERATURE HEAT
TREATMENT AND TO
DENSIFICATION BY CHEMICAL
VAPOR INFILTRATION
]22[
]31[
]51[
]71[
]87[
]74[
11.07.2003
02/08822
]32[ 12.07.2002
Int. Cl.8 C04B 035/83
MESSIER-BUGATTI, FRANCE
WO/2004/014818
LUZZATTO & LUZZATTO,
INDUSTRIAL PARK, OMER,
P.O.B. 5352,
BEER-SHEVA 84152
[57] A method of subjecting carbon
preforms to high temperature heat
treatment and to densification, the method
being characterized in that it comprises the
steps consisting in: placing the carbon fiber
preforms in an enclosure (11); subjecting
the performs in the enclosure to heat
treatment at a temperature sufficient for
eliminating metallic impurities contained in
the carbon fibers while sweeping the
enclosure with inert gas under low
pressure; during the heat treatment,
407
165815
‫שיטה ומתקן לחשיפת אריגי פחמן לטיפול‬
‫חום בטמפרטורה גבוהה ולדחיסה על–ידי‬
‫הסתננות אדים כימיים‬
]33[
FR
,‫לוצאטו את לוצאטו‬
‫ באר שבע‬,5352 .‫ד‬.‫ ת‬, ‫ עומר‬,‫גן תעשייה‬
continuously extracting gaseous effluent
containing metallic impurities through a
first effluent (30) connected to an effluent
exhaust circuit; at the end of heat
treatment, closing the first gas effluent
outlet so as to isolate the effluent exhaust
circuit from the enclosure; interrupting
sweeping of the enclosure with inert gas;
and leaving the heat-treated preforms in the
enclosure and subjecting them to
densification by admitting a reagent gas
into the enclosure through at least one
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
reagent gas admission duct opening out
into the enclosure, gaseous effluent being
extracted through a second effluent outlet
(60) distinct from the first, said second
outlet being closed during the heat
treatment step.
__________
]11[]21[
166175
‫תהליך ליצירה סלקטיבית של נגזרות של‬
‫טקסנים‬
]54[
PROCESS FOR SELECTIVE
DERIVATIZATION OF TAXANES
]22[
]31[
17.08.1998
60/056000
]32[ 18.08.1997
]33[ US
60/081265
09.04.1998
US
60/063477
20.04.1998
US
Int. Cl.8 A61K 031/337, A61P 035/00, C07D 305/00, 305/14, C07F 007/18
DIVISION FROM 129386
FLORIDA STATE UNIVERSITY,
U.S.A.
WO/1999/009021
EITAN, PEARL, LATZER AND
,‫ לצר וכהן צדק‬,‫ פרל‬,‫איתן‬
COHEN ZEDEK,
‫ הרצליה‬,12688 .‫ד‬.‫ ת‬, 7 ‫רחוב שנקר‬
P.O.B. 12688,
HERZLIYA 46733
]51[
]62[
]71[
]87[
]74[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
408
[57] A process for the silylation of a
C(10) hydroxy group of a taxane, the
process comprising treating the taxane with
s silylamide or a bissilylamide to form a
C(10) silylated taxane, wherein the
silylamide or bissilylamide corresponds to
the structures
wherein RD, RE, RF, RG, and RH are
independently hydrocarbyl, substituted
hydrocarbyl, or heteroaryl.
The applications for division
from this application have
not yet been published
,184321,184320
‫בקשות חלוקה מבקשה זו‬
.‫שטרם פורסמו‬
___________
]11[]21[
]54[
HIGH POWER COMPACT
FLUORESCENT LAMP
]22[
]51[
]71[
]74[
10.01.2005
Int. Cl.8 H01J 061/30
GIL TEVA
GIL TEVA,
20 MEKOR HAIM, JERUSALEM
93465
[57] A compact fluorescent lamp (23)
comprising two contact screws (24) or
bayonet plugs, a plurality of electronic
ballasts (22) a plurality of fluorescent tubes
(21), each having length of 7-70
centimeters, and power of 5-50 watt, and
each tube having two hot or cold electrodes
409
166209
‫מנורת פלורוסנט קומפקטית להספק גבוה‬
‫ ירושלים‬,‫גיל טבע‬
,‫גיל טבע‬
‫ ירושלים‬,20 ‫מקור חיים‬
(25) and each electronic ballast is
connected to the two electrodes of its
appropriate tube, and the number of the
tubes is any number, from 2 tubes having
the same length up to 200 tubes that are
substantially but not absolutely the same
length.
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫ לתקנות‬35 ‫פירוט זה נבחן בהתאם לתקנה‬
1968 – ‫ תשכ"ח‬,‫הפטנטים‬
This specification was examined in
accordance with regulation 35 of the Patent
Regulations, 5728 - 1968
__________
]11[]21[
]54[
SLIDING SEAL ADAPTER FOR A
FEEDING SYSTEM
]22[
]51[
]71[
22.08.2002
Int. Cl.8 A61B 019/00, A61M 005/162
SHERWOOD SERVICES AG,
SWITZERLAND
WO/2004/017852
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] An adapter (10) comprising: a body
member (12) having a body portion
defining an annular flange (34) and at least
one leg portion (26) extending therefrom;
said body portion further including at least
one protrusion (28) formed therealong; a
spike member (14) coupled with said body
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
166653
‫מתאם נעילה מחליק עבור מערכת הזנה‬
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
member including a spike body (42)
defining at least one opening adapted to
securely engage said at least one leg
portion, said spike body further including
at least one slot (44) corresponding to said
at least one protrusion, said spike member
further defines a spike (52) connected to
410
said spike body; a spring (10), said spring
disposed within said body member for
applying a spring force against said spike
member; a collar member (16) forming a
channel (64) with opposed openings, said
collar member including an annular groove
adjacent one of said openings said groove
being adapted to securely engage said
annular flange; and a hollow sliding shaft
seal disposed at least partially within said
body member, said sliding shaft seal
including a body having opposed openings
(73, 75) with a conduit (77) formed
therebetween, said conduit being adapted
to sealingly and slidingly engage around
said spike.
__________
]11[]21[
]54[
MOTORIZED LOCKING
MECHANISM
]22[
]31[
]51[
]71[
12.11.2003
10/305650
]32[ 26.11.2002
Int. Cl.8 E05B 047/06
SARGENT MANUFACTURING
COMPANY, U.S.A.
WO/2004/048722
REINHOLD COHN AND PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A motorized locking mechanism for
locking and unlocking a device having a
hub (58) rotatable by a handle (14) about a
hub axis, the motorized locking mechanism
411
168358
‫מנגנון נעילה ממונע‬
]33[
US
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
comprising: a reversible motor (36) having
a shaft; a spring screw mounted on the
shaft, the motor rotating the spring screw in
a locking direction to lock the device and
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
in an opposite unlocking direction to
unlock the device; a locking spring having
an engaged portion moved by the spring
screw towards a first position when the
motor rotates the spring screw in the
locking direction and towards a second
position when the motor rotates the spring
screw in the unlocking direction; a
connecting arm (42) mounted for motion
between locked and unlocked positions, the
locking spring urging the connecting arm
towards the locked position when the
engaged portion of the locking spring is in
the first position and the locking spring
urging the connecting arm towards the
unlocked position when the engaged
portion of the locking spring is in the
second position; and a locking slide (28)
driven by the connecting arm through a
pivoting connection the pivoting
connection having an axis of pivot parallel
to the hub axis, the locking slide
interferingly engaging the hub to prevent
rotation of the hub and lock the device
when the connecting arm is in the locked
position and the locking slide disengaging
from the hub to allow rotation of the hub
and unlock the device when the connecting
arm is in the unlocked position, the
pivoting action of the locking slide parallel
to the hub axis operating to limit the
transmission of damaging forces from the
hub to the connecting arm; the locking
spring having sufficient spring action to
allow the engaged portion of the spring to
move to the first position when the
connecting arm is prevented from moving
to the locked position by misalignment
between the hub and the locking slide, the
spring action of the locking spring being
sufficient thereafter to move the connecting
arm to the locked position when the hub is
aligned with the locking slide.
__________
]11[]21[
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
169383
412
]54[
DIAPHRAGM VALVE FOR
VACUUM EVACUATION SYSTEM
]22[
]31[
]51[
]71[
09.02.2004
2003-039541 ]32[ 18.02.2003
Int. Cl.8 F16K 007/12, 027/00
TADAHIRO OHMI, JAPAN
FUJIKIN INCORPORATED, JAPAN
]87[
]74[
WO/2004/074722
WOLFF, BREGMAN AND GOLLER,
P.O.B. 1352,
JERUSALEM 91013
[57] A diaphragm valve (1) in a vacuum
exhaustion system comprising a body (2)
having a flow-in passage (6), a flow-out
passage (7) and a valve seat (8) formed
between the passages; a diaphragm (3)
installed in the body and permitted to rest
on and move away from the valve seat; and
‫שסתום דיאפרגמה עבור מערכת ריקון‬
‫אוויר‬
]33[
JP
,‫ ברגמן וגולר‬,‫וולף‬
‫ ירושלים‬,1352 .‫ד‬.‫ ת‬,
a driving means (4) provided on the body
to allow the diaphragm to rest on and move
away from the valve seat, wherein
synthetic resin films (5) of a predetermined
thickness are coated on the fluid-contacting
parts (25) of the afore-mentioned body and
diaphragm.
__________
]11[]21[
413
172893
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
]54[
PROCESS OF MAKING HIGHLY
ORIENTED POLYOLEFIN FIBRE
]22[
]31[
]51[
]62[
]71[
24.02.1999
1010413
]32[ 28.10.1998
Int. Cl.8 D01D 005/04, D01F 006/04
DIVISION FROM 142789
DSM IP ASSETS B.V., THE
NETHERLANDS
WO/2000/024952
REINHOLD COHN AND
PARTNERS,
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] Process for the preparation of a
highly oriented polyolefin fibre containing
polyolefin with an intrinsic viscosity (in
decalin at 135o C.) of at least 5 dl/g, which
fibre has a tensile strength of at least 26
cN/dtex and a modulus of tension of at
‫תהליך להכנת סיבי פוליאולפין בעלי‬
‫כיווניות גבוהה‬
]33[
NL
,‫ריינהולד כהן ושותפיו‬
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
least 700 cN/dtex, which comprises
contacting the fibre with a solvent for the
polyolefin, with the fibre taking up 0.05-5
wt.% of a solvent for the polyolefin
(relative to the total fibre weight).
__________
]11[]21[
173679
‫אספקת חוזי דחוס‬
]54[
PROVIDING COMPRESSED
VIDEO
]22[
]51[
]62[
]71[
27.07.1998
Int. Cl.8 G06F 019/00, H04L 012/00, H04N 007/10, 007/16, 007/173
DIVISION FROM 141104
MICROSOFT CORPORATION,
U.S.A.
WO/2000/007091
REINHOLD COHN AND
,‫ריינהולד כהן ושותפיו‬
PARTNERS,
‫ תל אביב‬,4060 .‫ד‬.‫ ת‬, 21 ‫רחוב אחד העם‬
21 AHAD HA'AM ST.,
P.O.B. 4060,
TEL AVIV 61040
]87[
]74[
[57] A method of interactive TV,
comprising: providing a compressed video
stream representing a TV channel;
overlaying on said compressed video
stream an interaction layer, including at
least one control; receiving from a viewer
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
of said video stream an interaction with
said control, wherein said overlaying
comprises overlaying a compressed
interaction layer on said compressed video,
without decompressing said compressed
video; and modifying said compressed
414
video stream responsive to said received
interaction.
__________
PATENTS
415
‫פטנטים‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫פטנטים שניתנו‬
‫‪PATENTS GRANTED‬‬
‫‪155695‬‬
‫‪156454‬‬
‫‪157125‬‬
‫‪158607‬‬
‫‪160384‬‬
‫‪122278‬‬
‫‪140975‬‬
‫‪150768‬‬
‫‪151349‬‬
‫‪152024‬‬
‫‪152463‬‬
‫‪152997‬‬
‫‪153758‬‬
‫‪154649‬‬
‫‪155427‬‬
‫‪129097‬‬
‫‪145456‬‬
‫‪146818‬‬
‫‪148152‬‬
‫‪148756‬‬
‫‪149617‬‬
‫‪178091‬‬
‫‪142290‬‬
‫‪143464‬‬
‫‪162686‬‬
‫‪167154‬‬
‫‪136905‬‬
‫‪156386‬‬
‫‪157074‬‬
‫‪158326‬‬
‫‪160238‬‬
‫‪162160‬‬
‫‪140781‬‬
‫‪150754‬‬
‫‪151311‬‬
‫‪151922‬‬
‫‪152430‬‬
‫‪152968‬‬
‫‪153738‬‬
‫‪154610‬‬
‫‪155422‬‬
‫‪128960‬‬
‫‪145428‬‬
‫‪146660‬‬
‫‪147832‬‬
‫‪148554‬‬
‫‪149543‬‬
‫‪175206‬‬
‫‪142063‬‬
‫‪143361‬‬
‫‪162637‬‬
‫‪166720‬‬
‫‪171711‬‬
‫‪136225‬‬
‫‪156350‬‬
‫‪157051‬‬
‫‪158295‬‬
‫‪160077‬‬
‫‪161792‬‬
‫‪139934‬‬
‫‪150661‬‬
‫‪151054‬‬
‫‪151859‬‬
‫‪152398‬‬
‫‪152952‬‬
‫‪153511‬‬
‫‪154535‬‬
‫‪155149‬‬
‫‪128877‬‬
‫‪145356‬‬
‫‪146634‬‬
‫‪147673‬‬
‫‪148552‬‬
‫‪149490‬‬
‫‪175205‬‬
‫‪141670‬‬
‫‪143291‬‬
‫‪144850‬‬
‫‪165345‬‬
‫‪171479‬‬
‫‪135361‬‬
‫‪156260‬‬
‫‪157032‬‬
‫‪158141‬‬
‫‪159253‬‬
‫‪161492‬‬
‫‪139786‬‬
‫‪150659‬‬
‫‪151053‬‬
‫‪151745‬‬
‫‪152344‬‬
‫‪152911‬‬
‫‪153461‬‬
‫‪154487‬‬
‫‪154859‬‬
‫‪116221‬‬
‫‪131926‬‬
‫‪146454‬‬
‫‪147310‬‬
‫‪148529‬‬
‫‪149438‬‬
‫‪175204‬‬
‫‪141659‬‬
‫‪143280‬‬
‫‪144729‬‬
‫‪164441‬‬
‫‪170791‬‬
‫‪135008‬‬
‫‪156128‬‬
‫‪156904‬‬
‫‪157994‬‬
‫‪159167‬‬
‫‪161420‬‬
‫‪139702‬‬
‫‪150369‬‬
‫‪150949‬‬
‫‪151720‬‬
‫‪152337‬‬
‫‪152821‬‬
‫‪153304‬‬
‫‪154472‬‬
‫‪154858‬‬
‫‪115314‬‬
‫‪130369‬‬
‫‪146303‬‬
‫‪147285‬‬
‫‪148368‬‬
‫‪149359‬‬
‫‪149923‬‬
‫‪128018‬‬
‫‪142773‬‬
‫‪144503‬‬
‫‪163871‬‬
‫‪170763‬‬
‫‪133959‬‬
‫‪156051‬‬
‫‪156895‬‬
‫‪157762‬‬
‫‪158727‬‬
‫‪160947‬‬
‫‪139109‬‬
‫‪150288‬‬
‫‪150856‬‬
‫‪151639‬‬
‫‪152191‬‬
‫‪152782‬‬
‫‪153301‬‬
‫‪154333‬‬
‫‪154748‬‬
‫‪155586‬‬
‫‪129852‬‬
‫‪145933‬‬
‫‪147215‬‬
‫‪148365‬‬
‫‪148917‬‬
‫‪149904‬‬
‫‪179576‬‬
‫‪142589‬‬
‫‪144205‬‬
‫‪163727‬‬
‫‪169302‬‬
‫‪133777‬‬
‫‪156016‬‬
‫‪156885‬‬
‫‪157574‬‬
‫‪158709‬‬
‫‪160764‬‬
‫‪137240‬‬
‫‪141017‬‬
‫‪150801‬‬
‫‪151603‬‬
‫‪152102‬‬
‫‪152745‬‬
‫‪153223‬‬
‫‪153957‬‬
‫‪154721‬‬
‫‪155527‬‬
‫‪129523‬‬
‫‪145548‬‬
‫‪147195‬‬
‫‪148304‬‬
‫‪148828‬‬
‫‪149895‬‬
‫‪179148‬‬
‫‪142448‬‬
‫‪143638‬‬
‫‪163104‬‬
‫‪167955‬‬
‫‪133760‬‬
‫‪155854‬‬
‫‪156707‬‬
‫‪157139‬‬
‫‪158652‬‬
‫‪160671‬‬
‫‪122443‬‬
‫‪140980‬‬
‫‪150800‬‬
‫‪151524‬‬
‫‪152093‬‬
‫‪152662‬‬
‫‪153173‬‬
‫‪153847‬‬
‫‪154716‬‬
‫‪155428‬‬
‫‪129350‬‬
‫‪145546‬‬
‫‪147077‬‬
‫‪148210‬‬
‫‪148824‬‬
‫‪149654‬‬
‫‪178092‬‬
‫‪142389‬‬
‫‪143579‬‬
‫‪162687‬‬
‫‪167954‬‬
‫פטנטים שחודשו‬
‫‪PATENTS RENEWED‬‬
‫‪416‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫‪93366‬‬
‫‪93454‬‬
‫‪93515‬‬
‫‪108282‬‬
‫‪108549‬‬
‫‪108641‬‬
‫‪108701‬‬
‫‪108738‬‬
‫‪108788‬‬
‫‪121414‬‬
‫‪123011‬‬
‫‪123168‬‬
‫‪123266‬‬
‫‪123393‬‬
‫‪123516‬‬
‫‪126692‬‬
‫‪130594‬‬
‫‪131010‬‬
‫‪131170‬‬
‫‪131214‬‬
‫‪131276‬‬
‫‪131321‬‬
‫‪131393‬‬
‫‪131540‬‬
‫‪131669‬‬
‫‪132418‬‬
‫‪136081‬‬
‫‪139190‬‬
‫‪141694‬‬
‫‪143783‬‬
‫‪144763‬‬
‫‪146669‬‬
‫‪147785‬‬
‫‪148287‬‬
‫‪148391‬‬
‫‪148914‬‬
‫‪149576‬‬
‫‪150386‬‬
‫‪150956‬‬
‫‪152217‬‬
‫‪153538‬‬
‫‪154945‬‬
‫‪157155‬‬
‫‪157429‬‬
‫‪158381‬‬
‫‪164648‬‬
‫‪93357‬‬
‫‪93445‬‬
‫‪93513‬‬
‫‪107937‬‬
‫‪108548‬‬
‫‪108622‬‬
‫‪108698‬‬
‫‪108730‬‬
‫‪108787‬‬
‫‪121412‬‬
‫‪122994‬‬
‫‪123139‬‬
‫‪123261‬‬
‫‪123390‬‬
‫‪123496‬‬
‫‪126538‬‬
‫‪130543‬‬
‫‪130993‬‬
‫‪131164‬‬
‫‪131200‬‬
‫‪131273‬‬
‫‪131315‬‬
‫‪131374‬‬
‫‪131478‬‬
‫‪131660‬‬
‫‪132073‬‬
‫‪135909‬‬
‫‪138907‬‬
‫‪141370‬‬
‫‪143714‬‬
‫‪144757‬‬
‫‪146634‬‬
‫‪147688‬‬
‫‪148248‬‬
‫‪148375‬‬
‫‪148756‬‬
‫‪149573‬‬
‫‪150288‬‬
‫‪150955‬‬
‫‪152147‬‬
‫‪153512‬‬
‫‪154709‬‬
‫‪156993‬‬
‫‪157420‬‬
‫‪158362‬‬
‫‪164503‬‬
‫‪93342‬‬
‫‪93444‬‬
‫‪93509‬‬
‫‪107471‬‬
‫‪108537‬‬
‫‪108611‬‬
‫‪108678‬‬
‫‪108726‬‬
‫‪108779‬‬
‫‪113617‬‬
‫‪122966‬‬
‫‪123134‬‬
‫‪123236‬‬
‫‪123370‬‬
‫‪123473‬‬
‫‪126456‬‬
‫‪129350‬‬
‫‪130984‬‬
‫‪131161‬‬
‫‪131191‬‬
‫‪131270‬‬
‫‪131310‬‬
‫‪131373‬‬
‫‪131469‬‬
‫‪131608‬‬
‫‪132025‬‬
‫‪135812‬‬
‫‪138269‬‬
‫‪141220‬‬
‫‪143553‬‬
‫‪144423‬‬
‫‪146548‬‬
‫‪147548‬‬
‫‪148152‬‬
‫‪148372‬‬
‫‪148552‬‬
‫‪149563‬‬
‫‪150120‬‬
‫‪150954‬‬
‫‪151949‬‬
‫‪153365‬‬
‫‪154500‬‬
‫‪156943‬‬
‫‪157407‬‬
‫‪157801‬‬
‫‪162871‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫‪93331‬‬
‫‪93434‬‬
‫‪93490‬‬
‫‪106567‬‬
‫‪108536‬‬
‫‪108603‬‬
‫‪108672‬‬
‫‪108722‬‬
‫‪108776‬‬
‫‪108822‬‬
‫‪122963‬‬
‫‪123110‬‬
‫‪123216‬‬
‫‪123348‬‬
‫‪123468‬‬
‫‪126443‬‬
‫‪128740‬‬
‫‪130966‬‬
‫‪131146‬‬
‫‪131187‬‬
‫‪131252‬‬
‫‪131309‬‬
‫‪131351‬‬
‫‪131464‬‬
‫‪131585‬‬
‫‪131915‬‬
‫‪135759‬‬
‫‪138241‬‬
‫‪140697‬‬
‫‪143361‬‬
‫‪144271‬‬
‫‪146303‬‬
‫‪147478‬‬
‫‪148049‬‬
‫‪148369‬‬
‫‪148463‬‬
‫‪149454‬‬
‫‪149988‬‬
‫‪150781‬‬
‫‪151720‬‬
‫‪153259‬‬
‫‪154341‬‬
‫‪156934‬‬
‫‪157369‬‬
‫‪157789‬‬
‫‪161088‬‬
‫‪93318‬‬
‫‪93427‬‬
‫‪93489‬‬
‫‪93607‬‬
‫‪108530‬‬
‫‪108602‬‬
‫‪108666‬‬
‫‪108717‬‬
‫‪108768‬‬
‫‪108811‬‬
‫‪122929‬‬
‫‪123043‬‬
‫‪123197‬‬
‫‪123342‬‬
‫‪123453‬‬
‫‪126379‬‬
‫‪128513‬‬
‫‪130843‬‬
‫‪131133‬‬
‫‪131179‬‬
‫‪131250‬‬
‫‪131298‬‬
‫‪131346‬‬
‫‪131455‬‬
‫‪131559‬‬
‫‪131856‬‬
‫‪134597‬‬
‫‪137815‬‬
‫‪140276‬‬
‫‪143291‬‬
‫‪144062‬‬
‫‪146217‬‬
‫‪147194‬‬
‫‪148025‬‬
‫‪148352‬‬
‫‪148452‬‬
‫‪149359‬‬
‫‪149895‬‬
‫‪150754‬‬
‫‪151492‬‬
‫‪153248‬‬
‫‪153815‬‬
‫‪156674‬‬
‫‪157308‬‬
‫‪157758‬‬
‫‪160172‬‬
‫‪93314‬‬
‫‪93397‬‬
‫‪93485‬‬
‫‪93572‬‬
‫‪108529‬‬
‫‪108599‬‬
‫‪108661‬‬
‫‪108713‬‬
‫‪108767‬‬
‫‪108796‬‬
‫‪122893‬‬
‫‪123030‬‬
‫‪123195‬‬
‫‪123335‬‬
‫‪123445‬‬
‫‪126198‬‬
‫‪128407‬‬
‫‪130827‬‬
‫‪131132‬‬
‫‪131178‬‬
‫‪131248‬‬
‫‪131293‬‬
‫‪131343‬‬
‫‪131448‬‬
‫‪131552‬‬
‫‪131766‬‬
‫‪133195‬‬
‫‪137808‬‬
‫‪140246‬‬
‫‪142589‬‬
‫‪144015‬‬
‫‪146183‬‬
‫‪147077‬‬
‫‪147830‬‬
‫‪148308‬‬
‫‪148430‬‬
‫‪149285‬‬
‫‪149866‬‬
‫‪150659‬‬
‫‪151377‬‬
‫‪152848‬‬
‫‪153758‬‬
‫‪156048‬‬
‫‪157258‬‬
‫‪157717‬‬
‫‪159441‬‬
‫‪93294‬‬
‫‪93394‬‬
‫‪93468‬‬
‫‪93556‬‬
‫‪108515‬‬
‫‪108595‬‬
‫‪108657‬‬
‫‪108706‬‬
‫‪108766‬‬
‫‪108794‬‬
‫‪121804‬‬
‫‪123021‬‬
‫‪123182‬‬
‫‪123305‬‬
‫‪123419‬‬
‫‪123554‬‬
‫‪128018‬‬
‫‪130812‬‬
‫‪131126‬‬
‫‪131177‬‬
‫‪131226‬‬
‫‪131291‬‬
‫‪131327‬‬
‫‪131406‬‬
‫‪131550‬‬
‫‪131765‬‬
‫‪132884‬‬
‫‪137598‬‬
‫‪140207‬‬
‫‪142047‬‬
‫‪143785‬‬
‫‪145959‬‬
‫‪147072‬‬
‫‪147826‬‬
‫‪148307‬‬
‫‪148420‬‬
‫‪148990‬‬
‫‪149642‬‬
‫‪150539‬‬
‫‪151293‬‬
‫‪152766‬‬
‫‪153737‬‬
‫‪156022‬‬
‫‪157194‬‬
‫‪157630‬‬
‫‪158541‬‬
‫‪93281‬‬
‫‪93371‬‬
‫‪93455‬‬
‫‪93537‬‬
‫‪108458‬‬
‫‪108572‬‬
‫‪108653‬‬
‫‪108704‬‬
‫‪108747‬‬
‫‪108792‬‬
‫‪121795‬‬
‫‪123012‬‬
‫‪123175‬‬
‫‪123297‬‬
‫‪123399‬‬
‫‪123525‬‬
‫‪127988‬‬
‫‪130658‬‬
‫‪131056‬‬
‫‪131172‬‬
‫‪131225‬‬
‫‪131277‬‬
‫‪131326‬‬
‫‪131394‬‬
‫‪131543‬‬
‫‪131702‬‬
‫‪132428‬‬
‫‪137222‬‬
‫‪139702‬‬
‫‪141990‬‬
‫‪143784‬‬
‫‪144764‬‬
‫‪146735‬‬
‫‪147807‬‬
‫‪148306‬‬
‫‪148399‬‬
‫‪148989‬‬
‫‪149597‬‬
‫‪150490‬‬
‫‪150957‬‬
‫‪152355‬‬
‫‪153627‬‬
‫‪155188‬‬
‫‪157188‬‬
‫‪157525‬‬
‫‪158490‬‬
‫‪417‬‬
‫‪166875‬‬
‫‪171061‬‬
‫‪166725‬‬
‫‪168187‬‬
‫‪166722‬‬
‫‪168176‬‬
‫‪166704‬‬
‫‪168175‬‬
‫‪166551‬‬
‫‪167968‬‬
‫‪166420‬‬
‫‪167967‬‬
‫‪165490‬‬
‫‪167082‬‬
‫‪176511‬‬
‫‪165464‬‬
‫‪166876‬‬
‫‪171062‬‬
‫פטנטים שתוקפם פקעו בגלל אי תשלום אגרת חידוש‬
‫‪418‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
PATENTS NOT IN FORCE DUE TO NON-PAYMENT OF RENEWAL
FEES
90751
90918
91007
106192
106300
106365
121206
121236
122885
127752
128097
129276
140854
147831
158902
90779
90919
91009
106196
106306
106377
121209
121242
126409
127764
128101
132740
142288
150334
90787
90925
91016
106219
106307
106392
121210
121263
126586
127837
128127
133495
143995
151223
90811
90931
91044
106221
106308
106417
121211
121272
127124
127850
128136
136841
144208
152170
90813
90960
106153
106243
106318
116818
121212
121278
127286
127970
128139
137559
145194
153772
90879
90990
106157
106270
106326
121164
121213
121282
127487
127971
128168
137561
146564
154232
90908
90999
106162
106274
106333
121197
121231
121302
127571
128049
128175
139660
146690
154592
90910
91005
106178
106282
106334
121198
121232
121321
127587
128060
128791
139706
147088
157554
‫פטנטים שחודשו לעשרים שנה‬
PATENTS RENEWED FOR 20 YEARS
419
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
115314
148240
157090
‫צווי הארכה שחודשו‬
EXTENSION ORDERS RENEWED
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
420
79887
87437
Patents for which applications have been
filed for extension of the patent term under
chapter 4, part B1 of the Patents Law
421
‫פטנטים שלגביהם הוגשו בקשות להארכת‬
‫ לחוק‬1'‫תקופת ההגנה על פי פרק ד' סימן ב‬
‫הפטנטים‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫‪111719‬‬
‫‪422‬‬
‫‪102917‬‬
‫‪94021‬‬
‫‪86531‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫הודעה‬
NOTICE
‫ לחוק‬60 ‫לפי סעיף‬
1967-‫ תשכ"ז‬,‫הפטנטים‬
‫הוגשה בקשה להחזר‬
‫תוקפו של הפטנט המפורט‬
‫ שתוקפו פקע מחמת‬,‫מטה‬
‫אי תשלום אגרות החידוש‬
:‫הקבועות‬
Under section 60 of the
Patent Law, 5727-1967
Application has been filed
for the restoration of the
patent recorded below,
which has lapsed through
non-payment of the
prescribed renewal fees:
No. of Patent
Acceptance published in
journal no:
Proprietors:
‫מס' הפטנט‬
:'‫קיבול פורסם ביומן מס‬
148087
12/2004
:‫שם בעל הפטנט‬
JOSEPH A. MCGILL
Title of invention:
:‫שם האמצאה‬
‫עמעמת מתכווננת עבור מערכות איוורור‬
ADJUSTABLE DAMPER FOR AIRFLOW SYSTEMS
Any person may oppose the
‫כל אדם רשאי להתנגד‬
said application within three
‫לבקשה האמורה תוך‬
months from the date of this
‫שלושה חודשים מתאריך‬
Patents Journal, as
‫ כפי שנקבע‬,‫יומן פטנטים זה‬
prescribed by section 61 of
92 ‫ לחוק ובתקנה‬61 ‫בסעיף‬
the law and by regulation 92
‫ תשכ"ח‬,‫לתקנות הפטנטים‬
of the Patent Regulations,
5728-1968
1968
423
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫שינויים בפרטים רשומים בפנקס‬
CHANGES IN PARTICULARS ENTERED IN REGISTER
‫שינוי שם הבעלים‬
CHANGE OF NAME OF PROPRIETORS
No. of Patent:
Previous name:
172136
:‫מס' פטנט‬
:‫השם הקודם‬
‫קותי גרוסמן‬
‫קותי גרוסמן‬
New name:
KUTI GROSSMAN
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
424
‫תיקוני טעויות‬
CORRIGENDA
Journal
9/2007
‫יומן‬
P. 3503 Patent application No. 126138
126138 '‫ בקשת פטנט מס‬3503 '‫ע‬
Correct name of applicant to-‫תקן שם המבקשת ל‬
DAIICHI SANKYO
COMPANY, LIMITED
Journal
P. 2427 Patent No. 135597
Delete the patent from the list.
The patent remains in force.
6/2007
‫יומן‬
135597 '‫ פטנט מס‬2427 '‫ע‬
.‫מחק את הפטנט מהרשימה‬
.‫הפטנט עדיין בתוקף‬
Journal
P. 3102 Patent application No. 133959
Correct date of application
to-
8/2007
‫יומן‬
133959 '‫ בקשת פטנט מס‬3102 '‫ע‬
-‫תקן תאריך הבקשה ל‬
Journal
P. 3293 Patent application No. 167154
Add: Division from
Journal
P. 3292 Patent application No. 166720
Correct date of application
toAdd: Division from
425
15.7.1998
8/2007
153025
8/2007
30.6.2000
153432
‫יומן‬
167154 '‫ בקשת פטנט מס‬3293 '‫ע‬
:‫הוסיף‬
‫יומן‬
166720 '‫ בקשת פטנט מס‬3292 '‫ע‬
-‫תקן תאריך הבקשה ל‬
:‫הוסיף‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
Journal
7/2007
P. 2727 Patent application No. 135812
Correct international
publication no. toWO/1999/23111
‫יומן‬
135812 '‫ בקשת פטנט מס‬2727 '‫ע‬
‫תקן את מספר הפרסום‬
-‫הבינלאומי ל‬
Journal
10/2007
P. 4021 Patent application No. 165179
Add second applicant–
ISHIKAWAJIMA-HARIMA
HEAVY INDUSTRIES CO.,
LTD.
WO/2004/011696
Correct international
publication no. to–
‫יומן‬
165179 '‫ בקשת פטנט מס‬4021 '‫ע‬
– ‫תוסיף מבקשת שניה‬
‫תקן את מספר הפרסום‬
-‫הבינלאומי ל‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
426
‫קודים למדינת המופיעים ביומן‬
COUNTRY CODES APPEARING IN THIS JOURNAL
Code
AR
AT
AU
BA
BE
BR
CA
CH
CN
CU
CZ
DE
DK
EC
EP
ES
FI
FR
GB
GE
GR
GT
HR
HU
IE
IL
IN
IT
JP
KR
LK
LU
LV
MX
427
Country or Organization
Argentina
Austria
Australia
Herzegovina
Belgium
Brazil
Canada
Switzerland
China
Cuba
Czech Republic
Germany
Denmark
Ecuador
European Patent Office
Spain
Finland
France
United Kingdom
Georgia
Greece
Guatemala
Croatia
Hungary
Ireland
Israel
India
Italy
Japan
Republic of Korea
Sri Lanka
Luxembourg
Latvia
Mexico
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
MY
NL
NO
NZ
PL
PT
RU
SE
SG
SI
SK
TH
TR
TW
UA
US
UY
UZ
WO
ZA
Malaysia
The Netherlands
Norway
New Zealand
Poland
Portugal
Russian Federation
Sweden
Singapore
Slovenia
Slovakia
Thailand
Turkey
Taiwan
Ukraine
United States of America
Uruguay
Uzbekistan
World Intellectual Property Organization (W.I.P.O.)
South Africa
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
428
‫מדגמים‬
DESIGNS
‫מדגמים שנרשמו‬
DESIGNS REGISTERED
40405
8(06)
7. 3.2005
Class
‫סוג‬
‫פאב ייצור ויבוא ציוד תעשייתי‬
‫בע"מ‬
FAB MANUFACTURING &
IMPORT OF INDUSTRIAL
EQUIPMENT LTD.
‫ידית‬
Handle
40467
13(03)
17. 3.2005
Class
‫סוג‬
‫עמוס רשף ומשה גלון‬
AMOS RESHEF AND MOSHE
GALON
‫מתאם חשמלי‬
Electrical adapter
Class
41430
11(01)
29. 9.2005
‫סוג‬
DAVID W. SO
Precious stone
Convention date (U.S.A.)
Class
27.8.2003
41559
11(01)
2. 11.2005
‫אבן יקרה‬
)‫הברית‬
)‫ארה"ב‬
‫(ארצות‬
( ‫האמנה‬
‫תאריךאמנה‬
‫תאריך‬
‫סוג‬
JACQUES-PASCAL SALEMBIER
Medallion
Convention date (OHIM)
Class
ASFIR LTD.
Car skid plate
429
12.7.2005
41872
12(16)
19. 1.2006
‫תליון‬
)‫הברית‬
)‫אוהיים‬
‫(ארצות‬
( ‫האמנה‬
‫תאריך אמנה‬
‫סוג‬
‫אספיר בע"מ‬
‫מיגון גחון לרכב‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
42126
25(01)
9. 3.2006
Class
‫סוג‬
‫קליל תעשיות בע"מ‬
KLIL INDUSTRIES LTD.
‫פרופיל‬
Profile
42270
7(01)
4. 4.2006
Class
‫סוג‬
‫עלית ממתקים בע"מ‬
ELITE CONFECTIONERY LTD.
‫מערכת כלי שולחן‬
Tableware set
42528
19(07)
25. 5.2006
Class
‫סוג‬
‫אייל ג'מילי ואורון ג'מילי‬
EYAL GAMILI AND ORON
GAMILI
‫מבנה כיפתי‬
Dome structure
42615
2(04)
15. 6.2006
Class
‫סוג‬
CROCS, INC.
Footwear
Convention date (U.S.A.)
Class
20.3.2006
42837
7(06)
2. 8.2006
‫פריט הנעלה‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫תאריך‬
‫סוג‬
UNISTRAW PATENT HOLDINGS LTD.
Drinking straw with soluble pellets
Convention date (Australia)
Class
KOL CHEN LTD. AND HAIM
AZOULAY
Profile
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
6.2.2006
42997
25(01)
4. 9.2006
‫קש שתייה עם כדורים מסיסים‬
)‫הברית‬
)‫טרליה‬
‫(ארצות‬
‫האמנה (אוס‬
‫תאריך אמנה‬
‫סוג‬
‫כל חן בע"מ וחיים אזולאי‬
‫פרופיל‬
430
Class
43153
8(03)
3. 10.2006
‫סוג‬
ANNA STOCKER
‫כלי חיתוך‬
Cutting tool
Class
43188
28(03)
15. 10.2006
‫סוג‬
UNILEVER PLC
‫מיכל עם מכסה‬
)‫הברית‬
)‫ארצותהברית‬
‫(ארצות‬
( ‫האמנה‬
‫תאריך אמנה‬
Container with lid
Convention date (U.S.A.)
25.4.2006
Class
43193, 43194, 43195
2(04)
15. 10.2006
‫סוג‬
‫פאפאיה אופנה בע"מ‬
PAPAYA FASHION LTD.
‫סוליה‬
Sole
Class
43203, 45130, 45131,
45134, 45135
23(02)
15. 10.2006
‫סוג‬
VIEGA GMBH & CO.KG
Wall-mounted panel for toilet flushing system
‫פנל קיר למערכת שטיפה סניטרית‬
10.4.2006
Convention date (OHIM)
)‫הברית‬
)‫אוהיים‬
‫(ארצות‬
( ‫האמנה‬
‫תאריך אמנה‬
Class
43346
11(01)
21. 11.2006
‫סוג‬
‫יעקב צרור‬
JACKOB TSROR
‫יהלום‬
Diamond
Class
43408, 43409
28(03)
29. 11.2006
‫סוג‬
KONINKLIJKE PHILIPS ELECTRONICS N.V.
Shaver
Convention date (OHIM)
431
9.6.2006
‫מכונת גילוח‬
)‫הברית‬
)‫אוהיים‬
‫(ארצות‬
( ‫האמנה‬
‫תאריך אמנה‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
Class
43418
24(04)
30. 11.2006
‫סוג‬
CIPLA LIMITED
‫משאף‬
)‫(ארצות הברית‬
)‫האמנה (הודו‬
‫תאריך אמנה‬
Inhaler
1.6.2006
Convention date (India)
Class
43916
9(07)
6. 3.2007
‫סוג‬
UNILEVER PLC
‫מכסה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Lid
Convention date (OHIM)
Class
6.9.2006
43952
25(01)
20. 3.2007
‫סוג‬
‫יגאל בלכר‬
IGAL BLECHER
‫פרופיל‬
Profile
Class
43989
9(01)
26. 3.2007
A.G.S. GREEN COMMERCE AND
SERVICES LTD.
‫סוג‬
‫ ירוק מסחר ושירותים‬.‫ס‬.‫ג‬.‫א‬
‫בע"מ‬
‫צנצנת‬
Jar
Class
43993, 43994, 43995,
43996, 43997
25(01)
27. 3.2007
‫סוג‬
‫יגאל בלכר‬
IGAL BLECHER
‫פרופיל‬
Profile
Class
MENASHE ROGOTNER
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
44054
9(03)
15. 4.2007
‫סוג‬
‫מנשה רוגוטנר‬
432
‫מגש‬
Tray
Class
44058
25(01)
17. 4.2007
‫סוג‬
‫יגאל בלכר‬
IGAL BLECHER
‫פרופיל‬
Profile
Class
44105
25(01)
2. 5.2007
‫סוג‬
‫יגאל בלכר‬
IGAL BLECHER
‫פרופיל‬
Profile
Class
44193
14(03)
15. 5.2007
‫סוג‬
‫ישי קוקבקה ורוני עטיה‬
ISHAY KOKAVKA AND RONI
ATIYA
‫כיסוי סיליקון לשלט‬
Silicone cover for remote control
Class
44204
11(01)
20. 5.2007
‫סוג‬
‫נטע וינרוט‬
NETTA WEINROTH
‫חרוז‬
Bead
Class
44214
6(01)
21. 5.2007
‫סוג‬
HAGAR BROTMAN
‫הגר ברוטמן‬
Sitting stool
‫שרפרף ישיבה‬
Class
44251
2(04)
29. 5.2007
BANANA SHOES INDUSTRY LTD.
Shoe
433
‫סוג‬
‫בננה תעשיות נעליים בע"מ‬
‫נעל‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
Class
44272, 44273
1(01)
4. 6.2007
‫סוג‬
‫הרצל יוגב‬
HERZL YOGEV
‫כעך‬
Pretzel
Class
44334
9(01)
11. 6.2007
‫סוג‬
CONCORDIA DEVELOPMENT S.R.L.
Preform bottle
29.12.2006
Convention date (Italy)
Class
44397, 44398, 44399,
44400
11(02)
21. 6.2007
‫קדם הכנה לבקבוק‬
)‫הברית‬
)‫(איטליה‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫הדר קפלן‬
HADAR KAPLAN
‫צמח סרוג‬
Knitted plant
Class
44463
13(02)
5. 7.2007
‫סוג‬
‫לול עיצוב תעשייתי בע"מ‬
LOOL INDUSTRIAL DESIGN LTD.
‫סוללה סולרית‬
Solar battery
Class
CORRECT IMPORT AND
MARKETING GIFTS LTD.
44487
19(04)
11. 7.2007
‫סוג‬
‫קורקט יבוא ושיווק מתנות בע"מ‬
‫תיק מסמכים‬
Bag for documents
Class
44506
8(08)
16. 7.2007
‫סוג‬
PALMAT RELIANCE LTD.
‫פלמט רילאיינס בע"מ‬
Aluminum profile joint
‫מחבר לפרופילי אלומיניום‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
434
44596
7(05)
1. 8.2007
Class
‫סוג‬
ANGEL SALES INC.
‫התקן לכביסה של בגדים עדינים‬
Washing device for delicate garments
44597
14(03)
2. 8.2007
Class
‫סוג‬
HUNTER DOUGLAS INC.
Remote control
Convention date (U.S.A.)
(U.S.A)
‫שלט רחוק‬
)‫הברית‬
)‫(ארצותהברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
)‫(ארצות הברית‬
22.5.2007
5.2.2007
44598
6(03)
2. 8.2007
Class
‫סוג‬
‫דוד‬-‫מישל מיכאל בן‬
MICHEL MICHAEL BEN-DAVID
‫שולחן מתקפל‬
Foldable table
44613
9(01)
8. 8.2007
Class
TNUVA CENTRAL COOPERATIVE
FOR THE MARKETING OF
AGRICULTURAL PRODUCE IN
ISRAEL LTD.
‫סוג‬
‫תנובה מרכז שתופי לשווק‬
‫תוצרת חקלאית בישראל בע"מ‬
‫בקבוק‬
Bottle
44623
8(07)
12. 8.2007
Class
‫סוג‬
‫פלמט רילאיינס בע"מ‬
PALMAT RELIANCE LTD.
‫מנעול דו כנפי‬
Two winged lock
Class
44625, 44626, 44628,
44629, 44630
11(01)
14 8.2007
AMARO JEWELLERY LTD.
Bracelet
435
‫סוג‬
‫אמארו תכשיטים בע"מ‬
‫צמיד‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
)‫צות הברית‬
44627, 44631
11(01)
14. 8.2007
Class
‫סוג‬
‫אמארו תכשיטים בע"מ‬
AMARO JEWELLERY LTD.
‫שרשרת‬
Necklace
Class
44633, 44634, 44635,
44636
25(01)
14. 8.2007
‫סוג‬
‫אל דלתות מקבוצת דלויה‬-‫דור‬
‫בע"מ‬
DOORAL & DELOUYA LTD.
‫פרופיל‬
Profile
Class
44639, 44640
8(09)
15. 8.2007
‫סוג‬
‫מרדכי קבסו‬
MORDEHAY CABASSO
‫מנוף לתריס‬
Lever for shutter
Class
44650, 44651, 44652,
44653, 44654, 44655
25(01)
16. 8.2007
‫סוג‬
‫פרופקט בע"מ‬
PROFECT LTD.
‫יחידת בניה‬
Building unit
Class
44669
12(12)
20. 8.2007
‫סוג‬
JANE, S.A.
Baby walker
Convention date (OHIM)
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
12.3.2007
‫הליכון לתינוק‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
436
Class
44671, 44672
6(01)
20. 8.2007
‫סוג‬
JANE, S.A.
‫מושב לתינוק‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
Infant seat
12.3.2007
Convention date (OHIM)
Class
44688, 44689, 44690,
44691,44692, 44694,
44696, 44697, 44698
2 (04)
28. 8.2007
BANANA SHOES INDUSTRY LTD.
‫סוג‬
‫בננה תעשיות נעליים בע"מ‬
‫נעל‬
Shoe
Class
44726
2 (04)
2. 9.2007
ANTELOPE SHIVUK (1994) LTD.
‫סוג‬
‫) בע"מ‬1994( ‫אנטילופ שיווק‬
‫סוליה‬
Sole
Class
44743
15(07)
13. 3.2007
‫סוג‬
SOCIETE DES PRODUITS NESTLE S.A.
Freezer
9.10.2006
Convention date (Switzerland)
Class
44759
9 (01)
4. 9.2007
NEVIOT-NATURE OF GALILEE
LTD.
‫מקפיא‬
)‫(שוויץ)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
‫טבע הגליל בע"מ‬-‫נביעות‬
‫בקבוק‬
Bottle
Class
YITZHAK SHABTAY
437
44781
7 (05)
11. 9.2007
‫סוג‬
‫יצחק שבתאי‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫אטב‬
Pin
44782
20 (03)
18. 6.2007
Class
‫סוג‬
‫ערן אסיס‬
ERAN ASISS
‫פאנל פרסומי למתקני מים‬
Advertisement panel for water dispensers
44787
9 (03)
16. 9.2007
Class
CAESAREA LANDSCAPE DESIGN
LTD.
‫סוג‬
‫קיסריה עיצוב בנוף בע"מ‬
‫אשפתון‬
Litter box
44814
26(03)
19. 9.2007
Class
‫סוג‬
SCHREDER
Lighting apparatus
20.3.2007
Convention date (OHIM)
44842
3(01)
7. 10.2007
Class
‫התקן תאורה‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
KETER PLASTIC LTD.
Tool box
Convention date (OHIM)
Class
23.7.2007
44845
15(07)
7. 10.2007
‫ארגז כלים‬
)‫הברית‬
)‫(אוהיים‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
‫סוג‬
SOCIETE DES PRODUITS NESTLE S.A.
Freezer
Convention date (Switzerland)
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
13.4.2007
‫מקפיא‬
)‫(שוויץ)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
438
Class
44854
8 (01)
8. 10.2007
ROSENFELD PROMOTION LTD.
‫סוג‬
‫רוזנפלד פרומושיין בע"מ‬
‫מקדחה‬
Drill
Class
44855
8 (02)
8. 10.2007
ROSENFELD PROMOTION LTD.
‫סוג‬
‫רוזנפלד פרומושיין בע"מ‬
‫פטיש‬
Hammer
Class
44869
7(02)
9. 10.2007
‫סוג‬
GUNEY ITHALAT VE PAZARLAMA ANONIM SIRKETI
‫מצנם‬
Toaster
Class
44878
15(07)
11. 10.2007
‫סוג‬
SOCIETE DES PRODUITS NESTLE S.A.
Freezer
Convention date (Switzerland)
439
20.4.2007
‫מקפיא‬
)‫(שוויץ)הברית‬
‫האמנה(ארצות‬
‫תאריך אמנה‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫מדגמים שחודשו‬
‫‪DESIGNS RENEWED‬‬
‫‪30882‬‬
‫‪37440‬‬
‫‪37497‬‬
‫‪37674‬‬
‫‪37769‬‬
‫‪38152‬‬
‫‪440‬‬
‫‪30878‬‬
‫‪37439‬‬
‫‪37491‬‬
‫‪37673‬‬
‫‪37768‬‬
‫‪38151‬‬
‫‪29771‬‬
‫‪37438‬‬
‫‪37477‬‬
‫‪37658‬‬
‫‪37767‬‬
‫‪37778‬‬
‫‪29594‬‬
‫‪37437‬‬
‫‪37476‬‬
‫‪37641‬‬
‫‪37765‬‬
‫‪37777‬‬
‫‪29593‬‬
‫‪37416‬‬
‫‪37445‬‬
‫‪37603‬‬
‫‪37764‬‬
‫‪37773‬‬
‫‪29412‬‬
‫‪37405‬‬
‫‪37443‬‬
‫‪37601‬‬
‫‪37763‬‬
‫‪37772‬‬
‫‪29200‬‬
‫‪37399‬‬
‫‪37442‬‬
‫‪37600‬‬
‫‪37762‬‬
‫‪37771‬‬
‫‪27683‬‬
‫‪30885‬‬
‫‪37441‬‬
‫‪37595‬‬
‫‪37737‬‬
‫‪37770‬‬
‫‪38153‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫מדגמים שבוטלו‬
DESIGNS VOID
20321
20372
28159
36690
36701
36758
20327
20373
28162
36692
36702
36759
20330
20379
28164
36694
36703
36769
Dr. Meir Noam
Commissioner of Patents,
Designs and Trade Marks
441
20358
20380
28166
36695
36709
36779
20360
20381
28186
36696
36710
38216
20361
20383
28225
36697
36721
38217
20362
28136
28256
36698
36732
38218
20366
28146
36687
36699
36757
‫ד"ר מאיר נועם‬
‫ המדגמים‬,‫רשם הפטנטים‬
‫וסימני מסחר‬
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫‪442‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫מפתחות לבקשות שקובלו‬
‫‪INDICES OF APPLICATIONS ACCEPTED‬‬
‫מפתח שמי‬
‫אי‪ .‬טי‪ .‬אם‪ .‬ייצור כלים מדוייקים בע"מ‬
‫‪159027‬‬
‫אי‪.‬סי‪.‬איי‪ .‬טלקום בע"מ ‪152193‬‬
‫אייל אליאב ‪159990‬‬
‫אלעד יום‪-‬טוב ‪143420‬‬
‫אס‪.‬די‪.‬אס‪.‬איי‪ .‬טכנולוגיות בע"מ ‪162217‬‬
‫בקלייף בע"מ ‪150593‬‬
‫ברוך סגל ‪161552‬‬
‫‪NAME INDEX‬‬
‫מדינול בע"מ ‪141860‬‬
‫מדינת ישראל ‪ -‬משרד החקלאות ופיתוח‬
‫הכפר‪ ,‬מינהל המחקר החקלאי‪ ,‬מרכז‬
‫וולקני ‪128193‬‬
‫מוסד הטכניון למחקר ופיתוח בע"מ‬
‫‪131591‬‬
‫מיכאל להיאני ‪156785‬‬
‫סאיטקס ויז'ן בע"מ ‪155512‬‬
‫סטפאק ל‪.‬א‪ .‬בע"מ ‪156996‬‬
‫גיל טבע ‪166209‬‬
‫עודד נחליאלי ‪148616‬‬
‫דני לביא ‪159990‬‬
‫פרוקוגניה (ישראל) בע"מ ‪152639‬‬
‫הלת'קייר טכנולוג'ים בע"מ ‪129835‬‬
‫התעשייה הצבאית לישראל בע"מ ‪143620‬‬
‫ידע חברה למחקר ופיתוח בע"מ ‪,106271‬‬
‫‪131929 ,130960 ,128193 ,108584 ,106591‬‬
‫יישום חברה לפיתוח המחקר של‬
‫האוניברסיטה העברית בירושלים ‪,130162‬‬
‫‪149461‬‬
‫ישקר בע"מ ‪,158497 ,158098 ,152161‬‬
‫‪162147 ,159157 ,159027‬‬
‫ישקר בע"מ ‪,158497 ,158098 ,152161‬‬
‫‪162147 ,159157‬‬
‫‪ALEJANDRO MONESTIER 160842‬‬
‫‪ALZA CORPORATION 143778‬‬
‫‪APPLIED RESEARCH SYSTEMS ARS‬‬
‫‪HOLDING N.V. 139575, 140778‬‬
‫‪ARM LIMITED 155407‬‬
‫‪ASTRAZENECA AB 151380, 151427,‬‬
‫‪153158‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫קורפלו בע"מ ‪131591‬‬
‫רונן רדומסקי ‪161552‬‬
‫ריט טכנולוגיות בע"מ ‪142157‬‬
‫שורש ערכות נוודים בע"מ ‪144802‬‬
‫שי עמישר ‪161552‬‬
‫‪ABBOTT LABORATORIES 152856‬‬
‫‪ACTELION PHARMACEUTICALS‬‬
‫‪LTD. 155806‬‬
‫‪ADVANSA BV, 147523‬‬
‫‪AIR PRODUCTS AND CHEMICALS,‬‬
‫‪INC. 159769‬‬
‫‪ALBERTO GIOVANNONE 152462‬‬
‫‪i‬‬
ASTRAZENECA AB 154803
AURORA NETWORKS, INC. 156396
LIMITED 142619, 157216
DANNY LAVIE 159990
AVAYA TECHNOLOGY CORP.
155354
AZIENDE CHIMICHE RIUNITE
ANGELINI FRANCESCO A.C.R.A.F.
S.p.A. 160046
DAVID GEORGES DE SOUZA 139465
DENTSU INC. 155749
DEUTSCHE GELATINE-FABRIKEN
STOESS AG 162868
DOM-SICHERHEITSTECHNIK GMBH
& CO. KG 150462
DREAMWELL LTD. 150596
DSM IP ASSETS B.V. 172893
BACKLIFE LTD. 150593
BARUCH SEGAL 161552
BASF AKTIENGESELLSCHAFT
142397
BASF AKTIENGESELLSCHAFT
158403
BAYER AKTIENGESELLSCHAFT
149554
BAYER CROPSCIENCE AG 151986
BAYER SCHERING PHARMA AG
156437, 162555
BELDEN WIRE AND CABLE
COMPANY 148239
BIOLIFE, L.L.C. 152453
BRADBURY R. FACE 159658
BRISTOL-MYERS SQUIBB
COMPANY 136901, 147939
BRISTOL-MYERS SQUIBB PHARMA
COMPANY 150449
BRITISH TELECOMMUNICATIONS
PUBLIC LIMITED COMPANY 156936
BROOKWOOD PHARMACEUTICALS,
INC. 148343
BROWN & WILLIAMSON TOBACCO
COMPANY 160150
CELLTRAN LIMITED 146933
CITRIX SYSTEMS, INC. 152797
CLARK DAVIS BOYD 159658
COAPT SYSTEMS, INC. 152817
COLEY PHARMACEUTICAL GMBH
139646
COLEY PHARMACEUTICAL GROUP
INC. 139646
COREFLOW LTD. 131591
CROSSJECT 147267
CRUCELL HOLLAND B.V. 160406
E. T. M. PRECISION TOOL
MANUFACTURING LTD. 159027
E.I. DU PONT DE NEMOURS AND
COMPANY 139466
E.I. DUPONT DE NEMOURS AND
COMPANY 147523
ECI TELECOM LTD. 152193
EISAI CO.,LTD. 153995
EISAI R&D MANAGEMENT CO., LTD.
153995
ELAD YOM-TOV 143420
ELAN PHARMACEUTICALS, INC.
143929
ELECTRONICS FOR IMAGING, INC.
153694
ENSIGN-BICKFORD AEROSPACE &
DEFENSE COMPANY 150652
EURO-CELTIQUE S.A. 151057
EYAL ELIAV 159990
F. HOFFMANN-LA ROCHE AG 153282
F. HOFFMANN-LA ROCHE AG 154079
FERRING BV 151588
FINISAR CORPORATION 157192
FLORIDA STATE UNIVERSITY
166175
FUJIKIN INCORPORATED 169383
GENENCOR INTERNATIONAL, INC.
139466
GENENTECH, INC. 142794
GENERAL ELECTRIC COMPANY
138566
GIL TEVA 166209
GUY CAMPET 139465
DAIICHI SANKYO COMPANY
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
ii
H. LUNDBECK A/S 143875
H.C. STARCK GMBH 154827
HANS OETIKER AG MASCHINENUND APPARATEFABRIK 157620
HEALTHCARE TECHNOLOGIES LTD.
129835
HEARTLINK LIMITED 132186
HEARTLINK WORLD PATENT
CORPORTION 132186
HER MAJESTY THE QUEEN IN
RIGHT OF CANADA A.R.B. THE
SOLICITOR GENERAL ACTING
THROUGH THE COMMISSIONER OF
THE RCMP 136683
HEWLETT PACKARD INDUSTRIAL
PRINTING LTD. 155512
HORMOS MEDICAL CORPORATION
153823
HUNTER-FLEMING LIMITED 153541
HYDROPAC/LAB PRODUCTS, INC.
161494
IBM CORPORATION 151740
IBM CORPORATION 157673
ID BIOMEDICAL CORPORATION
117483
IMMUNEX CORPORATION 122408
INGENEUS CORPORATION 150284
INGENEUS INC 150284
INTERDIGITAL TECHNOLOGY
CORPORATION 150991, 151895,
152099
INVERNESS MEDICAL LIMITED
155681
ISCAR LTD. 152161, 158098, 158497,
159027, 159157, 162147
ISCAR LTD. 152161, 158098, 158497,
159157, 162147
ISRAEL MILITARY INDUSTRIES
LTD. 143620
JACQUES BONNET 139465
JAN W. BEENKER 154779
JANSSEN PHARMACEUTICA N.V.
142444, 153559
JOSEPH PORTIER 139465
JUAN CARLOS MONESTIER 160842
iii
KABUSHIKI KAISHA WATANABE
SHOKO 156978
KAO CORPORATION 159318
KIMBERLY-CLARK WORLDWIDE,
INC 158755, 161451
KONINKLIJKE PHILIPS
ELECTRONICS N.V. 147610
KOSLOW TECHNOLOGIES
CORPORATION 163057, 163159
KOSLOW TECHNOLOGIES
CORPORATION 165739, 165740,
165741, 165742, 165743
KX INDUSTRIES, L.P. 163057, 163159,
163567, 165739, 165740, 165741,
165742, 165743
KX TECHNOLOGIES LLC 163057,
163159, 163567, 165739, 165740,
165741, 165742, 165743
LAB PRODUCTS, INC. 161494
LABORATOIRE DE
CONTACTOLOGIE APPLIQUEE-LCA
157928
LABORATOIRES SERONO SA 139575,
140778
L'AIR LIQUIDE SOCIETE ANONYME
A DIRECTOIRE ET CONSEIL DE
SURVEILLANCE POUR L'ETUDE ET
L'EXPLOITATIONDES PROCEDES
GEORGES CLAUDE 162299
LAM RESEARCH CORPORATION
159497, 161297
LFK-LENKFLUGKORPERSYSTEME
GMBH 159170
LG LIFE SCIENCES LTD. 152403
LIFESCAN, INC. 153582, 153584
LIFESCAN, INC. 158399
LITTON SYSTEMS, INC. 151085
LOCKHEED MARTIN CORPORATION
153274
LTS LOHMANN THERAPIESYSTEME GMBH 129649
LUIDIA, INC. 153694
MARINE DESALINATION SYSTEMS,
L.L.C. 164702
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
MEADWESTVACO PACKAGING
SYSTEMS, LLC 157682
HARVARD COLLEGE 128999
PROCOGNIA (ISRAEL) LTD. 152639
MEDICAL BIOSYSTEMS LTD. 145579
MEDINOL LTD. 141860
MERCK FROSST CANADA & CO.
153406
MERCK FROSST CANADA LTD
153406
MERCK PATENT GMBH 147494
MERCKLE GMBH 150752
MERZ PHARMA GMBH & CO. KGAA
149401
MESSIER-BUGATTI 165815
MICHAEL LAHYANI 156785
MICROSOFT CORPORATION 173679
MICROVISION, INC. 149092
MITSUBISHI PHARMA
CORPORATION 151533
MOUNT SINAI SCHOOL OF
MEDICINE OF NEW YORK
UNIVERSITY 140264
PROCOGNIA (ISRAEL) LTD. 129835
PROTEUS (S.A.) 141372
NATIONAL STARCH AND
CHEMICAL INVESTMENT HOLDING
CORPORATION 129649
NCUBE CORPORATION 148751
NEWSSTAND, INC. 152843
NICODEL, S.A. 156347
NICOX SA 151380, 151427
NOVARTIS AG 156819
NYCOMED GMBH 160271, 160272
ODED NAHLEILI 148616
OLE-BENDT RASMUSSEN 163469
ORDNANCE DEVELOPMENT AND
ENGINEERING COMPANY OF
SINGAPORE (1996) PTE LTD. 165655
ORIENT INSTRUMENT COMPUTER
CO., LTD. 154770
PFIZER INC. 143225
PFIZER ITALIA S.R.L. 147924
PFIZER PRODUCTS, INC. 145453
PHARMA MAR, S.A. 146434
POLYGANICS B.V. 140049
POTENCIA MEDICAL AG 147962
PRESIDENT AND FELLOWS OF
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
QINETIQ LIMITED 160130
QUALCOMM INCORPORATED
143648
QUALCOMM INCORPORATED
154899
QUARK PHARMACEUTICALS, INC.
145539
RAULAND-BORG CORPORATION
163327
RAYTHEON COMPANY 157859
RESEARCH DEVELOPMENT
FOUNDATION 134978
RICHARD L. PEDERSON 149720
RIJKSUNIVERSITEIT LEIDEN 160406
RIT TECHNOLOGIES LTD. 142157
ROBERT H. GRUBBS 149720
ROHM GMBH & CO. KG 151151
RONEN RADOMSKI 161552
ROUTESCIENCE TECHNOLOGIES,
INC. 155354
S.D.S.A. TECHNOLOGIES LTD.
162217
SAFE ZONE SYSTEMS, INC. 146734
SANOFI-AVENTIS DEUTSCHLAND
GMBH 150248
SANOFI-AVENTIS DEUTSCHLAND
GMBH 145646
SARGENT MANUFACTURING
COMPANY 168358
SCHERING CORPORATION 136290
SCIOS INC. 146309
SCITEX VISION LTD 155512
SEALY TECHNOLOGY LLC 153233
SHAI AMISAR 161552
SHEREE H. WEN 162958
SHERWOOD SERVICES AG 166653
SHIRE BIOCHEM INC. 117483
SILVERBROOK RESEARCH PTY.
LTD. 164693
iv
SMITHKLINE BEECHAM
BIOLOGICALS S.A. 147926
SOCIETE DES PRODUITS NESTLE
S.A. 152442, 153129, 157869
SOFT SHOE COMPANY, INC. 158980
SOLUTIA INC. 162701
SONY CORPORATION 140202
SOPHIE TUFFET 139465
SOURCE VAGABOND SYSTEMS
LTD. 144802
SOUTHERN RESEARCH INSTITUTE
148343
STANELCO RF TECHNOLOGIES
LIMITED 151645
STEPAC L.A. LTD. 156996
SUMITOMO CHEMICAL COMPANY,
LIMITED 153495
SUMITOMO CHEMICAL COMPANY,
LIMITED 153962
SWAGELOK COMPANY 157248
THE TORO COMPANY 163181
THIERRY NOEL 139465
TODA MASAYUKI 156978
TOTO LTD. 150889
TRANSWITCH CORPORATION
156183
TADAHIRO OHMI 169383
TECHNION RESEARCH AND
DEVELOPMENT FOUNDATION LTD.
131591
TEMPLE UNIVERSITY-OF THE
COMMONWEALTH SYSTEM OF
HIGHER EDUCATION 146851
THE CHILDREN'S MEDICAL CENTER
CORPORATION 124153
THE GILLETTE COMPANY 148537
THE REGENTS OF THE UNIVERSITY
OF MICHIGAN 146222
THE ROCKEFELLER UNIVERSITY
162093
THE SECRETARY OF STATE FOR
DEFENCE DSTL 156406
THE STATE OF ISRAEL- MINISTRY
OF AGRICULTURE & RURAL
DEVELOPMENT, AGRICULTURAL
RESEARCH ORGANIZATION
VOLCANI CENTER 128193
WARNER-LAMBERT COMPANY LLC
146969
WISCONSIN ALUMNI RESEARCH
FOUNDATION 152020
WYETH 143929
v
U.S. ARMY MEDICAL RESEARCH
AND MATERIAL COMMAND 146192
UNIVERSITE PIERRE ET MARIE
CURIE 158934
UNIVERSITY OF CALIFORNIA
130247
VACU VIN INNOVATIONS LTD.
155351
VALINGE ALUMINIUM AB 156528
VERISITY DESIGN, INC. 154481
VERTEX PHARMACEUTICALS
INCORPORATED 152393
YALE UNIVERSITY 150566
YEDA RESEARCH AND
DEVELOPMENT CO. LTD. 106271,
106591, 108584, 128193, 130960, 131929
YISSUM RESEARCH DEVELOPMENT
COMPANY OF THE HEBREW
UNIVERSITY OF JERUSALEM
130162, 149461
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫מפתח ענייני‬
SUBJECT MATTER INDEX
A01K – 161494
A01N – 143225, 152403, 160046
B01J – 163057, 163159
B05B – 163181
A24D – 160150
B23B– 158497, 162147
A43B – 158980
A45F – 144802
B23C – 152161, 158098, 159157
B25B – 159027
A47C – 150596, 153233, 160842
B25J – 131591
A47G – 159990
A47J – 152442, 153129, 156785,
157869
A47K – 161451
A61B – 132186, 138566, 143420,
152817, 155681
A61F – 141860, 147962, 148616,
157928, 165740
B26B – 148537
B29C – 163469
B32B – 154770, 165739, 165741,
165742, 165743
B41J – 155512
B65B – 155351
B65D– 147523, 157682, 158755
A61H– 150593
B81B – 164693
A61J– 151645
A61K – 130247, 134978, 136290,
136901, 139646, 143778,
143929, 145453, 146222,
146434, 147926, 148343,
151057, 151151, 151380,
151427, 152020, 152453,
153282, 155806, 156437,
160272, 162555, 162868
A61L– 152462
A61M – 147267, 156347, 161552,
166653
B01D – 162958
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
C03C –162701
C04B – 165815
C07C – 146969, 149720, 150449,
152856, 153495, 153823,
159318
C07D– 142444, 146309, 146851,
147494, 147924, 147939,
149401, 149554, 150752,
151533, 151588, 151986,
152393, 153158, 153406,
153559, 153962, 153995,
154079, 154803, 160271
vi
F42C – 143620
C07F– 159769, 166175
C07H – 157216
F42D – 136683
C07J –153541
G01N – 153582, 153584, 158399
C07K – 106271, 106591, 108584,
117483, 139575, 140778,
162093
G01S – 146734, 157859
C08G – 140049, 146192
G02B – 151085
C09J – 129649
G06F – 151740, 152843, 154481,
155407
C12N –122408, 124153, 128193,
128999, 130960, 131929,
139465, 140264, 141372,
142619, 142794, 146933,
150566, 160406
G01V – 149092
G06Q – 155749
G08B – 163327
G08C – 153694
C12P – 139466, 142397, 145646,
150248
C12Q – 129835, 130162, 145539,
145579, 150284, 152639
G11B – 140202, 147610
G11C – 160130
H01B – 148239
C22B – 154827
H01H – 159658
C23C – 158934
E04F – 156528
H01J – 161297, 166209
H01L – 149461, 156978, 159497
E05B – 168358
H01R – 142157
F04B – 154779
F16K – 169383
H03K – 154899
H03M – 143648
F16L –157248, 157620
H04B – 150991, 152099, 157192
F24F – 163567
F24H – 162217
H04J – 148751, 151895, 152193,
156183
F25B – 162299
H04L – 152797, 155354, 156936
F41A – 165655
H04M – 157673
F42B – 150652, 156406
H04N – 159170, 173679
vii
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬
‫‪H05K – 153274, 156396‬‬
‫‪viii‬‬
‫י"ג באדר ב' התשס"ח –‪March 20, 2008‬‬
‫ ירושלים‬,‫ משרד המשפטים‬,‫נערך ע"י רשות הפטנטים‬
‫ ירושלים‬,‫הופק והודפס במדפיס הממשלתי‬
EDITED BY THE PATENT OFFICE, MINISTRY OF JUSTICE, JERUSALEM
PRINTED AND PUBLISHED BY THE GOVERNMENT PRINTER
9
March 20, 2008– ‫י"ג באדר ב' התשס"ח‬